DOI,Title,Authors,Abstract,Journal,Date
10.1016/j.cell.2025.08.038,multiscale proteomic modeling reveal protein network drive alzheimer 's,"Wang E, Yu K, Cao J, Wang M, Katsel P, Song WM, Wang Z, Li Y, Wang X, Wang Q, Xu P, Yu G, Zhu L, Geng J, Habibi P, Qian L, Tuck T, Li A, Tcw J, Roussos P, Brennand KJ, Haroutunian V, Johnson ECB, Seyfried NT, Levey AI, Bennett DA, Peng J, Cai D, Zhang B","molecular mechanism underlie pathogenesis alzheimer 's disease ( ad ) , most common form dementia , remain poorly understand . proteomic offer crucial approach elucidate ad pathogenesis , alteration protein expression be more directly link phenotypic outcome change genetic or transcriptomic level . study , develop multiscale proteomic network model ad integrate large-scale match proteomic and genetic datum brain region vulnerable disease . model reveal detailed protein interaction structure and identify putative key driver protein ( kdp ) involve ad progression . notably , network analysis uncover",Cell,25/09/2025
10.1016/j.phymed.2025.157280,glaucocalyxin a induce autophagy-mediated ferroptosis target prdx1 and,"Wang Y, Luo W, Shen S, Zhuang Y, Zhu Y, Liu Y, Zhang J, Meng Y, Pan L, Luo T, Xia F, Liu Y, Li S, Shen S, Liu Q, Wang J, Gu L","background : non-small cell lung cancer ( nsclc ) remain far most prevalent cancer worldwide . natural product be one important source development drug nsclc . weifuchun be traditional chinese medicine formula widely use chinese medicine hospital treatment gastric precancerous lesion . glaucocalyxin a ( gla ) be one particularly important active ingredient , have wide range pharmacological activity , include antitumor , antifibrotic , and osteoprotective effect . however , promising therapeutic potential , precise molecular mechanism underlie gla 's activity nsclc and cellular target remain poorly characterize . purpose : objective study be to assess role gla anti-nsclc and to far investigate pharmacological effect . method : systematic evaluation anti-nsclc effect gla be conduct vitro and vivo experiment . use activity-based protein profiling ( abpp ) technology , identify molecular target and elucidate underlying mechanism . result : study confirm significant inhibitory activity gla nsclc both vitro and vivo . more importantly , gla selectively form covalent bond cys(173 ) peroxiredoxin 1 ( prdx1 ) and cys(59 ) , cys(64 ) , cys(497 ) and sec(498 ) thioredoxin reductase 1 ( txnrd1 ) , and base computational chemistry to derive covalent bind reactivity order ( sec(498 ) > cys(59 ) > cys(497 ) > cys(64 ) ) . dual-target inhibition significantly disrupt cellular redox homeostasis , lead significant accumulation intracellular reactive oxygen specie ( ros ) . result oxidative stress trigger activation autophagy pathway and ultimately induce ferroptosis nsclc cell . conclusion : present study demonstrate gla may target prdx1 and txnrd1 protein , inhibit enzymatic activity . action lead excessive accumulation intracellular ros and ultimately induce autophagy-mediated ferroptosis . work not only delineate novel molecular mechanism gla 's anti-nsclc effect , but also provide critical insight development covalent inhibitor target redox-regulating protein cancer therapeutic .",Phytomedicine : international journal of phytotherapy and phytopharmacology,20/09/2025
10.1016/j.ccell.2025.09.003,sensory neuron drive pancreatic cancer progression glutamatergic,"Ren L, Liu C, Çifcibaşı K, Ballmann M, Rammes G, Mota Reyes C, Tokalov S, Klingl A, Grünert J, Goyal K, Neckel PH, Mattheus U, Schoeps B, Yıldızhan SE, Sezerman OU, Cevik NC, Sever EA, Karakas D, Safak O, Steiger K, Muckenhuber A, Görgülü K, Chen Z, Zhang J, Ye L, Maula Ali MI, Tiwari VK, Romanyuk N, Giesert F, Saur D, Rad R, Schmid RM, Algül H, Krüger A, Friess H, Ceyhan GO, Istvanffy R, Demir IE","cancer thrive neuronal input . here , demonstrate presence pseudo-synaptic connection sensory nerve ending and cancer cell extracerebral cancer , i.e. , pancreatic ductal adenocarcinoma ( pdac ) . synaptic site exhibit selective enrichment glutamatergic n-methyl-d-aspartate receptor ( nmda ) receptor subunit nmdar2d ( grin2d ) cancer cell , turn pdac cell responsive neuron-derived glutamate and promote tumor growth and spread . intriguingly , neuron transform subset co-culture pdac cell calcium-responsive cell grin2d-type glutamate receptor neuron-cancer pseudo-synapse . find expression subunit be due increase glutamate availability provide sensory innervation neurotrophic feedforward loop . moreover , interference glutamate-grin2d signal neuron-cancer pseudo-synapse markedly improve survival vivo . discovery peripheral cancer-neuron pseudo-synapse may provide opportunity cancer-neuroscience-instructed oncological therapy .",Cancer cell,25/09/2025
10.1007/s12672-025-03347-9,dnmt3a-r882 mutation promote acute myeloid leukemia progression recruit,"Chen Y, Zhu X, Lin C, Xu R, Xu P, Xin L, Li L, Zhang L","background : patient acute myeloid leukemia ( aml ) harbor dnmt3a-r882 mutation ( dr882mut ) be often more difficult to treat and more likely to relapse . however , dr882mut modulate aml progression circrnas remain unknown . methods : bioinformatics be use to assess aberrant expression circrnas associate aml . dr882mut cell line model be establish . circrna expression aml cell treat dr882mut be analyze use rt-qpcr .",Discover oncology,29/09/2025
10.1016/j.ccell.2025.09.002,ketogenic diet inhibit glioma progression promote gut microbiota-derived,"Chen ML, He Y, Dong XH, Liu HF, Yan ZX, Lu XL, Miao QQ, Zhao QN, Zhang H, Luo L, Wang S, Li JY, Xiang DF, Lin Y, Li TR, Zhou XY, Zhou YY, Mao M, Zhang X, Wei H, Shi Y, Liu XD, Ping YF, Bian XW","ketogenic diet ( kd ) be potential therapeutic strategy glioma ; however , underlie mechanism remain unclear . herein , first identify glioma patient exhibit distinct gut microbial profile characterize reduce butyrate-producing bacteria abundance , particularly r . faecis , decrease butyrate level . notably , kd reshape gut microbiota especially enrich a . muciniphila mucin-2-dependent manner , elevate butyrate production , and activate caspase-3 microglia . change promote anti-tumor microglial phenotype , ultimately suppress glioma progression mouse . crucially , kd 's anti-glioma effect be notably abolish antibiotic treatment ; germ-free condition ; or specific depletion mucin-2 , microglia , or microglial caspase-3 . furthermore , butyrate , a . muciniphila , r . faecis , or a . muciniphila plus r . faecis restore kd-induce microglial caspase-3 activation and anti-tumor phenotype microglia antibiotics-treated or germ-free mouse . finding highlight target gut microbiota kd or supplement butyrate could be effective strategy glioma therapy .",Cancer cell,25/09/2025
10.1016/j.ceb.2025.102583,dynamic regulation cell death signal .,"Majoul A, Garcia-Saez AJ","be many way cell to die , but cell only die once , cause inherent variability result common trigger activate interconnected signal network diverge key decision point cell death initiation , progression , and execution . death cell be unique biomolecular event , share feature allow to categorize process depend pathway activate and outcome . here outline core concept dynamic interplay cell death pathway , focus apoptosis , necroptosis , pyroptosis , and ferroptosis . highlight unresolved decision point , include dynamic pore formation and point return . also discuss conceptual commonality system and outline key recent development refine understanding dynamic regulation cell death .",Current opinion in cell biology,26/09/2025
10.1016/S0140-6736(25)01148-1,"oral iptacopan therapy patient c3 glomerulopathy : randomised ,","Kavanagh D, Bomback AS, Vivarelli M, Nester CM, Remuzzi G, Zhao MH, Wong EKS, Wang Y, Krishnan I, Schuhmann I, Trapani AJ, Webb NJA, Meier M, Israni RK, Smith RJH","background : c3 glomerulopathy be ultra-rare , severe form glomerulonephritis cause overactivation alternative complement pathway . aim to assess efficacy and safety iptacopan ( lnp023 ) , oral , proximal complement inhibitor target factor b to selectively inhibit alternative pathway complement cascade . methods : appear-c3 g be multicentre , randomise , double-blind , placebo-controlle , phase 3 study iptacopan placebo ( addition supportive care [ renin-angiotensin-aldosterone system ( raas ) inhibitor ] and immunosuppression ) . adult participant ( aged 18-60 year ) biopsy-confirmed c3 glomerulopathy be enrol 35 hospital or medical centre 18 country . inclusion criterion include reduce serum c3 concentration ( ie , < 77 mg/dl [ define < 0·85 × low limit central laboratory normal range ] ) screening , urine protein-creatinine ratio ( upcr ) 1·0 g/g or high day -75 and day -15 randomisation , estimate glomerular filtration rate ( egfr ) 30 ml/min 1·73 m(2 ) or high screening and day -15 , and vaccination neisseria meningitidi and streptococcus pneumoniae . eligible participant be randomise 1 :1 interactive response technology either iptacopan or placebo group , stratify treatment corticosteroid , mycophenolic acid , or ( yes or no ) . 6-month double-blind period , participant orally receive either iptacopan 200 mg twice daily or placebo ; be follow 6-month open-label period participant receive iptacopan 200 mg twice daily . primary endpoint be relative reduction proteinuria ( measure log-transformed ratio baseline upcr sample 24-h urine collection ) 6 month . primary analysis be do full analysis set ( ie , participant to study treatment be assign randomisation ) ; participant receive at least one dose study treatment be include safety analysis . trial be register ( nct04817618 ) and adult cohort have be complete . finding : july 28 , 2021 , and feb 15 , 2023 , 132 participant be screen , 58 do not complete screening period and 74 ( 64 % male ; 69 % white ) be randomise 1 :1 to receive either iptacopan ( n=38 ) or placebo ( n=36 ) . one participant placebo group discontinue treatment open-label period . 24-h upcr percentage change relative baseline 6 month be -30·2 % ( 95 % ci -42·8 -14·8 ) iptacopan group and 7·6 % ( -11·9 31·3 ) placebo group . iptacopan group , geometric mean 24-h upcr be 3·33 g/g ( 95 % ci 2·79 3·97 ) baseline and 2·17 g/g ( 1·62 2·91 ) 6 month ; placebo group , be 2·58 g/g ( 2·18 3·05 ) baseline and 2·80 g/g ( 2·37 3·30 ) 6 month . primary endpoint be meet relative reduction 24-h upcr 6 month iptacopan placebo 35·1 % ( 13·8 51·1 ; p=0·0014 ) . 30 ( 79 % ) 38 participant iptacopan group have treatment-emergent adverse event , compare 24 ( 67 % ) 36 participant placebo group ; most be mild or moderate severity . be death , treatment discontinuation due treatment-emergent adverse event , and meningococcal infection . serious adverse event be report three ( 8 % ) participant iptacopan group and one ( 3 % ) participant placebo group . interpretation : iptacopan show statistically significant , clinically meaningful proteinuria reduction addition raas inhibitor and immunosuppression 6 month . iptacopan be well tolerate acceptable safety profile patient c3 glomerulopathy . funding : novartis pharma .","Lancet (London, England)",25/09/2025
10.1016/j.cmet.2025.09.001,catenibacteriummitsuokai promote hepatocellular carcinogenesis bind,"Zhang Y, Liu W, Wong CC, Song Q, Zhang X, Zhou Q, Ren X, Ren X, Xuan R, Zhao Y, Xu L, Li X, Xu L, Zhang X, Kuang M, Yu J","role gut microbe pathogenesis hepatocellular carcinoma ( hcc ) remain unclear . here , identify catenibacterium be enrich both fece and tumor patient hcc . c . mitsuokai accelerate hcc carcinogenesis conventional and germ-free mouse . furthermore , c . mitsuokai disrupt gut barrier and translocate liver live bacteria . critically , c . mitsuokai surface protein gtr1/raga interact γ-catenin receptor hcc cell , facilitate attachment and colonization mouse liver . far reveal pro-tumorigenic effect c . mitsuokai depend secrete metabolite , quinolinic acid . mechanistically , quinolinic acid bind and activate tyrosine kinase immunoglobulin and epidermal growth factor homology domain 2 ( tie2 ) hcc cell . phosphorylate tie2 subsequently activate downstream oncogenic phosphatidylinositol 3-kinase/protein kinase b ( pi3k/akt ) pathway , thereby promote hcc progression . summary , c . mitsuokai disrupt gut barrier , colonize hcc cell gtr1/raga-γ-catenin , and secrete quinolinic acid , bind tie2 and drive pi3k/akt pathway to promote hcc development .",Cell metabolism,25/09/2025
10.1111/ppe.12615,acetaminophen use pregnancy and risk attention deficit,"Masarwa R, Platt RW, Filion KB","background : association acetaminophen use pregnancy and development attention deficit hyperactivity disorder ( adhd ) offspring may be due to bias . objective : primary objective be to assess role potential unmeasured confound estimation association acetaminophen use pregnancy and risk adhd , bias analysis . secondary objective be to assess role selection bias and exposure misclassification . data source : search medline , embase , scopus , and cochrane library december 2018 . study selection and data extraction : include observational study examine association acetaminophen use pregnancy and risk adhd . synthesis : meta-analyse datum study , use random-effect model . conduct bias analysis study do not adjust important confounder , to explore systematic error relate unmeasured confounding , selection bias , and exposure misclassification . result : search result seven study include meta-analysis . adjusted estimate be pool study , risk ratio ( rr ) adhd be 1 . 35 ( 95 % confidence interval [ ci ] 1 . 25 , 1 . 46 ; i(2 ) = 48 % ) . sensitivity analysis unmeasured confound meta-analysis show confounder 1 . 69 rr scale would reduce 10 % proportion study true effect size rr > 1 . 10 . unmeasured confound bias analysis decrease point estimate five seven study and increase two study , suggest observed association could be confound parental adhd . unadjusted and bias-corrected risk ratio ( bcrrs ) be : rr = 1 . 34 , bcrr = 1 . 13 ; rr = 1 . 51 , bcrr = 1 . 17 ; rr = 1 . 63 , bcrr = 1 . 38 ; rr = 1 . 44 , bcrr = 1 . 17 ; rr = 1 . 16 , bcrr = 1 . 18 ; rr = 1 . 25 , bcrr = 1 . 05 ; and rr = 0 . 99 , bcrr = 1 . 18 . conclusion : bias analysis suggest previously report association acetaminophen use pregnancy and increase risk adhd offspring may be due unmeasured confounding . ability to conclude causal association be limited .",Paediatric and perinatal epidemiology,01/05/2020
10.1183/13993003.01126-2025,european respiratory society clinical practice guideline management,"Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, Blasi F, Herrero-Cortina B, Dhar R, Chotirmall SH, Ringshausen FC, Altenburg J, Morgan L, Nigro M, Crichton ML, Van Meel C, Sibila O, Timothy A, Kompatsiari E, Hedberg T, Vandendriessche T, McShane PJ, Tonia T, Winthrop K, Loebinger MR, Lorent N, Goeminne P, Shteinberg M, Polverino E, Aliberti S","background : bronchiectasis be common lung condition associate wide range infectious , immunological , autoimmune , allergic and genetic condition . exacerbation and daily symptom have large impact patient and healthcare system , and be key focus treatment . current practice be heterogeneous globally , and bronchiectasis have historically be neglect disease . here , present evidence-based international guideline management adult bronchiectasis . method : european respiratory society ( ers ) task force , comprise global expert , methodologist , and patient representative , develop clinical practice guideline accordance ers methodology and grade ( grading recommendations , assessment , development and evaluations ) approach . systematic literature search , datum extraction , and meta-analysis be perform to generate evidence table , and recommendation be formulate use evidence-to-decision framework . total 8 pico ( patient , intervention , comparator , outcomes ) question and 3 narrative question be develop . recommendation : task force recommendation include strong recommendation favour airway clearance technique most patient bronchiectasis and pulmonary rehabilitation impaired exercise capacity . issue strong recommendation use long-term macrolide treatment patient high risk exacerbation and strong recommendation favour long-term inhaled antibiotic patient chronic pseudomonas aeruginosa infection high risk exacerbation . conditional recommendation support use eradication treatment or mucoactive drug specific circumstance . suggest not to routinely use long term oral , non-macrolide antibiotic treatment or inhaled corticosteroid . additional guidance be also provide testing underlying cause , manage exacerbation , and manage deteriorate patient . conclusion : ers bronchiectasis guideline provide evidence-based framework optimal management adult bronchiectasis and serve benchmark evaluate quality care . scope and objective : european respiratory society ( ers ) guideline management bronchiectasis adult provide evidence-based recommendation care people clinically significant bronchiectasis , define presence permanent dilatation bronchi evident chest ct scan , characteristic clinical symptom . [ 1 ] guideline be intend healthcare professional involve care adult bronchiectasis , as well policymaker , regulatory authority , and pharmaceutical company . bronchiectasis be complex and heterogeneous disease ; therefore , guideline can be entirely comprehensive or replace clinical judgement . guideline recommendation must be interpret specific clinical context be apply . separate ers guideline management bronchiectasis child exist [ 2 ] . bronchiectasis cystic fibrosis ( cf ) have distinct evidence base ; therefore , guidance management cf be provide elsewhere . [ 3 ] bronchiectasis-associated condition also have distinct guideline investigation and management , such primary ciliary dyskinesia ( pcd ) [ 4 ] , allergic bronchopulmonary aspergillosis ( abpa ) [ 5 ] and non-tuberculous mycobacterial ( ntm ) pulmonary disease [ 6 ] . present guideline apply condition , should be interpret conjunction relevant syndrome-specific recommendation .",The European respiratory journal,28/09/2025
10.1016/j.chroma.2018.01.015,profiling polyunsaturated fatty acid human serum use off-line and,"Gu WY, Liu MX, Sun BQ, Guo MQ, Wu JL, Li N","polyunsaturated fatty acid ( pufa ) play pivotal role biological effect , and be potential biomarker disease . however , structural diversity and similarity , low concentration , and interference high abundant endogenous component challenge pufas profiling . herein , novel analytical approach , off-line and on-line solid phase extraction-nano-liquid chromatography-quadrupole-time-of-flight mass spectrometry ( off-line and on-line spe-nano-lc-q-tof-ms ) , be establish to monitor pufa . combination off-line and on-line spe remove most impurity , and recovery range 80 . 1 % 93 . 0 % and matrix effect be 85 . 1 % 92 . 8 % . use method , 51 pufa could be separate well and quantify limit quantification 0 . 006 and 2 . 2 pg . finally , develop method be apply successfully to simultaneously qualify and quantify potential biomarker allergic patient . 21 pufa include ltb(4 , ) 5s- , 11s- , 15s-hete and 15s-hepe show significant difference . study indicate establish method have potential to sensitively and accurately determine pufa biological sample .",Journal of chromatography. A,16/02/2018
10.1016/j.cell.2018.05.051,common disease be more complex imply core gene omnigenic model .,"Wray NR, Wijmenga C, Sullivan PF, Yang J, Visscher PM","evidence most adult-onset common disease have polygenic genetic architecture fully consistent robust biological system support multiple back-up mechanism be now overwhelming . context , consider recent "" omnigenic "" or "" core gene "" model . key assumption model be be relatively small number core gene relevant disease . intuitively appealing , model may underestimate biological complexity common disease , and therefore , goal to discover core gene should not guide experimental design . consider other implication polygenicity , conclude focus patient stratification be need to achieve goal precision medicine .",Cell,14/06/2018
10.1186/s13058-025-02123-5,hsa-mir-155-5p expression primary breast tissue may have potential,"Koyama Y, Muguruma M, Horimoto Y, Narui K, Yamada A, Yamada K, Yamamoto S, Orihara S, Kaise H, Kogure A, Yoshioka Y, Ochiya T, Ishikawa T","background : know incidence brain metastasis breast cancer , useful biomarker have be clinically establish breast cancer brain metastasis ( bcbm ) . present study , aim to examine expression micrornas ( mirnas ) relate bcbm formalin-fixed paraffin-embedded ( ffpe ) tissue to identify usefulness predictive biomarker breast cancer brain recurrence ( bcbr ) . methods : pair primary breast and metastatic site tissue sample be collect 38 patient experience first recurrence metastasis single distant organ ( brain/lungs/liver/bone = 11/12/9/6 patient ) january 2007 and december 2021 five institution japan . evaluate expression 15 mirnas ffpe specimen untreated breast and metastatic site same patient use quantitative polymerase chain reaction . result : analysis select 15 mirnas reveal hsa-mir-155-5p exhibit significant bcbr-specific overexpression untreated primary breast tissue ( p < 0 . 001 ) . two other mirnas , hsa-mir-150-5p and hsa-mir-20b-5p , exhibit moderate ( ρ = 0 . 587 ) and weak ( ρ = 0 . 350 ) positive correlation hsa-mir-155-5p , respectively . bcbr prediction model demonstrate high discrimination ability hsa-mir-155-5p ( auc = 0 . 960 ) . localization hsa-mir-155-5p primary breast cancer tissue situ hybridization confirm hsa-mir-155-5p be uniformly stain breast cancer cell . conclusion : hsa-mir-155-5p expression untreated primary breast tissue may be valuable biomarker predict bcbr . personalized escalation strategy be expect to be helpful conquer brain metastasis .",Breast cancer research : BCR,29/09/2025
10.1111/sjop.12866,relation resilience and personality trait : role hopelessness and,"Nieto M, Visier ME, Silvestre IN, Navarro B, Serrano JP, Martínez-Vizcaíno V","resilience refer process individual use ability to cope challenge to successfully adapt adverse situation , incline future and hope . main aim study be to analyze relation resilience , personality trait , and hopelessness . furthermore , conduct comparison two age group : young and old adult . sample comprise 439 spanish participant ( 66 . 7 % woman ; m = 43 . 73 , sd = 26 . 41 ; age range = 18-98 year ) . connor-davidson resilience scale , neo-five factor inventory , and beck hopelessness scale be use to measure main study variable . result reveal negative relation resilience and neuroticism , and positive association other personality trait . additionally , level resilience be find to be negatively relate hopelessness . group old adult show significantly low resilience level young adult , age be not significant predictor resilience . neuroticism , extraversion , openness , and hopelessness be only predictor resilience current study . work contribute study resilience and related factor , attempt to understand role resilience and resistance risk and individual tackle challenge time , important implication mental health .",Scandinavian journal of psychology,01/02/2023
10.1186/s40364-025-00831-w,1-year risk cancer associate covid-19 vaccination : large,"Kim HJ, Kim MH, Choi MG, Chun EM","oncogenic potential sars-cov-2 have be hypothetically propose , but real-world datum covid-19 infection and vaccination be insufficient . therefore , large-scale population-based retrospective study seoul , south korea , aim to estimate cumulative incidence and subsequent risk overall cancer 1 year covid-19 vaccination . datum 8 , 407 , 849 individual 2021 and 2023 be obtain korean national health insurance database . participant be categorize two group base covid-19 vaccination status . risk overall cancer be assess use multivariable cox proportional hazard model , and datum be express hazard ratio ( hrs ) and 95 % confidence interval ( ci ) . hrs thyroid ( hr , 1 . 351 ; 95 % ci , 1 . 206-1 . 514 ) , gastric ( hr , 1 . 335 ; 95 % ci , 1 . 130-1 . 576 ) , colorectal ( hr , 1 . 283 ; 95 % ci , 1 . 122-1 . 468 ) , lung ( hr , 1 . 533 ; 95 % ci , 1 . 254-1 . 874 ) , breast ( hr , 1 . 197 ; 95 % ci , 1 . 069-1 . 340 ) , and prostate ( hr , 1 . 687 ; 95 % ci , 1 . 348-2 . 111 ) cancer significantly increase 1 year post-vaccination . term vaccine type , cdna vaccine be associate increase risk thyroid , gastric , colorectal , lung , and prostate cancer ; mrna vaccine be link increase risk thyroid , colorectal , lung , and breast cancer ; and heterologous vaccination be relate increase risk thyroid and breast cancer . give observed association covid-19 vaccination and cancer incidence age , sex , and vaccine type , further research be need to determine specific vaccination strategy may be optimal population need covid-19 vaccination .",Biomarker research,26/09/2025
10.1056/NEJMoa2508170,sotatercept pulmonary arterial hypertension first year,"McLaughlin VV, Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Kopeć G, Meyer G, Olsson KM, Fu W, Shi Y, Miller B, Kim SS, Mackenzie HS, Brambatti M, Patel MJ, Koglin J, Cornell AG, Humbert M","background : sotatercept , activin-signale inhibitor , reduce morbidity and mortality patient long-standing pulmonary arterial hypertension . effect patient pulmonary arterial hypertension first year diagnosis be unclear . method : phase 3 trial , enrol adult patient world health organization functional class ii or iii pulmonary arterial hypertension have receive diagnosis less 1 year early , have intermediate or high risk death , and be receive double or triple background therapy . patient be randomly assign to receive add-on therapy subcutaneous sotatercept ( start dose , 0 . 3 mg kilogram body weight ; escalate to target dose , 0 . 7 mg kilogram ) or placebo 21 day . primary end point be clinical worsening , composite death cause , unplanned hospitalization last least 24 hour worsen pulmonary arterial hypertension , atrial septostomy , lung transplantation , or deterioration performance exercise testing pulmonary arterial hypertension , assess time-to-first-event analysis . result : trial be stop early owe loss clinical equipoise reporting positive result previous sotatercept trial . total 320 patient be include ( 160 sotatercept and placebo group ) . median duration follow-up be 13 . 2 month . least one primary end-point event occur 17 patient ( 10 . 6 % ) sotatercept group and 59 patient ( 36 . 9 % ) placebo group ( hazard ratio , 0 . 24 ; 95 % confidence interval , 0 . 14 0 . 41 ; p<0 . 001 ) . deterioration performance exercise testing pulmonary arterial hypertension occur 8 patient ( 5 . 0 % ) sotatercept group and 46 patient ( 28 . 8 % ) placebo group ; unplanned hospitalization worsen pulmonary arterial hypertension occur 3 patient ( 1 . 9 % ) and 14 patient ( 8 . 8 % ) , respectively ; and death cause occur 7 patient ( 4 . 4 % ) and 6 patient ( 3 . 8 % ) . case atrial septostomy or lung transplantation occur . most common adverse event sotatercept be epistaxis ( 31 . 9 % ) and telangiectasia ( 26 . 2 % ) . conclusion : adult pulmonary arterial hypertension have receive diagnosis less 1 year early , addition sotatercept background therapy result low risk clinical worsening placebo . ( fund merck sharp and dohme , subsidiary merck [ rahway , nj ] ; hyperion clinicaltrials.gov number , nct04811092 . ) .",The New England journal of medicine,30/09/2025
10.1136/gutjnl-2025-336391,gut microbial modulation 3-hydroxyanthranilic acid and dopaminergic signalling,"Castells-Nobau A, Fumagalli A, Del Castillo-Izquierdo Á, Rosell-Díaz M, de la Vega-Correa L, Samulėnaitė S, Motger-Albertí A, Arnoriaga-Rodríguez M, Garre-Olmo J, Puig J, Ramos R, Burokas A, Coll C, Zapata-Tona C, Perez-Brocal V, Ramio L, Moya A, Swann J, Martín-García E, Maldonado R, Fernández-Real JM, Mayneris-Perxachs J","background : obesity-related alteration gut microbiota have be link cognitive decline , yet relationship attention remain poorly understand . objective : to evaluate possible relationship gut metagenomic , plasma metabolomic and attention . design : conduct faecal shotgun metagenomic and target plasma metabolomic three independent cohort ( n=156 , n=124 , n=804 ) functional validation preclinical model , include three faecal microbiota transplantation ( fmt ) experiment mouse and drosophila melanogaster . result : obesity be consistently associate reduced attention . metagenomic analysis identify proteobacteria specie and microbial function relate biosynthesis anthranilic acid ( aa ) negatively associate attention obesity . plasma metabolic profiling and machine learning reveal 3-hydroxyanthranilic acid ( 3-haa ) be positively associate attention , particularly obesity , aa show negative association . bariatric surgery improve attention and enrich microbial specie link attention . mouse , diet-induced obesity ( dio ) and microbiota depletion reduce 3-haa and 5-hydroxy-indole acetic acid ( 5-hiaa ) concentration prefrontal cortex ( pfc ) , be restore fmt . global metabolic profiling ( > 600 metabolite ) pfc fmt group identify 3-haa and tryptophan and tyrosine pathway most significant mouse receive microbiota high-attention donor . second fmt experiment also reveal consistent enrichment tryptophan and tyrosine metabolism transcriptional level pfc , haao ( 3-hydroxyantrhanilic acid dioxygenase ) and aox4 ( aldehyde oxidase 4 ) , key 3-haa and 5-hiaa degradation , significantly regulate gene . third fmt study , attentional trait be transmit human mouse modulation serotonergic and dopaminergic pathway . drosophila , mono-colonisation enterobacter cloacae and dio induce attention deficit-like behaviour , be mitigate 3-haa supplementation . conclusion : have identify microbiota and 3-haa potential therapeutic target to improve attention , especially obesity .",Gut,27/09/2025
10.1038/s41392-025-02409-2,tumor microenvironment delineate differential responder trastuzumab,"Pan H, Wang J, Sun Y, Li F, Sun C, Liu M, Xu H, Tao J, Mao X, Wang C, Wang S, Li W, Ding Q, Zhou W","trastuzumab emtansine ( t-dm1 ) have be approve treatment her2-positive breast cancer . however , efficacy t-dm1 patient failure pyrotinib and/or trastuzumab plus pertuzumab have not be clear . additionally , biomarker have be report to predict effect t-dm1 . multicenter phase ii trial ( nct06125834 ) , 36 participant her2-positive metastatic breast cancer be enrol to receive t-dm1 therapy 21-day cycle progression or unacceptable toxicity . primary endpoint be objective response rate ( orr ) . secondary endpoint include disease control rate ( dcr ) , clinical benefit rate ( cbr ) , progression-free survival ( pfs ) , and toxicity . primary endpoint be orr 47 . 2 % ( 17/36 , 95 % ci 30 . 4-64 . 5 ) . treatment exhibit manageable toxicity profile . dcr be 66 . 7 % ( 24/36 , 95 % ci 49 . 0-81 . 4 ) , and cbr be 50 . 0 % ( 18/36 , 95 % ci 32 . 9-67 . 1 ) . median pfs be 6 . 6 ( 95 % ci 5 . 2-na ) month . single-cell rna sequence reveal low cell cycle activity cancer cell , activate macrophage and cd8 + t cell be associate good efficacy t-dm1 , be validate neoadjuvant cohort . study suggest t-dm1 be effective measurable safety profile patient metastatic her2-positive breast cancer failure pyrotinib and/or trastuzumab plus pertuzumab . preliminary finding suggest potential biomarker may help predict t-dm1 efficacy , generate hypothesis novel therapeutic target may address t-dm1 resistance .",Signal transduction and targeted therapy,29/09/2025
10.1002/14651858.CD016131,efficacy and safety respiratory syncytial virus vaccine .,"Saif-Ur-Rahman KM, King C, Whelan SO, Blair M, Donohue S, Madden C, Kothari K, Sommer I, Harder T, Dauby N, Moustsen-Helms IR, Ruta S, Frère J, Schönfeld V, Poukka E, Lutsar I, Olsson K, Melidou A, Adel Ali K, Dwan K, Devane D","rationale : respiratory syncytial virus ( rsv ) be highly transmissible pathogen cause vary degree respiratory illness age group . safety and efficacy profile available rsv vaccine , critical consideration integration public health strategy and clinical practice , remain uncertain . objective : to assess benefit and harm rsv vaccine compare placebo , intervention , vaccine other respiratory infection , other rsv vaccine , or monoclonal antibody ( mabs ) human population . search methods : conduct comprehensive literature search central , medline , embase , clinicaltrials.gov , and who ictrp follow standard systematic review methodology 2000 april 2024 . eligibility criteria : include randomise control trial ( rcts ) and non-randomised study intervention ( nrsi ) involve human population compare rsv vaccine placebo , intervention , vaccine other respiratory infection , other rsv vaccine , or mabs . exclude study focus dose-finding schedule and immunogenicity assessment . outcomes : benefit include frequency rsv illness ( both low and upper respiratory illness ) confirm laboratory test ( rsv-associated low respiratory tract illness and rsv-associated acute respiratory illness ) ; hospitalisation rsv disease ( both low and upper respiratory illness ) confirm laboratory test ; mortality illness cause rsv ( confirm laboratory test ) ; all-cause mortality ; and admission intensive care unit . harm include serious adverse event ( saes ) relate vaccination , include neurological disorder such guillain-barré syndrome . risk bias : assess risk bias rcts use cochrane 's rob 2 tool . synthesis method : use standard cochrane method . included study : identify 14 rcts : five trial ( 101 , 825 participant ) old adult ; three trial ( 12 , 010 participant ) maternal vaccination and effect infant ; one trial ( 300 participant ) woman childbeare age ; and five trial ( 192 participant ) infant and child . identify nrsi . synthesis result : rsv prefusion vaccine placebo old adult vaccine reduce rsv-associated low respiratory tract illness vaccine efficacy ( ve ) 77 % ( 95 % confidence interval ( ci ) 0 . 70 0 . 83 ; risk ratio ( rr ) 0 . 23 , 95 % ci 0 . 17 0 . 30 ; 4 rcts , 99 , 931 participant ; high-certainty evidence ) and",The Cochrane database of systematic reviews,29/09/2025
10.1016/j.jhep.2025.09.018,parg inhibition halt cholangiocarcinoma progression hippo pathway and,"Yu M, Xie P, Yu Q, Zhao Y, Xu W, Yang Z, Wei Y, Zhou B, Liu S, Dong S, Xu Y, Xiao Y, Zhang B, Guo L, Ye Q, Li H","background & aims : cholangiocarcinoma ( cca ) be fatal malignancy limited therapeutic option . seek to investigate oncogenic role poly(adp-ribose ) glycohydrolase ( parg ) and test potential therapeutic strategy . method : tissue microarray comprise 275 cca patient sample be analyze immunohistochemistry . liquid chromatography-tandem mass spectrometry be utilize to identify downstream target parg . transgenic mouse ( parg(f/f ) ) be employ to establish spontaneous cca model hydrodynamic tail vein injection ( htvi ) and biliary instillation ( bi ) . efficacy parg inhibition be test various cca preclinical model , include patient derive organoid ( pdos ) , patient-derived xenograft ( pdx ) , immunocompetent syngeneic murine model , and orthotopic xenograft model . cytometry time flight ( cytof ) analysis be utilize to profile change tumor microenvironment follow parg inhibition and anti-pd-1 therapy . result : parg be highly express cca and predict dismal prognosis base analysis large patient cohort . genetic depletion parg spontaneous cca model induce two method , include htvi and bi , significantly halt carcinogenesis . parg inhibition alone show impressive efficacy and potentiate gem/cis pdo , pdx , and orthotopic model . mechanistically , parg deparylates and suppresse itch autoubiquitination , thus inhibit hippo pathway , promote cca proliferation and chemoresistance . moreover , cytof analysis reveal crosstalk tumor and stroma , could be suppress parg inhibitor teads/cxcr4/cxcl12 axis . combine blockade and gem/cis parg inhibitor result significantly great reduction tumor burden , as well survival benefit . conclusion : target parg limit cca progression , alleviate desmoplasia , and enhance response anti-pd-1 therapy and chemotherapy . lay summary : little be know role parg cca development and progression . herein , show parg expression be upregulate and hyperactivate cca , promote tumor cell proliferation , cancer-associated fibroblast recruitment , and resistance therapy . pharmacological inhibition parg suppresse cca development and could be effective therapeutic strategy combine chemotherapy and immunotherapy .",Journal of hepatology,26/09/2025
10.1038/s41418-025-01590-9,ampk-activate bap1 regulate pvhl stability and tumor-suppressive function .,"Li M, Huang L, Chen J, Guan T, Wen Y, Zhu Y, Yang X, Zhang C, Ma X, Wan R, He Y, Zhou Y, Song Y, Zhang H, Liu T","von hippel-lindau ( vhl ) protein ( pvhl ) function potent tumor suppressor mediate degradation or inactivation various substrate , include hifα and akt . however , be frequently downregulate numerous cancer harbor wild-type vhl , and underlie mechanism remain elusive . aberrant glucose metabolism be hallmark cancer , drive tumor progression and therapeutic resistance . , connection glucose homoeostasis and pvhl turnover and function have yet to be define . study , demonstrate dysregulate glucose metabolism destabilize pvhl pancreatic ductal adenocarcinoma ( pdac ) , colorectal , and ovarian cancer cell . mechanistically , energy stress induce glucose starvation , 2-deoxyglucose ( 2-dg ) , or metformin activate amp-activated protein kinase ( ampk ) , subsequently phosphorylate and activate bap1 , deubiquitinase specific function target pvhl deubiquitination and stabilization have not be previously characterize . specifically , ampkα phosphorylate bap1 residue s123 , s469 , and s583 , enhance interaction bap1 and pvhl and promote pvhl stabilization and tumor-suppressive function both vitro and vivo . conversely , disrupt bap1 phosphorylation ampkα depletion or reconstitution phosphorylation-defective bap1 mutant ( s123a/s469a/s583a ) abolish bap1-pvhl interaction , lead impair pvhl stabilization and accelerate tumor progression cancer cell line and patient-derived xenograft model . clinically , analysis reveal positive correlation level phosphorylate ampkα ( p-ampkα ) , phosphorylate ser123-bap1 ( pser123-bap1 ) , and pvhl level pdac , colorectal cancer , and ovarian cancer specimen . collectively , finding elucidate novel mechanism link dysregulate glucose metabolism compromise function bap1-pvhl tumor-suppressive axis . result suggest therapeutic strategy design to activate pathway may represent promising approach treat cancer characterize downregulate wild-type vhl and aberrant glucose metabolism .",Cell death and differentiation,27/09/2025
10.1016/j.cell.2025.09.001,safe immunosuppression-resistant pan-cancer immunotherapeutic velcro-like,"Zhou RW, Purohit PK, Kim JH, Lee SU, Burshteyn N, Tifrea D, Cordon A, Grigorian A, Newton BL, Edwards RA, Demetriou M","bispecific antibodie and chimeric antigen receptor t cell be most potent cancer immunotherapeutic clinical use , yet most cancer remain poorly targetable . high-affinity antibodie require to maximize kill detect low antigen expression normal tissue , risk "" on-target , off-cancer "" toxicity . compel identification cancer-restricted cell-surface protein antigen , be rare . tumor-associate carbohydrate antigen ( taca ) be most abundant and widespread cancer antigen know but be poorly targetable antibody . here , describe glycan-dependent t cell recruiter ( glytr ) pan-cancer immunotherapeutic utilize high-avidity "" velcro-like "" lectin bind to kill cell high but not low taca expression . glytr1 and glytr2 bind immunosuppressive β1 , 6glcnac-branched n-glycans or multiple taca ( tn , sialyl-tn , lacdinac , and gd2 ) , respectively , overcome immunosuppressive mechanism tumor microenvironment and trigger target-density-dependent t cell-mediated pan-cancer killing , yet lack toxicity mouse human-like taca expression . density-dependent lectin bind taca provide highly potent and safe pan-cancer immunotherapeutic .",Cell,25/09/2025
10.1016/j.jare.2025.09.039,"global , regional , and national burden cardiovascular disease","Xu S, Jia S, Yang S, Li D, Zhang E, Lei F, Zeng ML, Lin L","background : cardiovascular disease ( cvds ) remain lead cause morbidity and mortality worldwide . postmenopausal woman , physiological change and hormonal transition accelerate cardiovascular risk , yet global , sex-specific evidence group remain limited . understand burden be essential to address biological vulnerability and structural inequity . aim review : review provide first comprehensive global , regional , and national assessment cvd burden woman aged ≥ 55 year 1990 2021 and project trend 2040 . synthesize epidemiological pattern , socio-demographic disparity , and major modifiable risk factor , goal inform gender-sensitive and equity-oriented cardiovascular prevention and policy strategy . key scientific concepts review : datum be obtain global burden disease ( gbd ) study 2021 , encompass 204 country and territory . incidence , prevalence , mortality , and disability-adjusted life year ( daly ) be analyze use age-standardized rate ( asr ) . temporal trend be quantify estimate annual percentage change ( eapc ) , and decomposition analysis identify demographic ( population growth , aging ) and epidemiological contribution . inequality be evaluate use slope and concentration index socio-demographic index ( sdi ) level . bayesian age-period-cohort model be apply to forecast cvd burden 2040 . key finding indicate asir and asmr decline globally , absolute cvd case and death nearly double due demographic expansion . disparity widen : high-sdi region achieve steep reduction , low-sdi region show slow progress or worsen trend . ischemic heart disease and stroke remain dominant contributor , endocarditis be fastest-rising subtype , and high systolic blood pressure consistently emerge lead modifiable risk factor . collectively , finding highlight grow and uneven burden cvd postmenopausal woman . strengthen hypertension control , integrated prevention strategy , and investment primary healthcare-particularly low-sdi settings-are urgently need . review provide woman-centered evidence base to support equitable cardiovascular health policy and resource allocation .",Journal of advanced research,24/09/2025
10.1186/1471-2407-8-221,esophageal cancer risk type alcohol drinking and smoking : case-control,"Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG, Moreno-Osset E","background : effect tobacco smoking and alcohol drink esophageal cancer ( ec ) have never be explore spain black tobacco and wine consumption be quite prevalent . estimate independent effect different alcoholic beverage and type tobacco smoking risk ec and main histological cell type ( squamous cell carcinoma ) hospital-based case-control study mediterranean area spain . methods : only include incident case histologically confirm ec ( n = 202 ) . control be frequency-matched case age , sex and province ( n = 455 ) . information risk factor be elicit train interviewer use structured questionnaire . multiple logistic regression be use to estimate adjusted odd ratio and 95 % confidence interval ( ci ) . result : alcohol drinking and tobacco smoking be strong and independent risk factor esophageal cancer . alcohol be potent risk factor clear dose-response relationship , particularly esophageal squamous-cell cancer . compare never-drinker , risk heavy drinker ( > or = 75 g/day pure ethanol ) be 7 . 65 ( 95%ci , 3 . 16-18 . 49 ) ; and compare never-smoker , risk heavy smoker ( > or = 30 cigarettes/day ) be 5 . 07 ( 95%ci , 2 . 06-12 . 47 ) . low consumption only wine and/or beer ( 1-24 g/d ) do not increase risk strong positive trend be observe type alcoholic beverage include combination hard liquor beer and/or wine ( p-trend<0 . 00001 ) . significant increase ec risk be only observe black-tobacco smoking ( 2 . 5-fold increase ) , not blond tobacco . effect alcohol drinking be much strong analysis be limit esophageal squamous cell carcinoma ( n = 160 ) , lack effect adenocarcinoma be evidence . smoking cessation show beneficial effect ten year drinking cessation do not . conclusion : study show risk ec , and particularly squamous cell type , be strongly associate alcohol drinking . consumption combination hard liquor seem to be harmful low consumption only wine may not . may relate presence certain antioxidant compound find wine but practically lack liquor . tobacco smoking be also clear risk factor , black more blond .",BMC cancer,1/08/2008
10.1016/j.jare.2025.09.038,analyze and forecast global cervical cancer burden base who be,"Huang Y, Lin W, Chen X, Zheng X, Yi H, Zhang L","introduction : cervical cancer remain major global public health challenge . 2018 , who launch strategy to eliminate cervical cancer , emphasize need precise epidemiological assessment . objective : study utilize global burden disease ( gbd ) datum to analyze epidemiological indicator , geographical pattern , and temporal trend cervical cancer , evaluate global impact who 's strategy . method : datum cervical cancer 204 country and territory ( 1990 2021 ) be retrieve gbd database . year 2018 , mark who 's global call elimination , be use to divide datum two period : 1990 2018 and 2019 2021 . trend age-standardized incidence rate and disability-adjusted life year ( daly ) be assess use estimate annual percentage change ( eapc ) and joinpoint regression . socio-demographic index ( sdi ) be regress epidemiological indicator to explore disparity . health inequality analysis recommend be conduct , and autoregressive integrate moving average ( arima ) model be apply to predict future trend . result : 1990 2021 , global age-standardized incidence rate and daly decline . 1990 2018 , high eapc value be observe southern sub-saharan africa ( 2·18 ) , east asia ( 0·69 ) , and eastern europe ( 0·31 ) . 2019 , more significant improvement be note globally . regression analysis reveal",Journal of advanced research,25/09/2025
10.1111/irv.12474,efficacy medical mask and respirator respiratory infection,"MacIntyre CR, Chughtai AA, Rahman B, Peng Y, Zhang Y, Seale H, Wang X, Wang Q","objective : aim to examine efficacy medical mask and respirator protect respiratory infection use pool datum two homogenous randomised control clinical trial ( rcts ) . methods : datum collect 3591 subject two similar rct conduct beijing , china , examine same infection outcome , be pool . four intervention be compare : ( i ) continuous n95 respirator use , ( ii ) target n95 respirator use , ( iii ) medical mask use and ( iv ) control arm . outcome be laboratory-confirmed viral respiratory infection , influenza a or b , laboratory-confirmed bacterial colonisation and pathogen group mode transmission . result : rate outcome be consistently low continuous n95 and/or target n95 arm . adjusted analysis , rate laboratory-confirmed bacterial colonisation ( rr 0 . 33 , 95 % ci 0 . 21-0 . 51 ) , laboratory-confirmed viral infection ( rr 0 . 46 , 95 % ci 0 . 23-0 . 91 ) and droplet-transmitted infection ( rr 0 . 26 , 95 % ci 0 . 16-0 . 42 ) be significantly low continuous n95 arm . laboratory-confirmed influenza be also low continuous n95 arm ( rr 0 . 34 , 95 % ci 0 . 10-1 . 11 ) , but difference be not statistically significant . rate laboratory-confirmed bacterial colonisation ( rr 0 . 54 , 95 % ci 0 . 33-0 . 87 ) and droplet-transmitted infection ( rr 0 . 43 , 95 % ci 0 . 25-0 . 72 ) be also low target n95 arm , but not medical mask arm . conclusion : result suggest classification infection droplet airborne transmission be oversimplification . most guideline recommend mask infection spread droplet . n95 respirator , "" airborne precaution , "" provide superior protection droplet-transmitted infection . to ensure occupational health and safety healthcare worker , superiority respirator prevent respiratory infection should be reflect infection control guideline .",Influenza and other respiratory viruses,01/11/2017
10.1016/j.mam.2025.101413,double-edged sword : sars-cov-2 might fuel lung cancer : investigate,"Shen W, Guo Y, Ai C, Wang X, Li G","covid-19 pandemic , cause sars-cov-2 , have have far-reaching consequence acute respiratory illness , grow evidence suggest potential long-term oncogenic effect . lung cancer , lead cause cancer-related mortality , may intersect covid-19 share molecular pathway and altered disease dynamic . sars-cov-2 can exacerbate outcome exist cancer patient and potentially contribute de novo lung carcinogenesis or accelerate progression chronic inflammation , oxidative stress , immune dysregulation , cellular senescence , cell cycle disruption , metabolic reprogramming , and autophagy impairment . have be prove sars virus be not capable integrate host genome , use mechanism other human oncoviruse to cause lung cancer . pulmonary fibrosis , observe one-third severe case , may act tumor precursor bridge sustained tissue remodeling , extracellular matrix stiffness , and hypoxia-induced epithelial-mesenchymal transition . epidemiological study indicate increase cancer-related mortality , metastatic reactivation dormant cancer cell , and diagnostic delay , shift presentation advanced stage pandemic . synergistic risk factor , include smoking , air pollution , occupational exposure , and genetic predisposition , may far amplify oncogenic potential . convergence viral , environmental , and host factor create critical need vigilant surveillance , biomarker development , and preventive strategy . study aim to synthesize current epidemiological evidence , elucidate molecular and cellular mechanism sars-cov-2 may influence lung carcinogenesis , and highlight clinical implication to guide future research , screening , and therapeutic intervention .",Molecular aspects of medicine,26/09/2025
10.1186/s13045-025-01739-6,combination immunotherapy hepatocellular carcinoma : synergy immune,"Dai S, Chen Y, Cai W, Dong S, Zhao J, Chen L, Cheng CS","combination therapy be rapidly become cornerstone hepatocellular carcinoma ( hcc ) treatment . immune checkpoint inhibitor ( ici ) have emerge central strategy systemic therapy , yet efficacy monotherapie remain limited . consequently , combinatorial approach , such icis-tyrosine kinase inhibitor ( tkis ) , icis-chemotherapy , and dual ici regimen , be gain momentum . clinical trial have establish efficacy benchmark , mechanistic insight remain scarce , partly due limitation current preclinical model mimic complex tumor microenvironment ( tme ) . give substantial heterogeneity hcc , span genetic , transcriptomic , and immunologic dimension , treatment outcome vary widely . additional factor such gut microbiota and epigenetic modification far influence therapeutic response and resistance . pd-1 , pd-l1 , and ctla-4 inhibitor be widely use , unresponsiveness be common . novel target such lag-3 , tim-3 , tigit , and vista , as well strategy to reprogram fibrotic and immunosuppressive tme , be active investigation . ultimately , translate basic insight personalized therapy will depend predictive biomarker and integrated analysis account complex interaction tumor cell , immune system , and tme . review synthesize current knowledge and cellular mechanism underpin combination therapy , highlight therapeutic synergy , and discuss emerge direction stratified treatment hcc .",Journal of hematology & oncology,26/09/2025
10.1159/000480657,geniposide attenuates post-ischaemic neurovascular damage glun2a/akt/,"Huang B, Chen P, Huang L, Li S, Zhu R, Sheng T, Yu W, Chen Z, Wang T","background/aims : calcium-permeable ionotropic nmdar-mediate hyperactivity be regard critical factor modulate development ischaemic stroke . recently , have be increase interest prevent post-stroke neuronal death focus intervene function subpopulation nmdar and downstream signal . geniposide , iridoid glycoside , have be find to have cytoprotective function various condition . however , be still unclear and geniposide affect neuronal insult experimental stroke . method : demonstrate dose-dependent geniposide significantly decrease infarct volume tmcao model . result : medium level geniposide improve anti-apoptotic function and inhibited bbb leakage/haemorrhage elevate glun2a-containe nmdar expression tmcao rat . importantly , effect could be eliminate co-treatment geniposide glun2a antagonist nvp but not glun2b inhibitor ifenprodil . moreover , geniposide 's protection be due enhancement glun2a-dependent survival signal , include pakt , perk and psd-95 . conclusion : result suggest geniposide protect neuron post-ischaemic neurovascular injury activation glun2a/akt/erk pathway . very promising natural agent , geniposide may be future therapeutic stroke patient .",Cellular physiology and biochemistry : international journal of experimental,01/01/2017
10.1038/s41586-025-09574-y,spp1 be require maintain mesenchymal cell fate pancreatic cancer .,"Li H, Lan L, Chen H, Zaw Thin M, Ps H, Nelson JK, Evans IM, Ruiz EJ, Cheng R, Tran L, Allen M, Ma J, Yi T, Wang C, He Y, Guppy N, Sadanandam A, Lin SZ, Zhang C, Behrens A","elucidate complex network communication tumour cell be central understand cell fate decision and progression pancreatic ductal adenocarcinoma ( pdac)(1 , 2 ) . previously show constant suppression bmp activity bmp antagonist grem1 secrete mesenchymal pdac cell be essential maintain fate epithelial pdac cells(3 ) . here identify spp1 ( also know osteopontin)(4 ) key regulator mesenchymal cell fate pancreatic cancer . proteomic analysis plasma patient pdac show spp1 be substantially upregulate late-stage disease . inactivation spp1 lead delay tumorigenesis mouse pdac model and abolish metastasis formation . spp1 be express epithelial pdac cell , and inactivation result conversion mesenchymal epithelial pdac cell . mechanistically , spp1 bind cd61 receptor mesenchymal pdac cell to induce bmp2 and grem1 expression , and grem1 inhibition bmp signalling be require spp1 expression epithelial cell , thereby form intercellular regulatory loop . concomitant inactivation grem1 revert epithelial phenotype knockout fully mesenchymal pdac . conversely , grem1 heterozygosity combine knockout result wild-type pdac histology , result confirm direct antagonistic function factor . hence , mesenchymal and epithelial pdac cell fate be determine reciprocal paracrine regulation soluble factor grem1 and spp1 .",Nature,24/09/2025
10.1016/j.chom.2025.09.010,bacteroides fragilis protease activate host par(2 ) to induce intestinal pain,"Lakemeyer M, Latorre R, Blazkova K, Wood HM, Jensen DD, Shakil N, Thomas SC, Saxena D, Mulpuri Y, Poolman D, Duran P, Keller LJ, Reed DE, Schmidt BL, Jiménez-Vargas NN, Xu F, Lomax AE, Bunnett NW, Bogyo M","protease-activate receptor 2 ( par(2 ) ) be central regulator intestinal barrier function , inflammation , and pain . upregulated intestinal proteolysis and par(2 ) signal be implicate inflammatory bowel disease ( ibds ) and irritable bowel syndrome ( ibs ) , condition often associate gut microbiome alteration . to identify potential bacterial regulator par(2 ) activity , develop functional assay par(2 ) processing to screen library diverse gut microbe . identify multiple bacteria secrete protease capable cleave host par(2 ) . use chemoproteomic profiling covalent irreversible inhibitor , uncover previously uncharacterized bacteroides fragili serine protease 1 ( bfp1 ) and show cleave and activate par(2 ) multicellular and murine model . par(2 ) cleavage bfp1 disrupt intestinal barrier , sensitize nociceptor , and trigger colonic inflammation and abdominal pain . collectively , finding uncover bfp1-mediate par(2 ) processing axis host-commensal interaction gut have potential to be target therapeutic intervention ibd or ibs .",Cell host & microbe,26/09/2025
10.1038/s41591-025-03918-x,genomically match therapy advanced solid tumor : randomized phase 2 rome,"Marchetti P, Curigliano G, Biffoni M, Lonardi S, Scagnoli S, Fornaro L, Guarneri V, De Giorgi U, Ascierto PA, Blandino G, D'Amati G, Aglietta M, Cremolini C, Conte P, Crimini E, Ceracchi M, Pisegna S, Verkhovskaia S, Bordonaro R, Bracarda S, Butturini G, Del Mastro L, DeCensi A, Fabbri A, Fenocchio E, Gori S, Metro G, Pessino A, Pozzessere D, Puglisi F, Tamberi S, Zambelli A, Marino D, Capoluongo E, Cappuzzo F, Cerbelli B, Giannini G, Malapelle U, Mazzuca F, Nuti M, Pruneri G, Simmaco M, Strigari L, Tonini G, Martini N, Botticelli A","recent advancement demonstrate potential tumor-agnostic biomarker to guide effective therapy , randomize evidence support clinical superiority precision oncology approach compare standard therapy remain limited . rome trial be multicenter , randomize , open-label phase 2 study compare tailor treatment ( tt ) standard care ( soc ) patient advanced solid tumor progress one or two line therapy . comprehensive genomic profiling tissue and blood be perform to identify actionable alteration . overall response rate ( orr ) be primary endpoint , and progression-free survival ( pfs ) , overall survival ( os ) , time treatment failure ( ttf ) , time next treatment ( ttnt ) and safety be secondary endpoint . november 2020 and august 2023 , 1 , 794 patient be screen , 897 be evaluate molecular tumor board ( mtb ) and 400 be randomize tt or soc . tt achieve significantly high orr ( 17 . 5 % 10 % ; p = 0 . 0294 ) and improve median pfs ( 3 . 5 month 2 . 8 month ; hazard ratio = 0 . 66 ( 0 . 53-0 . 82 ) , p = 0 . 0002 ) . tt also show superior 12-month pfs rate ( 22 . 0 % 8 . 3 % ) . median os be similar , 52 % crossover rate . grade 3/4 adverse event be also similar ( 40 % tt 52 % soc ) . result highlight potential tt to improve outcome patient diverse actionable genomic alteration . result also provide relevant evidence support tumor-agnostic precision oncology strategy and highlight potential tts , guide genomic profiling and mtb recommendation , to significantly improve outcome patient diverse actionable genomic alteration . clinicaltrials.gov identifier : nct04591431 .",Nature medicine,29/09/2025
10.1016/S1474-4422(25)00249-2,blood and csf biomarker multiple sclerosis : emerge clinical application .,"Chitnis T, Magliozzi R, Abdelhak A, Kuhle J, Leppert D, Bielekova B","neurofilament light chain ( nfl ) , glial fibrillary acidic protein ( gfap ) , chitinase-3-like protein 1 ( chi3l1 ) , and other protein assay be be develop diagnostic or prognostic biomarker multiple sclerosis . increase nfl concentration reflect axonal damage result acute new inflammatory disease activity occur relapse . nfl concentration can also reflect occurrence new mri lesion . gfap concentration be increase people progressive form multiple sclerosis , and gfap be emerge biomarker progression independent relapse . chi3l1 be emerge biomarker associate progression independent relapse activity and several mri lesion type , include paramagnetic rim lesion . biomarker , particularly nfl , can help monitor treatment response , and combination multivariate biomarker provide additional accuracy specific clinical scenario . multiple sclerosis , fluid-based biomarker be quickly emerge instrument clinical monitoring disease course and patient ' response treatment .",The Lancet. Neurology,24/09/2025
10.1152/advan.00039.2021,effect self-regulated learning and technology-enhanced activity anatomy,"Bains M, Kaliski DZ, Goei KA","problem-base learning ( pbl ) offer advantage teach anatomy and physiology physical therapy student clinical case provide scaffold comprehensive review body system . utilization interactive anatomy software greatly contribute active learn environment and efficient use time , simply provide textbook reading , access anatomy software , and model be not enough to engage student to become active reach learn goal . time constraint , meaningful technology implementation , resource abundance , and unfamiliarity be challenge decrease effectiveness both facilitate and learn anatomy . present study investigate use three supplemental learning tool to support anatomy instruction self-regulated manner . friedman test result demonstrate significant difference perceive engagement [ χ(2)(2 ) = 15 . 74 , p < 0 . 001 , w = 0 . 23 ] but not perceive learning . survey response demonstrate perceive engagement be great nondigital supplemental learning tool compare two technology-enhanced learning tool ( ibooks author + softchalk and softchalk alone ) . multivariate regression analysis demonstrate statistically significant relationship nondigital supplemental learning tool and anatomy practical score ( p < 0 . 001 ) . technology-enhanced supplemental learning tool do not far increase learn outcome measure practical score compare nondigital learning tool . incorporation instructor-created instructional material independent technology be efficient method to drive self-regulated learning , enhance engagement , and improve anatomy course outcome and may overcome barrier associate purely self-directed pbl model .",Advances in physiology education,1/06/2022
10.1088/1361-6560/aca3f8,experimental feasibility xenon-enhanced dual-energy radiography imaging,"Basharat F, Tanguay J","chronic obstructive pulmonary disease ( copd ) be lead cause death worldwide . experimentally investigate feasibility two-dimensional xenon-enhanced dual-energy ( xede ) radiography imaging lung function . optimize image quality quantum-noise-limited condition use chest phantom consist rectangular chamber represent thoracic volume and pmma slab simulate x-ray attenuation soft tissue . seal , air-filled cavity thin pmma wall be position chamber to simulate 2 cm thick ventilation defect . chamber be ventilate xenon and dual-energy imaging be perform use diagnostic x-ray tube and flat-panel detector . contrast-to-noise ratio ventilation defect normalize patient x-ray exposure maximize kv-pair approximately 60/140-kv and approximately one third total exposure be allocate he image . use optimize technique to image second phantom contain lung-parenchyma-mimicke pmma clutter , rib-mimicke aluminum slat and insert simulate ventilation defect thickness range 0 . 5 cm 2 cm and diameter range 1 cm 2 cm . result image compute area receiver operate characteristic curve ( auc ) non-prewhitening model observer eye filter and internal noise . xenon concentration 75 % , good auc ( i.e. 0 . 8-0 . 9 ) to excellent aucs ( i.e. > 0 . 9 ) be obtain defect diameter be great 1 . 3 cm and defect thickness be 1 cm . xenon concentration be reduce 50 % , auc be ∼0 . 9 defect 1 . 2 cm diameter and ∼1 . 5 cm thickness . two-dimensional xede radiography may therefore enable detection functional abnormality associate early-stage copd , xenon ventilation defect can occupy to 20 % lung volume , and should be far develop low-cost alternative mri-base approach and low-dose alternative ct-based approach .",Physics in medicine and biology,12/12/2022
10.1016/j.ccell.2025.09.001,single-cell resolution spatial analysis antigen-presenting cancer-associated,"Chen X, Zhou Z, Xie L, Qiao K, Jia Y, Liu S, Yazgan Z, Rossi F, Liu Y, Zhang B, Polanco PM, Zeh HJ 3rd, Kim AC, Huang H","recent study identify unique subtype cancer-associated fibroblast ( cafs ) term antigen-presenting cafs ( apcafs ) , remain poorly understand . to gain comprehensive understanding origin and function apcafs , construct fibroblast molecular atla 15 type tissue and solid tumor . integration study unexpectedly reveal two distinct apcaf population present most cancer type : one associate mesothelial-like cell and other fibrocyte . use high-resolution single-cell spatial imaging platform , characterize spatial niche apcaf population . find mesothelial-like apcaf be locate cancer cell , fibrocyte-like apcaf be associate lymphocyte-enriched niche . additionally , discover apcaf population can up-regulate secrete phosphoprotein 1 ( spp1 ) , facilitate primary tumor formation , peritoneal metastasis , and therapy resistance . take together , study offer unprecedented resolution analyze apcafs and spatial niche .",Cancer cell,25/09/2025
10.1016/j.xgen.2025.101012,genetic landscape human oocyte/embryo defect .,"Chen B, Wang W, Shi J, Sun X, Guan Y, Hao G, Zhao J, Mu J, Zhang Z, Xu F, Gao D, Pan Z, Yu R, Gu H, Fan H, Luo Y, Xie S, Du X, Jing H, Ye Z, Zhang X, Hai R, Zhu H, Wu T, Li Q, Fu J, Wu L, Wang W, Li C, Diao F, Shi Q, Li L, Xu S, Li D, Dong X, Xu P, Wang J, He L, Kuang Y, Sang Q, Wang L","oocyte/embryo defect can result oocyte maturation arrest , fertilization failure , embryonic arrest , and infertility as well recurrent in vitro fertilization ( ivf ) or intracytoplasmic sperm injection ( icsi ) failure . however , genetic determinant human oocyte/embryo defect remain largely unknown , and overall genetic diagnostic yield such defect have not be evaluate . here , perform exome sequence 3 , 627 patient oocyte/embryo defect . identify total 479 positive case carry variant 37 know gene , indicate diagnostic yield 13 . 2 % . case-control association study combine gene set enrichment analysis identify 123 novel candidate gene responsible oocyte/embryo defect . result provide comprehensive genetic landscape human oocyte/embryo defect and highlight clinical significance genetic counseling infertile patient oocyte/embryo defect . study will lay foundation transform traditional clinical practice fail ivf/icsi attempt genetic-based precision and personalized treatment patient .",Cell genomics,25/09/2025
10.1038/s41590-025-02289-2,chemotherapy-induce ca-repeat dna fragment breast cancer trigger antitumor,"Zhang X, Huang P, Chen H, Yang C, Yang X, Liu Y, Wu B, Zeng W, Saw PE, Ye S, Li J, Wang J, Wu Z, Wang J, Li H, Huang JD, Zeng M, Li M, Liu Q, Su S, Song E, Chen J","damage-associate molecular pattern generate cancer treatment can modulate antitumor immunity , but underlie mechanism effect be unclear . here show ca-enriche dna fragment result dna-damage chemotherapy msh2-low tumor preferentially bind cga strong affinity and form biomolecular condensate phase separation cytoplasm , result antitumor immunity . however , classical ca-poor dna release msh2-high tumor cell engage aim2 , result immunosuppression upregulate pd-l1 and ido . intratumoral administration ca-rich dna fragment enhance antitumor immunity syngrafte pymt tumor . clinically , ca-rich dna abundance breast cancer follow chemotherapy be associate increased tumor-antigen-reactive t cell and well chemotherapeutic response . therefore , different tumor dna fragment can trigger oppose immune response depend preference differential sensor . study highlight mechanistic link genome instability and immune modulation and therapeutic potential ca-rich dna to enhance antitumor immunity .",Nature immunology,29/09/2025
10.7326/ANNALS-24-01863,association body composition and cardiometabolic outcomes : prospective,"Jung M, Reisert M, Rieder H, Rospleszcz S, Lu MT, Bamberg F, Raghu VK, Weiss J","background : current measure adiposity have limitation . artificial intelligence ( ai ) model may accurately and efficiently estimate body composition ( bc ) routine imaging . objective : to assess association ai-derived bc compartment magnetic resonance imaging ( mri ) cardiometabolic outcome . design : prospective cohort study . setting : uk biobank ( ukb ) observational cohort study . participant : 33 432 ukb participant history diabetes , myocardial infarction , or ischemic stroke ( mean age , 65 . 0 year [ sd , 7 . 8 ] ; mean body mass index [ bmi ] , 25 . 8 kg/m(2 ) [ sd , 4 . 2 ] ; 52 . 8 % female ) undergo whole-body mri . measurement : ai tool be apply mri to derive 3-dimensional ( 3d ) bc measure , include subcutaneous adipose tissue ( sat ) , visceral adipose tissue ( vat ) , skeletal muscle ( sm ) , and sm fat fraction ( smff ) , and then calculate relative distribution . sex-stratified association relative compartment incident diabete mellitus ( dm ) and major adverse cardiovascular event ( mace ) be assess use restrict cubic spline . result : adipose tissue compartment and smff increase and sm decrease age . adjustment age , smoking , and hypertension , great adiposity and low sm proportion be associate high incidence dm and mace median follow-up 4 . 2 year sex-stratified analysis ; however , additional adjustment bmi and waist circumference ( wc ) , only elevated vat proportion and high smff ( top fifth percentile cohort ) be associate increase risk dm ( respective adjust hazard ratio [ ahrs ] , 2 . 16 [ 95 % ci , 1 . 59 to 2 . 94 ] and 1 . 27 [ ci , 0 . 89 to 1 . 80 ] female and 1 . 84 [ ci , 1 . 48 to 2 . 27 ] and 1 . 84 [ ci , 1 . 43 to 2 . 37 ] male ) and mace ( 1 . 37 [ ci , 1 . 00 1 . 88 ] and 1 . 72 [ ci , 1 . 23 to 2 . 41 ] female and 1 . 22 [ ci , 0 . 99 to 1 . 50 ] and 1 . 25 [ ci , 0 . 98 to 1 . 60 ] male ) . addition , male only , bottom fifth percentile sm proportion have increase risk dm ( ahr bottom fifth percentile cohort , 1 . 96 [ ci , 1 . 45 to 2 . 65 ] ) and mace ( ahr , 1 . 55 [ ci , 1 . 15 to 2 . 09 ] ) . limitation : result may not be generalizable non-white or people united kingdom . conclusion : artificial intelligence-derived bc proportion be strongly associate cardiometabolic risk , but bmi and wc be account , only vat proportion and smff ( both sex ) and sm proportion ( male only ) add prognostic information . primary funding source : none .",Annals of internal medicine,30/09/2025
10.1016/j.annonc.2025.09.008,esmo-estro consensus statement safety combine radiotherapy,"van Aken ESM, Devnani B, Prelaj A, Castelo-Branco L, Marijnen CAM, Martins-Branco D, Gambacorta MA, Lamarca A, Harrington K, Minniti G, Hecht M, Papamichael D, Krause M, Cathomas R, Lindberg K, O'Cathail SM, Nestle U, Barriuso J, Nowicki S, Rödel C, Boot P, Belka C, Ricardi U, Lordick F, De Ruysscher D, Pentheroudakis G, de Jong MC, Gandhi AK","background : combination radiotherapy ( rt ) target agent or immunotherapy may result improved outcome , but can also increase toxicity . however , be paucity high-quality toxicity datum , lead absence evidence-based guideline . design : to address , esmo and estro initiate series systematic review follow delphi consensus process to develop multidisciplinary , evidence-based consensus statement regard safety combine rt such agent . current publication describe combination rt immune checkpoint inhibitor ( ici ) , vascular endothelial growth factor ( receptor ) ( vegf(r ) ) inhibitor , or multitargete tyrosine kinase inhibitor ( tkis ) . systematically cover different drug class and irradiated area , 76 clinical scenario be evaluate two delphi round 20 international expert . safety statement be develop scenario , base systematic literature review . result : total 5 , 921 record be screen systematic literature review process ici , vegf(r ) inhibitor and multitargete tki , and 159 report be select inclusion final literature review and database . two delphi round , agreement be reach regard safety statement 74 clinical scenario . conclusion : generally , expect toxicity combine rt ici be low , particularly pd-(l)1 inhibitor . most combination vegf(r ) inhibitor and multitargete tki , exercise caution be recommend . evidence-based safety statement develop comprehensive project , provide practical guidance combine rt target cancer therapy and immunotherapy .",Annals of oncology : official journal of the European Society for Medical,26/09/2025
10.1016/j.beem.2025.102038,preconception use glp-1 and glp-1/gip receptor agonist obesity treatment .,"Koceva A, Janež A, Jensterle M","obesity be rise woman reproductive age and significantly contribute subfertility . conception occur , maternal obesity be associate increase risk maternal and neonatal complication , potential long-term effect offspring 's health . current clinical guideline emphasize importance preconception weight optimization woman obesity to reduce maternal and fetal risk . rise use incretin-based anti-obesity medication , particularly young woman , potential role preconception care be receive grow clinical and research interest . unplanned pregnancy remain common , incidental exposure early pregnancy be become more likely . parallel , be increase interest potential agent to support preconception weight loss and enhance fertility outcome woman obesity . narrative review examine current human evidence glp-1 and dual glp-1/gip receptor agonist approve obesity treatment , focus potential role preconception care and address key safety consideration and challenge relate use preconception period , as well inadvertent exposure early pregnancy .",Best practice & research. Clinical endocrinology & metabolism,24/09/2025
10.1016/j.xcrm.2025.102373,gut symbiont-derived ursodeoxycholic acid promote fatty acid oxidation,"Xie M, Zheng J, Yu Y, Yang Q, Zhou Z, Xue J, Wang B, Qiu Y, Zhu Z, Sun Q, Shi X, Shangguan W, Li L, Zou Z, Zhao J, Wu P","renal ischemia-reperfusion injury ( iri ) be common complication renal surgery currently lack effective prevention or treatment strategy . gut microbiota and metabolite be closely associate kidney injury . however , exact mechanism underlie link be unclear . here , find renal iri reduce ursodeoxycholic acid ( udca ) , metabolite eubacterium limosum ( e . limosum ) , mouse cecal content and serum . conversely , supplementation e . limosum or udca prevent mouse iri . mechanistically , udca directly bind and activate peroxisome proliferator-activated receptor-gamma ( pparγ ) to increase fatty acid oxidation , induce atp production and reduce lipid accumulation proximal tubular epithelial cell , ultimately protect kidney iri . importantly , renal iri patient markedly lower serum udca , patient high pre-iri udca or e . limosum level develop less severe iri . collectively , finding highlight rationale use udca and e . limosum prevention or treatment renal iri .",Cell reports. Medicine,26/09/2025
10.1016/j.phymed.2025.157284,atractylenolide iii alleviate cerebral ischemia-reperfusion injury target,"Guo R, Quan S, Yan X, Jia Y, Wang N, Bu J, Zhao Y, Su L, Yue Z, Wang J, Li Z, Li Y","background : atractylenolide iii ( atl iii ) , natural sesquiterpene lactone , exhibit neuroprotective property cerebral ischemia-reperfusion injury ( ciri ) , but underlying mechanism remain unclear . purpose : to identify pharmacological target and elucidate mechanism atl iii ciri protection . method : middle cerebral artery occlusion/reperfusion ( mcao/r ) mouse and oxygen-glucose deprivation/reperfusion ( ogd/r ) ht22 cell be employ to evaluate protective effect atl iii neurological function , oxidative stress , and apoptosis . network pharmacology , molecular docking , surface plasmon resonance , and molecular dynamic be use to identify direct target . molecular mechanism be validate use western blot , immunofluorescence , and pharmacological inhibitor both vitro and vivo . result : atl iii ( 10 , 20 , 40 mg/kg ) significantly reduce infarct volume mcao/r mouse 42 % 33 % , 27 % , and 20 % , and decrease neurological score 13 9 , 7 , and 5 . histology reveal alleviate hippocampal neuronal damage . ht22 cell , atl iii decrease ogd/r-induce apoptosis , lower ros level 374 % 202 % , increase sod and gsh , and reduce mda level . keap1 be identify direct target ; atl iii disrupt keap1-nrf2 interaction , reduce keap1 protein level , increase nrf2 expression and nuclear translocation , and upregulate ho-1 expression . nrf2 inhibition ml385 abolish antioxidative and neuroprotective effect model . conclusion : atl iii protect ciri directly target keap1 and activate nrf2/ho-1 pathway . give favorable safety profile and blood-brain barrier ( bbb ) permeability , atl iii hold promise translational potential plant-derived prophylactic agent ischemic stroke .",Phytomedicine : international journal of phytotherapy and phytopharmacology,19/09/2025
10.1038/s41467-025-63343-z,circular rna-base protein replacement therapy mitigate osteoarthritis male,"Suo J, Li L, Tan W, Yin X, Wang J, Shao R, Sun S, Guo SK, Feng J, Gao BQ, Wang Y, Wei MY, Wang L, Feng H, Gao X, Hu P, Zheng X, Chen LL, Lei G, Huang Y, Zou W","vitro-transcribed and circularize rnas ( ivcrnas ) represent robust platform sustained protein translation , offer promise potential localized therapeutic delivery joint disease . osteoarthritis ( oa ) , most prevalent degenerative joint disorder , remain major clinical challenge progressive nature and lack disease-modifying treatment . study , identify musashi2 ( msi2 ) deficiency articular chondrocyte key contributor oa pathogenesis . to evaluate efficacy ivcrna-mediate protein replacement therapy , develop localize delivery strategy enable high-yield and prolonged protein expression chondrocyte . use destabilization medial meniscus ( dmm ) mouse model , demonstrate intra-articular delivery ivcrna encode msi2 effectively mitigate oa progression male mouse . furthermore , therapeutic supplementation sox5 , downstream effector msi2 , ivcrna delivery far validate approach . finding establish ivcrna-base protein replacement potential rna therapeutic strategy osteoarthritis .",Nature communications,26/09/2025
10.1002/cph4.70056,understand myalgic encephalomyelitis/chronic fatigue syndrome physical fatigue,"Luo Y, Xu H, Xiong S, Ke J","background : myalgic encephalomyelitis/chronic fatigue syndrome ( me/cfs ) be debilitate illness mark persistent fatigue , yet mechanism remain unclear . grow evidence implicate immunosenescence-the age-related decline immune function-in onset and persistence fatigue . method : review synthesize clinical and experimental datum to examine immunosenescence contribute to me/cfs . focus chronic inflammation , senescent immune phenotype , mitochondrial dysfunction , and neuroendocrine imbalance , emphasis maladaptive crosstalk immune , muscular , neuroendocrine , and vascular system . result : age immune cell drive chronic inflammation impairs mitochondrial atp production and promote muscle catabolism . concurrently , hpa-axis suppression and β(2)-adrenergic dysfunction amplify immune dysregulation and energy imbalance . together , process illustrate immunosenescence sustain pathological cross-organ signal underlying systemic fatigue . conclusion : immunosenescence provide unifying framework link immune , metabolic , and neuroendocrine dysfunction me/cfs . recognize cross-organ communication highlight clinical relevance , suggest biomarker such cytokine and exhaustion marker , and support integrate therapeutic strategy target immune and metabolic network .",Comprehensive Physiology,01/10/2025
10.1016/j.lanhl.2025.100763,integrate exercise and medication management geriatric care : holistic,"Izquierdo M, Ramírez-Vélez R, Fiatarone Singh MA","integrate exercise prescription medication management represent novel approach enhance health and function , optimise medication effectiveness , and reduce adverse drug reaction and polypharmacy old adult ( ie , aged ≥60 year ) . personal view highlight need comprehensive assessment lifestyle , diagnosis , geriatric syndrome , and medication emphasis fully incorporate exercise treatment geriatric care . exercise be alternative less effective or unsafe medication many condition , include depression , anxiety , insomnia , osteoarthritis , and dementia . exercise be important adjunct pharmacotherapy many common chronic condition such coronary artery disease , heart failure , diabetes , osteoporosis , cancer , and chronic obstructive pulmonary disease . add exercise drug management can mitigate adverse drug reaction , enhance medication compliance , and reduce adverse effect sedentary behaviour and ageing process chronic disease expression . target exercise programme have also be show to ameliorate drug-induced side-effect , include anorexia , fall , sarcopenia , osteoporosis , and orthostatic hypotension , and to overcome constraint such reduce aerobic fitness , balance impairment , and muscle atrophy medication . health-care professional require additional training and support to ensure exercise assume key , central role old adult multimorbidity and polypharmacy , support current literature . personal view describe practical approach incorporate exercise clinical practice step integrated geriatric care model , ultimate aim increase health span and minimise disability .",The lancet. Healthy longevity,24/09/2025
10.1038/s42255-025-01379-7,cholesterol metabolic reprogramme mediate microglia-induced chronic,"Zhao Q, Li J, Feng J, Wang X, Liu Y, Wang F, Liu L, Jin B, Lin M, Wang YC, Guo X, Chen J, Hao J","chronic neuroinflammation be major obstacle post-stroke recovery , yet underlie mechanism , particularly link prolonged microglial activation and cholesterol metabolism , be not fully know . here show ischaemic injury induce persistent microglial activation perpetuate chronic inflammation , lead microglial cholesterol accumulation and metabolic reprogramme . use single-cell rna sequencing , identify distinct stroke-associated foamy microglia cluster characterize extensive reprogramming cholesterol metabolism . furthermore , direct intracerebral free cholesterol or cholesterol crystal infusion recapitulate sustained microglial activation , directly link aberrant cholesterol metabolism prolong neuroinflammatory response . therapeutically , demonstrate reduce microglial cholesterol overload genetic or pharmacological activation cyp46a1 male mouse promote white matter repair and functional recovery . finding highlight microglial cholesterol metabolism key driver post-stroke inflammation , offer therapeutic strategy target cholesterol metabolism to mitigate long-term brain damage and promote neurorestoration , potentially improve stroke-related disability outcome .",Nature metabolism,23/09/2025
10.1016/j.phymed.2025.157301,"integrate metagenomic , lipidomic and proteomic to explore effect and","Zhao Y, Song T, Ren P, Wu X, Luo Q, Xie J, Lai H, Li X, Wen Y, Liao X, Zhou J","background : comorbidity atherosclerosis ( as ) and depression present significant clinical challenge . pathogenesis entail complex abnormality inflammatory response , lipid metabolism , and gut microbiota homeostasis . ginsenoside rb1 ( grb1)-a bioactive compound derive dry root panax ginseng ( araliaceae)-demonstrate anti-inflammatory , antioxidant , lipid-lowering , and neuroprotective property . however , grb1 's therapeutic potential and underlying mechanism co-depression remain inadequately characterize . purpose : study aim to elucidate mechanism grb1 co-depression disease , identify potential therapeutic target , and thereby develop novel therapeutic strategy condition . method : co-depression comorbidity model be establish use apoe(⁻/⁻ ) mouse feed high-fat diet and subject chronic restraint stress . to evaluate grb1 's therapeutic efficacy , assess serum lipid profile , perform aortic oil red o staining , and conduct behavioral test depressive-like phenotype . furthermore , employ integrated multi-omic approach-combining metagenomic , target lipid metabolomic , and proteomics-to identify key alteration gut microbiota , lipid metabolite , and protein , subsequent correlation analysis . key differential protein and associate pathway identify multi-omic be validate use vivo ( co-depression mouse model ) and vitro ( ht22 cell ) experiment . finally , grb1 's effect ferroptosis and specific signal pathway ( cd44/gls2 , acsl4/lpcat3/alox15 , slc7a11/gpx4 ) be examine western blotting , immunofluorescence , and transmission electron microscopy both mouse tissue and ht22 cell . result : proteobacteria , helicobacter , and helicobacter_typhlonius represent significant intestinal microbiota component . primary differential lipid include phosphatidylethanolamine ( pe ) , phosphatidylcholine ( pc ) , and lysophosphatidylcholine ( lpc ) , key differential protein encompass cd44 , gls2 , and snrpf . notably , strong correlation exist helicobacter_typhlonius , pe , and cd44 . grb1 modulate pe metabolic dysregulation reduce relative abundance helicobacter_typhlonius , thereby inhibit lipid peroxidation and ameliorate oxidative stress . furthermore , grb1 suppress cd44/gls2 axis , acsl4/lpcat3/alox15 pathway , and activate slc7a11/gpx4-mediate ferroptosis pathway , thereby exert anti-as co-depression effect multi-target mechanism . conclusion : grb1 regulate intestinal microbiota , abnormal lipid metabolism , modulate protein function , inhibit lipid peroxidation , improve oxidative stress , inhibit ferroptosis , regulate cd44/gls2 , acsl4/lpcat3/alox15 , slc7a11/ gpx4 signal pathway , and prevent progression co-depression disease .",Phytomedicine : international journal of phytotherapy and phytopharmacology,22/09/2025
10.1056/NEJMoa2510095,hypertonic saline or carbocisteine bronchiectasis .,"Bradley JM, O'Neill B, McAuley DF, Chalmers JD, De Soyza A, Hill AT, Carroll M, Loebinger MR, Duckers J, Clarke M, McLeese RH, Ferguson K, Jackson A, Campbell C, McDowell C, Agus A, Norrie J, Copeland F, Downey DG, Convery R, Kelly M, Flight W, Talbot NP, Hurst JR, Steer J, Anwar M, Shahidi M, Gatheral T, Etumi M, Sullivan AL, Ionescu AA, Patil V, Bhattacharya M, Caskey S, Cosgrove D, Hagan C, Shoemark A, McManus T, Davies G, Elborn JS","background : bronchiectasis guideline be inconsistent regard effectiveness mucoactive agent , and use vary geographically . large trial be need to assess safety and effectiveness . method : open-label , randomize , two-by-two factorial trial 20 site united kingdom , enrol participant non-cystic fibrosis bronchiectasis have frequent pulmonary exacerbation and daily sputum production . current smoker and person have recently receive mucoactive treatment be exclude . participant receive standard care and be also assign either one three mucoactive-drug group - hypertonic saline ( hypertonic-saline group ) , hypertonic saline and carbocisteine ( combination group ) , or carbocisteine ( carbocisteine group ) - or standard care alone . comparison be hypertonic saline and hypertonic saline and carbocisteine and carbocisteine , category consist two group . primary outcome be number pulmonary exacerbation 52-week period . key secondary outcome be score disease-specific health-related quality-of-life assessment , time next pulmonary exacerbation , and safety . result : total 288 participant undergo randomization . treatment interaction be find . mean number adjudicate fully qualify pulmonary exacerbation 52-week period be 0 . 76 ( 95 % confidence interval [ ci ] , 0 . 58 0 . 95 ) hypertonic saline compare 0 . 98 ( 95 % ci , 0 . 78 to 1 . 19 ) hypertonic saline ( adjust between-group difference mean , -0 . 25 [ 95 % ci , -0 . 57 0 . 07 ; p = 0 . 12 ] ) and 0 . 86 ( 95 % ci , 0 . 66 to 1 . 06 ) carbocisteine compare 0 . 90 ( 95 % ci , 0 . 70 to 1 . 09 ) carbocisteine ( adjust between-group difference mean , -0 . 04 [ 95 % ci , -0 . 36 0 . 28 ; p = 0 . 81 ] ) . secondary outcome and incidence adverse event , include serious adverse event , be similar group . conclusion : participant bronchiectasis , neither hypertonic saline nor carbocisteine significantly reduce mean incidence pulmonary exacerbation period 52 week . ( fund national institute health and care research health technology assessment programme and other ; isrctn registry number , isrctn89040295 . ) .",The New England journal of medicine,28/09/2025
10.1016/j.enfcli.2011.09.005,[ effectiveness pre-operative education reduce anxiety surgical,"Díez-Álvarez E, Arrospide A, Mar J, Alvarez U, Belaustegi A, Lizaur B, Larrañaga A, Arana JM","objective : to evaluate effectiveness structured pre-operative interview conduct operating room nurse order to reduce pre-operative anxiety patient , and to determine profile patient can benefit . material and method : randomised double-blind and prospective trial be conduct sample 335 patient schedule surgery two regional hospital basque region spain , alto deba hospital and mendaro hospital . compare alternative use structured briefing ( test group ) current situation formal intervention ( control group ) . effectiveness procedure be determine use stai state anxiety self-assessment questionnaire . chi-squared statistic be use to assess difference factor and student t-test comparison mean continuous variable . result : impact intervention measure state anxiety and trait anxiety be find to be not statistically significant , mean state anxiety state be slightly low intervention group ( 18 . 96 ) control ( 20 . 03 ) . woman undergo surgery specialty gynaecology show high state anxiety compare other specialty . regard trait anxiety high asa level be associate high anxiety . furthermore , consumption psychotropic drug be also relate high level trait anxiety . conclusion : preoperative visit can be helpful patient be select accord specific characteristic : type anaesthesia , gender , or type surgery . may also be beneficial effect preoperative education be tailor accord patient 's anxiety risk . time immediately surgery may not be good time conduct visit , may make patient more anxious .",Enfermeria clinica,01/02/2012
10.1007/s00520-025-09918-4,strategy premedication and g-csf application sacituzumab govitecan,"Pieniążek M, Polakiewicz-Gilowska A, Kubeczko M, Las-Jankowska M, Pacholczak-Madej R, Kilian-Van Miegem P, Ziobro M, Łacko A, Jarząb M, Püsküllüoğlu M","background : sacituzumab govitecan ( sg ) be approve advanced triple-negative breast cancer ( tnbc ) second-line setting and , offer improve survival compare chemotherapy . adverse event ( aes ) commonly include myelosuppression , gastrointestinal disturbance , and hepatic toxicity . effective premedication and prophylaxis be critical ae management . study assess premedication protocol sg-treate tnbc patient . material and method : retrospective cohort study five oncology center poland analyze premedication regimen patient complete sg treatment october 2024 . premedication evaluate include acetaminophen , corticosteroid , antihistamine , 5-ht3 and nk1 receptor antagonist , and granulocyte colony-stimulating factor ( g-csf ) need . aes be assess use national cancer institute-common terminology criteria adverse event , version 5 . 0 . result : 67 patient tnbc finish treatment sg , mean age sg initiation be 51 . 5 ± 12 . 4 year . premedication first cycle include corticosteroid and 5-ht3 receptor antagonist 66 ( 99 % ) and 65 ( 97 % ) patient , respectively ; acetaminophen 57 patient ( 85 % ) , h1 blocker 53 patient ( 79 % ) , and h2 blocker 52 patient ( 78 % ) . g-csf be use primary prophylaxis 27 patient ( 40 % ) and require 53 patient ( 79 % ) treatment . atropine premedication be need 4 patient ( 6 % ) grade 3 diarrhea secondary prophylaxis . conclusion : most patient receive standardized premedication regimen , but significant variability be observe g-csf use neutropenia prophylaxis . only 6 % patient require atropine diarrhea premedication . practice regard use g-csf varied center , reflect evolve smpc guidance and individual risk-based approach neutropenia management .",Supportive care in cancer : official journal of the Multinational Association of,28/09/2025
10.1038/s41467-025-63371-9,spatially-restricte inflammation-induced senescent-like glia multiple,"Fagiani F, Pedrini E, Martire MS, Gastoldi G, Vanden Bulcke C, Lin JP, Maric D, Brambilla E, Ruffini F, Peri C, Calabresi PA, Maggi P, Panina-Bordignon P, Martino G, Reich DS, Absinta M","multiple sclerosis ( ms ) , chronic compartmentalized inflammation be think to drive relentless clinical deterioration . here , investigate link unresolved parenchymal inflammation and cellular senescence ms progression . single-cell transcriptomic analysis human brain tissue reveal accumulation senescent-like glial cell diseased white matter , especially chronic active lesion , and less extent cortex . spatial transcriptomic show gradient senescence-like signature extend lesion core periplaque region , alongside rewire cellular network . experimental induction senescence ms hipsc-derive neural organoid demonstrate microglia be especially vulnerable inflammation-induced senescence , can be partially rescue cns-penetrant anti-inflammatory drug . patient level ( n = 466 ) , increase 3 t mri-estimate brain-age be observe , especially individual more four chronic active lesion . finding suggest chronic inflammation might accelerate senescence-like process , potentially contribute to disease progression , and modulation might help limit further propagation .",Nature communications,26/09/2025
10.1186/s40001-025-03122-0,association asthma and thyroid function as well thyroid hormone,"Li K, Ding Q, Liu R, Lin S, Qiu R, Wu G","objective : thyroid hormone significantly influence multiple physiological system , particularly respiratory system . limited research asthma-thyroid association , emerge study have begin explore link . cross-sectional study investigate relationship asthma , thyroid function , and thyroid hormone sensitivity u . s . adult use nhanes datum . method : total 8160 participant be include study . weight analysis datum 2007-2012 national health and nutrition examination survey ( nhanes ) be perform to examine association asthma , thyroid function , and thyroid hormone sensitivity index . subgroup analysis and roc curve investigation be also conduct . additionally , retrospective cohort 30 asthma patient and 30 non-asthmatic control see zhongshan hospital , xiamen university july 2023 and july 2025 be extract ; ft3 level be compare and asthma control be evaluate ft3 tertile . thyroid function parameter assess be follow : free triiodothyronine ( ft3 ) , free thyroxine ( ft4 ) , total triiodothyronine ( tt3 ) , total thyroxine ( tt4 ) , thyroid-stimulate hormone ( tsh ) , thyroid peroxidase antibody ( tpoab ) , thyroglobulin antibody ( tgab ) , and thyroglobulin ( tg ) . thyroid hormone sensitivity indices-namely , ft3/ft4 ratio , thyrotroph t4 resistance index ( tt4ri ) , thyroid-stimulate hormone index ( tshi ) , and thyroid feedback quantile index ( tfqi)-were calculate serum ft3 , ft4 , and tsh value . result : asthmatic exhibit high ft3 and ft3/ft4 level but low tpoab non-asthmatic . however , adjusted model ( 2 and 3 ) reveal inverse association asthma risk and ft3/ft4 ( β : - 0 . 05 , 95 % ci - 0 . 09 to - 0 . 01 ) . quartile stratification maintain inverse trend , significant dose-response relationship unadjusted model 1 ( p < 0 . 05 ) . subgroup analysis show mexican american asthmatic have low ft3 and ft3/ft4 level . roc curve indicate superior predictive accuracy tpoab ( auc = 0 . 60 ) compare ft3/ft4 . institutional validation reveal asthma patient have significantly low ft3 level control , and high ft3 be associate low proportion acute exacerbation ; however , trend do not reach statistical significance . conclusion : ft3 and ft3/ft4 level may inversely correlate asthma risk , causality remain unclear to study design limitation . further research be warrant .",European journal of medical research,27/09/2025
10.1038/s42003-025-08841-y,isoleucyl-trna synthetase depletion reveal vulnerability mycobacterium,"Luo D, Xie W, Wang C, Sun Y, Zhang L, Qian L, Zhang J, Dang G, Liu S, Wang Z","mycobacterium abscessus and mycobacterium marinum be nontuberculous mycobacteria pose significant challenge high drug resistance and persistence hostile host environment . aminoacyl-trna synthetase , such isoleucyl-trna synthetase ( ilers ) , be crucial protein synthesis and represent promise target antimicrobial development . study investigate role ilers mycobacterial growth , metabolism , and pathogenesis use conditional gene silence combine microbiological , metabolomic , and transcriptomic analysis . finding indicate ilers be essential mycobacterial growth and survival infection . depletion ilers disrupt branched-chain amino acid and pantothenate biosynthesis , lead metabolic vulnerability and impair persistence macrophage and mouse infection model . base metabolic finding , test drug susceptibility and find depletion ilers enhance sensitivity pyrazinamide , highlight synergistic effect could improve tuberculosis treatment . furthermore , global gene set enrichment analysis reveal ilers knockdown might promote bacterial clearance upregulate cholesterol metabolism and lysosome organization process macrophage . result establish ilers potential therapeutic target , offer new insight reduce drug resistance and enhance current treatment regimen mycobacterial infection , include tuberculosis .",Communications biology,29/09/2025
10.1016/j.cell.2025.08.039,intrinsic heterogeneity primary cilia reveal spatial proteomic .,"Hansen JN, Sun H, Kahnert K, Westenius E, Johannesson A, Villegas C, Le T, Tzavlaki K, Winsnes C, Pohjanen E, Mäkiniemi A, Fall J, Ballllosera Navarro F, Bäckström A, Lindskog C, Johansson F, von Feilitzen K, Delgado-Vega AM, Martinez Casals A, Mahdessian D, Uhlén M, Sheu SH, Lindstrand A, Axelsson U, Lundberg E","primary cilia be critical organelle find most human cell . dysfunction be link hereditary ciliopathie wide phenotypic spectrum . significance , specific role cilia different cell type remain poorly understand limitation analyze ciliary protein composition . employ antibody-based spatial proteomic to expand human protein atlas primary cilia . analysis identify subciliary location 715 protein three cell line , examine 128 , 156 individual cilia . find 69 % ciliary proteome be cell-type specific , and 78 % exhibit single-cilia heterogeneity . finding portray cilia sensor tune proteome to effectively sense environment and compute cellular response . reveal 91 cilia protein and find genetic candidate variant creb3 one clinical case feature overlap ciliopathy phenotype . open , spatial cilia atlas advance research cilia and ciliopathie .",Cell,25/09/2025
10.1038/s41413-025-00456-7,unravel mechanism bone disease : target dendritic cell,"Chen Y, Wang S, Chen X, Wu Z, He F, Chen Q","bone repair and regeneration be complex spatiotemporal process recruit variety cell type , need to precisely mediate effective healing post-damage . concept osteoimmunology emphasize extensive and intricate crosstalk bone and immune system . significant advancement understand osteoimmunology , precise role dendritic cell ( dcs ) field remain investigation . key antigen-presenting cell , dcs be critical orchestrate adaptive immune response and maintain tissue homeostasis . recent research have far reveal potential dcs to influence development or acceleration inflammatory and autoimmune bone disease , as well interaction skeletal cell context bone repair and regeneration . therefore , in-depth understanding dcs osteoimmunology would be valuable . herein , discuss effect dcs bone homeostasis and bone-related disease ( i.e. , rheumatoid arthritis ( ra ) , periodontitis , bone regeneration , and other bone abnormality disease ) , and introduce innovative dcs-targeting biomaterial , aim promote bone repair and regeneration . furthermore , summarize underlie crosstalk dcs and other cell ( i.e. , osteoclast , mesenchymal stromal stem cell ( mscs ) , hematopoietic stem and progenitor cell ( hspc ) , t and b cell ) bone homeostasis and bone-related disease . conclusion , propose osteoimmunology offer promising perspective unravel mechanism bone-related disease ; meanwhile , target dcs perspective osteoimmunology may provide innovative idea and resolution to achieve internal homeostasis balance .",Bone research,28/09/2025
10.1093/brain/awaf360,myc-driven gliosis impair neuron-glia communication amyotrophic lateral,"Fioretti PV, Barbieri A, Migazzi A, Bressan D, Grassano M, Donini L, Roccuzzo M, Torrieri MC, Conci F, Ferracci E, Invernizzi S, Bowden KM, Bacchetti F, Cappelli S, Peroni D, Belli R, Pancher M, Mugoni V, Scarduelli G, Gianesello M, Pasetto L, Canarutto G, Carra S, Soldano A, Bisio A, Robbiati S, Valentini C, Nardella C, Piazza S, D'Agostino VG, Quattrone A, Sleiman S, Whitfield JR, Soucek L, Vignoli B, Viero G, Tiberi L, Zippo A, Demichelis F, Bonetto V, Milanese M, Buratti E, Verde F, Ticozzi N, Calvo A, Ratti A, Shaw PJ, Terenzio M, Chiacchiera F, Pennuto M, Basso M","chronic activation glial cell lead dysfunction and degeneration motor and cortical neuron amyotrophic lateral sclerosis ( als ) and frontotemporal dementia ( ftd ) unknown mechanism . to shed light molecular pathogenetic process underlie exordium and contribution gliosis to disease onset and progression , use cell , mouse , and patient-derived cell modeling tdp-43 , sod1 , and c9orf72-linked and sporadic als . datum reveal sequential disease progression , start enhanced glial reactivity and proliferation , and transition inflammation upregulation pro-inflammatory gene . use mouse genetic , show expression mutant tdp-43 astrocyte be necessary to cause gliosis and behavioral abnormality . mechanistically , show glial myc gain-of-function drive neurodegeneration promote release astrocyte-derived ev nonetheless fail to provide trophic support surround neuron . research reveal novel functional role myc glia-to-neuron miscommunication als .",Brain : a journal of neurology,26/09/2025
10.1080/19490976.2025.2558071,systemic and gut microbiome change metformin and liraglutide youth-onset,"Glaros SB, Mishra SP, Jain S, Davis FS, Gabel SA, Mueller GA, Jarmusch AK, Mabundo L, Courville AB, Walter MF, Walter PJ, Overdahl KE, Yadav H, Chung ST","metformin ( met ) and liraglutide ( lira ) be preferred diabetes therapy may improve glycemia modulate gut microbiome , but mechanism and pathway be unknown and few datum exist youth-onset type 2 diabetes ( y-t2d ) . 3-month parallel clinical trial african american y-t2d randomize met ( n = 14 ) or met+lira ( n = 11 ) , compare gut microbial composition and metabolomic profile and determine relationship change microbial abundance glycemia and plasma metabolite . 3 month , met be associate great relative abundance eubacterium and eubacterium rectale and low bacteroides ovate ( p < 0 . 05 ) . met+lira be associate great bacteroides fragili and low streptococcus thermophilus ( p < 0 . 05 ) . met group have increase ( > 1 . 5-fold ) plasma cholic secondary bile acid ( sulfochenodeoxycholic acid , nutriacholic acid , alpha-muricholic acid , and c24 dihydroxy bile acid ; p ≤ 0 . 002 ) . change nutriacholic acid correlate low fast glucose ( r = -0 . 7 , p < 0 . 05 ) . shift microbiota taxa be not associate plasma short-chain fatty acid ( scfa ) , hemoglobin a1c or glucose . short-term met and met+lira y-t2d be relate distinct shift bile acid and scfa-produce gut microbiota taxa , and secondary bile acid metabolite correlate improved glycemia , suggest bile acid pathway may be important modulator glycemia youth metformin . clinical trials.gov identifi : nct02960659 .",Gut microbes,01/12/2025
10.1038/s41564-025-02126-0,epstein-barr virus exploit desmocollin 2 principal epithelial cell entry,"Wang H, Mou Z, Yeo YY, Ge Q, Liu X, Narita Y, Li Z, Wang C, Li W, Zhao KR, Li J, Bu W, Gewurz B, Cohen JI, Teng M, Dai X, Liu X, Jiang S, Zhao B","epstein-barr virus ( ebv ) infect b and epithelial cell , cause various lymphoma and epithelial malignancy . cell-free infection epithelial cell be inefficient , direct b-epithelial cell contact infection be highly efficient and probably dominant route . to identify mechanism contact-mediated infection , implement genome-wide crispr screen and uncover desmocollin 2 ( dsc2 ) ebv epithelial receptor and dsc3 co-factor infection . dsc2 and dsc3 double knockout significantly inhibit cell-free and cell-cell contact ebv infection normal oral keratinocyte , overexpression permit infection receptor-negative cell . antibodie dsc2 block infection normal oral keratinocyte , primary oral keratinocyte , and head and neck epithelial organoid . combine dsc2 and dsc3 antibodies efficiently block cell-cell contact infection . mechanistically , dsc2 interact ebv gh/gl glycoprotein and facilitate epithelial fusion . notably , epha2 overexpression fail to restore infection dsc2/3-deficient cell , indicate dependence dsc2/3 . finding establish dsc2 principal ebv entry receptor and target vaccine and therapeutic development .",Nature microbiology,26/09/2025
10.1161/CIRCULATIONAHA.125.075150,targeting calcium regulation heart failure and arrhythmia therapeutic : a,"Redel-Traub G, Marx SO, Marks AR","advance pharmacologic and procedural therapy , heart failure ( hf ) and cardiac arrhythmia remain significant global health burden , highlight urgent need novel therapeutic strategy . defective ca(2 + ) handling cardiac myocyte be recognize central pathogenic mechanism underlie heart failure and atrial and ventricular arrhythmia . review , critically assess current state research ca(2+)-handling protein and role cause heart failure and arrhythmia , highlight therapeutic implication . recent paradigm-shifting discovery , clinical trial outcome , and challenge target ca(2+)-handling protein be examine . outline review , improved understanding relevant protein and differential expression and function human health and disease be crucial develop ca(2 + ) handling-targeted therapeutic can fundamentally alter natural history heart failure and arrhythmia .",Circulation,30/09/2025
10.1161/CIRCULATIONAHA.125.074959,single-cell splicing isoform atlas adult human heart and heart failure .,"Pan T, Lu L, Youker K, Shiau CK, Wang M, Lin HY, Nguyen A, He Y, Tong E, Zhu P, Ranka R, Yan Y, Sinha A, Bharat A, Eagar T, Wilcox J, Bhimaraj A, Gao R","background : alternative splicing play crucial role normal heart development and cardiac disease influence protein-coding sequence , functional domain , and molecular network . however , detailed characterization human heart isoform landscape remain incomplete . methods : leverage long-read single-nucleus rna sequence and computational analysis , dissect full-length isoform heterogeneity , expression pattern , and usage shift cell type , cell state , and cardiac condition adult leave ventricle . apply silico approach to assess functional relevance identify isoform ; validate isoform composition representative cardiac gene use reverse transcription quantitative polymerase chain reaction and targeted amplicon sequence ; and develop web server interactive navigation result . result : datum reveal isoform heterogeneity be widespread cardiac cellular system , serve posttranscriptional buffer system calibrate molecule reservoir human heart . healthy left ventricle , ≈30 % cell type-specific gene be polyform , use multiple isoform tailor to cell type-specific program . ubiquitously express gene , > 300 show differential isoform usage cell type specificity . compare heart failure , 379 gene cardiomyocyte demonstrate marked isoform usage shift , most be predict to change protein code outcome direct change protein coding sequence and switch intron retention and non-protein-coding biotype . contrast , cell state-specific program tend to operate monoform gene associate change cell state . addition , datum reveal heart failure-associated differential isoform usage event stromal and immune cell type cardiac microenvironment . conclusion : present comprehensive atla splice isoform normal adult heart and heart failure long-read single-nucleus rna sequence and comprehensive computational analysis . result suggest crucial role isoform buffer core cellular program and contribute disease-associated cell state . full-length detail cell-specific isoform serve important reference downstream translational and mechanistic study and be available online datum portal https://github.com/gaolabtools/heart-isoform-atla .",Circulation,29/09/2025
10.3389/fimmu.2025.1653456,continuation atezolizumab plus bevacizumab initial progressive disease :,"Tabuchi T, Taniki N, Ojiro K, Kasuga R, Nakadai Y, Chu PS, Usui S, Shiba S, Tahara T, Komatsu H, Fujita Y, Kaneko F, Hoshi H, Yamaguchi A, Fukuhara S, Okamura Y, Kanamori H, Ebinuma H, Tamura M, Tsukada J, Hasegawa Y, Abe Y, Kitago M, Jinzaki M, Kitagawa Y, Kanai T, Nakamoto N","background : clinical significance treatment progression ( tbp ) immune checkpoint inhibitor-based therapy hepatocellular carcinoma ( hcc ) remain unclear . atezolizumab plus bevacizumab have become first-line therapy advanced hcc , understand real-world outcome tbp be increasingly relevant . method : conduct multicenter retrospective observational study involve 122 patient unresectable hcc treat atezolizumab plus bevacizumab nine liver center japan . patient experience radiologic progressive disease ( pd ) , clinical outcome be compare continue treatment progression ( tbp group ) and discontinue therapy . overall survival ( os ) , tumor response , and subgroup analysis base major vessel involvement ( mvi ) be evaluate . result : patient pd , median os be not reach tbp group , compare 13 . 6 month non-tbp group ( hr 2 . 04 ; 95 % ci 1 . 02-4 . 07 ; p=0 . 0435 ) . stratify mvi status , patient mvi receive tbp have significantly long os ( median not reach ) receive palliative care ( median 6 . 2 month ; hr 11 . 2 ; 95 % ci 3 . 89-32 . 5 ; p<0 . 001 ) . patient mvi , tbp do not confer os benefit palliative care ( median os : 10 . 4 month 7 . 4 month ; hr 2 . 24 ; p=0 . 260 ) , switch subsequent chemotherapy show improved os ( median 23 . 1 month 7 . 4 month ; hr 7 . 33 ; 95 % ci 1 . 44-37 . 3 ; p=0 . 0164 ) . multivariate analysis identify mvi independent negative prognostic factor ( hr 5 . 17 ; 95 % ci 1 . 34-20 . 0 ; p=0 . 0172 ) , even adjust afp ratio progression . conclusion : multicenter study suggest continuation atezolizumab plus bevacizumab radiologic progression may improve survival outcome select patient unresectable hcc , particularly major vessel involvement . finding support integration tbp personalized treatment strategy advanced hcc .",Frontiers in immunology,01/01/2025
10.1007/s00262-025-04143-8,efficacy and safety two-year fix continuous immune checkpoint,"Pandey T, Bhatti SA","background : optimal duration immune checkpoint inhibitor ( ici ) therapy advanced or metastatic non-small cell lung cancer ( amnsclc ) be unknown . most trial either continue ici indefinitely or electively stop two year progressive disease ( pd ) or treatment-limite immune-related adverse event ( iraes ) emerge . method : systematic review randomize control trial ( rcts ) and real-world evidence study ( rwes ) be perform adult amnsclc treat ici therapy august 24 , 2024 . patient be divide two cohort : 2 year fix cohort ici therapy be discontinue 2 year and continuous therapy cohort ici therapy be continue 2 year . result : twenty study and 5027 patient be include . 5-year overall survival ( os ) rate two-year fix cohort range 69 to 83 % study and be comparable continuous therapy cohort . four rwe compare survival outcome 2 year fixed and continuous cohort and find difference . patient complete 2 year therapy rcts tend to have great rate irae compare baseline rct population . three rwe report high rate iraes continuous two-year fix cohort . many patient develop pd two-year mark cohort remain alive data cutoff . larger/academic center favor two-year fix therapy compare community center . conclusion : survival outcome ici discontinuation 2 year be comparable continuous therapy amnsclc . iraes tend to accumulate time .","Cancer immunology, immunotherapy : CII",29/09/2025
10.3390/jcdd12090363,association pan-immune-inflammation value all-cause and cardiovascular,"Liu Q, Yang W, Zhang R, Guo X, Wei Y","background : inflammatory response critically impact long-term outcome myocardial infarction ( mi ) survivor , yet few biomarker comprehensively evaluate systemic immune-inflammatory status . study assess prognostic utility novel pan-immune-inflammation value ( predict all-cause and cardiovascular mortality post-mi . methods : use national health and nutrition examination survey datum ( 2001-2018 ) , 1559 mi survivor be include . piv be calculate ( neutrophil × platelet × monocytes)/lymphocyte . weighted cox model assess association log-transformed piv ( lnpiv ) and mortality . restrict cubic spline ( rcs ) model explore non-linear dose-response relationship , and predictive performance be evaluate time-dependent roc analysis . result : median 75-month follow-up , 675 death occur . lnpiv show significant non-linear association all-cause ( p < 0 . 0001 ) and cardiovascular mortality ( p = 0 . 0471 ) . lnpiv ≥ 5 . 59 , unit increase be associate 85 % ( hr = 1 . 85 , 95 % ci : 1 . 49-2 . 28 ) high all-cause mortality risk ; cardiovascular mortality , risk increase 77 % ( hr = 1 . 77 , 95 % ci : 1 . 20-2 . 63 ) lnpiv ≥ 5 . 68 . time-dependent roc analysis confirm strong prediction threshold . conclusion : piv demonstrate threshold-dependent mortality risk stratification mi patient , particularly effective high-inflammatory subgroup , offer potential tool personalized risk stratification .",Journal of cardiovascular development and disease,17/09/2025
10.1016/j.medcli.2025.107184,glp-1-base therapy obesity : impact comorbiditie or obesity-related,"Vilarrasa N, Pellitero S","agent target glucagon-like peptide-1 receptor ( glp-1r ) be effective manage metabolic condition associate obesity , such obstructive sleep apnea ( osa ) , metabolic dysfunction-associated steatotic liver disease ( masld ) , and chronic kidney disease ( ckd ) . osa , study first generation glp-1r agonist ( arglp-1 ) and co-agonist ( glp-1/gip ) have demonstrate significant improvement apnea-hypopnea index and weight reduction . masld , glp-1ras and co-agonist ( glp-1/gip or glp-1/glucagon ) have show efficacy reduce hepatic fat , improve fibrosis , and resolve steatohepatitis , promising result trial such essence and synergy-nash . ckd , semaglutide have be associate reduction renal event and slow disease progression . metabolic and cardiovascular benefit , agent represent comprehensive approach treat obesity and complication , ongoing research explore potential indication chronic inflammatory disease such psoriasis and hidradenitis suppurativa .",Medicina clinica,27/09/2025
10.1016/j.jacc.2025.08.047,inflammation and cardiovascular disease : 2025 acc scientific statement : report,"Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK","crucial role inflammation pathogenesis and clinical outcome cardiovascular disease ( cvd ) have recently gain increase attention . particular , residual inflammation , measure high-sensitivity c-reactive protein ( hscrp ) remain strongly predictive recurrent event , even statin-treated patient . similarly , elevated hscrp apparently healthy individual identify higher-risk group statin therapy significantly reduce risk first major cvd event even ldl-cholesterol be normal . report provide update understanding role chronic , low-grade inflammation cvd and highlight new seminal research finding , especially atherosclerosis , myocardial infarction , heart failure , and pericarditis . consensus recommendation be summarize screening , evaluation , and cvd risk assessment ; inflammatory biomarker cardiovascular imaging ; inflammation inhibition behavioral and lifestyle risk ; and anti-inflammatory approach primary and secondary prevention as well heart failure and other cvd . report also address current challenge and future opportunity . example , caution not trial anti-inflammatory therapy secondary prevention have be successful and such trial evidence be need broad recommendation other agent can be make . additionally , successful trial , interplay inflammation and key physiological system often remain incompletely examine . promising area research be role novel special pro-resolving bioactive lipid molecule play promote resolution inflammation and cvd risk reduction . aggregate , evidence link inflammation atherosclerotic cvd be no long exploratory but be compelling and clinically actionable . time take action have now arrive .",Journal of the American College of Cardiology,29/09/2025
10.1002/advs.202509781,procyanidin b3 and derivative alleviate neuronal injury target g3bp1,"Zhang H, Zhang Y, Chen Y, Zhong W, Tan S, Wang J, Yan H, Yan N, Lin M, Liu X, Chang J","ischemic stroke ( is ) be lead cause mortality and disability worldwide , but effective therapeutic option be limited . study , chemical proteomic strategy be employ use active compound procyanidin b3 ( pb3 ) chemical probe to identify therapeutic target is . be discover ras gtpase-activate protein sh3 domain-binding protein 1 ( g3bp1 ) be key target pb3 , exert neuroprotective effect inhibit degradation stress granule and reduce apoptosis . base finding , 14 pb3 derivative be design and synthesize , compound 6c exhibit potent neuroprotective activity and favorable blood-brain barrier permeability . study not only establish g3bp1 promising therapeutic target is but also highlight potential pb3 and derivative development is therapeutic agent .","Advanced science (Weinheim, Baden-Wurttemberg, Germany)",26/09/2025
10.1126/sciadv.adw9275,reinforce plant-derived lipid nanoparticle oral precise epigenome editing,"Gao Q, Gao Y, Cao Y, Xu H, Ma Y, Zu M, Yang Q, Yang K, Zhu Z, Liu C, Shi X, Reis RL, Kundu SC, Ma S, Han H, Xiao B","clinical application crispr-cas9 remain limited delivery challenge , particularly oral administration . lysine-specific demethylase 1 ( lsd1 ) play key role colonic inflammation and tumorigenesis . here , develop oral genome-editing platform ( tpgs-rnp@lnp ) , lsd1-targeting ribonucleoprotein ( rnps ) be encapsulate mulberry leaf lipid nanoparticle ( lnp ) and formulate d-α-tocopherol polyethylene glycol succinate ( tpgs ) . tpgs reinforce lipid bilayer lnp , enhance gastrointestinal stability , and facilitate colonic mucus penetration . galactose receptor-mediated endocytosis tpgs-rnp@lnps macrophage , fusion endosomal membrane and presence nuclear localization signal ensure nuclear delivery rnp . tpgs-rnp@lnps achieve 59 . 7 % lsd1 edit efficiency macrophage , surpass commercial crisprmax ( 43 . 0 % ) . oral tpgs-rnp@lnps promote h3k4 methylation to modulate epigenetic state , achieve inflammation mitigation , epithelial barrier restoration , and retardation colitis and associated tumorigenesis . lnp-based oral rnp delivery system , tpgs-rnp@lnps provide promising platform precise treatment colorectal disease .",Science advances,26/09/2025
10.1186/s13020-025-01189-9,salvianolic acid b and senkyunolide synergistically alleviate cardiac,"Liu C, Guo R, Zhou Y, Zhu M, Shao L, Wang Y, Zhao L","background : cardiac hypertrophy , characterize thickening heart muscle , arise factor such hypertension and genetic mutation , often lead adverse outcome heart failure and arrhythmia . guanxinne tablet ( gxnt ) , botanical drug compose blood-activating herb salvia miltiorrhiza bunge . and ligusticum striatum dc . , be widely use treatment cardiovascular disease . however , active ingredient and molecular mechanism be yet to be fully understand . method : evaluate anti-hypertrophic effect gxnt and screen active substance cardiac function live-image aristolochic acid a-stimulate zebrafish cardiac hypertrophy model , and f-actin immunostaine phenylephrine-induced hypertrophic nrcms model . additionally , protective effect gxnt 's active substance be analyze mouse model cardiac hypertrophy use echocardiography , histopathology analysis , and western blotting . result : anti-hypertrophic effect gxnt be assess use aristolochic acid a-stimulate zebrafish model and phenylephrine-induced hypertrophic nrcm . gxnt demonstrate significant anti-hypertrophic effect model . phenotypic screening identify senkyunolide ( sen i ) ligusticum striatum active component zebrafish model , salvianolic acid b ( sal b ) and rosmarinic acid salvia miltiorrhiza emerge key anti-hypertrophic compound nrcm . mouse model isoproterenol-induced cardiac hypertrophy , sal b and sen show synergistic effect , improve cardiac function , reduce oxidative stress , and suppress inflammation . mechanistically , transcriptomic sequence highlight cooperative modulation map3k1 signal two compound . notably , sirna-mediated knockdown map3k1 cardiomyocyte attenuate hypertrophic phenotype , support essential role pathological process . molecular docking and dynamic simulation far support bind potential map3k1 . conclusion : finding underscore gxnt 's potent anti-hypertrophic effect , possibly drive synergistic action sal b and sen i , and offer insight therapeutic potential map3k1 signal regulation .",Chinese medicine,28/09/2025
10.1126/sciimmunol.adx1582,design potent interleukin-21 mimic cancer immunotherapy .,"Chun JH, Lim BS, Roy S, Walsh MJ, Abhiraman GC, Zhangxu K, Atajanova T, Revach OY, Clark EC, Li P, Palin CA, Khanna A, Tower S, Kureshi R, Hoffman MT, Sharova T, Lawless A, Cohen S, Boland GM, Nguyen T, Peprah F, Tello JG, Liu SY, Kim CJ, Shin H, Quijano-Rubio A, Jude KM, Gerben S, Murray A, Heine P, DeWitt M, Ulge UY, Carter L, King NP, Silva DA, Kueh HY, Kalia V, Sarkar S, Jenkins RW, Garcia KC, Leonard WJ, Dougan M, Dougan SK, Baker D","long-stande goal cancer immunotherapy be to activate cytotoxic antitumor t cell range affinity tumor antigen suppress regulatory t cell . computational protein design have enable precise tailoring protein to meet specific need . here , report de novo design",Science immunology,26/09/2025
10.1038/s41573-025-01291-5,vivo chimeric antigen receptor ( car)-t cell therapy .,"Bot A, Scharenberg A, Friedman K, Guey L, Hofmeister R, Andorko JI, Klichinsky M, Neumann F, Shah JV, Swayer AJ, Trudeau K, Weissman D, Stephan MT, Buchholz CJ, June CH","chimeric antigen receptor ( car)-t cell therapy have transform outcome patient haematological malignancy , yet use be limit labour-intensive manufacturing , constrain production capacity and variable clinical performance . vivo car-t cell engineering , car-t cell be generate directly patient 's body , seek to overcome challenge eliminate need ex vivo cell processing and complex logistic , as well improve clinical performance . recent advance virology , rna medicine and nanotechnology have catalyse radical overhaul approach , use target delivery system such lentiviral vector and lipid nanoparticle to introduce car-encode genetic material endogenous t cell . early clinical study have show efficient transduction , sustain car expression and initial sign antitumour activity , establish proof concept . review explore underlie technology - include rna deliver lipid nanoparticle and engineer viral vector - and discuss be be adapt to develop more broadly applicable , scalable , safe and effective car-t cell therapy . remove need ex vivo manipulation and chemotherapeutic conditioning , strategy could enable wide application car-t cell therapy not just blood cancer but autoimmune disease ex vivo car-t cell therapy have show strong promise , such systemic lupus erythematosus .",Nature reviews. Drug discovery,30/09/2025
10.1007/s00280-025-04822-4,non-oncologic oncologic drug : systematic review drug repurpose,"Dhanush Y, Ganesh VS","purpose : systematic review investigate drug repurpose strategy to accelerate and improve cancer treatment specifically examine exist medication can effectively target establish hallmark cancer . research explore repurposed drug can address challenge conventional cancer drug development , include high cost , lengthy development timeline , and frequent clinical failure . method : review systematically analyze repurpose drug ability to target specific cancer hallmark , include oncogenic signal pathway , cell death regulation , metabolic reprogramming , growth suppressor reactivation , phenotypic plasticity , antitumor immunity , telomerase activity , angiogenesis , inflammation , cellular senescence , invasion and metastasis , dna damage response , microbiome modulation , and epigenetic regulation . result : analysis identify several promising repurpose medication target specific cancer hallmark : artemisinin derivative oncogenic signalling , niclosamide cell death pathway , leflunomide metabolic dysregulation , statin tumour suppressor reactivation , metformin phenotypic plasticity , liothyronine immune activation , parp inhibitor replication , itraconazole angiogenesis , celecoxib inflammation , bcl-2 inhibitor senescence , fluoroquinolone metastasis , spironolactone dna damage , isoliquiritigenin microbiome modulation , and various agent target non-mutational epigenetic regulation . conclusion : drug repurposing represent intriguing approach address limitation traditional cancer drug development effectively target fundamental hallmark cancer . leverage exist medication established safety profile , strategy offer potential more rapid translation clinical application and may enhance therapeutic arsenal various cancer type .",Cancer chemotherapy and pharmacology,27/09/2025
10.1093/europace/euaf242,peri-procedure and mid-long term effects pulse field ablation thermal,"Graeger S, Narayan SM, Meyer C, Linz D, Rillig A, Zylla MM, Ebrahimi R, Duru F, Perrotta L, Neven K, Heeger CH, Ruwald MH, Futyma P, Mulder BA, Mirzayeva G, Kiuchi MG, Martinek M, Pürerfellner H, Boveda S, Yin Y, Yang G, Liu H, Chen M, Schmidt B, Chun JKR, Qin M, Hou X, Liu X, Zhong J, Chen S","background/aim : ablation modality differ mechanism action , tissue specificity , and collateral effects-particularly cardiac-autonomic-nervous-system . study aim to compare autonomic effect pulse field ablation ( pfa ) thermal ablation ( ta ) patient atrial fibrillation ( af ) pooled-analysis . method : systematic search pubmed and embase be conduct april 5 , 2025 , to identify comparative study . primary outcome be increase-in-heart-rate ( ihr ) ablation , and secondary outcome be increase serum s100b ( is100b ) , marker neural injury . result : eight study involve 1007 af patient be include ( mean age : 63 , 39 ± 10 , 75 year ; 36 . 3 % female ; maximum follow-up : 12 month ) . baseline characteristic , include use antiarrhythmic drug , be similar pfa and ta group . pooled-analysis show pfa be associate significantly low ihr compare ta ( pfa : 4 . 41 ± 8 . 86 bpm ta : 10 . 81 ± 10 . 46 bpm ; p < 0 . 00001 ) . difference persist midterm ( 3-6 month ) and long-term ( 12 month ) follow-up and remain consistent age , sex , and different ta modality ( cryoballoon radiofrequency ) . correspondingly , is100b be significantly less pronounce pfa ( pfa : 33 . 27 ± 9 . 46 pg/ml ta : 97 . 53 ± 31 . 88 pg/ml ; p < 0 . 00001 ) . conclusion :","Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal",29/09/2025
10.1177/17534666251379586,clinical predictive model long-term survival progressive fibrosis,"Gu JM, Xiao SY, Chen BT, Kang ST, Li WC, Zhang MY, Yu Y, Han GL","background : patient chronic fibrose interstitial lung disease ( ild ) , may develop progressive fibrosing ( pf ) phenotype , present rapid progression and often result poor clinical outcome . objective : objective study be to construct and test model to identify independent predictor mortality pf-ild and to trace lung function trajectory patient pf-ild . design : multicenter retrospective cohort study enrol patient pf-ild two distinct center 8-year follow-up to develop and validate prognostic nomogram base clinical factor and assess longitudinal lung function trajectory . method : enrol patient diagnose pf-ild china-japan friendship hospital ( training cohort ) and jiulongpo hospital traditional chinese medicine ( validation cohort ) . survival status be record 8-year follow-up period . clinical demographic , laboratory datum , pulmonary function test ( pft ) result , and high-resolution computed tomography result be collect analysis . training cohort patient pf-ild be use to identify predictor mortality , be then validate external cohort . nomogram be establish base multivariate factor . predictive performance model be evaluate use receiver operate characteristic curve and calibration curve . survival estimate be perform use kaplan-mei method and compare use log-rank test . pft trajectory be estimate use linear mixed model . result : total 1419 patient pf-ild china-japan friendship hospital ( training cohort ) and 282 patient pf-ild jiulongpo hospital traditional chinese medicine ( validation cohort ) be enrol . 8-year follow-up , 150 ( 10 . 57 % ) patient receive lung transplantation , 43 . 55 % ( n = 618 ) case reach mortality , median survival time 53 month bj cohort . predictive model be build base ild subgroup , baseline forced vital capacity%(pred ) ( fvc%pred ) , baseline diffusing capacity lung carbon monoxide%(pred ) ( dlco%pre ) , age diagnosis , antifibrosis treatment , gastroesophageal reflux complication , c-reactive protein level , and bmi . also find aes and progressive decline fvc and dlco , particularly third year post-diagnosis , be strongly associate poor prognosis and may serve important longitudinal biomarker risk stratification pf-ild . conclusion : predictive model incorporate multiple factor effectively predict 8-year survival patient pf-ild . addition baseline predictor , aes and progressive decline fvc and dlco be strongly associate poor prognosis and may serve valuable longitudinal biomarker ongoing risk stratification .",Therapeutic advances in respiratory disease,01/12/2025
10.1097/ICL.0000000000001214,comparison corneal high-order aberration and relative corneal refractive,"Zhang R, Zhou Y, Ou Y, Chin MP, Li J, Jhanji V, Zhang M","purpose : study compare myopia control effect corneal high-order aberration ( choa ) two orthokeratology ( ok ) lense base relative corneal refractive power shift . method : prospective cohort study , 101 school child low to moderate myopia be divide three group : group a ( n=35 ) use 3-curve design lense , group b ( n=31 ) use 4-curve design lense , and group c ( n=35 ) wear regular spectacle . cycloplegic refraction , visual acuity , and axial length ( al ) be measure baseline and one year . keratometry and choa be assess before and 3 month lens wear . relative corneal refractive power shift and sum corneal power change ( scpc ) be calculate . one-way anova and plan comparison analyze group difference . result : group b show significantly slow al elongation group a ( p=0 . 017 ) ok treatment . group b 's scpc be significantly high group a 's ( p≤0 . 005 ) . group b have significant increase horizontal coma ( p=0 . 004 ) . increase scpc lead more coma aberration four-curve lens wear ( p<0 . 01 ) . conclusion : four-curve lens design be more effective slow al elongation ok treatment . also cause significantly high horizontal coma aberration three-curve design .",Eye & contact lens,1/08/2025
10.1016/j.tem.2025.09.004,mechanism and therapeutic insight mash-associated fibrosis .,"Zhu Y, Cai B","metabolic dysfunction-associated steatohepatitis ( mash ) be progressive liver disease pose major global health concern , closely related rise prevalence obesity . liver fibrosis be primary determinant adverse outcome mash . increase worldwide prevalence , economic impact , and adverse outcome mash-associated fibrosis have spur extensive research to elucidate pathogenesis and to address treatment . however , intricate mechanism drive transition metabolic dysfunction clinically significant fibrosis be not fully understand . moreover , effective therapy , particularly direct antifibrotic agent , be still lack , recent approval resmetirom and semaglutide mash-associated fibrosis . here , review current insight mechanism mash-associated fibrosis and provide comprehensive overview emerge therapeutic strategy .",Trends in endocrinology and metabolism: TEM,26/09/2025
10.1056/NEJMoa2510209,nexiguran ziclumeran gene editing hereditary attr polyneuropathy .,"Gillmore JD, Gane E, Täubel J, Pilebro B, Echaniz-Laguna A, Kao J, Litchy W, Shahda S, Haagensen A, Walsh L, Smith D, Kachadourian J, Ward JH, Lebwohl D, Zhu P, Xu Y, Leung A, Sonderfan A, Gutstein DE, Manvelian G, Adams D","background : hereditary transthyretin amyloidosis polyneuropathy ( attrv-pn ) be rare , multisystem , progressive , debilitating , and fatal disease characterize tissue deposition misfolde transthyretin ( ttr ) peripheral nerve . nexiguran ziclumeran ( nex-z ) be investigational vivo therapy base crispr-cas9 ( cluster regularly interspace short palindromic repeat and associate cas9 endonuclease ) be design to reduce serum ttr level selective inactivation ttr liver . method : phase 1 , open-label study , administer one infusion nex-z patient attrv-pn . primary objective include assessment safety and pharmacodynamic nex-z . secondary end point include change familial amyloid polyneuropathy stage , polyneuropathy disability score , serum neurofilament light chain ( nfl ) level , modify body-mass index ( modify bmi , define conventional bmi [ weight kilogram divide square height meter ] multiply albumin level gram liter ) , and modify neuropathy impairment score+7 ( mnis+7 ; range , 0 304 , high score indicate more impairment ) . result : total 36 patient receive nex-z ; mean follow-up be 27 month . mean percent change baseline serum ttr level be -90 % day 28 , be sustain month 24 ( -92 % ) . treatment-relate adverse event include transient infusion-related reaction ( 21 patient ) , decrease thyroxine level hypothyroidism or elevated thyrotropin level ( 8) , and headache ( 4 ) . one participant die cardiac amyloidosis , and one withdraw owe progressive decline motor function . serious adverse event be report 11 patient . month 24 , familial amyloid polyneuropathy stage and polyneuropathy disability score remain stable 29 and 27 patient , respectively ; improve 2 and 5 , respectively ; and worsen 2 and 2 , respectively . mean change serum nfl level be -9 . 0 pg milliliter , and change modify bmi be 24 . 7 . mean change baseline mnis+7 be -8 . 5 . conclusion : single administration nex-z patient attrv-pn be associate rapid , deep , and durable reduction serum ttr level . result support further investigation nex-z to treat attrv-pn . ( fund intellia therapeutics and regeneron pharmaceuticals ; clinicaltrials.gov number , nct04601051 . ) .",The New England journal of medicine,25/09/2025
10.1001/jamainternmed.2025.4917,rise early-onset cancer us population-more apparent real .,"Patel VR, Adamson AS, Welch HG","importance : rise rate early-onset cancer have generate substantial medium coverage and public concern . response , early-onset cancer have become federal research priority , and clinical guideline have shift to recommend early screening cancer . yet , remain unclear rise rate represent true increase cancer occurrence or may instead be explain increase diagnostic scrutiny . observation : aggregate , 8 cancer fastest-rising incidence ( > 1 % year ) us adult young 50 year ( thyroid , anus , kidney , small intestine , colorectum , endometrium , pancrea , and myeloma ) have double incidence 1992 , aggregate mortality cancer have remain flat . colorectal and endometrial cancer show slight rise mortality ; other , stable or decline mortality rise diagnosis suggest great detection ( rather more disease ) account trend . cancer , such thyroid and kidney cancer , overdiagnosis be well document . other , incidental detection or early diagnosis may explain trend . not fast growing ( 0 . 6 % year ) , breast cancer remain most common early-onset cancer , and rise diagnosis woman young 50 year , mortality have decrease approximately half . conclusion and relevance : rise early-onset cancer incidence do not consistently signal rise occurrence clinically meaningful cancer . increase early-onset cancer be likely clinically meaningful , appear small and limited few cancer site . much increase appear to reflect increase diagnostic scrutiny and overdiagnosis . interpret rise incidence epidemic disease may lead unnecessary screening and treatment also divert attention other more pressing health threat young adult .",JAMA internal medicine,29/09/2025
10.13201/j.issn.1001-1781.2018.04.006,[ therapeutic effect psychological intervention combine manual reduction,"Wang X, Tian YJ, Shan J","objective : to explore good treatment elderly patient benign paroxysmal positional vertigo ( bppv ) . method : sixty-eight bppv patient age 60-85 year be randomly divide two group . control group be treat simple manipulation . study group be treat manual reduction combine psychological intervention . curative effect be compare . result : cure rate control group and study group be 44 . 4 % and 43 . 8 % respectively , significant difference ( p>0 . 05 ) ; effective rate be 52 . 78 % and 87 . 50 % respectively , significant difference ( p<0 . 05 ) . recurrence rate control group and study group be 8 . 3 % and 3 . 1 % 2 week treatment , respectively , significant difference ( p>0 . 05 ) . recurrence rate 3 month be 5 . 6 % and 0 respectively , significant difference ( p>0 . 05 ) . difference sas and sds two group treatment be statistically significant ( p<0 . 05 ) . be significant difference residual symptom two group first follow-up ( p>0 . 05 ) , and 1 week and 4 week ( p<0 . 05 ) . residual symptom patient reoperation be relieve compare control group . dhi score study group 60-70 year old and 71-85 year old group first time , 1 week and 4 week be statistically significant ( p<0 . 05 ) , and residual symptom 60-70 year group be reduce compare 71-85-year-old group . conclusion : elderly people bppv be susceptible anxiety and depression . manipulation combine psychological intervention can promote curative effect well , but personalize treatment plan should be develop .",Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical,01/02/2018
10.1007/s00415-025-13374-9,cognitive stimulation parkinson 's disease mild cognitive impairment .,"Buonocore J, Iaccino N, Torchia G, Curcio F, Pirrotta FM, Contrada M, Pucci C, Gambardella A, Quattrone A, Pilotto A, Pignolo L, Arabia G","background : cognitive impairment be most frequent and disable non-motor symptom parkinson 's disease ( pd ) , often emerge early and substantially impact autonomy and quality life . cognitive stimulation ( cs ) be support other neurodegenerative condition , role pd be less explore . study aim to compare efficacy therapist-guided , home-based cs program , deliver virtual reality rehabilitation system , conventional in-person cs intervention . methods : 123 individual screen , 45 patient pd and mild cognitive impairment ( pd-mci ) be randomize either tele-rehabilitation group ( trg ; n = 25 ) or control group ( cg ; n = 20 ) . group receive same standardized 4-week cs program ( 20 multi-domain session , 5 days/week ) , target memory , attention , executive function , language , and visuospatial skill . trg train home vrrs platform remote supervision , cg attend outpatient session . neuropsychological and clinical outcome be assess baseline ( t1 ) , post-intervention ( t2 ) , and 6-month follow-up ( t3 ) . analysis include repeated-measures anova , multivariate linear regression , and categorical comparison base predefine clinical cut-off . result : participant complete intervention adherence exceed 90 % group . t2 , trg show great improvement cg global cognition , working memory , and delay recall . effect remain significant adjust age , sex , baseline performance , and cognitive reserve index , and be robust false discovery rate correction . regression model confirm improvement . categorical analysis also show mark reduction pathological score trg same domain . conclusion : short-term , therapist-guided cs program deliver tele-rehabilitation effectively improve cognitive functioning pd-mci , partial benefit maintain 6 month , especially memory and executive domain . intervention be particularly beneficial memory and executive function , highlight telemedicine promising and accessible option cognitive care pd .",Journal of neurology,27/09/2025
10.1038/s41366-025-01920-4,effect tirzepatide weight management patient and,"Cerchi E, Santo PADE, de Oliveira MC, Janovsky CCPS, Halpern B","aims : to conduct systematic review and meta-analysis compare tirzepatide placebo weight management , analysis stratify diabetes status to precisely assess efficacy and safety individual and diabetes . method : systematically search medline , embase , and cochrane library randomized control trial compare once-weekly tirzepatide ( 5-15 mg ) placebo adult or diabetes at least 26 week . subpopulation analysis , random-effects model be use to calculate pool risk ratio ( rrs ) and mean difference ( mds ) , 95 % confidence interval , dichotomous and continuous endpoint , respectively . statistical significance be consider p < 0 . 05 . result : include five trial ( n = 2 , 174 ) patient diabetes ( bmi ≥ 23 kg/m(2 ) ) and five ( n = 4 , 467 ) patient diabetes ( bmi ≥ 27 [ ≥24 asia ] kg/m(2 ) ) . compare placebo , tirzepatide lead significantly great relative and absolute weight reduction patient ( rr -9 . 54 % , p < 0 . 01 ; md -9 . 06 kg , p < 0 . 01 ) and diabetes ( rr -17 . 15 % , p < 0 . 01 ; md -18 . 11 kg , p < 0 . 01 ) . subpopulation , tirzepatide also significantly increase probability achieve weight reduction ≥5 % , ≥10 % , and ≥15 % , as well improved bmi , waist circumference , blood pressure , hemoglobin a1c , and lipid level . notably , weight-related benefit tirzepatide be significantly great patient diabetes , safety be similar subpopulation and predominantly consist mild to moderate , well-tolerated adverse event . conclusion : compare placebo , tirzepatide result statistically significant and clinically meaningful weight reduction , especially patient diabetes ( overweight/obesity ) , acceptable safety profile .",International journal of obesity (2005),27/09/2025
10.1111/acel.70233,age-associated transcriptomic and epigenetic alterations mouse hippocampus .,"Bilgic M, Obata R, Panfil VI, Zhu Z, Saeki M, Gotoh Y, Kishi Y","aging represent major risk human neurodegenerative disorder , such dementia and alzheimer 's disease , and be associate functional decline neuron and impair synaptic plasticity , lead gradual decline memory . previous research have identify molecular and functional change associate age transcriptomic study and neuronal excitability measurement , role chromatin-level regulation vulnerability aging-related disease be not well understand . moreover , causal relationship molecular alteration and aging-associated decline function different cell type remains poorly understand . here , systematically characterize gene regulatory network cell type-specific manner age mouse hippocampus , central brain region involve learning and memory formation , simultaneously profile gene expression and chromatin accessibility single-nucleus level . analysis multiome ( rna and atac ) sequence recapitulate diversity glial and neuronal cell type hippocampus and reveal transcriptomic and chromatin accessibility level change different cell type , oligodendrocyte and dentate gyrus ( dg ) neuron exhibit most drastic change . find pronounce aging-dependent chromatin-level change neuron , especially gene relate synaptic plasticity . datum suggest bach2 , candidate transcription factor implicate aging-mediated functional decline dg neuron , potentially regulate gene associate synaptic plasticity , cell death , and inflammation age . take together , single-nucleus multiome analysis reveal potential cell type-specific regulator involve aging neuron and glial cell .",Aging cell,28/09/2025
10.1016/j.jep.2025.120641,shaoyao decoction promote isc proliferation activate wnt/β-catenin and,"Yang R, Han L, Zhang Y, Dong J, Ma Q, Hua Y, Ji P, Yao W, Yuan Z, Wei Y","ethnopharmacological relevance : shaoyao decoction ( syd ) be classic traditional chinese medicine formulation present significant therapeutic effect damp-heat colitis . however , potential pharmacological mechanism remain not fully elucidated . aim study : study aim to investigate effect syd intestinal epithelial regeneration analyze activity intestinal stem cell ( iscs ) mouse model damp-heat colitis . material and method :",Journal of ethnopharmacology,25/09/2025
10.1186/s12933-025-02921-3,association triglyceride-glucose index combine body shape index,"Chen M, Guo J, Shangguan Y, Sun Z, He X, Tu Q, Yan Q","background : triglyceride-glucose ( tyg ) index , measure insulin resistance , have be confirm to be associate adverse clinical outcome . new composite indicator , tyg-a body type index ( tyg-absi ) , integrate tyg index and body type index , have demonstrate superior efficacy predict risk cardiovascular death general population compare traditional indicator . study aim to deeply explore association tyg-absi and all-cause mortality and cvd mortality population cardiovascular kidney-metabolic syndrome ( ckm ) stage 0-3 . analysis will be conduct multiple dimension such intensity indicator correlation and potential influence mechanism , order to comprehensively reveal relationship two . result : analyze datum 13 , 480 participant nhanes cohort ( 1999-2018 ) use cox proportional hazard model and restrict cubic spline function . result indicate elevated tyg-absi value be independently associate high risk all-cause mortality ( hr = 1 . 226 , 95 % ci 1 . 104-1 . 361 ) and cardiovascular mortality ( hr = 1 . 377 , 95 % ci 1 . 149-1 . 651 ) . time-dependent receiver operating characteristic ( roc ) curve and concordance index evaluation demonstrate tyg-absi yield more accurate long-term prognostic performance other tyg-derive metric . area curve ( auc ) indicator reach 0 . 688-0 . 708 prediction all-cause mortality risk 5-15 year , and 0 . 696-0 . 739 prediction cardiovascular mortality risk . external validation use charls datum confirm robustness finding predict all-cause mortality . conclusion : individual ckm stage 0-3 , tyg-absi demonstrate strong association mortality risk and superior predictive ability compare other tyg-derive metric . performance suggest potential role capture variation diverse clinical subgroup , and inform optimal timing preventive intervention .",Cardiovascular diabetology,23/09/2025
10.1016/j.clcc.2016.02.004,plasma-based protein marker panel colorectal cancer detection identify,"Jones JJ, Wilcox BE, Benz RW, Babbar N, Boragine G, Burrell T, Christie EB, Croner LJ, Cun P, Dillon R, Kairs SN, Kao A, Preston R, Schreckengaust SR, Skor H, Smith WF, You J, Hillis WD, Agus DB, Blume JE","introduction : colorectal cancer ( crc ) testing program reduce mortality ; however , approximately 40 % recommend population should undergo crc testing do not . early colon cancer detection patient population ineligible testing , such elderly or significant comorbiditie , could have clinical benefit . many attempt to identify individual protein marker disease , little progress have be make . target mass spectrometry , use multiple reaction monitoring ( mrm ) technology , enable simultaneous assessment group candidate improved detection performance . material and method : multiplex assay be develop 187 candidate marker protein , use 337 peptide monitor 674 simultaneously measure mrm transition 30-minute liquid chromatography-mass spectrometry analysis immunodepleted blood plasma . to evaluate combined candidate marker performance , present study use 274 individual patient blood plasma sample , 137 biopsy-confirmed colorectal cancer and 137 age- and gender-matched control . use 2 well-matched platform run 5 day week , 274 sample be analyze 52 day . result : use one half datum discovery set ( 69 disease case and 69 control case ) , elastic net feature selection and random forest classifier assembly be use cross-validation to identify 15-transition classifier . mean training receiver operate characteristic area curve be 0 . 82 . final classifier assembly use entire discovery set , 136-sample ( 68 disease case and 68 control case ) validation set be evaluate . validation area curve be 0 . 91 . point maximum accuracy ( 84 % ) , sensitivity be 87 % and specificity be 81 % . conclusion : result have demonstrate ability simultaneous assessment candidate marker protein use high-multiplex , targeted-mass spectrometry to identify subset group crc marker significant and meaningful performance .",Clinical colorectal cancer,01/06/2016
10.3881/j.issn.1000-503X.2014.01.021,[ role micrornas allergic airway disease ] .,"Teng YS, Cao XL, Li Y","micrornas ( mirnas/mirs ) be class short non-coding rnas regulating protein translation mrnas silencing . study have show micrornas play critical role allergic disease , tumor , and infection . allergic airway disease be characterize inflammation and hyperresponsiveness respiratory tract . several mirnas be find to be involve series pathophysiologic process allergic airway disease include inflammatory cell infiltration , cytokine ' expression , airway hyperresponsiveness , and proliferation and change phenotype smooth muscle cell . therefore , mirnas may be new therapeutic target allgeric disease . article review role mirnas asthma and allergic rhinitis and molecular biological mechanism .",Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,01/02/2014
10.1016/S1474-4422(25)00270-4,diagnosis multiple sclerosis : 2024 revision mcdonald criterion .,"Montalban X, Lebrun-Frénay C, Oh J, Arrambide G, Moccia M, Pia Amato M, Amezcua L, Banwell B, Bar-Or A, Barkhof F, Butzkueven H, Ciccarelli O, Chataway J, Cohen JA, Comi G, Correale J, Deisenhammer F, Filippi M, Fiol J, Freedman MS, Fujihara K, Granziera C, Green AJ, Hartung HP, Hellwig K, Kappos L, Kimbrough D, Killestein J, Lublin F, Marignier R, Ann Marrie R, Miller A, Otero-Romero S, Ontaneda D, Ramanathan S, Reich D, Rocca MA, Rovira À, Saidha S, Salter A, Sastre-Garriga J, Saylor D, Solomon AJ, Sormani MP, Stankoff B, Tintore M, Tremlett H, Van der Walt A, Viswanathan S, Wiendl H, Wildemann B, Yamout B, Zaratin P, Calabresi PA, Coetzee T, Thompson AJ","advance understanding multiple sclerosis and development biomarker pathophysiology prompt substantial revision 2017 mcdonald diagnostic criterion . new 2024 mcdonald criterion provide unified approach diagnose multiple sclerosis individual relapse or progressive course lifespan ( ie , paediatric late-life presentation ) . optic nerve can now serve fifth anatomical location cns diagnosis . central vein sign , paramagnetic rim lesion , and kappa free-light chain concentration csf can be use , available , to provide supportive evidence and confer specificity diagnosis multiple sclerosis specific situation . certain case , radiologically isolate syndrome or neurological symptom do not constitute clear attack or progression disability can fulfil criterion multiple sclerosis diagnosis . also provide guidance diagnosis multiple sclerosis old individual ( ≥50 year ) and comorbiditie . 2024 revise criterion should expedite diagnosis multiple sclerosis , maintain specificity .",The Lancet. Neurology,01/10/2025
10.1186/s12984-025-01738-1,effect intermittent theta-burst stimulation cognition and glymphatic,"Yang CC, Huang KY, Hsu JL, Hu CJ, Lu YH, Kuan YC","background : repetitive transcranial magnetic stimulation ( rtms ) have demonstrate efficacy alleviate cognitive symptom alzheimer 's disease ( ad ) and mild cognitive impairment ( mci ) . animal study suggest rtm may enhance glymphatic system efficiency and reduce amyloid deposit , impact human glymphatic activity remain uncertain . method : double-blind , randomize , sham-controlled trial investigate effect intermittent theta-burst stimulation ( itbs ) , novel rtm technique , cognitive function and glymphatic system activity use diffusion tensor image analysis perivascular space ( dti-alps ) 52 participant amnestic mci or very mild ad . participant undergo 10 session target left dorsolateral prefrontal cortex two week . cognitive and glymphatic assessment be conduct baseline , week 2 , and week 6 . 52 participant , 28 receive active itbs , 24 receive sham stimulation . first two week , sham group transition active itbs . result : significant cognitive improvement be observe week 6 itbs group , indicate delay cognitive enhancement , immediate change cognition or glymphatic system activity ( measure alps index ) be observe . adverse event be report . conclusion : finding suggest itbs can produce delay cognitive enhancement individual amnestic mci and very mild ad , impact glymphatic system remain uncertain and require further investigation . trial registration : clinicaltrials.gov ( nct04555941 ) .",Journal of neuroengineering and rehabilitation,26/09/2025
10.3390/ijms21030969,precision psychiatry applications pharmacogenomics : artificial intelligence,"Lin E, Lin CH, Lane HY","grow body evidence now suggest precision psychiatry , interdisciplinary field psychiatry , precision medicine , and pharmacogenomic , serve indispensable foundation medical practice offer accurate medication accurate dose accurate time patient psychiatric disorder . light late advancement artificial intelligence and machine learn technique , numerous biomarker and genetic loci associate psychiatric disease and relevant treatment be be discover precision psychiatry research employ neuroimaging and multi-omic . review , focus late development precision psychiatry research use artificial intelligence and machine learning approach , such deep learning and neural network algorithm , together multi-omic and neuroimage datum . firstly , review precision psychiatry and pharmacogenomic study leverage various artificial intelligence and machine learn technique to assess treatment prediction , prognosis prediction , diagnosis prediction , and detection potential biomarker . addition , describe potential biomarker and genetic loci have be discover to be associate psychiatric disease and relevant treatment . moreover , outline limitation regard previous precision psychiatry and pharmacogenomic study . finally , present discussion direction and challenge future research .",International journal of molecular sciences,1/02/2020
10.1158/1940-6207.CAPR-09-0165,detection chromosomal aneusomy fluorescence situ hybridization,"Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, Yin X, Hirsch FR, Kennedy TC, Keith RL, Barón AE, Belinsky SA, Miller YE, Byers T, Franklin WA","lung cancer usually be disseminate ( advanced ) and have poor prognosis diagnosis . current and former smoker be high risk lung cancer and be candidate prevention and early detection strategy . sputum be potential source biomarker might determine either lung cancer risk or presence early lung cancer , but current sputum test be sufficiently sensitive and specific effective screening . use fluorescence situ hybridization ( fish ) to measure chromosomal aneusomy ( ca ) sputum sample collect prospectively 100 incident lung cancer case and 96 control ( match age , gender , and date collection ) nest ongoing high-risk cohort . ca-fish assay be aim four dna target : epidermal growth factor receptor , myc , 5p15 , and cep 6 . sensitivity positive ca-fish assay ( abnormal two or more four marker ) lung cancer be substantially high sample collect 18 month ( 76 % sensitivity ) sample collect more 18 month ( 31 % ) lung cancer diagnosis . sensitivity be high squamous cell cancer ( 94 % ) other histologic type ( 69 % ) .","Cancer prevention research (Philadelphia, Pa.)",01/04/2010
10.1038/s41575-025-01120-5,"clinical trial design , biomarker and end point metabolic and alcohol-related","Diaz LA, Thiele M, Louvet A, Lee BP, Ajmera V, Tavaglione F, Hsu CL, Huang DQ, Pose E, Bataller R, McClain C, Mellinger J, Tincopa M, Mitchell MC, Ratziu V, Rinella ME, Sarin SK, Shah VH, Szabo G, Wong VW, Bansal MB, Leggio L, Kamath PS, Krag A, Sanyal AJ, Arrese M, Arab JP, Anstee QM, Mathurin P, Loomba R","metabolic and alcohol-related liver disease ( metald ) be newly define entity spectrum steatotic liver disease , characterize interplay cardiometabolic risk factor and alcohol consumption . evolve epidemiology and complex pathophysiology metald present unique challenge and opportunity clinical trial design . inclusion criterion should require simultaneous evidence metabolic dysfunction ( least two cardiometabolic feature ) and verify quantifiable alcohol exposure record precede 3-6 month . traditional histological end point be limit invasiveness , sample error and interpretative variability . thus , imaging modality , serum-based fibrosis biomarker and quantitative measure alcohol intake be gain relevance non-invasive , reproducible and patient-centric end point aim to improve trial feasibility . furthermore , incorporate alcohol biomarker , stratify patient metabolic risk factor burden , and use adaptive design trial might enhance precision and generalizability metald clinical trial . uncertainty remain regard optimal patient selection criterion , event rate and dynamic interplay metabolic dysfunction and alcohol intake , ongoing research effort aim to refine diagnostic criterion , standardize methodology and validate novel end point . advance will ultimately accelerate drug development , improve trial efficiency and foster intervention to treat metald .",Nature reviews. Gastroenterology & hepatology,26/09/2025
10.3390/nursrep13040116,aggression nursing personnel first wave covid-19 pandemic :,"Cruz JPS, Genis-Mendoza AD, López-Narváez ML, González-Castro TB, Juárez-Rojop IE, Tovilla-Zárate CA, Nicolini H","( 1 ) background : health care worker , particularly nurse , have be regularly assault covid-19 pandemic . purpose : to evaluate prevalence and location assault nursing personnel latin america , and to determine predictor factor aggression nurse . ( 2 ) method : cross-sectional online survey be answer 374 nurse work health care covid-19 pandemic . aggression nurse be estimate use victimization scale . ( 3 ) result : total 288 nurse be include study . victimization scale show 52 . 1 % nurse have suffer aggression general population covid-19 pandemic . male be more likely to be attack female ( p < 0 . 05 ) . additionally , male be attack more frequently public transport ( x(2 ) = 6 . 72 , p = 0 . 01 ) . home neighborhood and market be other location high risk be assault ( or : 3 . 39 , ci : 1 . 53-7 . 50 ) . ( 4 ) conclusion : result indicate nurse latin america work covid-19 pandemic and social isolation have be frequently assault general public . male be more frequently attack female and main place aggression be public transportation , home neighborhood and supermarket . implication nursing practice : be necessary to create and implement protocol and guideline to support nursing personnel covid-19 pandemic . study be retrospectively register juarez autonomous university tabasco ( 103/cipdacs/2020 ) ( 08/2020 ) .","Nursing reports (Pavia, Italy)",7/10/2023
10.1097/HC9.0000000000000812,ipsc-base hepatic organoid reveal heterozygous myo5b variant driver,"Sgodda M, Gebel E, Dignas L, Alfken S, Eggenschwiler R, Stalke A, Dröge C, Pfister ED, Baumann U, Luedde T, Esposito I, Keitel V, Cantz T","background : hereditary intrahepatic cholestasis be cause variant various gene involve enterohepatic bile circulation , metabolization , and conjugation . originally classify 3 group , number contribute gene be still increase , underline need deep understanding molecular interaction intrahepatic cholestasis . method : present study , investigate interplay heterozygous variant 3 cholestasis-associated gene ( abcb11 , abcb4 , and myo5b ) exploit ipsc-base hepatic organoid patient suffering recurrent intrahepatic cholestasis . result : functional characterization mrp2-mediate cholyl-lysyl-fluorescein ( clf ) and bsep-mediate tauro-nor-thca-24-dbd transport demonstrate mark reduction transport myo5b-deficient organoid , comparison unaffected control organoid . moreover , ipsc-base organoid derive patient carry 3 heterozygous variant abcb11 , abcb4 , and myo5b also exhibit absence bsep-mediated tauro-nor-thca-24-dbd transport , but functional mrp2-mediate clf-transport . interestingly , crispr/cas9-mediated correction mutate abcb11 allele could not restore impaired bsep function , suggest heterozygous myo5b variant main driver transport deficiency . fact , crispr/cas-mediated correction myo5b variant finally result restoration bsep-mediated tauro-nor-thca-24-dbd transport . conclusions : ipsc-base organoid serve authentic model functional assessment hepatobiliary transport fluorescent substrate . allow characterization variant uncertain significance and other variant cholestasis-associated gene and reveal heterozygous myo5b variant increase susceptibility defective hepatobiliary bsep-mediated transport .",Hepatology communications,1/10/2025
10.1007/s10495-025-02190-1,integrate pathology genomic and single-cell genomic to identify lactate,"Zhao S, Liang X, Xie J, Lin Z, Li Z, Jiang Z, Chen W, Dai H, He Y, Li L","cutaneous melanoma ( skcm ) be highly malignant and prone develop treatment resistance . lactate metabolism tumor microenvironment ( tme ) play crucial role skcm progression , immune evasion , and therapy resistance . study aim to integrate multi-omic datum to systematically characterize molecular feature lactate metabolism skcm , construct effective prognostic model , and explore potential therapeutic strategy . quantitative pathological feature be extract use cellprofiler and combine deep learning feature obtain pre-trained resnet50 convolutional neural network . gene set variation analysis ( gsva ) be use to calculate lactate metabolism score and identify associated pathological feature . single-cell rna sequence be apply to assess lactate metabolic activity different cell type . datum , together spatial transcriptomic , genomic alteration , immune infiltration profile , and immunotherapy response datum , be integrate to construct lactate metabolism signature ( lms ) prognostic model ( comprise 3 pathological feature and 11 gene ) . model be develop use 101 combination 10 machine learning algorithm . furthermore , rab32 knockdown experiment be perform to verify effect melanoma cell proliferation , migration , invasion , and metabolism . total 443 pathological imaging feature significantly associate lactate metabolism be identify . single-cell analysis reveal melanoma cell exhibit high lactate metabolic activity , markedly enhance intercellular communication high-metabolism group . lms model demonstrate excellent prognostic performance both tcga training and validation cohort . patient high-lms group have significantly short survival , show immune evasion feature , and exhibit activation melanoma-related metabolic and signal pathway ( e.g. , oxidative phosphorylation ) . contrast , low-lms group have strong immune infiltration and high expression immune checkpoint molecule . key gene rab32 be significantly correlate lactate metabolism-related pathological feature , be highly express tumor core , and high expression predict poor prognosis . rab32 knockdown markedly inhibit melanoma cell proliferation , migration , and invasion ; reduce lactate production ; suppress expression glycolytic enzyme and lactate transporter ; and decrease extracellular acidification rate ( ecar ) and oxygen consumption rate ( ocr ) . addition , significantly inhibit tumor growth mouse xenograft model . study develop multi-omics-integrated prognostic model ( lms ) base lactate metabolism , provide novel tool risk stratification and therapeutic decision-making skcm patient . also identify rab32 central player tumor metabolic reprogramme and invasiveness , promise potential therapeutic target .",Apoptosis : an international journal on programmed cell death,26/09/2025
10.1038/s41467-025-63682-x,anti-tslp monoclonal antibody uncontrolled crswnp : dubhe randomize,"Xian M, Lan F, Yan B, Shen S, Liu S, Wan L, Song X, Jiang L, Jiang Y, Xue J, Chen J, Su L, Ye J, Yang Y, Fang H, Tan G, Zhang Q, Qu S, Wei X, Luo X, Xu Y, Yu S, Xiao Z, Liu F, Li Q, Zhang Y, Xie Y, Wang L, Yang G, Yan H, Zhao G, Chen B, Wang C, Zhang L","to explore therapeutic potential block thymic stromal lymphopoietin ( tslp ) patient chronic rhinosinusitis nasal polyp ( crswnp ) , conduct phase 1b/2a , randomize , double-blind , placebo-controlled trial to assess safety and efficacy cm326 , monoclonal antibody tslp . enrol 84 eligible patient uncontrolled crswnp and stratify base baseline tissue eosinophil count . patient be assign to receive cm326 220 mg ( n = 40 ) or placebo ( n = 20 ) 2 week ( q2w ) and cm326 220 mg ( n = 20 ) or placebo ( n = 4 ) 4 week ( q4w ) 16 week . subsequently , patient continue cm326 220 mg q2w or q4w additional 36 week , follow 12-week follow . primary endpoint be safety cm326 and change baseline nps week 16 patient eosinophilic crswnp ( ecrswnp ) . main secondary endpoint include change baseline nps week 16 non-eosinophilic crswnp ( nonecrwnp ) and pharmacodynamic marker . 64-week study , treatment-emergent adverse event ( teae ) be mild or moderate . cm326 q2w improve nps patient ecrswnp compare placebo week 16 ( mean difference [ 95 % ci ] , -1 . 2 [ -2 . 3 -0 . 1 ] , p = 0 . 04 ) , sustained benefit open-label and follow-up period . notably , peripheral blood and tissue eosinophil count and concentration plasma il-13 and be reduce week 16 treatment cm326 q2w placebo . post-hoc analysis demonstrate participant baseline tslp > 330 fg/ml achieve substantial reduction nps week 16 treatment cm326 q2w ( mean difference placebo : -1 . 75 [ 95%ci , -3 . 06 -0 . 44 ] , p = 0 . 01 ) . overall , cm326 be well tolerated and effective patient uncontrolled ecrswnp . baseline plasma tslp level 330 fg/ml may serve predictive marker treatment efficacy cm326 . clinicaltrials.gov identifi : nct05324137 .",Nature communications,29/09/2025
10.1038/s41598-021-98584-7,large-bodie bird be over-represente unstructured citizen science datum .,"Callaghan CT, Poore AGB, Hofmann M, Roberts CJ, Pereira HM","citizen science platform be quickly accumulate hundred million biodiversity observation world annually . quantifying and correct bias citizen science dataset remain important first step datum be use to address ecological question and monitor biodiversity . one source potential bias dataset be difference citizen science program have unstructured protocol and have semi-structure or structured protocol submit observation . to quantify bias unstructured citizen science platform , contrast bird observation unstructured inaturalist platform semi-structured citizen science continental united states . test four trait specie ( body size , commonness , flock size , and color ) predict species be under- or over-represente unstructured dataset compare semi-structured dataset . find strong evidence large-bodied bird be over-represente unstructured citizen science dataset ; moderate evidence common specie be over-represente unstructured dataset ; strong evidence specie large group be over-represente ; and evidence colorful specie be over-represente unstructured citizen science datum . result suggest bias exist unstructured citizen science datum compare semi-structured datum , likely result detectability species and inherent recording process . importantly , program inaturalist detectability process be two-fold-first , individual organism need to be detect , and second , need to be photograph , be likely easy many large-bodied specie . result indicate caution be warrant use unstructured citizen science datum ecological modelling , and highlight body size fundamental trait can be use covariate model opportunistic species occurrence record , represent detectability or identifiability unstructured citizen science dataset . future research space should continue to focus quantify and document bias citizen science datum , and expand research include structured citizen science datum to understand bias differ unstructured , semi-structured , and structured citizen science platform .",Scientific reports,24/09/2021
10.1038/s41467-025-63339-9,distinct cell state ecosystem nodular lymphocyte-predominant hodgkin,"Subramanian A, Su S, Flerlage J, Alig S, Younes S, Marks LJ, Pinnix C, Vega F, Steiner R, Kumar P, Mocikova H, Sykorova A, Prochazka V, Milito C, Allen P, Paulino D, Ramsay A, Flerlage T, Palese M, West R, Zhu C, Noordenbos T, Schroers-Martin J, Zhao S, Park NJ, Kalbasi A, Moding EJ, Newman AM, Advani RH, Hoppe RT, Diehn M, Natkunam Y, Alizadeh AA, Binkley MS","nodular lymphocyte-predominant hodgkin lymphoma ( nlphl ) be rare cancer , and few study have comprehensively investigate immune microenvironment and rare lymphocyte-predominant ( lp ) cell . here develop nlphl specific lymphocyte-predominant ecotype ( lpe ) model to identify 34 distinct cell state 14 cell type co-occur 3 lpe 171 case . lpe1 and lpe2 be characterize immunosuppressive microenvironment high expression b2 m lp cell , cd8 t-cell exhaustion , immune checkpoint gene express follicular t-cells , and improve freedom progression compare lpe3 training ( n = 109 , 65 % lpe1/2 ) and validation cohort ( n = 62 , 61 % lpe1/2 ) . validate co-occurrence and co-localization cell state use spatial transcriptomic . protein expression hla-i and hla-ii lp cell and sstr2 dendritic cell be predictive lpe1 ( c-statistic=0 . 69 ) , lpe2 ( c-statistic=0 . 79 ) , and lpe3 ( c-statistic=0 . 60 ) . study establish clinically relevant biologic categorization nlphl .",Nature communications,26/09/2025
10.1038/s12276-025-01534-w,cholesterol-driven pathological astrocytic response diabetes-associated,"Niu T, Wang S, Zhang H, Zhu W, Liu K, Zhou X, Sun R, Niu D, Yuan Y","diabetic environment , characterize hyperglycemia , advanced glycation end product and cerebral insulin resistance , trigger pathological astrocytic response contribute cognitive decline diabetes-associated cognitive impairment . cholesterol accumulation brain , particularly astrocyte , contribute pathological process . scap , cholesterol sensor involve lipid imbalance , regulate metabolic disease , but role astrocyte remain unclear . c57bl/6j wild-type and astrocyte-specific scap knockout mouse be feed high-fat diet and treat streptozotocin to induce type 2 diabetes mellitus ( t2dm ) . behavioral test and hippocampal histology be perform 28 week . investigate nf-κb-c3 signal pathway to elucidate scap induce pathological astrocytic response diabetic condition . cognitive function be assess patient t2dm use montreal cognitive assessment ( moca ) and mini-mental state examination ( mmse ) . find elevated scap expression astrocyte t2dm mouse , correlate cognitive dysfunction , impaired synaptic plasticity and alter astrocyte morphology . effect be mitigate astrocyte-specific scap knockout mouse . scap elevation activate nf-κb recruit iκbα golgi apparatus , promote c3 transcription . conversely , inhibition scap suppress nf-κb activation . patient t2dm , serum c3 level be high mild cognitive impairment , show u-shaped correlation low-density lipoprotein-cholesterol ( ldl-c ) level . finding uncover critical regulatory axis underlie astrocytic dysfunction , scap mediate pathological astrocytic response nf-κb-c3 pathway , golgi act platform scap-driven activation . here highlight interaction cholesterol disorder and pathological astrocytic response , present scap potential target therapeutic intervention diabetes-associated cognitive impairment . research hypothesis illustration : scap and complement c3 play role cholesterol-driven astrocyte response diabetes-associated cognitive impairment . astrocytic scap expression be abnormally increase hfd/stz-induced diabetic mouse , impair neuronal synaptic plasticity activate iκbα/nf-κb/c3 signal pathway . upregulated scap astrocyte directly bind iκbα , increase activation golgi apparatus , promote nf-κb nuclear translocation and trigger complement c3 transcriptional activation and inflammatory immune response , ultimately lead neuronal and cognitive damage .",Experimental & molecular medicine,29/09/2025
10.1016/j.neuron.2025.09.001,treg-microglia partnership injure spinal cord preserve treg cell,"Qin T, Jiang T, Zhou Z, Wu M, Zhang Y, Yang Z, Zheng Z, Yi J, Wang X, Luo M, Gao P, Liu J, Huang Y, Liu H, Li Q, Zhou W, Zhang S, Guo X, He B, Wang Y, Fan J, Zhao S, Chen J, Yin G","spatiotemporal dynamic and specific role regulatory t ( treg ) cell spinal cord injury ( sci ) remain unclear . use single-cell rna sequencing , flow cytometry , and immunofluorescence , find thymus-derived treg cell infiltrate injure spinal cord peripheral blood 3 day post-sci . treg cell depletion worsen sci and impaired long-term recovery . transcriptomic profiling reveal strong anti-inflammatory function treg cell and potential to regulate cholesterol metabolism neighboring microglia . far single-cell rna sequence uncover clonality sci-associate treg cell . major histocompatibility complex class ii ( mhc ii ) expression microglia , not macrophage , be crucial sustain treg cell number and neuroprotective function , myelin-phagocytose microglia-activated treg cell show significant neuroprotective effect . treg cell mitigate microglial inflammation ctla-4 and upregulate atp-binde cassette transporter g1 ( ) receptor microglia , help to manage myelin load and reduce lipid droplet formation . finding offer mechanistic insight sci-associated treg cell and lie groundwork future treg-based therapy sci treatment .",Neuron,29/09/2025
10.1038/s41591-025-03977-0,full-spectrum extract cannabis sativa dkj127 chronic low back pain :,"Karst M, Meissner W, Sator S, Keßler J, Schoder V, Häuser W","chronic low back pain ( clbp ) affect billion people worldwide . current pharmacologic treatment offer limited efficacy and carry substantial risk , warrant development safe and effective alternative . multicenter , randomize , placebo-controlled phase 3 trial evaluate efficacy and safety ver-01 clbp . enrol 820 adult clbp ( ver-01 , n = 394 ; placebo , n = 426 ) and include double-blind 12-week treatment phase ( phase a ) , 6-month open-label extension ( phase b ) , follow either 6-month continuation ( phase c ) or randomize withdrawal ( phase d ) . primary endpoint phase a be change mean numeric rating scale ( nrs ) pain intensity , change total neuropathic pain symptom inventory ( npsi ) score key secondary endpoint participant neuropathic pain component ( paindetect > 18 ) . primary endpoint phase d be time treatment failure . study meet primary endpoint phase a , mean pain reduction -1 . 9 nrs point ver-01 group ( mean difference ( md ) placebo = -0 . 6 , 95 % confidence interval ( ci ) -0 . 9 -0 . 3 ; p < 0 . 001 ) . pain far decrease -2 . 9 nrs point phase b , effect sustain phase c . study also meet key secondary endpoint phase a , mean npsi decrease -14 . 4 ( standard error , 3 . 3 ) point baseline ver-01 arm ( md placebo = -7 . 3 , 95 % ci = -13 . 2 -1 . 3 ; p = 0 . 017 ) . phase d do not meet primary endpoint ( hazard ratio = 0 . 75 , 95 % ci = 0 . 44-1 . 27 ; p = 0 . 288 ) , pain increase significantly more placebo withdrawal ( md = 0 . 5 , 95 % ci = 0 . 0-1 . 0 ; p = 0 . 034 ) . phase a , incidence adverse events-mostly mild to moderate and transient-wa high ver-01 placebo ( 83 . 3 % 67 . 3 % ; p < 0 . 001 ) . ver-01 be well-tolerate , sign dependence or withdrawal . ver-01 show potential new , safe and effective treatment clbp . clinicaltrials.gov registration : nct04940741 .",Nature medicine,29/09/2025
10.1080/02640414.2016.1171890,"new insight professional horse racing ; "" in-race "" heart rate datum , elevate","O'Reilly J, Cheng HL, Poon ET","weight-make practice have be show to impair musculoskeletal and physiological function jockey . study investigate "" in-race "" heart rate ( hr ) response and hydration status competitive racing , as well select physiological and lifestyle parameter professional jockey base hong kong . "" in-race "" hr response and early morning hydration status 20 male jockey be examine hot and moderate climactic occasion . additionally , bone mineral density ( bmd ) , dietary intake and lifestyle choice be assess . osteopenia be observe calcanei jockeys ( left : 0 . 51 ± 0 . 06 ; right : 0 . 46 ± 0 . 12 g · cm(-2 ) ) . energy and protein intake be significantly low race day compare non-race day ( p < 0 . 05 ) . "" in-race "" hr(max ) value be similar vo(2max ) laboratory test ( 186 ± 14 185 ± 8 bpm ) . hypohydration be observe racing day . ( usg : 1 . 0247 ± 0 . 006 and 1 . 0256 ± 0 . 0258 mg · l(-1 ) hot and moderate condition , respectively ) . sauna usage ( 25 . 5 % ) and food restriction ( 20 . 4 % ) be most common weight-making practice . current lifestyle choice jockeys result suboptimal bone health , hydration status and nutritional intake , can significantly enhance fracture risk . further research should develop exercise and nutrition guideline optimise skeletal health .",Journal of sports sciences,01/03/2017
10.1038/s41467-025-63338-w,cd137l promote immune surveillance melanoma hltf regulation .,"Liang L, Zhu L, Li X, Zhou W, Zhang Y, Hung MC, Zhang G, Chen Y, Kuang X, Su J, Liu J, Chen X, Liu H","immune checkpoint blocker ( icb ) have demonstrate substantial efficacy various malignancy , yet benefit icb be limit subset patient . therefore , be essential to identify novel therapeutic target . integrate multi-omic datum cohort patient melanoma treat icb , positive correlation be observe tumor cd137l expression and efficacy pd-1 blockade . functionally , cd137l induction cancer cell significantly enhance anti-tumor immunity promote cd8(+ ) t cell survival , vivo and vitro . mechanistically , helicase-like transcription factor ( hltf ) be identify pivotal transcriptional regulator cd137l , control expression phosphorylation serine position 398 . therapeutically , ampk agonist aicar ( acadesine ) inducer cd137l , exhibit synergistic effect pd-1 or ctla-4 blockade . summary , finding elucidate mechanism control cd137l expression and highlight promising combination therapy to enhance efficacy icb melanoma . one sentence summary : induce co-stimulatory immune checkpoint cd137l expression melanoma cell enhance t cell-mediated anti-tumor immunity .",Nature communications,26/09/2025
10.1002/alz.70726,alzheimer 's disease diagnostic progression be associate cerebrovascular,"Edwards NC, Lao PJ, Alshikho MJ, Ericsson OM, Rizvi B, Petersen ME, O'Bryant S, Flores-Aguilar L, Simoes S, Mapstone M, Tudorascu DL, Janelidze S, Hansson O, Handen BL, Christian BT, Lee JH, Lai F, Rosas HD, Zaman S, Lott IT, Yassa MA, Gutierrez J, Wilcock DM, Head E, Brickman AM","introduction : have few vascular risk factor , people down syndrome ( ds ) have mri evidence cerebrovascular disease ( cvd ) and neuroinflammation worsen alzheimer 's disease ( ad ) severity . investigate marker cvd and inflammation be associate ad-relate diagnostic progression people ds . methods : include 149 participant ( mean age [ sd ] = 44 . 6 [ 9 ] ) alzheimer 's biomarkers consortium-down syndrome have two ( n = 24 ) or three follow-up visit ( n = 125 ) . derive white matter hyperintensity ( wmh ) volume and plasma biomarker ( glial fibrillary acidic protein [ gfap ] , amyloid beta [ aβ]42/aβ40 , hyperphosphorylated tau-217 [ p-tau217 ] , and neurofilament light [ nfl ] ) concentration baseline and examine association progression clinical diagnosis . result : high baseline wmh volume and high gfap be associate great likelihood diagnostic progression . combine wmh and gfap p-tau217 improve clinical conversion classification accuracy ad biomarker alone . individual evidence amyloidosis , both wmh and gfap be associate clinical progression . discussion : ds , marker cvd and inflammation be independently and synergistically associate clinical ad progression . highlight : high baseline white matter hyperintensity ( wmh ) volume and plasma glial fibrillary acidic protein ( gfap ) concentration be associate high likelihood progress cognitively stable either mild cognitive impairment or clinical alzheimer 's disease down syndrome . wmh volume and gfap concentration discriminate progress and do not . model include independent and interactive effect wmh and gfap more accurately discriminate participant progress diagnostically do not . individual evidence amyloid pathology be more likely to progress also have elevate wmh or gfap .",Alzheimer's & dementia : the journal of the Alzheimer's Association,01/10/2025
10.1016/j.heares.2011.01.015,role prostaglandin e2 cochlea .,Nakagawa T,"prostaglandin be one major group chemical mediator mammalian body . prostaglandin , prostaglandin e2 ( pge2 ) be most abundant prostanoid human and involve regulate many different fundamental biological function . pge2 signaling be mediate four distinct e-prostanoid receptor ( eps ) namely ep1-4 . recently , accumulate evidence indicate critical , but complex role ep signal pathogenesis neuronal disease depend context neuronal injury . four distinct eps be express stria vascularis , spiral ligament , spiral ganglion and organ corti , indicate involvement ep signal cochlear function . activation ep4 cochleae significantly attenuate noise-induced damage cochleae , and activation ep2 or ep4 induce formation vascular endothelial growth factor cochleae . finding strongly suggest individual ep signal may be involve maintenance cochlear sensory system similarly central nervous system . review highlight recent finding ep signal central nervous system , and present possible role regulation blood flow , protection sensory cell and immune response cochleae .",Hearing research,01/06/2011
10.1038/s41417-025-00967-9,paricalcitol and hydroxychloroquine modulate extracellular matrix and enhance,"Bandi DSR, Sarvesh S, Foote J, Welsch D, Cheng C, Akce M, Nagaraju GP, El-Rayes BF","pancreatic ductal adenocarcinoma ( pdac ) be highly aggressive cancer poor prognosis and limited therapeutic option . previous publication , group define mechanism vitamin d analogue paricalcitol ( p ) and hydroxychloroquine ( h ) potentiate effect gemcitabine-based chemotherapy pdac . base , hypothesize ph may potentiate 5-fluorouracil ( 5fu ) and oxaliplatin-base chemotherapy , and may involve novel mechanism extracellular matrix ( ecm ) modulation . combination ph 5fu+oxaliplatin significantly increase cell death , apoptosis , and s-phase cell cycle arrest compare untreated or 5fu + oxaliplatin-treate mia paca-2 , hpac and kpc cell line . vivo , combination therapy inhibit pdac growth and alter immune landscape activate t and nk cell . proteomic analysis reveal significant reduction ecm protein , specifically integrin beta-4 ( itgb4 ) . confirmation role itgb4 be perform genetic knockdown itgb4 , lead ecm inhibition . conclusion , combination ph significantly enhance efficacy oxaliplatin and 5fu . identify new mechanism action ph inhibit itgb4 , lead ecm modulation . result suggest combination ph cytotoxic chemotherapy should be test pdac clinical trial .",Cancer gene therapy,27/09/2025
10.1016/j.immuni.2025.09.003,intra-tumoral hypoxia promote cd8(+ ) t cell dysfunction chronic activation,"Alicea Pauneto CDM, Riesenberg BP, Gandy EJ, Kennedy AS, Clutton GT, Hem JW, Hurst KE, Hunt EG, Green JM, Miller BC, Angus SP, Johnson GL, Esther RJ, Guerriero JL, Gao P, Soto-Pantoja DR, Ferris RL, Modliszewski JL, Coleman MF, Chung HK, Milner JJ, Moschos SJ, Wiseman RL, Thaxton JE","metabolic stress tumor microenvironment ( tme ) promote t cell dysfunction and immune checkpoint inhibitor ( ici ) resistance . examine contribution activate transcription factor 4 ( atf4 ) , central node integrated stress response ( isr ) , t cell dysfunction tumor . cd8(+ ) tumor-infiltrating lymphocyte ( til ) patient sample exhibit chronic atf4 activity , be reflect various tumor model . hypoxia tme impose chronic atf4 activity isr kinase . atf4 overexpression cd8(+ ) t cell induce metabolic polarity , mitochondrial oxidative stress , and cell death , impair antitumor immunity . chronic atf4 transcriptional activity replicate terminal exhaustion cd8(+ ) t cell state independent t cell receptor ( tcr ) stimulation . genetic or pharmacologic attenuation atf4 reduce mitochondrial oxidative stress and promote cd8(+ ) til viability , enable response program cell death protein-1 ( pd-1 ) inhibitor therapy and confer protection re-emergent disease . thus , isr converge chronic atf4 activity cd8(+ ) til barrier ici response , position isr therapeutic candidate immunotherapy .",Immunity,25/09/2025
10.1002/advs.202504138,adamts1 exacerbates post-myocardial infarction scar formation mechanosensing,"Kong CY, Guo Z, Ma YL, Wang MY, Ni HY, Wang P, Qiu WJ, Wang EG, Li Z, Yang Z, Shen B, Tang QZ","-myocardial infarction ( mi ) remain lead cause morbidity and mortality worldwide , post-infarction cardiac remodeling , particularly excessive scar formation , represent critical determinant patient outcome . however , mechanistic pathway govern pathological scar formation remain incompletely understood . here , demonstrate adamts1 ( disintegrin and metalloproteinase thrombospondin motifs 1 ) , significantly upregulate endothelial cell ( ecs ) follow mi , play pivotal role regulate cardiac fibroblast activation novel mechanotransduction pathway involve integrin α8 ( itgα8 ) . use ec-specific adamts1 overexpression and knockout mouse combine cardiac fibroblast-specific itgα8 deletion model , find adamts1 overexpression exacerbate cardiac dysfunction and increase scar size , adamts1 deficiency provide cardioprotection . mechanistically , adamts1 modulate extracellular matrix stiffness proteoglycan ( pg ) cleavage rather direct protein interaction , activate itgα8 mechanosense specifically cardiac fibroblast . integrin family member test , itgα8 show selective responsiveness adamts1-mediated mechanical cue , confirm tunable-stiffness hydrogel experiment and validate comprehensive proteomic and functional analysis . itgα8 deficiency rescue adamts1-induced cardiac dysfunction and reduce pathological scar formation . finding reveal previously unrecognized adamts1-itgα8 mechanotransduction pathway , represent promising therapeutic target optimize post-infarction cardiac remodeling .","Advanced science (Weinheim, Baden-Wurttemberg, Germany)",27/09/2025
10.1186/s40168-025-02230-7,gut gamete : microbiome influence fertility and preconception,"Munyoki SK, Vukmer N, Rios JM, Kallen A, Jašarević E","global fertility rate continue to decline advancement assist reproductive technology , highlight significant gap understanding mechanism underlie preconception physiology . commentary , review grow body work demonstrate microbiome play crucial yet underexplored role woman 's reproductive health . work have show microbial community produce substrate support metabolic , immune , and hormonal function critical period , affect fertility , pregnancy outcome , and offspre health . woman reproductive disorder , include endometriosis , polycystic ovarian syndrome , primary ovarian insufficiency , and recurrent pregnancy loss , harbor distinct microbial signature . animal study provide key mechanistic insight , show disruption microbiota accelerate ovarian aging , but translate finding human preconception health require careful consideration . finding be compelling , emerge field currently lack clear understanding microbial signal affect reproductive tissue metabolite , immune response , or hormonal pathway . outline criterion establish microbial causation preconception health , include sufficiency , necessity , specificity , and timing . move correlation involve select appropriate model , focus key developmental window , conduct longitudinal study conception , and investigate specific microbial metabolite influence reproductive outcome . incorporate microbiome research preconception care could lead development new therapy and intervention . principle outline here primarily address preconception reproductive health , also offer framework microbiome research general , emphasize need mechanistic understanding , timely intervention , and progress association causation rapidly evolve field .",Microbiome,26/09/2025
10.1016/j.xcrm.2025.102372,phenotype obesity two-dimensional tree structure reveal,"Jia X, Lin H, Ding Y, Hu C, Wang S, Li M, Xu Y, Xu M, Huang F, Shen F, Gu X, Mu Y, Chen L, Zeng T, Shi L, Su Q, Yu X, Yan L, Qin G, Wan Q, Chen G, Tang X, Gao Z, Hu R, Luo Z, Qin Y, Chen L, Hou X, Huo Y, Li Q, Wang G, Zhang Y, Liu C, Wang Y, Wu S, Zhu Y, Yang T, Deng H, Zhao J, Zhang Y, Xu X, Wei H, Zheng J, Wang T, Zhao Z, Ning G, Chen Y, Wang W, Bi Y, Lu J","obesity , major public health challenge , be characterize substantial phenotypic heterogeneity . here , employ discriminative dimensionality reduction tree ( ddrtree ) method to routine clinical datum 18 , 733 chinese individual obesity enrol nationwide china cardiometabolic disease and cancer cohort ( 4c ) study . identify five distinct metabolic phenotype , phenotype characterize hyperglycemia and insulin resistance exhibit high risk glycemic deterioration , phenotype characterize hypertension and dyslipidemia demonstrate elevated risk microvascular and macrovascular disease . finding be validate independent prospective cohort . additionally , reveal distinctive metabolomic feature contribute heterogeneity obesity 4c study . to translate finding practice , develop user-friendly online tool to assess event risk obese population . overall , analysis illustrate underlie phenotypic variation influence subsequent obesity-related outcome , emphasize importance precision medicine obesity management .",Cell reports. Medicine,25/09/2025
10.1177/1060028015606469,association prenatal acetaminophen exposure and future risk attention,"Hoover RM, Hayes VA, Erramouspe J","objective : to evaluate effect prenatal acetaminophen exposure future development attention deficit/hyperactivity disorder ( adhd ) child . data source : literature search medline ( 1975 june 2015 ) , international pharmaceutical abstracts ( 1975 june 2015 ) , and cochrane database ( publication june 2015 ) prospective clinical trial assess relationship prenatal acetaminophen exposure and development attention deficit disorder or hyperactivity . study selection and data extraction : study compare self-reported maternal acetaminophen use pregnancy development adhd or adhd-like behavior offspring age 3 and 12 year . data synthesis : four study examine effect prenatal acetaminophen exposure subsequent adhd behavior be identify . , one early study find link adhd behavior other study find statistically significant correlation most prominent be study find high risk use adhd medication ( hazard ratio = 1 . 29 ; 95 % ci , 1 . 15-1 . 44 ) or have behavior age 7 year determine strengths and difficulties questionnaire ( risk ratio = 1 . 13 ; 95 % ci , 1 . 01-1 . 27 ) child mother use acetaminophen pregnancy . conclusion : do appear to be mild correlation prenatal acetaminophen use and development adhd symptom child , current datum do not provide sufficient evidence prenatal acetaminophen exposure lead development adhd symptom late life . acetaminophen be preferred option pain management pregnancy compare other medication such nonsteroidal anti-inflammatory drug or opioid pyretic or pain relief .",The Annals of pharmacotherapy,01/12/2015
10.1002/ana.78046,"skeletal muscle biomarkers amyotrophic lateral sclerosis : large-scale ,","Dergai O, Wuu J, Koziczak-Holbro M, Malaspina A, Granit V, Hernandez JP, Cooley A, Sachdev R, Yu L, Bidinosti M, Flotte L, Nash M, Jennings LL, Berry JD, Bruijn LI, Brachat S, Benatar M","objective : biomarker clear context use be important tool amyotrophic lateral sclerosis ( als ) therapy development . understand longitudinal trajectory untreated state be key use potential marker pharmacodynamic response . end , undertake large-scale proteomic study well-phenotyped cohort to identify biomarker candidate als disease state and disease progression . method : clinical phenotypic datum and biofluid sample , collect patient als and healthy control multiple longitudinal natural history study , be use to identify biomarker candidate . slow off-rate modify aptamer ( somamer)-base relatively quantitative measurement ~7 , 000 protein be perform plasma and cerebrospinal fluid ( csf ) , immunoassay validation candidate interest . result : identify 329 plasma protein significantly differentially regulate als and control ( adjust p-value < 0 . 05 ) , 25 show > 40 % relative abundance . pdlim3 , tnnt2 , and myl11 have great log-fold elevation , antxr2 and art3 have great log-fold reduction . similar set plasma protein be find to increase ( eg , pdlim3 , tnnt2 , and myl11 ) or decrease ( eg , antxr2 , art3 , and mstn ) disease progression . csf protein great log-fold elevation include nefl , nefh , chit1 , ca3 , myl11 , and gpnmb . result be confirm independent replication cohort . moreover , tissue-specific signature enrichment suggest significant contribution muscle source biomarker . plasma kcnip3 be elevate ~60 % riluzole . immunoassay provide orthogonal validation plasma tnnt2 and csf gpnmb . interpretation : identify array novel biomarker potential to serve response biomarker to aid therapy development , as well to shed light underlie biology disease . ann neurol 2025 .",Annals of neurology,29/09/2025
10.1016/j.bcp.2025.117372,advance understand mechanism noncode rna ( ncrna)-mediate,"Ge C, Yuan Y, Li X, Zhang J, Ling J, Zheng X, Wu Y, Huang X, Yang P, Liu X, Zhang D, Liu J, Zhang J, Yu P","nonalcoholic fatty liver disease ( nafld ) , recently reclassify metabolic dysfunction-associated steatotic liver disease ( masld ) , have emerge most prevalent chronic liver disorder worldwide , progress simple steatosis nonalcoholic steatohepatitis ( nash ) , fibrosis , cirrhosis , and hepatocellular carcinoma ( hcc ) . increase evidence highlight pivotal role immune-inflammatory response nafld pathogenesis , macrophage polarization serve key regulatory mechanism influence disease initiation , progression , and potential resolution . noncoding rnas ( ncrnas ) , include micrornas ( mirnas ) , long noncode rnas ( lncrnas ) , and circular rnas ( circrnas ) , have emerge essential modulator macrophage phenotype and function influence transcriptional checkpoint , inflammatory signal pathway , and intercellular communication . recent finding far underscore role lipotoxicity-associated ncrnas transmit stress signal hepatocyte macrophage , thereby amplify immune dysregulation and fibrogenesis . review summarize current knowledge ncrna expression and function nafld , focus regulatory role macrophage polarization disease stage , steatosis hcc . categorize ncrna-targeted therapy specific approach ( e.g. , mirna mimic or inhibitor ) and nonspecific intervention ( e.g. , exosome- or compound-mediated modulation ) , and far discuss therapeutic potential and challenge , as well emerge macrophage-targeted delivery system . link molecular mechanism therapeutic strategy , propose ncrna-based modulation macrophage polarization promising avenue diagnosis and treatment nafld .",Biochemical pharmacology,25/09/2025
10.1038/s41591-025-03944-9,prevention type 2 diabete prediabete remission weight loss .,"Sandforth A, Arreola EV, Hanson RL, Wewer Albrechtsen NJ, Holst JJ, Ahrends R, Coman C, Gerst F, Lorza-Gil E, Cheng Y, Sandforth L, Katzenstein S, Ganslmeier M, Seissler J, Hauner H, Perakakis N, Wagner R, Machann J, Schick F, Peter A, Lehmann R, Weigert C, Maurer J, Preissl H, Heni M, Szendrödi J, Kopf S, Solimena M, Schwarz P, Blüher M, Häring HU, Hrabé de Angelis M, Schürmann A, Kabisch S, Mai K, Pfeiffer AFH, Bornstein S, Stumvoll M, Roden M, Stefan N, Fritsche A, Birkenfeld AL, Jumpertz von Schwartzenberg R","clinical practice guideline recommend define weight loss goal prevention type 2 diabetes ( t2d ) individual increase risk , such prediabete . however , achieve prediabete remission , that is , reach normal glucose regulation accord american diabetes association criterion , be more efficient prevent t2d solely reach weight loss goal . here present post hoc analysis large , multicenter , randomize , control prediabetes lifestyle intervention study ( plis ) , demonstrate prediabete remission be achievable weight loss or even weight gain , and also protect incident t2d . underlie mechanism include improve insulin sensitivity , β-cell function and increment β-cell-glp-1 sensitivity . weight gain be similar achieve prediabete remission ( responder ) compare nonresponder ; however , adipose tissue be differentially redistribute responder and nonresponder compare other-while nonresponder increase visceral adipose tissue mass , responder increase adipose tissue subcutaneous depot . finding be reproduce us diabetes prevention program . datum uncover essential pathway prediabete remission weight loss and emphasize need to include glycemic target current clinical practice guideline to improve t2d prevention .",Nature medicine,29/09/2025
10.1007/s10549-022-06562-y,feasibility use autologous gm-csf-secreting breast cancer vaccine to,"Anderson KS, Erick TK, Chen M, Daley H, Campbell M, Colson Y, Mihm M, Zakka LR, Hopper M, Barry W, Winer EP, Dranoff G, Overmoyer B",purpose : antigenic target immunity and role vaccination breast cancer be unknown . perform phase study autologous,Breast cancer research and treatment,01/07/2022
10.1016/j.cmet.2025.08.009,hebp2-governe glutamine competition tumor and macrophage dictate,"Xiao Y （肖毅）, Xu Y （徐颖）, Wang H （王晗）, Yang F （杨帆）, Ding XH （丁晓洪）, Fu T （傅彤）, Chen L （陈力）, Jin X （金希）, Zhao YX （赵雅鑫）, Wang Y （王莹）, Chen F （陈芬芳）, Shao ZM （邵志敏）, Jiang YZ （江一舟）","immunotherapy demonstrate limited efficacy triple-negative breast cancer ( tnbc ) , influence intricate metabolic interaction tumor microenvironment . here , develop single-cell rna sequence ( scrna-seq ) immunotherapy cohort ( n = 27 ) and spatial transcriptomic cohort ( n = 88 ) elucidate metabolic crosstalk associate therapeutic efficacy tnbc . illustrate heme bind protein 2 ( hebp2)(high ) tumor cell ( feature active glutathione metabolism ) and ccl3(+ ) macrophage ( characterize oxidative metabolism ) indicate immunotherapy efficacy and be quantitatively and spatially negatively correlate . hebp2-mediate glutamine cell type induce phenomenon . mechanistically , hebp2 disrupt foxa1 cytoplasmic phase separation , promote nuclear translocation upregulate glutathione s-transferase p1 ( gstp1 ) expression and glutamine consumption tumor cell . metabolic shift induce ferroptosis ccl3(+ ) macrophage , impair antitumor immunity . utilization gstp1 inhibitor sensitize tnbc immunotherapy . collectively , delineate tumor-macrophage metabolic checkpoint govern hebp2/gstp1 axis and pioneer single-cell-level immunometabolism paradigm evaluate immunotherapeutic vulnerability .",Cell metabolism,23/09/2025
10.1016/j.phymed.2025.157299,enzyme-responsive liposome target endoplasmic reticulum stress-mediated,"Li C, Qian C, Zhang J, Huang Y, Zhao X, Su H, Hou Y, Li C","background : rheumatoid arthritis ( ra ) be chronic autoimmune disease characterize persistent synovial inflammation and joint destruction . insufficient apoptosis fibroblast-like synoviocyte ( flss ) significantly contribute pathogenesis ra promote hyperplasia and inflammatory cytokine secretion . celastrol ( clt ) , pentacyclic triterpene derive tripterygium wilfordii , have show promise induce apoptosis endoplasmic reticulum ( er ) stress-mediated pathway . however , clinical application be limit poor solubility and off-target effect . target delivery clt fls and er could enhance therapeutic efficacy minimize toxicity . method : engineer clt-loaded , enzyme-responsive liposome ( clt-felipos ) functionalize hyaluronic acid ( ha ) , oligopeptide gpa ( fap-α recognition fls ) , er-targeting kdel peptide , and cleavable peg chain . vitro ,",Phytomedicine : international journal of phytotherapy and phytopharmacology,23/09/2025
10.1016/j.bbadis.2025.168060,age interactome : cellular dysregulation therapeutic frontier,"Abo Qoura L, Churov AV, Maltseva ON, Arbatskiy MS, Tkacheva ON","biological aging be complex , multifaceted process characterize progressive erosion cellular homeostasis , drive intersect pathway inflammaging , immune senescence , mitochondrial dysfunction , and genomic instability . review delineate current knowledge interconnect mechanism underlie aging-related disease , include atherosclerosis , obesity , sarcopenia , neurodegenerative disorder , rheumatoid arthritis , and cancer . far discuss critical role contribute factor such microbiome dysbiosis , sex difference , and exosome-mediated communication modulate disease progression . advancement multi-omics technology and ai-driven biomarker , particularly epigenetic clock , be highlight ability to precisely quantify biological aging and stratify disease risk . finally , explore therapeutic potential and promising clinical trial target share mechanism senolytic , mitochondrial enhancer , and immunomodulator , offer paradigm shift disease-specific treatment holistic intervention design to extend healthspan .",Biochimica et biophysica acta. Molecular basis of disease,26/09/2025
10.1038/s41467-025-63349-7,"exo1 therapeutic target fanconi anaemia , zrsr2 and brca1-a complex","Maric M, Segura-Bayona S, Kuthethur R, Takaki T, Borel V, Stanage TH, Ivanov MP, Parnandi N, Hewitt G, Millar R, Fonseca CS, Patel H, Llorian M, Warchal S, Howell M, Chaudhuri AR, Kotsantis P, Boulton SJ","exonuclease exo1 perform multiple role dna replication and dna damage repair ( ddr ) . however , exo1 loss be well-tolerate , suggest existence compensatory mechanism could be exploit ddr-deficient cancer . use crispr screening , find exo1 loss synthetic lethal many ddr gene somatically inactivate cancer , include fanconi anaemia ( fa ) pathway and brca1-a complex gene . also identify spliceosome factor and tumour suppressor zrsr2 synthetic lethal loss exo1 and show zrsr2-deficient cell be attenuate fa pathway activation , exhibit cisplatin sensitivity and radial chromosome formation . furthermore , fa or zrsr2 deficiency depend exo1 nuclease activity and can be potentiate combination parp inhibitor or ionize radiation . finally , uncover dysregulate replication-coupled repair driver synthetic lethality exo1 and fa pathway attributable defective fork reversal , elevated replication fork speed , post-replicative single strand dna exposure and dna damage . finding implicate exo1 synthetic lethal vulnerability and promise drug target broad spectrum ddr-deficient cancer unaddresse current therapy .",Nature communications,26/09/2025
10.1186/s12879-025-11577-z,molecular epidemiology and increase macrolide resistance bordetella,"Mai Q, Wen J, Luo Y, Guo J, Qin Y, Lai W, Deng W, Ji C, Mai R, Zheng M, Chen Z, Chen Y, Gu C, Guo L, Li H, Tang Y, Huang D, Luo M","background : pertussis ( whoop cough ) , highly contagious respiratory disease cause bordetella pertussis , have resurge worldwide and require increase attention . study aim to characterize molecular epidemiology and antimicrobial susceptibility profile b . pertussis isolate circulate guangzhou , china . methods : total 91 culture-confirmed pertussis case guangzhou january 2020 and august 2024 be enrol and study . b . pertussis isolate ( january 2020 may 2024 ) be recover 62 case . isolate undergo antigenic genotyping and phylogenetic analysis base whole-genome sequence . antimicrobial susceptibility testing use e-test be perform 12 representative isolate . result : majority culture-confirmed case occur child 1 year age be unvaccinate or partially vaccinate . genotypic analysis reveal significant shift : only 3 isolate ( all 2022 ) harbor ptxp1 allele , remain 59 exhibit ptxp3 . three type pertactin ( prn ) allele be identify : prn1 ( 4 . 84 % , 3/62 ) , prn2 ( 11 . 29 % , 7/62 ) , prn150 ( 80 . 65 % , 50/62 ) , and 2 untype prn allele . 2024 , prn150 become predominant allele . phylogenetic analysis reveal distinct branch separate ptxp1 and ptxp3 lineage . result demonstrate macrolide-resistant isolate ( exhibit mic > 256 mg/l erythromycin , azithromycin , and clarithromycin ) carry a2047 g mutation 23s rrna gene . proportion isolate harbor mutation increase significantly 2022 and dominate 2024 . test isolate display low mic alternative agent : trimethoprim/sulfamethoxazole ( mic ≤ 0 . 5/9 . 5 mg/l ) , cefoperazone/sulbactam ( mic ≤ 0 . 064/0 . 032 mg/l ) , and piperacillin/tazobactam ( mic ≤ 0 . 064/4 mg/l ) . notably , macrolide-resistant isolate harbor ptxa1-ptxp3-prn150 genotype form distinct sub-clone ptxp3 clade . conclusion : finding demonstrate current dominance macrolide-resistant b . pertussis strain harbor ptxp3 and prn150 guangzhou 2024 . study provide epidemiological and microbiological insight to guide local pertussis control strategy and to offer antimicrobial resistance monitoring effort .",BMC infectious diseases,26/09/2025
10.1007/s10522-025-10324-w,multifaceted dynamic circadian timing system influence aging and longevity .,"Jagota A, Khan ZA, Sharma SA, Priyanka","circadian time keep system ( cts ) consist network central and peripheral clock regulate physiological , metabolic , and behavioural process alignment 24 hour . desynchrony central and peripheral clock contribute pathogenesis age-related condition such metabolic syndrome , cognitive decline , immune dysfunction , and neurodegenerative disease etc . sex-specific susceptibility far modulate circadian resilience , hormonal change and redox imbalance play key role age trajectory . immune senescence and hormonal dampening , particularly cortisol and melatonin rhythm , exacerbate circadian misalignment , accelerate systemic decline aging . interestingly , aging and clock dysfunction be bidirectional process , i.e. age progressively influence circadian rhythm multiple level and vice versa , molecular architecture core clock gene feedback loop functionality central pacemaker-the suprachiasmatic nucleus ( scn)-and coordination peripheral oscillator . review critically highlight complex alteration circadian mechanism associate aging , include diminish transcriptional rhythmicity , epigenetic drift , mitochondrial desynchronization , and disruption neurotransmitter system . such change turn lead weakened scn output , impaired photic entrainment , and loss temporal coherence organ system . far , review demonstrate cts and aging multiple level such behavioural , physiological , biochemical and molecular level be link push-pull mechanism i.e. , breakdown harmony circadian rhythm systemic level push organism early aging and aging turn be link cts disorder .",Biogerontology,27/09/2025
10.1016/j.jep.2025.120650,dantao formula alleviates hepatic fibrosis and portal hypertension modulation,"Zeng R, Guo Y, Qi J, Li M, Huang K, Peng Y, Li Z, Liu C","ethnopharmacological relevance : dantao formula ( dtf ) consist salvia miltiorrhiza bunge ( danshen ) and prunus persica ( l . ) batsch seed ( taoren ) , be component promote circulation and remove stasis anti-fibrotic herbal--- fuzheng huayu formula ( fzhy ) . have demonstrate efficacy alleviate hepatic fibrosis and portal hypertension ( ph ) ; however , pharmacological mechanism remain unclear . aim study : aim be to investigate effect and molecular mechanism dtf liver fibrosis and ph . materials and method : vivo experiment be evaluate use ccl(4)-induced mouse model rivaroxaban ( riva ) drug control . ph be assess direct puncture method . fibrosis be assess sirius red staining and hydroxyproline . network pharmacology analysis predict potential molecule or signal mediator . vitro , lx-2 cell be activate et-1 , and y-33075 use drug control . elisa , western blot , immunohistochemistry and immunofluorescence be conduct to assess target expression et-1 , endra , rock , camp , pka , mlc and p-mlc . result : dtf or riva could alleviate liver fibrosis and ph compare model group . network pharmacology analysis suggest camp/pka/rock signal pathway act key target dtf . vivo , dtf or riva suppress et-1 , ednra and rock expression , enhance camp and pka expression . vitro , dtf or y-33075 attenuate activation lx-2 cell induce et-1 , down-regulated rock and p-mlc expression , up-regulate camp and pka expression . conclusion : dtf alleviate liver fibrosis and ph regulate camp/pka/rock signal pathway activate hsc .",Journal of ethnopharmacology,25/09/2025
10.1016/j.biopha.2025.118608,immune cell dynamic and role cardiac injury : mechanism and therapeutic,"Liu C, Wu R, Yang H, Yao Y","cardiovascular injury initiate temporally regulate immune cascade govern tissue damage and repair . neutrophil , macrophage , dendritic cell , and t cell contribute distinct yet overlap function acute inflammation , resolution , and chronic remodeling . review synthesize recent finding single-cell transcriptomic , spatial omic , immunometabolism , and neuroendocrine-immune interaction to delineate immune cell dynamic major cardiac disease , include myocardial infarction , heart failure , viral myocarditis , hypertensive remodeling , and sepsis-induce cardiomyopathy . far examine immune cell communicate cardiomyocyte , fibroblast , endothelial cell , and neurohormonal regulator to shape myocardial microenvironment . particular emphasis be place macrophage polarization , regulatory t cell activity , extracellular vesicle-mediated signaling , and metabolic checkpoint key determinant immune behavior . base mechanistic insight , propose framework precision immunotherapy integrate immune profiling , metabolic status , and neuroendocrine cue to guide individualized intervention . emerge strategies-include low-dose interleukin-2 , immune checkpoint blockade , mesenchymal stem cell-derived extracellular vesicle , and immunometabolic reprogramming-are highlight promising mean to recalibrate immunity tissue repair . overall , review provide translational perspective aim shift cardiovascular therapy non-specific immunosuppression to adaptive , stage-specific immunomodulation .",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,27/09/2025
10.1038/s41375-025-02776-3,refining pet-base response extramedullary multiple myeloma use total lesion,"Zanwar S, Belge Bilgin G, Broski SM, Thorpe M, Bilgin C, Gonsalves W, Kapoor P, Kourelis T, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Gertz MA, Leung N, Lin Y, Muchtar E, Warsame R, Kyle RA, Rajkumar SV, Kumar S","positron emission tomography ( pet)-based assessment be integral part response assessment patient multiple myeloma ( mm ) extramedullary disease ( emd ) , yet utility emd remain to be systematically study . retrospectively evaluate 95 patient emd undergo fdg pet/ct imaging metabolic response assessment use visual deauville scores ( ds ) and total lesion glycolysis ( tlg ) . tlg response be categorize complete metabolic response ( cmr ; 100 % reduction ) , major metabolic response ( mmr ; < 100 % to ≥50 % reduction ) , and non-significant metabolic response ( nmr ; < 50 % reduction ) . median progression-free survival ( pfs ) differ significantly ds ( 22 . 4 4 . 3 2 . 8 month ds ≤ 3 , = 4 , and 5 , respectively ; p < 0 . 0001 ) and tlg response ( 36 . 5 5 . 4 2 . 2 month cmr , mmr , nmr ; p < 0 . 0001 ) . tlg offer well discrimination ds , approximately one-third patient ds stratum be reclassify tlg stratification . multivariable analysis , tlg response [ hr 2 . 6 ( 95 % ci : 1 . 8-3 . 8) , p < 0 . 0001 ] remain independently prognostic adjust cytogenetic , triple-class refractoriness , and de novo emd status . 18-month os rate be 89 % , 42 % and 19 % tlg cmr , mmr , and nmr cohort ( p < 0 . 001 ) . finding support integration tlg response criterion emd .",Leukemia,28/09/2025
10.1016/j.phymed.2025.157330,astragaloside iv potentiate cisplatin sensitivity triple-negative breast,"Bai B, Zhang L, Zhang Y, Yue R, Lu Y, Shi R, Zhou Q","background : astragaloside iv ( ) , bioactive tetracyclic triterpenoid saponin astragalus membranaceus , exhibit diverse pharmacological property include anti-inflammatory , anticancer and immunomodulatory activity . however , potential role targeted therapeutic agent cisplatin sensitization triple-negative breast cancer ( tnbc ) sting signal pathway remain unexplored . purpose : study aim to investigate cisplatin-sensitizing potential tnbc and elucidate underlie molecular mechanism . method : bioinformatic analysis identify key module gene public database use weighted gene co-expression network analysis ( wgcna ) , follow feature selection least absolute shrinkage and selection operator ( lasso ) regression . immune microenvironment characterization be perform use cibersort deconvolution analysis . potential target tnbc be systematically identify multi-database mining , protein-protein interaction ( ppi ) network construction , pathway enrichment analysis and molecular docking simulation . transcriptomic profiling reveal treatment-induced differentially express gene and enrich signal pathway murine tissue . combinatorial anti-tumor efficacy be evaluate use orthotopic tnbc model ( 4t1 cell-derived ) vivo and 4t1 , mda-mb-231 , and mcf-7 cell line vitro . mechanistic validation be conduct integrate vivo and vitro experiment . result : integrated bioinformatics analysis ( wgcna , lasso , and cibersort ) identify sting chemotherapy-sensitive module six endoplasmic reticulum ( er)-associate gene co-expression network . sting exhibit significant enrichment antitumor immune pathway and correlate heterogeneous immune cell infiltration . kegg pathway analysis implicate immune/inflammatory signal and dna damage response cisplatin-sensitizing effect as . molecular docking confirm stable binding and sting ( bind energy : -36 . 09 kcal/mol ) . vivo , synergistically enhance cisplatin 's tumor growth inhibition mitigate cisplatin-induced toxicity , include weight loss , nephrotoxicity , and systemic inflammation . transcriptomic and immunohistochemical analysis validate as-mediated dna damage , sting pathway activation , immune cell recruitment . vitro mechanistic study use dnase i and sting inhibitor ( c-176 ) demonstrate potentiate cisplatin cell cycle arrest , mitochondrial dysfunction and sting cascade activation . c-176 weaken antitumor activity as- cisplatin combination treatment . conclusion : synergistically enhance therapeutic efficacy cisplatin tnbc ameliorate adverse effect , primarily activation sting signal pathway and potentiation antitumor immunity . dual mechanism-simultaneously boost host defense ( "" fuzheng "" ) and inhibit tumor progression ( "" kang ` ai "" )-provide molecular basis observed "" qi-tonifying "" property traditional chinese medicine ( tcm ) , bridge tcm contemporary immunopharmacology .",Phytomedicine : international journal of phytotherapy and phytopharmacology,24/09/2025
10.1186/s43556-025-00312-4,5-hydroxytryptamine promote non-small cell lung cancer metastasis,"Sun J, Liu CG, Chen S, Zhou H, Liu X, Wang FR, Luo YW, Zang D, Chen J","tumor metastasis severely compromise prognosis patient non-small cell lung cancer ( nsclc ) , yet underlie mechanism remain unclear . biogenic amine 5-hydroxytryptamine ( 5-ht ) , derive tryptophan ( trp ) , have be report to promote tumor growth , but role nsclc metastasis have not be fully elucitate . study , fecal metabolomic profiling reveal significant enrichment trp metabolism and serotonergic synapse pathway patient nsclc metastasis . notably , level 5-ht peripheral blood show positive correlation fecal trp concentration nsclc patient . functional experiment demonstrate 5-ht promote nsclc cell migration , invasion , epithelial-mesenchymal transition ( emt ) , and metastasis inhibit expression small nuclear ribonucleoprotein g ( snrpg ) . rna sequence ( rna-seq ) far identify cyclin-dependent kinase 14 ( cdk14 ) critical downstream target snrpg . snrpg downregulate cdk14 expression , thereby restrain malignant phenotype nsclc cell . furthermore , snrpg negatively regulate protein level wilms tumor 1 ( wt1 ) directly bind . loss snrpg lead wt1 accumulation , turn bind cdk14 promoter and activate transcription , ultimately drive nsclc metastasis . finding collectively suggest 5-ht/snrpg/wt1/cdk14 axis play pivotal role promote nsclc metastasis and highlight 5-ht and snrpg potential therapeutic target nsclc metastasis .",Molecular biomedicine,29/09/2025
10.1016/j.jare.2025.09.053,circcdyl promote glycolysis to drive progression nasopharyngeal,"Yang Y, Wang Y, Qu H, Wang D, Ge J, Wu P, Yan Q, Chen P, Xiang B, Zhou M, Guo C, Xiong W, Shi L, Zeng Z","introduction : circrnas play critical role onset and progression nasopharyngeal carcinoma ( npc ) , underlie mechanism remain incompletely understood . objective : study , investigate mechanism circcdyl promote proliferation , invasion and migration npc vitro and vivo . method : reanalyze rna sequence datum ( gse137543 , prjna391554 ) and validate finding rt-qpcr and situ hybridization experiment . functional assay be subsequently perform both vitro and vivo . result : identify circcdyl be highly express npc , expression level positively correlate clinical tumor staging . functionally , circcdyl promote tumor proliferation and metastasis both vitro and vivo . mechanistically , circcdyl bind 3 ' -utr ldha mrna , stabilize and upregulate ldha protein expression , thereby enhance cellular glycolysis and increase lactate production and accumulation . elevated lactate , turn , promote lactylation actin-binding protein cfl1 lysine 22 . modification reduce cell adhesion and stiffness , ultimately facilitate tumor cell proliferation , invasion , and migration . conclusion : finding indicate circcdyl and downstream pathway may serve potential diagnostic marker or therapeutic target npc .",Journal of advanced research,26/09/2025
10.1155/crp/9292002,relationship fibrinogen-to-albumin ratio and short-term mortality,"Guo LL, Liu P, Cai LN, Hu L, Zhou YS","background : recent study have identify association fibrinogen-to-albumin ratio ( far ) and prognosis coronary heart disease ; however , evidence regard significance heart failure patient remain limited . study aim to examine relationship far and short-term mortality individual heart failure . method : retrospective cohort study , conduct analysis clinical datum patient heart failure be hospitalize zigong fourth people 's hospital december 2016 june 2019 . primary exposure variable be far , outcome interest be mortality rate 28 day and 3 month . multivariate logistic regression evaluate far 's independent association short-term mortality , predictive accuracy assess roc curve and subgroup consistency stratified analysis . furthermore , smooth curve fitting be utilize to investigate linear relationship , and series sensitivity analysis be conduct to validate robustness finding . result : analysis include 1880 participant , 58 . 1 % be female and 54 . 1 % be age 60-80 year . study show one standard deviation rise far be link 45 % increase 28-day mortality ( or = 1 . 45 , 95 % ci = 1 . 02-2 . 06 , p=0 . 04 ) adjust potential confounding factor . 28-day mortality rate be markedly elevated high far group ( far > 0 . 126 ) compare low far group ( or = 4 . 01 , 95 % ci = 1 . 17-13 . 82 , p=0 . 028 ) . comparable finding be note 3-month mark . be significant interaction find subgroup analysis . linear association be identify far and short-term mortality . optimal far cutoff value predict 28-day mortality be 0 . 156 ( sensitivity 68 . 0 % , specificity 59 . 4 % , auc = 0 . 654 ) , 3-month mortality , be 0 . 156 ( sensitivity 68 . 0 % , specificity 58 . 3 % , auc = 0 . 647 ) . sensitivity analysis corroborate robustness finding . conclusion : positive correlation exist far and short-term mortality chinese patient heart failure . finding underscore necessity further investigation underlie pathophysiological mechanism and potential therapeutic intervention associate far context heart failure .",Cardiology research and practice,01/01/2025
10.1136/jitc-2025-012423,"transformer-base ai approach to unravel long-term , time-dependent prognostic","Cortellini A, Santo V, Brunetti L, Garbo E, Pinato DJ, La Cava G, Naidoo J, Katz A, Loza M, Neal JW, Genova C, Gettinger S, Kim SY, Jayakrishnan R, El Zarif T, Russano M, Pecci F, Di Federico A, Alessi JV, Montrone M, Owen DH, Ramella S, Signorelli D, Fidler MJ, Li M, Camerini A, Halmos B, Vincenzi B, Metro G, Passiglia F, Yendamuri S, Guida A, Ghidini M, D'Alessio A, Banna GL, Fulgenzi CAM, Grisanti S, Grossi F, D'Incecco A, Josephides E, Van Hemelrijck M, Russo A, Gelibter A, Spinelli G, Verrico M, Tomasik B, Giusti R, Balachandran K, Bria E, Sebastian M, Rost M, Forster M, Mukherjee U, Landi L, Mazzoni F, Aujayeb A, Dupont M, Curioni-Fontecedro A, Chiari R, Sforza V, Tiseo M, Friedlaender A, Addeo A, Zoratto F, De Tursi M, Cantini L, Roca E, Mountzios G, Rocco D, Della Gravara L, Kalvapudi S, Inno A, Bironzo P, Di Marco Barros R, O'Reilly D, Fitzpatrick O, Karapanagiotou E, Monnet I, Baena J, Macerelli M, Piedra A, Agustoni F, Cortinovis DL, Tonini G, Minuti G, Bennati C, Mezquita L, Gorría T, Servetto A, Beninato T, Lo Russo G, Prelaj A, De Giglio A, Rogado J, Moliner L, Nadal E, Biello F, Nana FA, Dingemans AM, Aerts JGJV, Ferrara R, Abu Hejleh T, Takada K, Naqash AR, Garassino MC, Peters S, Wakelee HA, Nassar AH, Ricciuti B, Soda P, Caruso CM, Guarrasi V","background : nearly one-third patient advanced non-small cell lung cancer ( nsclc ) and pd-l1 tumor proportion score≥50 % survive 5 year follow first-line pembrolizumab , long-term outcome challenge traditional paradigm cancer prognostication . emergence non-cancer-relate factor and time-dependent trend underscore need advanced analytical framework to unravel complex interplay . method : analyze pembro-real 5y registry , global real-world dataset 1050 patient treat 61 institution 14 country long-term follow-up and large panel baseline variable . two complementary approach be employ : ridge regression , choose ability to address multicollinearity retain interpretability , and not imputation method ( naim ) , transformer-based artificial intelligence model design to handle miss datum imputation . endpoint include risk death 6 , 12 , 24 , 60 month and 5-year survival . result : ridge regression model achieve c-statistic 0 . 66 ( 95 % ci : 0 . 59 0 . 72 ) risk death and area curve ( auc ) 0 . 72 ( 95 % ci : 0 . 65 0 . 78 ) 5-year survival , identify eastern cooperative oncology group performance status ( ecog-ps)≥2 , increase age , and metastatic burden primary risk factor . however , wide ci predictor highlight statistical instability . naim demonstrate robust handling miss datum , c-index 62 . 98±2 . 11 risk death and auc 60 . 52±3 . 71 5-year survival . comprehensive shapley additive explanation analysis reveal dynamic , time-dependent pattern , early mortality dominate acute factor ( eg ,",Journal for immunotherapy of cancer,29/09/2025
10.3389/fncel.2025.1655342,alzheimer 's disease : do stand now and be strategic,"González A, Geywitz S, Maccioni RB","alzheimer 's disease ( ad ) be multifactorial neurodegenerative disease , primary cause dementia people 65 year old . ad be characterize two molecular hallmark , intracellular neurofibrillary tangle tau and amyloid beta oligomer , be aggregate hyperphosphorylated tau and amyloid beta peptide , respectively . hallmark give rise two main theory have open way available treatment , such fda-approved memantine , and aβ ( aducanumab , lecanemab ) and tau immunotherapy . tau immunotherapy , especially multitarget approach , have be recently prove effective . however , drug amyloid plaque have non-successful outcome , contribution ad knowledge . innovative approach come multitarget concept , base bioactive molecule and nutraceutical . interestingly , use early detection biomarker such alz-tau ( ® ) , simoa ( ® ) , and recent lumipulse ™ test , be important support orient ad therapy base modification style life . include physical exercise , healthy diet , mindfulness , and cognitive stimulation , other . above analysis be critical to switch focus prevention ad .",Frontiers in cellular neuroscience,01/01/2025
10.1007/s00421-010-1658-5,"association basal serum bdnf , cardiorespiratory fitness and cardiovascular","Jung SH, Kim J, Davis JM, Blair SN, Cho HC","evidence suggest serum brain-derived neurotrophic factor ( serum bdnf ) can be affect cardiorespiratory fitness ( crf ) , but relationship be far clear . recent report show inverse relationship serum bdnf and crf healthy individual , and other study suggest possible association serum bdnf and cardiovascular disease . however , possible interaction serum bdnf , crf , and cardiovascular disease risk have not be study . purpose study be to examine association serum bdnf , crf , and cardiovascular disease risk factor healthy man . investigation involve large sample man ( n = 995 , age range : 20-76 year ) live central area south korea and be recruit preventive health study . study show significant inverse relationship serum bdnf and relative vo(2)max ( r = -0 . 412 , p < 0 . 0001 ) and heart rate reserve ( r = -0 . 194 , p < 0 . 0001 ) . serum bdnf be positively correlate body mass index ( r = 0 . 80 , p < 0 . 0001 ) , total cholesterol ( r = 0 . 185 , p < 0 . 0001 ) , and triglyceride ( r = 0 . 320 , p < 0 . 0001 ) . datum suggest serum bdnf may be associate effect increase crf cardiovascular disease . however , more research be clearly need determination , and extent , serum bdnf may be responsible health benefit associate crf .",European journal of applied physiology,01/02/2011
10.1126/sciadv.adx3827,usp13 stabilize nlrp3 to facilitate inflammasome activation prevent,"Li YT, Li KY, Tao SS, Wang T, Lu Y, Chen H, Zhan YQ, Zhao K, Xiang SS, Li JJ, Gao HY, Yu M, Li CY, Wang L, Yang XM, Ren GM, Yin RH",", lrr- , and pyrin domain-containing protein 3 ( nlrp3 ) have fundamental role host defense and be involve diverse inflammatory disease . nlrp3 protein expression be tightly control ubiquitin system . particular , nlrp3 protein degradation have be extensively study . contrast , mechanism to stabilize nlrp3 protein be much less known . here , demonstrate critical role ubiquitin-specific protease 13 ( usp13 ) regulate nlrp3 protein stability and inflammasome activation independently deubiquitinate enzyme activity . usp13 compete e3 ubiquitin ligase trim31 to interact nlrp3 and prevent trim31-mediate nlrp3 ubiquitination k192 and k496 site , thereby inhibit proteasomal degradation nlrp3 . usp13 deficiency reduce nlrp3 protein expression both human and mouse macrophage , consequently inhibit nlrp3 inflammasome assembly and activation . accordingly , deficiency usp13 attenuate monosodium urate crystal-induced mouse peritonitis . overall , finding reveal previously unrecognized regulatory mechanism nlrp3 stability usp13 and provide potential therapeutic target nlrp3-driven disease .",Science advances,26/09/2025
10.1097/MEJ.0000000000001270,early diagnosis and treatment acute heart failure prehospital and emergency,"Miró Ò, Chioncel O, Mebazaa A, Sato N, Butler J, Davison B, Biegus J, Pagnesi M, Ambrosy AP, Savarese G, Fudim M, Mentz RJ, Nauli SE, Lima IGCV, Bocchi EA, Sliwa-Hahnle K, Dzudie A, Harikrishnan S, Riccardi M, Zhang Y, Zhou J, Cotter G, Freund Y","acute heart failure ( ahf ) be diagnose 0 . 5 % patient see emergency medical system ( ems ) and represent about 1 % emergency department ( ed ) visit . leg swell and shortness breath be most frequent patient complaint . significant advancement patient care pathway , proper diagnosis , treatment and disposition ahf may be far improve emergency setting . present document be expert consensus document outline key point diagnosis , treatment and decision-making patient be diagnose ahf ems and ed . pillar correct diagnosis include detailed clinical assessment and accurate interpretation natriuretic peptide , chest x-ray be still most frequent image test use ed , could be substitute ultrasonography exploration appropriate patient . quick identification most severe case need intensive care be mandatory , most characterize hemodynamic instability , ventilatory failure or acute coronary syndrome need intervention . treatment could be start prehospital setting ems , and loop diuretic be still cornerstone decongestive therapy . measurement diuresis and natriuresis shortly provision first diuretic bolus be recommend , can help detect patient poor diuretic response dose augmentation or drug escalation addition acetazolamide or thiazide . selected patient , vasodilator ( especially acute cardiogenic pulmonary edema phenotype ) or inotropes/vasopressor ( cardiogenic shock ) can be need . oxygen therapy should be provide patient air-room spo2 95 % , and noninvasive ventilation be option patient respiratory distress . provision ed care , correct decision patient discharge or hospitalization be paramount , and risk stratification can help regard . other key point ahf management ed include adequate diagnosis and management trigger ahf episode ; to take aspect patient frailty account ; to avoid line , catheter , and patient overstay ed possible ; and to ensure proper follow-up plan discharge hospital .",European journal of emergency medicine : official journal of the European Society,29/09/2025
10.3390/cancers13030427,cancer treatment-induce accelerated aging cancer survivor : biology and,"Wang S, Prizment A, Thyagarajan B, Blaes A","rapid improvement cancer survival lead realization many modality use to treat or control cancer may cause accelerate aging cancer survivor . clinically , "" accelerate age "" phenotype cancer survivor include secondary cancer , frailty , chronic organ dysfunction , and cognitive impairment , can impact long-term health and quality life cancer survivor . treatment-induced accelerate aging cancer survivor could be explain telomere attrition , cellular senescence , stem cell exhaustion , dna damage , and epigenetic alteration . several age clock and biomarker aging have be propose to be potentially useful estimate biological age , can provide specific information old individual be biologically independent chronological age . measure biological age cancer survivor may be important two reason . first , can well predict risk cancer treatment-related comorbiditie chronological age . second , biological age may provide additional value evaluate effect treatment and personalize cancer therapy to maximize efficacy treatment . deep understanding treatment-induced accelerated aging individual cancer may lead novel strategy reduce accelerate aging and improve quality life cancer survivor .",Cancers,23/01/2021
10.1016/j.ejca.2025.115808,tecotabart vedotin claudin 18 . 2-positive advanced gastric/gastroesophageal,"Bai C, Zheng Y, Sun M, Ying J, Zhou F, Yu Y, Xing L, Zhang Y, Wen J, Wu H, Yang X, Wan L, Guo S, Zhao R, Zhu Z, Shen W, Wang Q, Gu S, Wu H, Chen W, Xia J, Zhao J, Dong X, Lou W, Jiang K, Zhang Z, Chen X, Fu D, Chen Y, Wang B, Liu J, Ji Y, Yuan S, Li Y, Gong Z, Fei D, Qin X, Qin C, Li J","background : tecotabart vedotin ( lm-302 ) be novel antibody-drug conjugate ( adc ) target cldn18 . 2 , promising therapeutic target gastrointestinal cancer . phase 1/2 study evaluate safety , pharmacokinetic , immunogenicity , and preliminary anti-tumor activity tecotabart vedotin patient advanced solid tumor , focus cldn18 . 2-positive gastric/gastroesophageal junction ( g/gej ) cancer . method : open-label , multicenter study utilize bayesian adaptive design . phase 1 enrol patient advanced solid tumor ; phase 2 focus cldn18 . 2-positive g/gej , pancreatic , biliary tract cancer , or gastrointestinal tumor low to moderate cldn18 . 2 expression . tecotabart vedotin be administer 0 . 2-2 . 8 mg/kg 3 week ( q3w ) or 1 . 8-2 . 0 mg/kg 2 week ( q2w ) . primary endpoint include dose-limiting toxicity ( dlt ) and safety phase 1 , and objective response rate ( orr ) phase 2 . secondary endpoint include safety , pharmacokinetic , immunogenicity , and other anti-tumor activity outcome . result : overall , 153 patient receive tecotabart vedotin ( phase 1 : 38 ; phase 2 : 115 ) . dlt occur 5 patient high dose level . maximum tolerate dose be 2 . 4 mg/kg q3w ; recommend phase 2 dose be 1 . 8 mg/kg q2w and 2 . 4 mg/kg q3w . 52 evaluable patient cldn18 . 2-positive g/gej cancer receive 1 . 8 mg/kg q2w , orr be 32 . 7 % ( 95 % confidence interval [ ci ] 20 . 3-47 . 1 ) , median progression-free survival 4 . 9 month ( 95 % ci 2 . 7-6 . 9 ) , and overall survival 10 . 9 month ( 95 % ci 9 . 1-17 . 1 ) . adverse event be manageable and consistent monomethyl auristatin e-based adcs . conclusion : tecotabart vedotin demonstrate encourage anti-tumor activity and manageable safety cldn18 . 2-positive g/gej cancer , support further clinical development gastrointestinal malignancy .","European journal of cancer (Oxford, England : 1990)",20/09/2025
10.1038/s44321-025-00307-2,selective inhibition mitochondrial kv1 . 3 prevent and alleviate multiple,"Angi B, Varanita T, Puthenparampil M, Scattolini V, Donadon M, Tavakoli M, Favero M, El Boustani M, Soddemann M, Biasutto L, Arcidiacono D, Ongaro A, Mattarei A, Trentin L, Wilson G, Gulbins E, Gallo P, Szabo I","multiple sclerosis ( ms ) be characterize invasion brain effector memory t ( t(em ) ) lymphocyte have be activate repeat auto-antigen stimulation . exist therapy target and other autoreactive lymphocyte but side effect include general immunosuppression and toxicity . kv1 . 3 potassium channel be highly express chronically activate autoreactive t(em)s , investigate specific targeting mitochondrial kv1 . 3 use pharmacological inhibitor paptp could selectively kill t(em)s patient and mouse ms . 1 µm paptp target and reduce number autoreactive t(em)s blood sample relapsing-remitting ms ( rrms ) patient , leave other t cell population unaffected . remarkably , pre-treatment entire t cell population paptp adoptive transfer experimental autoimmune encephalomyelitis ( eae ) kill t(em)s and completely prevent disease onset mouse model . moreover , paptp selectively eliminate activate t(em)s and halt eae progression administer follow disease onset . finding reveal potential paptp effective treatment ms adverse side effect .",EMBO molecular medicine,29/09/2025
10.1186/s12974-025-03536-x,dysregulation cellular metabolism gut-brain axis be associate,"Devereaux J, Robinson AM, Stavely R, Davidson M, Filippone RT, Ephraim R, Kiatos D, Apostolopoulos V, Nurgali K","background : inflammatory bowel disease ( ibd ) be chronic debilitating condition significantly affect patient quality life . exact aetiology remain unknown , accumulate evidence have show disruption gut-brain axis may be relate occurrence and development chronic intestinal inflammation . psychological disorder be highly prevalent patient ibd . however , association altered behaviour and dysregulate metabolic pathway gut-brain axis be yet to be explore . method : metabolic multiplexe phenotype system involve indirect calorimetry and flow-through respirometry monitor be use to assess energy metabolism winnie mouse spontaneous chronic colitis and c57bl/6 littermate . depressive and anxiety-like behaviour be evaluate light dark , open field , grooming , elevated plus maze , and force swimming test . to investigate underlying mechanism metabolic change winnie mouse , glycolysis/gluconeogenesis , fatty acid ß-oxidation , tricarboxylic acid cycle and oxidative phosphorylation gene expression be determine transcriptome analysis use high-throughput sequence mrna extract distal colon and brain sample . result : finding show energy metabolism and spontaneous activity be reduce winnie mouse correspond alteration expression cellular metabolism-associated gene distal colon . winnie mouse display depressive and anxiety-like behaviour reflect downregulation glycolysis/gluconeogenesis , fatty acid ß-oxidation , tricarboxylic acid cycle and oxidative phosphorylation distal colon and brain . subsequent analysis show pro-inflammatory cytokine expression be upregulate winnie mouse brain . conclusion : datum provide evidence dysregulation cellular metabolism gut-brain axis underlie change behaviour and energy metabolism chronic intestinal inflammation .",Journal of neuroinflammation,26/09/2025
10.1016/j.cub.2025.09.012,reduced oxytocin signal dbnst drive transition acute pain,"Fang S, Qin Y, Lian H, Zhong Y, Yang Y, Yu XD, Yang S, Liang J, Xiao W, Wen S, Zhang XM, Li B, Huang L","transient sensory experience can trigger sustained emotional disturbance , yet underlie neural mechanism remain unclear . here , show acute pain induce persistent anxiety male mouse , independent ongoing nociceptive input , reduce oxytocin signal dorsal bed nucleus stria terminalis ( dbnst ) . reactivate oxytocin receptor ( oxtrs ) dbnst markedly alleviate anxiety-like behavior follow pain resolution . mechanistically , chemogenetic inhibition somatostatin-expressing ( sst ) neuron dbnst ( dbnst(sst ) neuron ) abolish oxytocin 's anxiolytic effect , pharmacological blockade or selective knockdown oxtrs neuron increase anxiety-like behavior . transcriptomic and electrophysiological analysis far reveal alteration synaptic transmission and intrinsic excitability participate anxiety state . together , finding define multilevel framework-spanne molecular , cellular , and circuit mechanisms-by acute sensory input induce long-term emotional dysregulation . study advance understanding pain-related affective disorder and highlight oxytocin signaling and dbnst(sst ) neuron promise therapeutic target .",Current biology : CB,26/09/2025
10.1186/s12937-025-01205-6,association relative fat mass and obstructive sleep apnea and,"Guo Q, Xu W, Wang C, Xie M, Wu Z, Zhang N, Zhang B, Mu D","background : obesity have be identify one contribute factor obstructive sleep apnea ( osa ) . current obesity assessment indicator have poor ability to distinguish fat and muscle . relative fat mass ( rfm ) new indicator obesity take account gender difference and can predict body fat condition have advantage respect . study aim to investigate potential association rfm and osa , as well possible mediating effect hypertension . methods : cross-sectional study use datum national health and nutrition examination survey conduct 2005-2008 and 2015-2018 . multivariate logistic regression , restrict cubic spline ( rcs ) , and subgroup analysis be perform to evaluate association rfm and osa . addition , receiver operate characteristic curve ( roc ) different obesity indicator be compare to assess predictive ability osa . mediation analysis be use to explore potential mediating role hypertension positive correlation . result : study include 13 , 532 participant complete study datum , 6854 be assess have accord criterion , account 50 . 65 % study population . result multivariate logistic regression model fully adjust covariate show odd ratio rfm be 1 . 096 ( 95%ci :1 . 084-1 . 109 , p < 0 . 001 ) . result rcs show rfm be nonlinearly correlate osa ( p nonlinear < 0 . 01 ) . subgroup analysis show association rfm and osa be strong female and people young 60 . roc also indicate , compare body roundness index and weight-adjusted-waist index , rfm show potential predictor . mediation analysis and sensitivity analysis show hypertension have statistically significant but poorly robust mediating effect rfm and osa . conclusion : be positive and nonlinear correlation rfm and osa . hypertension play potential mediating role positive association rfm and osa , but robustness be poor . rfm show potential predictor osa , but more prospective study be need to confirm finding and determine causal relationship rfm and osa .",Nutrition journal,26/09/2025
10.1186/s12884-025-08116-8,non-code rnas diagnostic biomarker preeclampsia : systematic review,"Liu J, Zhao Q, Zhu Y","background : preeclampsia ( pe ) , grave obstetric complication , mandate expeditious formulation efficacious early diagnostic strategy . accumulate evidence suggest non - code rnas ( ncrnas ) , be present maternal circulation and placental tissue , display abnormal expression pattern patient pe , underscore potential diagnostic biomarker . systematic review and meta - analysis intend to assess diagnostic accuracy ncrnas detection pe . methods : comprehensive search be carry seven database ( china national knowledge infrastructure [ cnki ] , wanfang database , vip database , pubmed , web science , embase , and cochrane library ) december 25 , 2024 , to identify case - control and cohort study explore diagnostic value ncrnas pe . quality study be evaluate use quality assessment diagnostic accuracy studies - 2 ( quadas - 2 ) tool and newcastle - ottawa scale ( nos ) , and publication bias be assess use deek ' funnel plot . pooled sensitivity ( sen ) , specificity ( spe ) , diagnostic odd ratio ( dor ) , and area curve ( auc ) be compute use review manager 5 . 4 and meta - disc 1 . 4 . result : 2 , 201 identify study , 40 fulfil inclusion criterion qualitative synthesis . forty - eight ncrnas show diagnostic potential , include 25 micrornas ( mirnas ) , 9 long non - code rnas ( lncrnas ) , and 6 circular rnas ( circrnas ) . pooled sensitivity and specificity be 80 % ( 95 % confidence interval [ ci ] : 76-84 % ) and 82 % ( 95 % ci : 79-85 % ) , respectively . single mirna assay present superior diagnostic performance ( sensitivity [ sen ] : 85 % , specificity [ spe ] : 85 % ) comparison circrnas ( sen : 80 % , spe : 79 % ) . notably , combinatorial panel consist 2-3 ncrnas attain optimal diagnostic performance , sensitivity 91 % ( 95 % ci : 88-94 % ) , specificity 80 % ( 95 % ci : 76-84 % ) , and area curve ( auc ) 0 . 9418 ( standard error [ se ] = 0 . 0152 ) . conclusion : circulate ncrnas exhibit significant potential diagnostic biomarker pe , multi-analyte panel provide improve diagnostic accuracy compare single-marker strategy .",BMC pregnancy and childbirth,27/09/2025
10.1016/j.jare.2025.09.042,therapeutic strategy exosome-based bone regeneration osteoporosis :,"Dayanandan AP, Bello AB, Arai Y, Lee SJ, Lee SH","background : osteoporosis ( op ) be progressive bone disease mark reduce bone mass and microarchitectural deterioration , thereby increase fracture risk . current therapy only partly restore bone quality and often cause side effect long-term use . recent study highlight exosome , subtype extracellular vesicle , key regulator bone remodel promising regenerative potential . however , role osteoporosis remain underexplored . aim review : review aim to investigate establish role exosome bone regeneration may inform novel therapeutic strategy osteoporosis . link general bone repair mechanism osteoporotic pathology , evaluate translational potential and limitation exosome-based intervention . key scientific concepts review : exosomes derive mesenchymal stem cell , osteoblast , osteoclast , and macrophage regulate bone homeostasis modulate osteogenesis , osteoclastogenesis , and immune response . regenerative effect non-osteoporotic setting be well document . however , challenge such exosome heterogeneity , rapid clearance , and poor target efficiency impede direct application osteoporosis . recent bioengineering approach , include osteogenic rna or protein loading and surface modification bone targeting , show promise . moreover , combine exosome immunomodulatory or synergistic therapy may far enhance efficacy . advance , gap persist standardize isolation technique , ensure batch consistency , and scale production clinical use . review consolidate current knowledge and outline direction adapt exosome-based bone regenerative strategy osteoporosis treatment .",Journal of advanced research,25/09/2025
10.1016/j.celrep.2025.116330,igf2bp3 redirect glycolytic flux to promote one-carbon metabolism and rna,"Sharma G, Gutierrez M, Jones AE, Kapoor S, Jaiswal AK, Neeb ZT, Rios A, Dorairaj P, Thaxton ML, Lin TL, Tran TM, Kabbani LES, Ritter AJ, Scherer GM, Sorrentino JP, Stiles L, Hoeve JT, Damoiseaux RD, Garg NK, Divakaruni AS, Sanford JR, Rao DS","growth factor 2 mrna-binde protein 3 ( igf2bp3 ) , oncofetal",Cell reports,26/09/2025
10.1016/j.celrep.2025.116336,irg1 catalyze energy metabolite itaconic acid restrain type,"Chai L, Li C, Wang X, Qin Y, Sun H, Du J, Yang L, Hu D, Xiong J, Zhao Z, Gong R, Wu T, Wu M, Nie M, Gao J, Jia J, Gao C, Zhao W, Zhou H, Kang D, Jia M","perturbation energy metabolism be essential feature infection and inflammation . tank-binde kinase 1 ( tbk1 ) be crucial initiate innate immune response viral infection , aberrant and ongoing tbk1 activation induce excessive production type interferon ( ifn-i ) . nonetheless , mechanism energy metabolism control tbk1 activation remain unclear . here , elucidate mechanism link energy metabolism inhibition tbk1-induced ifn-i response immune response gene 1 ( irg1)-itaconic acid axis . mechanistically , itaconic acid and derivative alkylate tbk1 cys605 , thereby disrupt tbk1 dimerization and rapid activation . irg1 , enzyme catalyze itaconic acid production , be upregulate late-phase viral infection and act feedback regulator to restrain tbk1 activity . develop itaconic acid-based compound ita-5/ita-9 alternative tbk1 inhibitor . ita-5/ita-9 effectively limited excess",Cell reports,26/09/2025
10.1136/jitc-2025-012345,target sqle-mediate cholesterol metabolism to enhance cd8(+ ) t cell,"Qiao S, Zou H, Weng Y, Liu YF, Li W, Yu XJ, Li L, Zheng L, Xu J","background : sustained effectiveness anti-programmed cell death protein-1 ( pd1 ) treatment be limit subgroup patient hepatocellular carcinoma ( hcc ) tumor microenvironment heterogeneity , highlight need to identify targetable biomarker synergize pd1 blockade . abnormal cholesterol metabolism play critical role hcc progression , grow evidence indicate complex immunomodulatory effect tumor microenvironment . however , interplay cholesterol homeostasis and immune evasion remain elusive . method : transcriptomic and clinical datum hcc dataset be analyze to identify cholesterol metabolism-related target . multiplex immunostaining and flow cytometry be apply to examine immune landscape association squalene epoxidase ( sqle ) human and murine tumor . mechanistic study be conduct vitro , and co-culture experiment tumor cell and t cell be follow metabolomic and transcriptome analysis . therapeutic efficacy be evaluate mouse hcc model . result : demonstrate elevated sqle expression human hcc be associate poor clinical outcome and correlate reduce cd8(+ ) t cell infiltration and activation . pharmacological inhibition or genetic knockdown sqle tumor cell promote cd8(+ ) t cell proliferation and activation co-culture experiment . untargeted metabolomic identify 27-hydrocholesterol , oxysterol derive tumor cell , key factor impair cd8(+ ) t cell function cholesterol dysregulation . sqle inhibition tumor cell suppress oxysterol secretion , therefore overcome cholesterol restriction and enhance immune response cd8(+ ) t cell . moreover , sqle target terbinafine restore antitumor immunity and synergize anti-pd1 therapy hcc . conclusion : target tumorous sqle restore cd8(+ ) t cell function overcome cholesterol restriction signal , highlight sqle potential therapeutic target to enhance immunotherapy efficacy hcc .",Journal for immunotherapy of cancer,26/09/2025
10.1016/j.diabres.2025.112925,sglt-2 inhibitor diabetes : new frontier cancer treatment .,"Nakhaei A, Delavar K, Azim AS, Afshari S, Mohtashami A, Jalili-Nik M, Jalali M, Ahmadi SS, Karav S, Afshari AR, Kesharwani P, Sahebkar A","sodium-glucose co-transporter 2 ( sglt-2 ) inhibitor , new class antidiabetic medication include canagliflozin , dapagliflozin , ipragliflozin , and empagliflozin , recently come light possible anti-cancer therapeutic . confirmed presence sglt-2 many cancer cell line far substantiate potential therapeutic target . many cancer cell change metabolism to become more glucose-dependent , block glucose absorption",Diabetes research and clinical practice,26/09/2025
10.1016/j.lanhl.2025.100762,single-domain and multidomain lifestyle intervention prevention,"Mendes AJ, Ribaldi F, Sayin O, Khachvani G, Mulargia R, Volpara G, Remoli G, Nencha U, Gianonni-Luza S, Cappa S, Frisoni GB","background : prevent cognitive impairment old adult be public health priority . multidomain intervention have show promise preventive strategy , optimal combination intervention remain unclear . network meta-analysis aim to compare and rank relative efficacy single-domain and multidomain lifestyle intervention prevention cognitive impairment old adult be cognitively unimpaired . method : do systematic review and network meta-analysis randomise control trial ( rcts ) publish pubmed and embase inception date search may 7 , 2024 follow preregistere protocol prospero ( crd42024601975 ) . include rct old adult be cognitively unimpaire evaluate lifestyle intervention target diet , physical exercise , cognitive training , social activity , and health education , either alone or combination . primary outcome be global cognition , analyse use random-effect network meta-analysis , report standardise mean difference ( smd ) and 95 % ci , and compare health education , active control , or intervention . subgroup analyse explore potential age-related difference and effect intervention duration . risk bias be assess use cochrane risk bias 2 , and publication bias be evaluate assess funnel plot asymmetry . finding : 10 200 citation identify and 1183 full text screen eligibility , identify 109 eligible rct , include 23 010 participant ( median age 70·1 year [ iqr 68·7-73·8 ] , 14 957 [ 65 % ] female and 8053 [ 35 % ] male ) . compare health education , significant improvement global cognition be find physical exercise and cognitive training combine ( smd 0·26 [ 95 % ci 0·10-0·42 ; p=0·0011 ) ; cognitive training alone ( smd 0·21 [ 0·08-0·33 ] ; p=0·00092 ) ; diet , physical exercise , cognitive training , and health education combine ( smd 0·14 [ 0·02-0·27 ] ; p=0·028 ) ; and physical exercise alone ( smd 0·14 [ 0·05-0·22 ] ; p=0·0014 ) . random-effect model use active control and intervention comparator yield similarly significant effect aforementioned intervention , effect size same order . risk bias be high 44 ( 40 % ) study , and publication bias be suggest study compare intervention health education . interpretation : several single-domain and multidomain lifestyle intervention be efficacious modulate global cognition old adult be cognitively unimpaire , combination physical exercise and cognitive training demonstrate strong effect . combine lifestyle intervention might enhance efficacy , but increase number domain do not automatically translate great cognitive benefit . finding support lifestyle intervention key component prevention strategy ; however , optimal combination require further investigation . funding : none .",The lancet. Healthy longevity,25/09/2025
10.1002/ejhf.70057,acute heart failure care - consensus series international expert ' group .,"Cotter G, Biegus J, Fudim M, Miró Ò, Ambrosy AP, Pagnesi M, Chioncel O, Davison B, Freund Y, Bocchi EA, Butler J, Dzudie A, Harikrishnan S, Lima ICGV, Mentz RJ, Nauli SE, Riccardi M, Sato N, Savarese G, Sliwa K, Zhang Y, Zhou J, Mebazaa A, Collins S","care patient hospitalize acute heart failure ( ahf ) have be largely unchanged early 1960 few year ago , consist mainly oxygen and diuretic supplement sometimes other vasoactive drug . treatment , effective short term control congestion , do not prevent early readmission and death , occur 30 % patient 6 month ahf hospitalization . last year , study show ahf diagnosis can be improve , early diuretic care can be optimize , and early intensive therapy combined drug regimen can reduce rate adverse outcome . however , acute coronary syndrome , guideline have exist 1996 , be separate detailed guideline ahf . series four paper ( international expert opinion series ahf management ) international expert group highlight important aspect ahf care evidence base to inform clinical practice be lack . paper focus ( 1 ) diagnosis and treatment prehospital and emergency department , ( 2 ) management first day admission , ( 3 ) care and ahf discharge , and ( 4 ) hospitalize ahf management patient present cardiogenic shock , significant valvular disease , or end-stage renal disease . paper be not intend to serve guideline , but rather to suggest framework future recommendation diagnosis and treatment ahf . current summary paper , highlight main consideration and key recommendation part ahf care .",European journal of heart failure,28/09/2025
10.1038/s41467-025-63500-4,gtf2i-encode transcription factor tfii-i regulate myelination sox10 and mbp,"Levy G, Rokach M, Fischer I, Kimchi-Feldhorn O, Shoob S, Bar E, Rosenberg T, Bartman J, Parnas H, Grad M, Israel-Elgali I, Sfadia GE, Trangle SS, Vainshtein A, Eisenbach YE, Jahn O, Siems SB, Werner HB, Shomron N, Assaf Y, Peles E, Slutsky I, Marco A, Barak B","transcriptional regulatory network govern differentiation and functionality oligodendrocyte ( ols ) be essential formation and maintenance myelin sheath , and hence proper function nervous system . perturbation intricate interplay transcriptional effector network can lead variety nervous system pathology . study , identify gtf2i-encoded general transcription factor ii-i ( tfii-i ) regulator key myelination-related gene . gtf2i deletion myelinate glial cell male mouse lead functional alteration central nervous system ( cns ) myelin , include elevated mrna and protein expression level myelin basic protein ( mbp ) , central myelin component , enhance connectivity property , and thick myelin wrapping axon increase diameter . change result fast axonal conduction corpus callosum ( cc ) , and improve motor coordination . furthermore , show mature ols ( mols ) , tfii-i directly bind regulatory element sox10 and mbp . peripheral nervous system ( pns ) , gtf2i deletion schwann cell ( sc ) lead hypermyelination tibial branch sciatic nerve ( sn ) . finding add understanding myelination regulation and specifically elucidate cell-autonomous mechanism tfii-i myelinate glia transcriptional network .",Nature communications,26/09/2025
10.1016/j.canlet.2025.218064,tumor-derive ccl5 recruit ccr1(+ ) macrophage to suppress apoptosis and drive,"Li J, Zhang L, Zheng C, Lin X, Cao D, Zhao S, Wang S, Yu B, Wei G, Kong X, Liu X, He A, Xiao X, Xiang D","duodenal adenocarcinoma ( da ) be rare gastrointestinal malignancy associate poor prognosis and limited therapeutic option . to define da tumor microenvironment ( tme ) , perform single-cell rna sequence ( scrna-seq ) primary da tumor and match adjacent normal tissue . analysis reveal substantial heterogeneity malignant epithelial cell , include transcriptionally distinct subset characterize upregulation immune-related gene , constitute immune-associated transcriptional program . notably , program include high expression chemokine ccl5 , facilitate recruitment ccr1(+ ) macrophage . use patient-derived da organoid , identify malignant cell exhibit immune-related transcriptional signature , include elevated ccl5 . functional assay demonstrate ccl5 promote ccr1(+ ) macrophage migration , effect suppress both ccr1 antagonist bx471 and ccl5-neutralizing antibody . co-culture , ccl5-expresse da organoid display enhanced survival and proliferation presence ccr1(+ ) macrophage , pharmacological blockade ccr1 significantly increase tumor cell death . bulk transcriptomic profiling reveal ccr1 downregulate pro-apoptotic signal tumor cell , thereby promote cell survival and growth . importantly , combine ccl5/ccr1 inhibitor standard chemotherapeutic agent result synergistic tumor cell killing . together , finding establish ccl5/ccr1 axis key mediator tumor-macrophage crosstalk da , support immune evasion and chemoresistance suppression macrophage-induced apoptosis . target axis may represent promising therapeutic strategy to enhance efficacy conventional chemotherapy da .",Cancer letters,25/09/2025
10.1016/j.celrep.2025.116202,vitro protocol demonstrate five functional step train immunity,"González-Pérez M, Baranda J, Pérez-Rodríguez L, Conde P, Calle-Fabregat C, Berges-Buxeda MJ, Dimitrov A, Arranz J, Rius-Rocabert S, Zotta A, Dopazo A, Poddar N, Wang X, Nistal-Villán E, Duivenvoorden R, Madsen JC, Williams DL, Hasson D, Lozano-Ojalvo D, Ginhoux F, O'Neill LAJ, Ochando J","develop in vitro methodology to study train immunity use murine bone-marrow-derive macrophage stimulate β-glucan and lipopolysaccharide ( lps ) . longitudinal analysis interleukin ( il)-6 and tumor necrosis factor ( tnf ) production demonstrate train macrophage secrete high cytokine level follow primary stimulation β-glucan compare unstimulated macrophage ( step 1 ) . resting period , train macrophage return basal level cytokine production ( step 2 ) but rapidly produce enhanced level",Cell reports,25/09/2025
10.1001/jamapediatrics.2025.3568,population-level effectiveness and herd protection 17 year hpv vaccine,"DeSieghardt A, Ding L, Ermel A, Franco EL, Dagnall C, Brown DR, Yao S, Kahn JA","importance : human papillomavirus ( hpv ) vaccine clinical trial demonstrate high vaccine efficacy , but postlicensure population-level effectiveness datum be need to inform vaccination and cancer-prevention recommendation and policy . little be know effectiveness adolescent girl and young adult woman high risk hpv-related cancer or 9-valent hpv vaccine ( 9vhpv ) introduction . objective : to examine effectiveness and herd protection first 17 year hpv vaccine introduction adolescent girl and young woman increase risk hpv infection and related cancer . design , setting , and participant : cross-sectional study analyze datum 6 surveillance study 2006 2023 . consecutive sample sexually experience adolescent girl and young woman age 13 to 26 year be recruit clinical setting . exposure : participant be stratify hpv vaccination status ; receive at least 1 vaccine dose be define vaccinate . main outcomes and measures : effectiveness and herd protection be assess compare proportion vaccinated and unvaccinated participant positive at least 1 type 2-valent vaccine ( 2vhpv ) , 4-valent vaccine ( 4vhpv ) , and 9vhpv 6 study . prevalence vaccine-type hpv be compare vaccinate participant surveillance study 2 6 vs participant recruit surveillance study 1 , be unvaccinate . inverse probability treatment weighting propensity score be use to balance between-wave difference participant characteristic . result : 2335 participant ( mean [ sd ] age , 18 . 9 [ 2 . 7 ] year ; 1526 african american [ 65 . 4 % ] , 13 asian [ 0 . 6 % ] , 6 native american [ 0 . 3 % ] , 582 white [ 24 . 9 % ] , and 151 multiracial [ 6 . 5 % ] ; 173 hispanic [ 7 . 4 % ] ) , 1195 participant ( 51 . 2 % ) report sexually transmit infection history and 1843 participant ( 78 . 9 % ) report 2 or more male sex partner . vaccination rate increase 0 371 participant 330 402 participant ( 82 . 1 % ) 2006 2023 . vaccinated participant , positivity decrease 93 371 participant ( 27 . 7 % ) 1 330 participant ( 0 . 4 % ) 2vhpv ( relative difference , 98 . 4 % ) , 118 participant ( 35 . 4 % ) 3 participant ( 2 . 1 % ) 4vhpv ( relative difference , 94 . 2 % ) , and 163 participant ( 48 . 6 % ) 21 participant ( 11 . 8 % ) 9vhpv ( relative difference , 75 . 7 % ) . unvaccinated participant , positivity decrease 93 371 participant ( 25 . 8 % ) 3 72 participant ( 7 . 3 % ) 2vhpv ( relative difference , 71 . 6 % ) , 118 participant ( 25 . 3 % ) 4 participant ( 6 . 1 % ) 4vhpv ( relative difference , 75 . 8 % ) , and 163 participant ( 42 . 7 % ) 13 participant ( 31 . 1 % ) 9vhpv ( relative difference , 27 . 2 % ) . positivity rate , count be raw number and percentage be propensity score adjust . adjusted logistic regression demonstrate significant reduction odd at least 1 hpv type 2vhpv and 4vhpv ( adjust odd ratio [ aor ] , 0 . 03 ; 95 % ci , 0 . 01 0 . 07 and aor , 0 . 06 ; 95 % ci , 0 . 03 0 . 10 , respectively ) , vaccinate ( aor , 0 . 01 ; 95 % ci , < 0 . 01 0 . 05 and aor , 0 . 04 ; 95 % ci , 0 . 02 0 . 08 , respectively ) , and unvaccinate ( aor , 0 . 23 ; 95 % ci , 0 . 08 0 . 63 and aor , 0 . 19 ; 95 % ci , 0 . 07 0 . 52 , respectively ) participant and 9vhpv ( aor , 0 . 22 ; 95 % ci 0 . 16 0 . 31 ) and vaccinate ( aor , 0 . 14 ; 95 % ci 0 . 09 0 . 21 ) participant . conclusion and relevance : study , population-level effectiveness and herd protection be robust 17 year hpv vaccine introduction , even sexually experience adolescent girl and young woman relatively high risk hpv may not have receive full vaccination series .",JAMA pediatrics,29/09/2025
10.1111/bph.70209,oral administration low-molecular-weight heparin ameliorate colitis,"Zheng D, Chen S, Feng H, Zhang S, Zhang C, Wang Y, Tan W, Qing Q, Liu L, Liu X, Wang Z, Liang L, Sun J, Chen Y","background and purpose : previous study have report oral low-molecular-weight heparin ( lmwh ) ameliorate colitis undefined mechanism ulcerative colitis ( uc ) patient . study explore mechanism lmwh colitis perspective gut microbiota and metabolite . experimental approach : dextran sulfate sodium ( dss ; 2 . 5 % ) be use to induce colitis mouse model , and lmwh be administer oral gavage , intracolonic delivery or subcutaneous injection to compare therapeutic effect . pseudo-germ-free mouse be establish use antibiotic cocktail , and faecal microbial transplantation ( fmt ) be perform to verify role microbiota lmwh action . alcian blue stain , fluorescence situ hybridization eub338 and immunohistochemical staining be perform to evaluate integrity gut mucus barrier . amplicon sequence , transcriptome sequence and untargeted metabolome study be use to explore lmwh mechanism . ameliorate effect indole-3-propionic acid ( ipa ) be verify vitro and vivo . key result : oral , but not subcutaneous , administration lmwh alleviate colitis and enhance gut mucus barrier . pseudo-germ-free mouse and fmt assay confirm therapeutic effect oral lmwh be dependent gut microbiota . oral lmwh increase firmicutes abundance and decrease escherichia/shigella abundance , subsequently increase microbial metabolite , especially ipa . protective effect oral lmwh be reproduce ipa supplementation , mucus barrier enhance regulate wnt/β-catenin pathway . conclusion and implication : result provide new insight signal mechanism associate therapeutic potential lmwh colitis , and highlight application ipa uc treatment .",British journal of pharmacology,28/09/2025
10.1016/j.ajcnut.2025.09.036,association combined healthy lifestyle and adverse birth outcomes two,"Dong Y, Zheng JS, Yang Y, Wang T, Li F, Wu P, Lai Y, Wang Y, He X, Zhang P, Zhang S, Wu N, Li S, Yuan J, Shan D, Liu X, Liu G, Hu Y, Pan A, Pan XF","background : maternal lifestyle factor be report to be associate adverse birth outcome ( abo ) . factor may also dynamically influence gut microbiota composition and serum metabolic profile . objective : to investigate association combined healthy lifestyle and abo , and mediating role gut microbiota and serum metabolite . method : study be conduct base tongji-huaxi-shuangliu birth cohort ( thsbc ) , comprise 1086 participant repeat multi-omic datum collect three time point . independent validation be perform use 161 participant huaxi birth cohort ( hbc ) , available multi-omic datum five time point . participant be classify three lifestyle category ( unhealthy , low healthy , and highly healthy ) accord diet , physical activity , smoking , drinking , sleep , and body mass index . gut microbiota be characterize use rrna gene sequence thsbc and metagenomic hbc , serum metabolite be profile use untargeted liquid chromatography-mass spectrometry . clinical datum birth outcome , such gestational age , birth weight , and sex be collect thsbc . result : highly healthy lifestyle be associate low risk macrosomia ( mac ) ( odd ratio : 0 . 43 ; 95 % confidence interval : 0 . 33 , 0 . 57 ) , preterm birth ( ptb ) ( 0 . 60 ; 0 . 46 , 0 . 79 ) , and large gestational age ( lga ) ( 0 . 44 ; 0 . 35 , 0 . 56 ) . identify mediator , gut microbiota and serum metabolite , include eisenbergiella , tyzzerella , megamonas , pro-ile , and 1-amino-1-cyclobutane-carboxylic acid be negatively associate healthy lifestyle , lachnospiraceae nk4a136 group , 4-methoxyestrone , and lpc ( 0 : 0/18 :3 ) be positively associate . mediation analysis show eisenbergiella and 4-methoxyestrone explain 11 . 4 % and 13 . 0 % inverse association highly healthy lifestyle and ptb , respectively , other microbiota and metabolite mediate 5%-7 % association mac and lga . conclusion : maternal healthy lifestyle be associate low risk abo , gut microbiota and serum metabolite serve important mediator relationship .",The American journal of clinical nutrition,26/09/2025
10.1038/s41467-025-63414-1,comparison image base single-cell resolution spatial transcriptomic,"Ozirmak Lermi N, Molina Ayala M, Hernandez S, Lu W, Khan K, Serrano A, Lubo I, Hamana L, Tomczak K, Barnes S, Dou J, Liang Q, Raso MG, Tang X, Jiang M, Sanchez-Espiridion B, Weissferdt A, Heymach J, Zhang J, Sepesi B, Cascone T, Tsao A, Altan M, Mehran R, Gibbons D, Wistuba I, Haymaker C, Chen K, Solis Soto LM","imaging-based spatial transcriptomic ( st ) be evolve pivotal technology study tumor biology and associated microenvironment . however , strength commercially available st platform study spatial biology have not be systematically evaluate use rigorously control experiment . use serial 5 μm section formalin-fixed , paraffin-embedded surgically resect lung adenocarcinoma and pleural mesothelioma sample tissue microarray to compare performance st platform ( cosmx , merfish , and xenium ( uni/multi-modal ) ) reference bulk rna sequence , multiplex immunofluorescence , geomx , and hematoxylin and eosin stain datum . addition objective assessment automatic cell segmentation and phenotyping , perform manual phenotype evaluation to assess pathologically meaningful comparison st platform . here , show intricate difference st platform , reveal importance parameter such probe design determine data quality , and suggest reliable workflow accurate spatial profiling and molecular discovery .",Nature communications,26/09/2025
10.4291/wjgp.v16.i3.107573,"fatigue inflammatory bowel disease : prevalence , risk factor , assessment ,","Giri S, Harindranath S, Kulkarni A, Sahoo JK, Joshi H, Nath P, Sahu MK","fatigue be prevalent and often debilitate symptom individual inflammatory bowel disease ( ibd ) , affect substantial proportion patient , even period disease remission . prevalence fatigue ibd remain high , affect half ibd patient and be more common patient active disease remission . several risk factor contribute fatigue ibd , include active disease and pro-inflammatory state , nutritional deficiency and anemia , sleep disturbance , psychological comorbiditie , microbiota change and gut-brain axis , muscle dysfunction , sarcopenia , and physical inactivity . assess fatigue ibd be challenge subjective nature and lack uniformly quantifiable method . fatigue significantly impact quality life , affect physical functioning , psychological and emotional well-being , and social and relational consequence . management fatigue ibd require comprehensive , multidisciplinary approach . include address disease activity conventional drug treatment , biological and small molecule , and surgical treatment . psychological intervention such cognitive behavioral therapy , problem-solving therapy , solution-focused therapy , mindfulness-based cognitive therapy , and brief behavioral therapy have show promise improve fatigue . nutritional intervention , include treat deficiency and supplementation , and lifestyle intervention , such physical exercise , aromatherapy , and sleep intervention , be also important component fatigue management . pharmacological intervention modafinil and bupropion may be consider refractory case . review aim to summarize current evidence fatigue ibd , include prevalence , risk factor , assessment method , outcome , and management strategy .",World journal of gastrointestinal pathophysiology,22/09/2025
10.1186/s40001-025-03147-5,machine learning and nomogram prediction model to explore relationship,"Zou L, Zhao J, Ruan Y, Wang Y","background : asthma be prevalent chronic respiratory disease significant morbidity and healthcare burden . identify novel biomarker asthma risk prediction be crucial early intervention and personalized management . monocyte-to-high-density lipoprotein cholesterol ratio ( mhr ) have emerge potential inflammatory marker various chronic disease . study aim to investigate association mhr and asthma risk use datum national health and nutrition examination survey ( nhanes ) and to develop predictive model asthma risk incorporate mhr and other clinical variable . methods : datum nhanes ( 2001-2018 ) be use . weighted logistic regression be employ to assess relationship mhr and asthma risk . participant be randomly divide training ( 70 % ) and validation ( 30 % ) cohort . boruta algorithm be use to evaluate training cohort , select good model , and identify potential confound factor . nomogram-based predictive model be construct use variable select boruta algorithm [ smoke , age , hypertension , cardiovascular disease ( cvd ) , marital status , gender , race , poverty-income ratio ( pir ) , body mass index ( bmi ) , cancer , education , diabetes , and mhr ] . model 's performance be evaluate use receiver operating characteristic ( roc ) curve , calibration curve , and decision curve analysis ( dca ) curve . variable select boruta algorithm be include machine learning ( ml ) model analysis . shap ( shapley additive explanation ) analysis be perform to assess contribution variable . result : total 28 , 855 participant be include exclude miss datum . mhr be positively associate asthma incidence ( p < 0 . 05 ) . boruta algorithm achieve auc 0 . 64 validation cohort . ml model , xgboost model demonstrate good performance auc 0 . 640 ( 95 % ci 0 . 623-0 . 656 ) . shap analysis identify cvd most influential factor , follow age , bmi , pir , and gender . conclusion : study demonstrate positive association mhr and asthma risk , indicate significant cross-sectional relationship . nomogram-based predictive model incorporate mhr and other clinical variable show moderate discriminative ability .",European journal of medical research,26/09/2025
10.1038/s41418-025-01588-3,epithelial mst1 deficiency promote pyroptosis and aggravate inflammatory bowel,"Lu J, Li F, Wang H, Yu Y, Yuan Y, Zhang Y, Liu P, Zhao Q, Wu M, Ye M","hippo pathway have be implicate onset and pathogenesis inflammatory bowel disease ( ibd ) , mammalian ste20-like kinase 1 ( mst1 ) , core kinase pathway , play significant role inflammation and immune regulation . however , specific role mst1 ibd remain largely undefined . study , observe mst1 expression be significantly decrease ibd patient and acute colitis mouse . intestinal epithelial cell-specific mst1 knockout mouse exhibit heighten susceptibility dextran sodium sulfate ( dss)-induce colitis , characterize severe disruption intestinal epithelial barrier and markedly increase epithelial cell pyroptosis , thus exacerbate intestinal inflammation . pharmacological inhibition caspase-1/gsdmd-mediate pyroptosis ameliorate detrimental effect mst1 deficiency colitis . consistently , mst1 deficiency exacerbate intestinal barrier disruption and pyroptosis both vivo and vitro model tnfα-induce inflammation and dna damage . mechanistically , mst1 depletion promote yap nuclear translocation and enhance interaction p73 intestinal epithelial cell , lead increase p73 stability and transcriptional activity . , turn , facilitate recruitment p73 caspase-1 promoter , upregulate caspase-1 expression and translate increase pyroptosis tnfα-induce inflammatory condition . altogether , finding highlight critical role mst1 maintain intestinal mucosal barrier homeostasis regulate epithelial cell pyroptosis yap/p73 signal pathway . reduce mst1 expression may correlate well response anti-tnf therapy ibd patient . consequently , mst1 could serve promising predictive biomarker anti-tnf therapy responsiveness and potential therapeutic target ibd , offer valuable insight personalize treatment strategy .",Cell death and differentiation,26/09/2025
10.1177/0018720819875376,systematic review and meta-analysis direct objective measures situation,Endsley MR,"objective : to examine evidence sensitivity , predictiveness , and methodological concern regard direct , objective measure situation awareness ( sa ) . background : ability to objectively measure sa be important evaluation user interface and display , training program , and automation initiative , as well study seek to well understand sa individual and team . number methodological criticism have be raise create significant confusion research field . method : meta-analysis 243 study be conduct to examine evidence sensitivity and predictiveness , and to address methodological question regard situation awareness global assessment technique ( sagat ) , situation present assessment technique ( spam ) , and variant . result : sagat and spam be find to be equally predictive performance . spam ( 64 % ) and real-time probe ( 73 % ) be find to have significantly low sensitivity comparison sagat ( 94 % ) . sagat be find not to be overly memory reliant nor intrusive operator performance , spam result problem intrusiveness 40 % study examine , as well problem speed-accuracy tradeoff , sample bias , and confound workload . concern memory reliance , utility measure assess team sa , and other issue be also address . conclusion : sagat be find to be highly sensitive , reliable , and predictive measure sa be useful wide variety domain and experimental setting . application : direct , objective sa measurement provide useful and diagnostic insight research and design wide variety domain and study objective .",Human factors,01/02/2021
10.1126/sciadv.adx5495,stk11 coordinate il-4 signal metabolic reprogramme to control m2,"Yang J, Singh N, Xu C, Kong D, Sharma S, Liu S, Lechner J, Lkhagva A, Tan H, Wu Z, Richer MJ, Zang Y, Huang X, Kapur R, Wan J, High AA, Zhang X, Wang X, Lu X, Yang K","macrophage integrate microenvironmental cue to orchestrate complex transcriptional and metabolic program drive functional polarization . here , demonstrate stk11 link interleukin-4 ( il-4 ) signal metabolic reprogramme to restrain alternatively activate ( m2 ) macrophage polarization . integrative transcriptomic and metabolomic analysis , identify stk11 key transcriptional and metabolic regulator m2 polarization . stk11 deficiency enhance expression m2-associated marker and promote glutamine metabolism il-4-stimulate macrophage . mechanistically , stk11 deficiency lead increase foxo1 activation , thereby promote m2 polarization . pharmacological inhibition foxo1 or glutamine metabolism effectively reverse enhanced m2 polarization . orthotopic model pancreatic ductal adenocarcinoma , myeloid-specific deletion stk11 result increase accumulation m2-like tumor-associated macrophage , impaired antitumor immunity , and accelerate tumor progression . finding uncover previously unrecognized role stk11 modulate m2 macrophage polarization , offer mechanistic insight may inform development immunometabolic therapy pancreatic cancer .",Science advances,26/09/2025
10.1186/s40364-025-00829-4,bridge barrier : insight blood biomarker and therapeutic strategy,"Sharma N, Kim D, Sharma H, Kim MI, Lee H, Kim M, Ryoo N, Kang MJ, Pyun JM, Park YH, Ryu J, Oh HJ, Yang HS, Kim HR, Kim GH, Han S, Yang Y, Youn YC, Teunissen C, Zetterberg H, Scheltens P, An SSA, Kim YB, Kim S","alzheimer 's disease ( ad ) be most common cause dementia and account approximately 60-80 % total dementia patient . currently , accurate diagnosis ad relie cerebrospinal fluid ( csf ) sampling or positron emission tomography ( pet ) scan , method can not be do primary care center most people go cognitive complaint . limitation call urgent need to develop blood-related diagnostic test could facilitate early detection and enable timely treatment . recent csf proteomic research categorize ad five molecular subtype discrete genetic risk profile . subtype 1-3 , namely neuronal hyperplasticity , innate immune activation , and rna dysregulation , be characterize more classical ad-relate change , accumulation amyloid/tau and synaptic and immune dysfunction , respectively . contrary , non-traditional ad mechanism subtype 4-5 be choroid plexus ( cp ) dysfunction and blood-brain barrier ( bbb ) dysfunction , emphasize clearance deficit association brain barrier dysfunction . unchanged tau level later may be explain alternate disease mechanism ( clearance dysfunction ) . subtype include bbb and cp dysfunction . biomarker identification base mechanism disease progression would increase precision diagnosis , allow tailor intervention and aid creation novel therapy subtype might not react favorably conventional amyloid/tau-targeting strategy . find biomarker specific subtype would aid patient classification , result more individualized therapy oppose "" one-size-fits-all "" strategy . present review emphasize importance identify blood-based biomarker ( bbms ) relate brain barrier dysfunction csf study and personalize treatment strategy to streamline diagnostic workup , and may be utilize standard clinical practice early detection ad .",Biomarker research,26/09/2025
10.1002/advs.202512360,inflammation-targeting engineer probiotic escherichia coli nissle 1917,"Hua S, Li K, Shang P, Liu L, Pan J, Zhu B, Hua Z","probiotic escherichia coli nissle 1917 ( ecn ) , clinically use ulcerative colitis ( uc ) safety and genetic tractability , exhibit limited therapeutic efficacy owe poor targeting and colonization inflame site . phosphatidylserine ( ps ) exposure increase apoptotic colon epithelial cell uc progression , suggest ps-targeting could enhance ecn localization . here , ecn be engineer surface-display annexin a5 ( anxa5 ) , ps-binde protein , to improve inflammation target and colonization . tnf-α drive uc pathogenesis and anti-tnf-α biologics face cost and safety limitation , secretion-hindering lpp gene be concurrently knock anxa5-expresse ecn , create inflammation-targete , secretion-enhanced ecnδlpp : : a5 . base strain be far modify to secrete anti-tnf-α nanobody ( atn ) , generate ecnδlpp : : a5-atn . engineer strain demonstrate significantly strong colonic colonization wild-type ecn , effectively attenuate oxidative stress-mediated epithelial apoptosis , restore mucosal barrier , improve immune-microbiota balance , and alleviate murine colitis . ecnδlpp : : a5-atn show superior efficacy ecnδlpp : : a5 . study develop engineer ecn system enhanced targeting , colonization , and secretion . efficiently deliver anti-tnf-α nanobodie , ecnδlpp : : a5-atn exhibit strong therapeutic potential uc , overcome limitation hinder clinical application wild-type ecn .","Advanced science (Weinheim, Baden-Wurttemberg, Germany)",29/09/2025
10.1007/s00415-025-13383-8,association alcohol responsiveness and non-motor symptom isolated,"Junker J, Berman BD, König IR, Vidailhet M, Roze E, Perlmutter JS, Jinnah HA, Brüggemann N","objective : about 30 % patient isolated adult-onset dystonia report improvement motor symptom consumption alcohol . cross-sectional study , seek to investigate observed improvement be attributable anxiolytic , euphoric , and analgesic property alcohol , rather or addition effect dystonic movement , psychiatric symptom and pain frequently occur dystonia patient and emotional stress be well-established trigger symptom exacerbation . method : analyze datum 339 prospectively enrol participant recently diagnose isolated dystonia ( mean age : 55 . 2 ± 12 . 5 year , 228 female ) natural history project dystonia coalition , large international multicenter study . alcohol responsiveness be determine patient ´ self-report . symptom depression , as well generalized and social anxiety , be assess use hospital anxiety and depression scale and liebowitz social anxiety scale . severity pain be measure use question 21 rand 36-item health survey . result : participant more severe pain report great response alcohol less severe pain ( p = .004 ) , symptom depression ( p = .986 ) , generalize anxiety ( p = .395 ) and social anxiety ( p = .953 ) be not associate . conclusion : alcohol responsiveness isolated dystonia be associate high level pain , self-reported alcohol-related improvement dystonic movement or tremor do not depend euphoric or anxiolytic effect alcohol . finding underscore potential role pain management alleviate motor symptom dystonia .",Journal of neurology,29/09/2025
10.1038/s41467-025-63685-8,cytoplasmic trim24 promote colorectal cancer cell proliferation activate,"Wang Y, Yao Y, Liu Z, Long S, Yi F, Fang Q, Wu D, Zhu Q, Zai H, Xiao S, Wan F, Fu K","aberrant activation wnt/β-catenin signal be propose major molecular mechanism underlie occurrence and progression colorectal cancer ( crc ) . however , precise mechanism control accumulation β-catenin protein crc cell remain incompletely understood . here , show trim24 be elevate crc tissue and partially distribute cytoplasm . trim24 be phosphorylate serine 1042 aurora kinase b ( aurkb ) , promote cytoplasmic distribution . subsequently , trim24 activate wnt/β-catenin signal facilitate akt activation interaction and ubiquitination negative regulator von hippel-lindau ( vhl ) , result β-catenin accumulation and enhanced proliferation crc cell . moreover , chemical inhibition aurkb suppresse tumor growth subcutaneous mouse model and exhibit particular effectiveness tumor derive crc cell characterize prominent cytoplasmic trim24 distribution . together , finding reveal critical role trim24 crc cell proliferation , particularly activate wnt/β-catenin signal .",Nature communications,29/09/2025
10.1038/s41380-025-03272-x,frontotemporal dementia patient-derived ipsc neuron show cell pathological,"Huber N, Hietanen T, Heikkinen S, Shakirzyanova A, Hoffmann D, Rostalski H, Dhingra A, Rodriguez-Nieto S, Kärkkäinen S, Koskuvi M, Korhonen E, Hartikainen P, Pylkäs K, Krüger J, Malm T, Takalo M, Hiltunen M, Koistinaho J, Portaankorva AM, Solje E, Haapasalo A","frontotemporal dementia ( ftd ) be second most common cause dementia patient 65 year , characterize diverse clinical symptom , neuropathologie , and genetic background . synaptic dysfunction be suggest to play major role ftd pathogenesis . disturbance synaptic function can also be associate c9orf72 repeat expansion ( c9-hre ) , most common genetic mutation cause ftd . c9-hre lead distinct pathological hallmark , such c9orf72 haploinsufficiency and development toxic rna foci and dipeptide repeat protein ( dpr ) . ftd patient brain , include carry c9-hre , be also characterize neuropathologie involve accumulation",Molecular psychiatry,26/09/2025
10.1073/pnas.2502841122,mitochondrial ros trigger mitophagy activate dna damage response,"Guo QQ, Wang SS, Jiang XY, Xie XC, Zou Y, Liu JW, Guo Y, Li YH, Liu XY, Hao S, Zhang XY, Wu XX, Lu SM, Xu HD, Guo WD, Feng YL, Wang CG, Zhang SP, Li JB, Liu C, Song XY, Finkel T, Cao L","homeostatic link production mitochondrial ros ( mtros ) and mitophagy play significant role cell respond various physiological and pathological condition . however , remain unclear cell translate oxidative stress signal adaptive mitophagy response . here , show mtros act signal molecule activate ataxia-telangiectasia mutate ( atm)-cell cycle checkpoint kinase 2 ( chk2 ) , dna damage response ( ddr ) pathway . activate , chk2 regulate three critical step mitophagy . first , chk2 phosphorylate mitochondrial membrane protein atad3a ser371 , inhibit transport pink1 inner mitochondrial membrane and lead accumulation pink1 and commencement mitophagy . second , activate chk2 target autophagy adaptor optn ser177 and ser473 , thereby enhance targeting ubiquitinated mitochondria autophagosome . finally , chk2 phosphorylate beclin 1 ser90 and ser93 , hence promote formation autophagosomal membrane . consistent effect , chk2(-/- ) mouse show impair mitophagic induction and impaired recovery ros-dependent model renal ischemia-reperfusion . study reveal mtros-triggered adaptive pathway coordinate mitophagic induction , order to protect cell and tissue expose pathophysiological stress-induced damage .",Proceedings of the National Academy of Sciences of the United States of America,7/10/2025
10.1136/bmj-2024-083182,use new core risk score to predict 10 year risk liver cirrhosis general,"Strandberg R, Åberg F, Asteljoki JV, Luukkonen PK, Salomaa V, Jula A, Lundqvist A, Männistö S, Perola M, Talbäck M, Hammar N, Hagström H","objective : to develop and validate novel risk prediction model incident major adverse liver outcome ( malo ) primary care setting . design : population base cohort study . setting : sweden , validation finland and uk . participant : model development 480 651 individual know history liver disease and blood test take primary care or occupational healthcare screening ; validation two cohort 24 191 and 449 806 individual known history liver disease . main outcome measures : 10 year risk composite outcome compensate and decompensate cirrhosis , hepatocellular carcinoma , liver transplant , and liver relate mortality , collectively refer malo . result : new risk model be create use flexible parametric survival model and several easily available laboratory base biomarker . model include age , sex , aspartate aminotransferase , alanine aminotransferase , and γ-glutamyl transferase . model 's performance be assess term discrimination ( time dependent area curve ) , calibration ( calibration curve ) , and clinical utility ( decision curve analysis ) . external validation be do use datum uk biobank and finrisk and health 2000 cohort and compare fib-4 score . median follow-up time be 28 year , and 7168 malo event be observe time . incident risk malo 10 year be 0 . 27 % . new risk score , term core ( cirrhosis outcome risk estimator ) , achieve 10 year area curve 88 % ( 95 % confidence interval 87 % to 89 % ) compare 79 % ( 78 % to 80 % ) fib-4 . calibration core be good three cohort , and accord decision curve analysis provide high net benefit fib-4 risk threshold . conclusion : core model , base flexible modelling approach and use biomarker easily accessible primary care , outperform fib-4 predict liver relate outcome general population and could be novel mean to stratify patient risk liver disease general population .",BMJ (Clinical research ed.),29/09/2025
10.1016/j.disamonth.2025.102012,multiple sclerosis update and safety and efficacy bruton tyrosine kinase,"Prajjwal P, Patel PV, Patel ZV, Inban P, Patel D, Mahato P, Shamim L, Godinho NJS, Tekuru Y","background : multiple sclerosis ( ms ) be chronic neurodegenerative and autoimmune disease characterize cns inflammation and demyelination . current disease-modifying therapy ( dmt ) can reduce peripheral immune response , impact cns-compartmentalize inflammation remain limited . bruton tyrosine kinase inhibitor ( btkis ) have emerge promising oral agent target b cell and microglia . objective : to evaluate safety profile and effectiveness two btk inhibitors- tolebrutinib and evobrutinib management relapse multiple sclerosis . method : literature search be conduct use pubmed , embase , and scopus randomize control trial publish 2020 and 2024 . study compare evobrutinib and tolebrutinib ms patient be screen and evaluate base predetermine inclusion and exclusion criterion . four relevant rcts be match and examine more detail . result : mri , btk inhibitor show decrease gadolinium-enhance lesion ; tolebrutinib demonstrate dose-dependent efficacy reduce new gd-enhancing lesion and t2 lesion count , optimal effect 60 mg daily . evobrutinib show dose-dependent decrease serum neurofilament light ( nfl ) level and relapse rate , twice-daily dose provide great btk inhibition and clinical benefit . nasopharyngitis , temporary increase liver enzyme , and mild gastrointestinal symptom be frequent side effect agent . include study do not report direct clinical comparison cns penetration or microglial modulation . conclusion : good safety and efficacy profile treat relapse multiple sclerosis , btkis ( evobrutinib and tolebrutinib ) show promise . have promise oral treatment future , but tolebrutinib might have well effect central nervous system . to confirm long-term result and determine role progressive ms , more phase iii trial be necessary .",Disease-a-month : DM,26/09/2025
10.3390/nu17182984,microbiota gut-brain axis and autism spectrum disorder : mechanism and,"Petropoulos A, Stavropoulou E, Tsigalou C, Bezirtzoglou E","background/objective : autism spectrum disorder ( asd ) be neurodevelopmental condition often accompany gastrointestinal ( gi ) symptom and gut microbiota imbalance . microbiota-gut-brain ( mgb ) axis be bidirectional communication network link gut microbe , gi system , and central nervous system ( cns ) . narrative review explore role mgb axis asd pathophysiology , focus communication pathway , neurodevelopmental implication , gut microbiota alteration , gi dysfunction , and emerge therapeutic . method : narrative review methodology be employ . search major scientific database include pubmed , scopus , and google scholar research mgb axis mechanism , gut microbiota composition asd , dysbiosis , leaky gut , immune activation , gi disorder , and intervention ( probiotic , prebiotic , fecal microbiota transplantation ( fmt ) , antibiotic and diet ) . key finding recent human , animal and vitro study be synthesize thematically , emphasize mechanistic insight and therapeutic outcome . original reference initial manuscript draft be retain and supplement comprehensiveness and accuracy . result : mgb axis involve neuroanatomical , neuroendocrine , immunological , and metabolic pathway enable microbe to influence brain development and function . individual asd commonly exhibit gut dysbiosis characterize reduced microbial diversity ( notably low bifidobacterium and firmicutes ) and overpresentation potentially pathogenic taxa ( e.g. , clostridia , desulfovibrio , enterobacteriaceae ) . dysbiosis be associate increase intestinal permeability ( "" leaky gut "" ) and newly activate and alter microbial metabolite profile , such short-chain fatty acid ( scfas ) and lipopolysaccharide ( lpss ) . functional gastrointestinal disorder ( fgid ) be prevalent asd , link gut-brain axis dysfunction behavioral severity . therapeutically , probiotic and prebiotic can restore eubiosis , fortify gut barrier , and reduce neuroinflammation , show modest improvement gi and behavioral symptom . fmt and microbiota transfer therapy ( mtt ) have yield promising result open label trial , improve gi function and asd behavior . antibiotic intervention ( e.g. , vancomycin ) have be find to temporarily alleviate asd symptom associate clostridiales overgrowth , nutritional strategy ( high-fiber , gluten-free , or ketogenic diet ) may modulate microbiome and influence outcome . conclusion : accumulate evidence implicate mgb axis asd pathogenesis . gut microbiota dysbiosis and related gi pathology may exacerbate neurodevelopmental and behavioral symptom immune , endocrine and neural route . intervention target gut ecosystem , diet modification , probiotic , symbiotic , or microbiota transplant , offer therapeutic promise . however , heterogeneity finding underscore need rigorous , large-scale study to clarify causal relationship and evaluate long-term efficacy and safety . understand mgb axis mechanism asd could pave way novel adjunctive treatment to improve quality life individual asd .",Nutrients,17/09/2025
10.4088/JCP.18m12612,prenatal exposure acetaminophen and risk,"Chen MH, Pan TL, Wang PW, Hsu JW, Huang KL, Su TP, Li CT, Lin WC, Tsai SJ, Chen TJ, Bai YM","background : study have suggest significant association exist prenatal exposure to acetaminophen and offspring 's attention-deficit/hyperactivity disorder ( adhd ) risk . however , association have largely be unexplored asian population , generally , and taiwanese population , specifically . method : study , 950 study pair ( child adhd [ icd-9-cm code : 314 ] and mother ) and 3 , 800 control pair ( child adhd and mother ) match demographic characteristic be identify 1998 and 2008 taiwan longitudinal health insurance database . maternal use acetaminophen be assess first trimester , second trimester , and third trimester pregnancy and period 3 month pregnancy date last menstrual cycle . result : logistic regression analysis adjustment demographic datum , gestational infection , comorbid perinatal condition , and maternal mental health disorder indicate exposure to acetaminophen second trimester ( odd ratio [ or ] = 1 . 19 ; 95 % ci , 1 . 00-1 . 40 ) , both first and second trimester ( or = 1 . 28 ; 95 % ci , 1 . 00-1 . 64 ) , or trimester ( or = 1 . 20 ; 95 % ci , 1 . 01-1 . 42 ) be associate increase risk adhd offspring . sensitivity analysis exclude gestational infection and maternal mental health disorder confirm association ( or = 1 . 33 ; 95 % ci , 1 . 04-1 . 69 ) . conclusion : prenatal exposure to acetaminophen be associate increase risk adhd offspring , regardless gestational infection and maternal mental health disorder . additional study be necessary to clarify underlie mechanism prenatal exposure to acetaminophen lead neurodevelopmental risk .",The Journal of clinical psychiatry,10/09/2019
10.1016/j.preteyeres.2025.101406,"consensus and controversy cause , diagnosis and management diabetic","Ng DSC, Ruamviboonsuk P, Apte RS, Bajimaya S, Chan CKM, Chang A, Cheung CY, Chen SJ, Chaudhary V, Chaikitmongkol V, Chhablani J, Das T, Huang SS, Jonas JB, Lai TYY, Lai CC, Ma J, Munk MR, Narayanan R, Radke NV, Sagong M, Sabanayagam C, Sivaprasad S, Shimura M, Sonoda KH, Sun JK, Tan GSW, Takkar B, Virgili G, Vujosevic S, Wang M, Yu SY, Zhang X, Zhang J, Wong TY, Lam DSC","diabetic macular edema ( dme ) be most common cause vision-threatene diabetic retinopathy ( vtdr ) increase prevalence tie global epidemic diabetes . significant advance , management dme remain dynamic field many unresolved controversy . optical coherence tomography ( oct ) allow objective assessment , however , correlation vision and morphological change can be inconsistent , cause disagreement treatment strategy . dme be complex disease multifactorial pathophysiological pathway , lead heterogenous treatment response . be lack standardized definition treatment ' non-response "" and protocol switch second-line or adjuvant treatment . new anti-vascular endothelial growth factor ( anti-vegf ) drug and multi-targeted therapy seem to demonstrate improved durability , but long-term datum be not yet available . research artificial intelligence ( ai ) be develop rapidly , however , rigorous appraisal reliability and generalizability be necessary implementation . significant vision loss dme pregnant woman , young child and elderly patient systemic comorbiditie be challenging conundrum . international panel expert ( ipe ) comprise 36 expert 16 country formulate and vote consensus statement 5 key area : 1 ) diagnostic controversy classification and imaging ; 2 ) treatment controversy ; 3 ) management paradigm protocol-based and individualized approach ; 4 ) emerge controversy novel therapeutic and ai application , and 5 ) special consideration specific patient population . be imminent need mutual agreement best-possible approach dme management order to promote optimal patient outcome and to identify specific issue require prioritization resource and research .",Progress in retinal and eye research,24/09/2025
10.1016/j.canlet.2025.218067,exploit metabolic vulnerability cancer : mechanism therapeutic,"Xue ZR, Xin YY, Jin WL","metabolic reprogramme enable cancer cell to adapt hostile microenvironment and resist therapy , simultaneously reveal metabolic vulnerability offer new opportunity target treatment . review be first to propose unified ' mechanism-strategy-translation ' framework , focus two core mechanism underlie metabolic vulnerability : metabolic inflexibility and synthetic lethality . dual-axis model not only elucidate metabolic reprogramme drive tumor progression but also highlight "" achilles ' heel "" malignant tumor . article provide in-depth discussion key metabolic pathway tumor depend ( such glucose metabolism ) , epigenetic regulation ( e.g. , lactylation ) , and multi-layered stress defense mechanisms-including autophagy , redox homeostasis , anti-ferroptosis , and cuproptosis-while dissect inherent vulnerability . furthermore , emphasize tripartite crosstalk neural , immune , and metabolic component tme , systematically explain neural signal , immunometabolic reprogramming , and key metabolite collectively regulate tumorigenesis , commentary role microbiota tme . base mechanism , summarize several emerge target clinical translational potential , provide clear direction future research . strategy such combination therapy and dietary intervention be also consider highly promising . ongoing challenge such metabolic heterogeneity , deepening integration multidisciplinary approach and advance ai-driven multi-omic analysis be pave way transformative prospect cancer therapy .",Cancer letters,26/09/2025
10.1016/j.phymed.2025.157318,liuwei dihuang formula ameliorate perimenopausal atherosclerosis modulate,"Zhang S, Feng H, Jiang J, Feng S, Jiang Y, Chen G, Wu Y, Liu R, Ma Y, Ma Y, Li Y, Bian H, Meng Q, Zhu R","background : trimethylamine n-oxide ( tmao ) , product gut microbiota , be essential pathophysiology atherosclerotic cardiovascular disease ( ascvd ) . liuwei dihuang formula ( lwdh ) can ameliorate perimenopausal atherosclerosis ( as ) and modulate gut microbe , be unknown regulate trimethylamine ( tma)-tmao pathway . purpose : study aim to examine lwdh could attenuate perimenopausal modulate gut microbiota-tma-tmao axis and to clarify associated mechanism , emphasis possible synergistic interaction probiotic bifidobacterium animali subsp . lactis ( b.lactis ) . method : apoe knockout ( apoe(-/- ) ) mouse , perimenopausal model be establish bilateral ovariectomy combine high-fat diet ( hfd ) , follow lwdh intervention . tmao and tma level plasma and liver be measure use target metabolomic . microbial community be analyze use rrna sequence . vitro microbial culture experiment be carry to validate lwdh effect key bacterial population and metabolic pathway . combine intervention lwdh and b.lactis be also perform to evaluate potential synergistic effect . result : lwdh significantly reduce aortic plaque burden and decrease plasma and hepatic tmao level perimenopausal mouse . mechanistic analysis reveal lwdh remodel gut microbiota , suppress tma-producing bacteria , and enhance tma degradation , thereby reduce systemic tmao accumulation . notably , rrna sequence reveal close link decrease bifidobacterium abundance and elevated tmao level . vitro assay confirm lwdh enhance tma-degrading activity b . lactis and downregulate cutc gene escherichia coli , result reduce tma synthesis . combine lwdh and b.lactis intervention lead great reduction plasma tmao compare b . lactis alone , accompany improve lipid metabolism and attenuation systemic inflammation . conclusion : finding be first to show lwdh mitigate perimenopausal progression modulate gut microbiota-dependent tma-tmao axis . dual mechanism enhance tma degradation and inhibit tma production , together synergistic effect lwdh and b . lactis , highlight novel therapeutic strategy integrate traditional chinese medicine and probiotic management .",Phytomedicine : international journal of phytotherapy and phytopharmacology,24/09/2025
10.1016/j.arr.2025.102902,sirtuin parkinson 's disease : molecular mechanisms and pathophysiological,"Li X, Luo X, Cao X, Thomas ER, Wang W, Zhou X, Zhou S, Wu A, Gao R, Liu K, Wu J","parkinson 's disease ( pd ) be progressive neurodegenerative disorder be associate mitochondrial dysfunction , oxidative stress , neuroinflammation , and abnormal protein aggregation . silent information regulator 2 ( sir2 ) family protein , know sirtuin ( sirt1 - sirt7 ) , be nicotinamide adenine dinucleotide ( nad(+))-dependent histone deacetylase regulate important signal transduction pathway both prokaryote and eukaryote . increase number study reveal sirtuin play diverse role cellular homeostasis , such metabolic regulation , oxidative stress response , apoptosis , organelle protection , and gene stability . intriguingly , grow evidence suggest sirtuin may serve pivotal molecular mediator pd , yet comprehensive synthesis role disorder be lack . precise pathogenesis pd remain unmapped , identify common molecular node could offer effective therapeutic strategy . review , present first systematic integration current knowledge distinct contribution individual sirtuin pd pathophysiology offering promise molecular target treatment pd . previous study focus isolated aspect sirtuin biology , work uniquely consolidate multifaceted mechanism sirtuin modulate pd , offer holistic perspective therapeutic potential . underscore transformative potential sirtuin modulation , position promising and unexplored frontier neurodegenerative disease therapy . work aim to provide new insight potential sirtuin-targeted therapy pd .",Ageing research reviews,26/09/2025
10.1016/j.bbadis.2025.168061,mechanical stress accelerate vascular calcification piezo1/bmp2 vascular,"Li B, Zhao Z, Xia Y, Deng S, Chen X, Jiang N, Ke G, Wen S, Yuan Y, Wu Q, Tao Y, Chen B, Peng S, Huang W, Tang B, Hao W, Deng C, Liu S","hemodialysis be main renal replacement therapy end-stage renal disease . blood vessel be susceptible vascular calcification(vc ) patient maintenance hemodialysis , be link mortality . arteriovenous fistula frequently use hemodialysis access suffer mechanical stress , often develop vc , impair hemodialysis quality . piezo1 , mechanosensitive ion channel receptor vascular smooth muscle cell ( vsmc ) , be essential sensing and transduction mechanical stress . however , and mechanical stress accelerate vc piezo1 be unclear . here observe , radial artery vc patient maintenance hemodialysis show high piezo1 expression . vitro , vsmc high phosphoru or high hydrostatic pressure ( hp ) show more expression piezo1 , and calcification , include high calcium deposition and osteogenic differentiation . activate piezo1 yoda1 show significant calcification . inhibition piezo1 gsmtx4 or silence piezo1 inhibit hp-induce calcification . similar result be obtain rat aorta vitro . inhibition bmp2 noggin alleviate hp-induce or yoda1-induced calcification . endoplasmic reticulum stress and calcium ion influx be activate vsmc hp piezo1 . collectively , result suggest mechanical stress accelerate vc piezo1/bmp2 vsmc .",Biochimica et biophysica acta. Molecular basis of disease,26/09/2025
10.1186/s12931-025-03356-w,"precision medicine copd : phenotype , endotype , biomarker , and","Xie C, Wang K, Yang K, Zhong Y, Gul A, Luo W, Yalikun M, He J, Chen W, Xu W, Dong J","chronic obstructive pulmonary disease ( copd ) be heterogeneous disorder characterize diverse clinical manifestation , pathophysiological mechanism , and therapeutic response . review explore evolve landscape precision medicine copd management , particular emphasis optimize patient care integration phenotype , endotype , biomarker , and treatable trait . phenotypic classification base observable clinical and radiographic feature have facilitate identification distinct subgroup such "" emphysema-dominant "" or "" frequent-exacerbator "" subtype . emerge research , however , increasingly emphasize endotypes-disease subcategorie define unique biological mechanism include neutrophilic inflammation , eosinophilic airway involvement , or α(1 ) antitrypsin deficiency-which may demonstrate superior predictive value therapeutic response . biomarker encompass blood eosinophil count , serum c-reactive protein , and sputum transcriptomic be progressively be implement patient stratification and guidance targeted therapy , include inhaled corticosteroid or biologic . furthermore , "" treatable trait "" framework enhance personalize management address modifiable factor airflow limitation , such comorbiditie , psychosocial determinant , and exacerbation trigger . advancement , persistent challenge remain biomarker validation , standardization phenotypic definition , and clinical translation research finding . future direction involve early detection pre-copd state and treatable trait , integration multi-omic datum , machine learning-driven dynamic phenotyping , and pragmatic clinical trial evaluate precision-guided intervention . align pathobiological mechanism targeted therapy , precision medicine hold promise transform copd care reactive management proactive , individualized therapeutic paradigm .",Respiratory research,29/09/2025
10.1016/j.ebiom.2025.105945,peripheral blood neutrophil proteomic profiling transcriptomic datum,"Yang J, Lv Z, Liu L, Zhang H, Hu J, Geng X, Xin H, Liu Z, Gao L, Zhang X, Xu Y, Liu R, Jin Q, Zheng J","background : tuberculosis ( tb ) be one deadly infectious disease worldwide , cause million new case and death annually . rapid and accurate tb diagnostic be essential tb control , yet current method do not fully meet global need . peripheral blood neutrophil play critical role tb infection and represent promising source diagnostic marker . method : conduct cross-sectional proteomic analysis to characterise neutrophil protein profile individual active tb ( atb ) , latent tb infection ( ltbi ) , and healthy control ( hc ) . stringent criterion be apply to identify differentially express protein ( deps ) group . transcriptomic datum be integrate to perform pathway enrichment analysis deps . three dep ( b2 m , txn , and prdx5 ) be far validate candidate diagnostic biomarker mycobacterium tuberculosis ( mtb ) infection use automate western blotting cohort 319 individual , include 71 atb , 142 ltbi , and 106 hc . finding : hundred deps be identify three group . integrated transcriptomic analysis reveal significant enrichment deps nod-like receptor signal pathway . receiver operate characteristic analysis three-protein combination ( b2 m , txn , and prdx5 ) yield area curve 0 . 9847 , sensitivity 95 . 11 % and specificity 96 . 23 % detect mtb infection . interpretation : study present comprehensive proteomic profile neutrophil different mtb infection state , and three-protein combination may assist diagnosis mtb infection . funding : work be support chinese academy medical sciences ( cams ) innovation fund medical sciences ( 2021-i2m-1-037 ) and national science and technology major project china ( 20212017zx10201301-002-003 ) .",EBioMedicine,27/09/2025
10.1038/s41556-025-01764-0,remote control ampk extracellular adenosine control tissue growth .,"Zhang Y, Strassburger K, Teleman AA","adenosine monophosphate ( amp)-activate protein kinase ( ampk ) be regulator cellular catabolism be activate amp . amp accumulate cell low atp , ampk be consider stress-activated kinase . study organ growth drosophila development , find ampk can also be activate signal metabolite not relate stress . specifically , find two physiological input know to regulate organ growth rate ( ecdysone ( steroid hormone ) and dietary protein ) modulate expression adenosine deaminase intestine . , turn , alter circulate adenosine level . circulate adenosine act signal molecule enter cell , becoming phosphorylate amp and activate ampk to inhibit organ growth . thus , ampk activity be regulate developmentally , and ampk activity one tissue can be remote control tissue circulate adenosine . notably , mechanism account effect dietary protein tissue growth rate drosophila .",Nature cell biology,26/09/2025
10.3390/biom15091284,impact glucagon-like peptide-1 receptor agonists erectile function :,"Kounatidis D, Vallianou NG, Rebelos E, Vallianou K, Diakoumopoulou E, Makrilakis K, Tentolouris N","erectile dysfunction ( ed ) be common yet frequently underrecognized microvascular complication diabetes , affect to three four individual . key contributing factor include advance age , long-standing disease duration , and suboptimal glycemic control , as well insulin resistance and androgen latter be particularly common man type 2 diabetes ( t2d ) and obesity . numerous study have investigate effect various antidiabetic therapy diabetes-related ed , result remain inconsistent , limit definitive conclusion . recent year , increase attention have focus novel class antidiabetic medication , namely glucagon-like peptide-1 receptor agonist ( glp-1 ras ) . agent have become central treatment t2d potent glucose-lowering property and well-documented benefit cardiovascular outcome , and weight loss . give pleiotropic effect , glp-1 ra have be presume to positively influence erectile function-a hypothesis support grow body experimental and clinical research . however , preliminary report have also raise concern possible association glp-1 ra use and ed . narrative review aim to synthesize current evidence regard impact glp-1 ra erectile function , provide platform future research evolve field .",Biomolecules,5/09/2025
10.1186/s13024-025-00877-2,autophagic impairment sleep-wake circuitry be link to sleep loss,"Morrone CD, Tsang AA, Yu WH","background : proteostasis , particular impairment autophagic activity , be link to sleep dysregulation and be early sign dementia include alzheimer 's disease ( ad ) . coupling event may be critical alteration drive proteinopathy and ad progression . present study , investigate sleep-wake and memory regulating neuron vulnerability autophagic impediment , and relate finding progression sleep and cognitive phenotype . method : use double knock-in ad mouse model , app(nl-g-f)xmapt , examine phenotypic and pathological alteration several timepoint and compare age-matched single knock-in mapt mouse . spatial learning , memory and executive function be investigate barnes maze . sleep be investigate 24-h locomotor activity and eeg . immunostaine autophagic , neuronal and pathological marker be conduct brain region relate memory ( hippocampus , prefrontal cortex , entorhinal cortex ) and sleep-wake cycle ( hypothalamus , locus coeruleus ) . hippocampal electrophysiological recording be conduct to probe neuronal function object investigation . 3-day sleep disruption be conduct mapt mouse to investigate autophagic change follow sleep loss . autophagy be activate mapt mouse trehalose to probe effect sleep recovery . result : identify disrupt sleep occur early-stage app(nl-g-f)xmapt mouse , sleep decline age , and sleep deficit precede cognitive impairment late-stage . cytoplasmic autophagic impediment hypothalamic and locus coeruleus sleep-wake neuron occur early-stage app(nl-g-f)xmapt mouse , prior significant β-amyloid deposition region , failure lysosomal flux disease progression . autophagic change hippocampus and cortex early-stage be predominantly process and less frequently associate lysosome . plaque-associate autophagic and lysosomal accumulation be frequent early-stage . sex difference ad phenotype be prominent , include great cognitive decline male female , link increase proteostasis burden ec layer ii neuron and hippocampal tau late-stage . conversely , sleep impairment be more rapid female include less rem sleep recovery male , great autophagic burden hippocampal process female app(nl-g-f)xmapt mouse . probe sleep-cognition linkage demonstrate hippocampal electrophysiological slowing cognitive processing mid-stage app(nl-g-f)xmapt mouse , prior cognitive decline . provide evidence positive feedback loop autophagic-sleep relationship demonstrate disrupt sleep mapt mouse lead arrhythmic sleep pattern and accumulation autophagic aggregate hippocampus and hypothalamus , similar be see early alzheimer 's phenotype . far probe autophagy-sleep linkage treat mapt mouse trehalose to activate autophagy and demonstrate improvement sleep recovery follow sleep disruption . conclusion : finding demonstrate vulnerability sleep-regulating neuron proteostatic dysfunction and sleep-autophagy linkage early , and treatable , alzheimer 's disease mechanism .",Molecular neurodegeneration,26/09/2025
10.1016/j.phymed.2025.157238,plant-derive natural product modulate astrocyte function : therapeutic,"Wei H, Zhang G, Yan X, Zhao A, Zheng Y, Shao Y, Yang L, Wang J, Jiang X","background : alzheimer 's disease ( ad ) be gradually worsen neurodegenerative condition limited treatment option , highlight need novel therapy . astrocyte play key role ad pathogenesis . natural product show promise treat ad modulate amyloid-beta ( aβ ) and tau pathology , inhibit neuroinflammation and oxidative stress , and protect cellular organelle . preclinical evidence support efficacy target astrocyte-related mechanism , enhance cognition , and reduce neuronal damage . purpose : systematically summarize and evaluate medicinal benefit plant-derived natural product modulate astrocyte-mediated process to attenuate ad progression . method : comprehensive literature review be perform pubmed and web science , utilize targeted keyword such "" natural product "" , "" active compound "" , "" alzheimer 's disease "" , and "" astrocyte "" . review primarily focus study publish 2013 and 2024 , select literature systematically categorize and analyze . result : review highlight medicinal benefit plant-derived natural product , such flavonoid , alkaloid , polyphenols , and terpene target astrocyte morphology and function to combat ad . bioactive compounds modulate key pathological process , include neuroinflammation , oxidative stress , aβ metabolism , tau hyperphosphorylation , mitochondrial dysfunction , and er stress , outline pathway to alleviate ad astrocytic effect . review also summarize clinical progress and major challenge translate compound , such variability , low bioavailability , and delivery limitation . conclusion : study address critical gap systematically elucidate relationship astrocyte and ad , and therapeutic potential plant-derived natural product . aim to expand treatment option patient and advance development therapeutic strategy field ad management .",Phytomedicine : international journal of phytotherapy and phytopharmacology,7/09/2025
10.1007/s10142-025-01712-z,"cancer gene therapy : historical perspective , current application , and future","Zeng J, Luo J, Zeng Y","gene therapy have emerge transformative approach cancer treatment , leverage genetic modification to target malignancy enhanced precision . early effort face challenge such inefficient vector delivery ( < 5 % tumor transduction rate first-generation adenovirus ) , immune response ( neutralize antibodie ~ 30 % patient ) , and limited clinical efficacy ( < 10 % objective response rate 1990 trial ) . however , advancement viral and non-viral vector ( e.g. , aav achieve > 50 % transduction efficiency solid tumor ) , crispr-cas9 ( 90 % target gene knockout rate preclinical model ) and rna interference technology , have revolutionize field . presently , gene therapy strategy , include tumor suppressor gene restoration , oncogene silence , and immune modulation , demonstrate promise clinical outcome . persistent hurdle off-target effect and high cost , emerge innovation personalize gene editing , oncolytic virus , and combination therapy signal paradigm shift oncology . review explore evolution gene therapy cancer , highlight key milestone , current application , and future direction could unlock full therapeutic potential .",Functional & integrative genomics,29/09/2025
10.1186/s40001-025-03131-z,association eight anthropometric index relate obesity,"Huang J, Zhang X, Tang H, Jia S, Chen J, Liang R, Yang Q, Lin H, Luo N, Ren Y, Lin J, Zhang X","objective : aim current study be to investigate association clinical osteoarthritis ( oa ) and eight anthropometric index relate obesity , include non-hematological index ( body mass index [ bmi ] , body roundness index [ bri ] , weight-adjusted waist index [ wwi ] , and waist-height ratio [ whtr ] ) , and hematological index ( triglyceride-glucose index [ tyg ] , lipid accumulation product [ lap ] , visceral adiposity index [ vai ] , and waist triglyceride index [ wti ] ) . methods : utilize datum national health and nutrition examination surveys ( nhanes ) span year 2005-2018 , total 19 , 867 adult ( aged ≥ 20 year ) be examine . eight anthropometric index be calculate . clinical oa be assess participant ' self-reported response questionnaire . multivariable logistic regression analysis and secondary analysis such restrict cubic spline ( rcs ) , receiver operate characteristic ( roc ) , decision curve analysis ( dca ) and area curve ( auc ) analysis be employ to investigate association anthropometric index and clinical oa . result : average age participant be 46 . 94 and 49 . 98 % be female . multivariable logistic regression analysis demonstrate significant association index and clinical oa , especially bmi ( 1 standard deviation [ sd ] , odd ration [ or ] [ 95 % confidence interval [ ci ] ] = 1 . 52[1 . 40 , 1 . 66 ] ) , wti ( or [ 95%ci ] = 1 . 50[1 . 36 , 1 . 65 ] ) and whtr ( or [ 95%ci ] = 1 . 50[1 . 36 , 1 . 64 ] ) . latent profile analysis show high index could increase clinical oa risk . additionally , auc wwi be high , 0 . 6724 , and dca indicate net profit wwi be high other index threshold be 25 % . result subgroup analysis prove robustness finding different sub-population . conclusion : eight anthropometric index relate obesity be significantly positively associate clinical oa . particularly , non-hematological index such wwi and whtr may show well efficacy predict and intervention clinical oa outcome , indicate potential preferred strategy early detection and management clinical oa .",European journal of medical research,26/09/2025
10.1016/j.eururo.2025.08.010,comparison single- and multiport robot-assisted approaches prostate and,"Ficarra V, Romito I, Sorce G, Maravigna D, De Stefano A, Mottrie A, Abdollah F, Viganò S, Stabile A, Salonia A, Giannarini G, Crocerossa F, Gandaglia G, Montorsi F, Rossanese M","background and objective : aim systematic review meta-analysis be to assess perioperative , functional , and oncological outcome single-port ( sp ) robotic procedure surgical management prostate and renal disease . method : systematic review be conduct use medline and scopus database , cover literature publish december 2024 . study be include compare sp multiport ( mp ) approach robot-assisted procedure , specifically radical prostatectomy ( rarp ) , simple prostatectomy ( rasp ) , partial nephrectomy ( rapn ) , radical nephrectomy ( rarn ) , and pyeloplasty ( rap ; prospero registration number : crd42025616519 ) . perioperative outcome be assess procedure . functional and oncological outcome be analyse specifically patient undergo rarp , warm ischaemia time ( wit ) , off-clamp rate , and positive surgical margin rate be evaluate undergo rapn . key finding and limitation : total 26 , three , nine , one , and two study evaluate rarp , rasp , rapn , rarn , and rap , respectively . compare mp-rarp , sp-rarp be associate low estimate blood loss ( standardised mean difference [ smd ] = 0 . 51 ; 95 % confidence interval [ ci ] : 0 . 16-0 . 87 ) , short length stay ( smd = 1 . 12 ; 95 % ci : 0 . 63-1 . 62 ) , and reduce postoperative pain ( smd = 0 . 12 ; 95 % ci : 0 . 04-0 . 35 ) . only difference",European urology,27/09/2025
10.1016/j.ijid.2025.108089,explosive chikungunya virus outbreak china .,"Tee KK, Mu D, Xia X","background : chikungunya virus ( chikv ) , aedes-borne alphavirus , be grow global health concern . now , china have experience only sporadic outbreak link import case . method : analyze epidemiological , clinical , and public health datum ongoing 2025 guangdong outbreak , large chikungunya epidemic record china . result : outbreak begin foshan july 8 , 2025 , 3 , 000 confirm case first two week and more 10 , 000 late august . clinical presentation be typical chikungunya fever , include acute fever , arthralgia , and rash , severe complication or death . local and interregional spread include travel-associated case macao , hong kong , taiwan , and guangxi . authority implement expand pcr testing , isolation case mosquito-proof facility , and comprehensive vector control . clinical management remain supportive , licensed antiviral . conclusion : unprecedented scale and rapid spread chikv guangdong underscore role ecological and mobility factor transform local introduction large epidemic . strengthen surveillance , genomic analysis , regional datum sharing , and vaccine preparedness will be critical to curb future arbovirus threat china .",International journal of infectious diseases : IJID : official publication of the,26/09/2025
10.1186/s40001-025-03131-z,association eight anthropometric index relate obesity,"Huang J, Zhang X, Tang H, Jia S, Chen J, Liang R, Yang Q, Lin H, Luo N, Ren Y, Lin J, Zhang X","objective : aim current study be to investigate association clinical osteoarthritis ( oa ) and eight anthropometric index relate obesity , include non-hematological index ( body mass index [ bmi ] , body roundness index [ bri ] , weight-adjusted waist index [ wwi ] , and waist-height ratio [ whtr ] ) , and hematological index ( triglyceride-glucose index [ tyg ] , lipid accumulation product [ lap ] , visceral adiposity index [ vai ] , and waist triglyceride index [ wti ] ) . methods : utilize datum national health and nutrition examination surveys ( nhanes ) span year 2005-2018 , total 19 , 867 adult ( aged ≥ 20 year ) be examine . eight anthropometric index be calculate . clinical oa be assess participant ' self-reported response questionnaire . multivariable logistic regression analysis and secondary analysis such restrict cubic spline ( rcs ) , receiver operate characteristic ( roc ) , decision curve analysis ( dca ) and area curve ( auc ) analysis be employ to investigate association anthropometric index and clinical oa . result : average age participant be 46 . 94 and 49 . 98 % be female . multivariable logistic regression analysis demonstrate significant association index and clinical oa , especially bmi ( 1 standard deviation [ sd ] , odd ration [ or ] [ 95 % confidence interval [ ci ] ] = 1 . 52[1 . 40 , 1 . 66 ] ) , wti ( or [ 95%ci ] = 1 . 50[1 . 36 , 1 . 65 ] ) and whtr ( or [ 95%ci ] = 1 . 50[1 . 36 , 1 . 64 ] ) . latent profile analysis show high index could increase clinical oa risk . additionally , auc wwi be high , 0 . 6724 , and dca indicate net profit wwi be high other index threshold be 25 % . result subgroup analysis prove robustness finding different sub-population . conclusion : eight anthropometric index relate obesity be significantly positively associate clinical oa . particularly , non-hematological index such wwi and whtr may show well efficacy predict and intervention clinical oa outcome , indicate potential preferred strategy early detection and management clinical oa .",European journal of medical research,26/09/2025
10.1016/j.eururo.2025.08.010,comparison single- and multiport robot-assisted approaches prostate and,"Ficarra V, Romito I, Sorce G, Maravigna D, De Stefano A, Mottrie A, Abdollah F, Viganò S, Stabile A, Salonia A, Giannarini G, Crocerossa F, Gandaglia G, Montorsi F, Rossanese M","background and objective : aim systematic review meta-analysis be to assess perioperative , functional , and oncological outcome single-port ( sp ) robotic procedure surgical management prostate and renal disease . method : systematic review be conduct use medline and scopus database , cover literature publish december 2024 . study be include compare sp multiport ( mp ) approach robot-assisted procedure , specifically radical prostatectomy ( rarp ) , simple prostatectomy ( rasp ) , partial nephrectomy ( rapn ) , radical nephrectomy ( rarn ) , and pyeloplasty ( rap ; prospero registration number : crd42025616519 ) . perioperative outcome be assess procedure . functional and oncological outcome be analyse specifically patient undergo rarp , warm ischaemia time ( wit ) , off-clamp rate , and positive surgical margin rate be evaluate undergo rapn . key finding and limitation : total 26 , three , nine , one , and two study evaluate rarp , rasp , rapn , rarn , and rap , respectively . compare mp-rarp , sp-rarp be associate low estimate blood loss ( standardised mean difference [ smd ] = 0 . 51 ; 95 % confidence interval [ ci ] : 0 . 16-0 . 87 ) , short length stay ( smd = 1 . 12 ; 95 % ci : 0 . 63-1 . 62 ) , and reduce postoperative pain ( smd = 0 . 12 ; 95 % ci : 0 . 04-0 . 35 ) . only difference",European urology,27/09/2025
10.1016/j.ijid.2025.108089,explosive chikungunya virus outbreak china .,"Tee KK, Mu D, Xia X","background : chikungunya virus ( chikv ) , aedes-borne alphavirus , be grow global health concern . now , china have experience only sporadic outbreak link import case . method : analyze epidemiological , clinical , and public health datum ongoing 2025 guangdong outbreak , large chikungunya epidemic record china . result : outbreak begin foshan july 8 , 2025 , 3 , 000 confirm case first two week and more 10 , 000 late august . clinical presentation be typical chikungunya fever , include acute fever , arthralgia , and rash , severe complication or death . local and interregional spread include travel-associated case macao , hong kong , taiwan , and guangxi . authority implement expand pcr testing , isolation case mosquito-proof facility , and comprehensive vector control . clinical management remain supportive , licensed antiviral . conclusion : unprecedented scale and rapid spread chikv guangdong underscore role ecological and mobility factor transform local introduction large epidemic . strengthen surveillance , genomic analysis , regional datum sharing , and vaccine preparedness will be critical to curb future arbovirus threat china .",International journal of infectious diseases : IJID : official publication of the,26/09/2025
10.1038/s41591-025-03937-8,co-infusion cd19-targeting and bcma-targete car-t cell,"Feng J, Huo D, Hong R, Jin X, Cao H, Shao M, Wen R, Zhang Q, Zhang M, Fu S, Wang D, Xu H, Wei G, Cui J, Huang S, Cui D, Chang AH, Liu Z, Lu L, Lin J, Hu Y, Huang H","systemic lupus erythematosus ( sle ) remain refractory conventional immunosuppression subset patient . treatment-refractory sle , show peripheral cd19(⁺ ) b cell and bone marrow cd19⁻bcma⁺ long-lived plasma cell be dominant autoantibody source , motivate dual cd19 and bcma target . here report result cohort patient ( 14 female , one male ) ongoing phase 1 dose-escalation trial co-infuse autologous anti-cd19 and anti-bcma chimeric antigen receptor ( car ) t cell fludarabine/cyclophosphamide lymphodepletion . primary endpoint be dose-limiting toxicity ( dlt ) 28 day and adverse event 12 week ; key secondary endpoint comprise attainment lupus low disease activity state ( lldas ) and doris remission 12 week and vivo car-t persistence 24 week . exploratory endpoint be duration post-infusion b cell depletion and time recovery , kinetic immune reconstitution and longitudinal change autoantibody titer and serum immunoglobulin concentration car-t therapy . median 712-day follow-up ( range , 613-1 , 134 ) , dlt occur . grade 1 cytokine release syndrome develop 86 . 7 % patient , neurotoxicity or treatment-related death . most common grade 3 or high adverse event be neutropenia ( 100 % ) , thrombocytopenia ( 40 % ) and anemia ( 13 . 3 % ) , be reversible supportive care . week 12 , 12 15 patient ( 80 % ) fulfil both llda and doris remission criterion . multiomic analyse confirm elimination autoreactive cd19⁺bcma⁺ clone , reconstitution naive igm/igd b cell and durable downregulation interferon-stimulated and baff-dependent signature , indicate improve immune homeostasis . longitudinal monitoring three patient 1 year demonstrate sustained eradication pathogenic clone , suggest potential cure . dual anti-cd19/anti-bcma car-t cell therapy demonstrate good safety and promise clinical efficacy treatment-refractory sle . study support further development treatment approach patient rsle . clinicaltrials.gov identifier : nct05030779 .",Nature medicine,24/09/2025
10.1038/s41698-025-01093-3,single-cell rna-sequencing bcg naïve and recurrent non-muscle invasive bladder,"Juric I, Fink EE, Qiu H, Desprez PE, Ravi A, Holton M, Makarov V, Almassi N, Min B, Getz G, Chan TA, Alban T, Ting AH, Lee BH","bacillus calmette-guérin ( bcg ) be mainstay treatment intermediate- and high-risk non-muscle invasive bladder cancer ( nmibc ) , yet recurrence rate remain high . to improve efficacy bcg , well understanding immune landscape underlie bcg resistance be critical . here , perform single-cell",NPJ precision oncology,26/09/2025
10.1016/j.neurot.2025.e00759,inhibition microglial glutaminase alleviate chronic stress-induced,"Huang M, Li Y, Thomas AG, Sharma A, Liyanage W, Tichý T, Tenora L, Su Y, Ha J, Hin N, Obayashi M, Majer P, Kannan RM, Tsukamoto T, Ursini G, Rais R, Slusher BS, Zhu X","major depressive disorder ( mdd ) be prevalent and debilitate psychiatric condition significant societal and economic impact . many patient be resistant current antidepressant therapy , underscore need novel treatment target underlying mechanism . previously discover glutaminase ( gls1 ) , enzyme convert glutamine to glutamate , be upregulate specifically activate microglia mouse expose chronic social defeat stress ( csds ) . importantly , gls1 mrna be also upregulate microglia postmortem brain tissue mdd patient , highlight potential role microglial gls1 mdd pathophysiology . however , exist gls1 inhibitor lack brain penetrance and/or cause gastrointestinal toxicity , limit translational potential . to address , utilize hydroxyl-terminated poly(amidoamine ) dendrimer nanoparticle system to selectively target microglial gls1 . use structurally distinct gls1 inhibitor , synthesize two hydroxyl-dendrimer-gls1 inhibitor conjugate : dendrimer-ttm020 ( d-ttm020 ) and dendrimer-jhu29 ( d-jhu29 ) . murine csds model , evaluate microglial target engagement , safety , and efficacy use immunofluorescence , gls1 activity assay , gastrointestinal histopathology , and battery behavioral test . use cy5 fluorescently label hydroxyl-dendrimer ( d-cy5 ) , confirm systemically administer d-cy5 cross blood-brain barrier and be selectively engulf activate microglia mouse csds . d-ttm020 and d-jhu29 attenuate csds-induce microglial gls1 activity elevation affect non-microglial cell . furthermore , d-ttm020 and d-jhu29 alleviate",Neurotherapeutics : the journal of the American Society for Experimental,26/09/2025
10.1186/s12894-025-01919-z,comparative real-world study apalutamide and darolutamide japanese patient,"Ikeda M, Uemura K, Ito Y, Ito H, Kawahara T, Hasumi H, Teranishi JI, Makiyama K, Uemura H","background : non-metastatic castration-resistant prostate cancer ( nmcrpc ) be often asymptomatic but carry risk progression to metastatic disease . apalutamide ( apa ) and darolutamide ( daro ) have be show to improve metastasis-free survival ( mfs ) . study evaluate real-world efficacy and safety apa and daro japanese patient nmcrpc . methods : retrospectively analyze 67 nmcrpc patient treat apa ( n = 32 ) or daro ( n = 35 ) . outcomes include time treatment discontinuation or mcrpc progression , time mcrpc , psa response rate , treatment-related adverse event ( trae ) , post-mcrpc treatment pattern , and predictor progression . result : patient prostate-specific antigen double time ( psadt ) < 10 month , significant difference be observe apa and daro group time progression mcrpc . psa response and mfs be comparable group . trae be significantly more frequent apa ( 75 . 0 % 25 . 7 % ) , rash be most common . high psa treatment initiation ( ≥ 3 . 6 ng/ml ) and psa response < 90 % be independent predictor progression . abiraterone be most common first-line agent mcrpc . conclusion : daro be associate low incidence trae compare apa . rash be more prevalent apa . elevated baseline psa and suboptimal psa response be associate progression .",BMC urology,26/09/2025
10.1186/s12951-025-03698-z,injectable responsive hydrogel synergistic antibacterial and,"Li X, Zhang Z, Yang X, Yu M, Tang Y, Wei J, Li Z, Hai J, Zhang B","periodontitis be chronic inflammatory disease drive dysbiotic microbial biofilm and localize reactive oxygen specie ( ros ) accumulation , inflammation management make challenging recurrent infection residual pathogenic bacteria periodontal pocket . to address , engineer injectable ph-responsive hydrogel ( mh@zif-8/cs/β-gp ) integration minocycline hydrochloride ( mh)-encapsulate zeolitic imidazolate framework-8 ( zif-8 ) nanoparticle chitosan ( cs ) and β-glycerophosphate ( β-gp ) crosslinke matrix . mh@zif-8 display broad-spectrum antimicrobial efficacy key periodontal pathogen include porphyromonas gingivali ( pg ) , and aggregatibacter actinomycetemcomitan ( aa ) , primarily attribute synergistic antimicrobial effect zn ion and mh . additionally , mh@zif-8 effectively eliminate ros inhibit nlrp3/caspase-1/il-1β signal pathway , demonstrate potent anti-inflammatory effect lipopolysaccharide ( lps)-stimulate raw264 . 7 cell . mh@zif-8/cs/β-gp hydrogel , exhibit favor cytocompatibility human gingival fibroblast ( hgfs ) , undergo rapid sol-gel transition and ph-responsive sustained-release drug delivery acidic condition periodontal pocket , effectively respond periodontitis microenvironment . meanwhile , hydrogel effectively alleviate alveolar bone loss vivo . overall , develop mh@zif-8/cs/β-gp hydrogel present novel strategy chronic periodontitis treatment and demonstrate promise clinical application potential .",Journal of nanobiotechnology,26/09/2025
10.1111/eje.12828,concept map-base learning oral radiographic interpretation course : dental,"Gil YM, Lee BD","objectives : concept mapping be use to promote critical thinking and meaningful learning health profession education . study aim to evaluate dental undergraduate ' perception concept mapping learn tool oral radiographic interpretation competency . method : total 39 third-year undergraduate dental college participate oral radiological interpretation session . student receive 1 hour instruction create concept map ( cm ) . participant be provide assignment four relevant clinical case to draw individualised cm . student ' draft and final cm be submit . instructor evaluate cms to identify student could analyse , connect and organise information meaningful way . , 37 complete questionnaire experience and response to concept mapping . result : student perceive concept mapping positively . instructor 's feedback help recognise misconception and foster great motivation to learn . student attempt to integrate basic biomedical knowledge and clinical feature cross-linking . however , also express negative attitude concept mapping regard time consumption and heavy burden . conclusion : concept mapping motivated student ' direct learning and give opportunity to recognise misconception . study suggest potential use cms adjunctive learning strategy oral radiographic interpretation class .",European journal of dental education : official journal of the Association for,01/02/2023
10.1016/j.phymed.2025.157043,jinkui shenqi pill improve pancreatic islet function diabete modulate,"Zhang S, Song C, Zhang W, Wen Z, Zhang Y, Chen Y, Zhuang Z, Liu X, Chen C, Ni Q","background : macrophage infiltration be key contributor pancreatic β-cell dysfunction , mechanism inflammatory activation be unclear . china , jinkui shenqi pill ( jsp ) be know hypoglycemic effect and pancreatic protective property , but role macrophage-mediated inflammation be unstudied . purpose : study investigate effect jsp macrophage polarization and underlying molecular mechanism . method : type 2 diabetes mouse model be induce high-fat diet combine streptozotocin . fast glucose , insulin , lipid profile , homa-ir , and homa-β be measure . islet structure be evaluate stain and electron microscopy , and qrt-pcr detect dedifferentiation marker . flow cytometry assess pancreatic m1 and m2 macrophage percentage . target glucose metabolomic analyze jsp 's effect succinate level . vitro , jsp-containe serum effect macrophage polarization be analyze fluorescence and morphological observation . succinate be employ to reverse-validate effect jsp succinate/hif1α axis . macrophage-conditione medium be co-culture islet cell to clarify jsp 's role regulate β-cell function . px478 inhibit hif1α activity vivo and vitro to observe hypoglycemic , macrophage polarization , and islet-protective effect . result : jsp reduce blood glucose and lipid level , enhance insulin secretion , and improve insulin resistance . jsp inhibit macrophage infiltration , reduce m1 macrophage ( cd45(+)cd11b(+)f4/80(+)cd86(+ ) ) percentage ( p < 0 . 05 ) , and increase m2 macrophage ( cd45(+)cd11b(+)f4/80(+)cd206(+ ) ) percentage ( p < 0 . 01 ) . improve glycolysis , tca cycle , and oxidative phosphorylation pathway , inhibited succinate accumulation , and be associate hif1α signal . vitro , jsp inhibit hif1α nuclear accumulation , reduce pro-inflammatory cytokine ( il-1 ,",Phytomedicine : international journal of phytotherapy and phytopharmacology,5/07/2025
10.1002/alz.70746,amyloid beta and tau be associate dual effect neuroinflammation,"Povala G, Bellaver B, Bastiani MA, Ferrari-Souza JP, Aguzzoli CS, Leffa DT, Ferreira PCL, Lussier FZ, Rocha A, Zalzale H, Soares C, Bauer-Negrini G, Therriault J, Rahmouni N, Stevenson J, Servaes S, Tissot C, Zatt B, Karikari TK, Ikonomovic MD, Villemagne VL, Gauthier S, Zimmer ER, Tudorascu DL, Benedet AL, Rosa-Neto P, Pascoal TA","introduction : current literature present conflict result regard impact neuroinflammation alzheimer 's disease ( ad)-relate neurodegeneration . study suggest neuroinflammation potentiate neurodegeneration , other indicate protective effect . method : evaluate 145 individual positron emission tomography ( pet ) amyloid beta ( aβ ) , tau , and translocator protein ( tspo ) , proxy neuroinflammation , to test hypothesis aβ and tau be associate dual effect neuroinflammation neurodegeneration ad continuum . result : detrimental effect neuroinflammation gray matter density occur two wave . first neuroinflammation-related detrimental wave be associate brain aβ deposition , second be widespread tau tangle pathology . furthermore , concomitant presence neuroinflammation , aβ , and tau be associate fast cognitive decline 2 year . conclusion : result support model aβ- and tau-associated neuroinflammation be relate two wave deleterious effect ad-relate neurodegeneration . highlight : two wave detrimental neuroinflammation effect brain density associate aβ or tau . aβ associate deleterious effect neuroinflammation brain density early ad . tau associate deleterious effect neuroinflammation brain density late ad . interaction aβ , tau , and neuroinflammation be associate cognitive decline .",Alzheimer's & dementia : the journal of the Alzheimer's Association,01/10/2025
10.1016/j.phymed.2025.157319,psoraleae fructus combine walnut kernel improve postmenopausal,"Hu L, Luo M, Zhu X, Wang Z, Yan C, Wu L, Zhu H, Yang Z, Xin Y, Feng S, Wu Y, Li W","background : postmenopausal osteoporosis ( pmop ) be bone metabolic disorder cause estrogen ( e2 ) deficiency . traditional chinese medicine psoraleae fructus ( p ) be often use combination walnut kernels ( j , juglans regia l . ) to treat osteoporosis . however , combination walnut kernel and psoraleae fructus ( pj ) be more effective psoraleae fructus alone remain unclear , and material basis and mechanism synergistic effect combination be not fully understand . purpose : study aim to elucidate synergistic mechanism pj treatment pmop and to identify active component and target . method : compound pj be analyze use",Phytomedicine : international journal of phytotherapy and phytopharmacology,23/09/2025
10.3310/DWKT1327,effectiveness surgical intervention patient severe pressure ulcer :,"Reeves B, Pufulete M, Harris J, Dumville J, Adderley U, Burton A, Burton M, Atkinson R, Clout M, Cullum N, O'Connell A, O'Connor L, Palmer S, Ridd M, Rodrigues J, Wong J","background : surgical reconstruction to close severe pressure ulcer have not be evaluate . aim and objective : aim to investigate feasibility research to evaluate surgical reconstruction severe pressure ulcer : systematically review evidence : effectiveness surgical reconstruction severe pressure ulcer ; impact pressure ulceration health-related quality-of-life ( review 2 ) survey primary and secondary care healthcare professional surgical referral patient severe pressure ulcer and severe pressure ulcer management , include surgical reconstruction describe patient incident pressure ulcer and severe pressure ulcer have surgical reconstruction compare outcome patient severe pressure ulcer having/not have surgical reconstruction seek consensus treatment and management strategy severe pressure ulcer . design : systematic review ; survey ; binary choice experiment ; retrospective cohort study use routine datum ; consensus meeting . participant : general practitioner ; nurse ; and surgeon manage pressure ulcer ; people incident pressure ulcer and hospitalise severe pressure ulcer . intervention : surgical reconstruction . comparator : surgical reconstruction . outcomes : surgical reconstruction , time next admission severe pressure ulcer time next admission , hospital stay , all-cause mortality , surgical reconstruction discharge . result : review 1 include three study compare different surgical reconstruction technique . none report wound-free time . recurrence occur ≈ 20 % . review 2 include three randomise control trial measure health-related quality life , but none observe benefit intervention evaluate . primary care survey respondent , 54 % do not know surgical reconstruction can treat severe pressure ulcer ; > 50 % have never refer patient surgeon . nurse , 72 % have consider surgical reconstruction severe pressure ulcer ; 54 % believe surgical reconstruction should be more available . surgeon , 39 % have never offer surgical reconstruction and 52 % offer surgical reconstruction to < 50 % ; 68 % believe surgical reconstruction should be more available . routine datum record 367 , 884 admission severe pressure ulcer diagnose england 7 . 5 year ; surgical reconstruction be perform at least 404 and most 1018 admission . twenty english hospital perform > 70 % surgical reconstruction . compare surgical reconstruction ( n = 325 ) surgical reconstruction ( n = 1474 ) patient , time next admission severe pressure ulcer be long patient have surgical reconstruction ( hazard ratio = 0 . 79 , 95 % confidence interval 0 . 61 to 1 . 03 ; p = 0 . 07 ) . estimate pressure ulcer incidence primary care be ≈ 5/10 , 000 , but true incidence be believe to be ≈ 7 time high . episode pressure ulcer care could not be identify . be consensus referral pathway severe pressure ulcer patient want surgical reconstruction , include community-le and surgically lead multidisciplinary team meeting , and influence several patient and severe pressure ulcer characteristic suitability surgical reconstruction . limitation : surveys only consider factor one one . analysis hospital episode statistics cohort depend code accuracy . comparison surgical reconstruction and surgical reconstruction , surgical reconstruction group have to be admit . routine datum do not record wound healing outcome . primary care datum underestimate pressure ulcer incidence ; pressure ulcer care episode could not be identify . consensus meeting do not include surgeon . covid-19 pandemic cause delay , make team member unavailable and restrict face-to-face meeting . conclusion : be insufficient evidence to determine effectiveness surgical reconstruction health-related quality life or wound healing severe pressure ulcer . too few procedure be carry to enable randomised control trial to be feasible . future work : identify three area : qualitative research acceptability surgical reconstruction and impact spu patient 's quality-of-life ; core outcome set intervention to treat pressure ulcer ; and economic modelling surgical reconstruction cost-effectiveness . study registration : study be register prospero 2019 crd42019156436 , 2019 crd42019156450 ; isrctn13292620 . funding : award be fund national institute health and care research ( nihr ) health technology assessment programme ( nihr award ref : nihr127850 ) and be publish full health technology assessment ; vol . 29 , no . 47 . see nihr funding and awards website further award information .","Health technology assessment (Winchester, England)",01/09/2025
10.1016/j.ejphar.2025.178187,map evolving landscape lecanemab research alzheimer 's disease : a,"Zhao X, Ma R, Shen J, Xu D, Yang Z","background : lecanemab , monoclonal antibody target amyloid-beta aggregate , have emerge promising therapeutic alzheimer 's disease ( ad ) . ad be progressive neurodegenerative disorder characterize cognitive decline and amyloid pathology . research use lecanemab treat ad have increase ; however , relevant bibliometric analysis have be conduct . to address gap , study employ bibliometric method to search relevant literature and analyze research trend investigate ad and lecanemab . methods : perform literature search web science core database study investigate ad and lecanemab , publish database inception april 3rd , 2025 . rigorous screening , excel , vosviewer , and citespace be use to perform bibliometric analysis publication , citation , and collaboration network country , institution , and author , cluster and burst analysis keyword . coremine be use text mining entry significantly relate ad and lecanemab . result : number study publish ad and lecanemab have increase annually . country high publication output be united states , united kingdom , and china . lead institution produce most article be eisai inc. ( bunkyo city , tokyo , japan ) , uppsala university ( uppsala , sweden ) , and harvard medical school ( boston , ma , usa ) . top three author be lars lannfelt , shobha dhadda , and michio kanekiyo . most prolific journal include journal alzheimer 's disease , alzheimer 's and dementia , and ageing research reviews . most cite article be "" lecanemab early alzheimer 's disease , "" van dyck et al . , publish new england journal medicine 2023 , have accrue 172 citation . 10 most frequently occur keyword be alzheimer 's disease , lecanemab , dementia , aducanumab , amyloid-beta , immunotherapy , tau , a-beta , mouse model , and donanemab . text mining reveal drug , anatomical structure , chemical molecule , gene , disease , and procedure be significantly associate ad and lecanemab . conclusion : bibliometric and text mining analysis reveal trend research investigate correlation lecanemab and ad . analyze cooperation country , region , and author , highlight recent research hotspot . datum offer objective insight scientific research and clinical practice lecanemab and ad . finding provide roadmap prioritize clinical trial , optimize drug development strategy , and address knowledge gap amyloid-targeted therapy .",European journal of pharmacology,26/09/2025
10.12688/f1000research.163923.3,​​dapagliflozin empagliflozin cardiorenal risk reduction : real-world,"Cokro F, Sauriasari R, Tahapary DL, Setiawan H, Tricaesario C, Hidayati N, Soegondo S","background : previous study compare cardiorenal efficacy two type sglt2 inhibitor ; however , finding be inconsistent and do not reflect population type 2 diabetic mellitus ( t2dm ) patient indonesia , rank fifth globally diabetes prevalence . study aim to evaluate effect and safety dapagliflozin and empagliflozin cardiorenal risk factor t2dm indonesian patient 12-month . method : study utilize multicenter retrospective cohort to evaluate diverse cardiorenal risk factor , encompass glycemic control , blood pressure , lipid profile , body weight , body mass index ( bmi ) , calculate 10-year atherosclerotic cardiovascular disease ( ascvd ) risk , and estimate glomerular filtration rate ( egfr ) , safety profile sglt2is . pair data analysis , comparative analysis group , and linear regression be conduct to adjust confounding . result : group exhibit enhancement hba1c , fast plasma glucose ( fpg ) , systolic blood pressure ( sbp ) , and low-density lipoprotein cholesterol ( ldl-c ) . improvement bmi , diastolic blood pressure ( dbp ) , triglyceride , ascvd risk , and high-density lipoprotein cholesterol ( hdl-c ) be only see dapagliflozin group . dapagliflozin be associate great reduction body weight and bmi , difference be not statistically significant adjustment confound factor . significant difference be observe average alteration hba1c , fpg , sbp , dbp , ldl-c , hdl-c , triglyceride , total cholesterol , egfr , and ascvd risk value . comparable safety profile be find group . conclusion : dapagliflozin and empagliflozin provide similar advantage reduce cardiorenal risk and safety 12 month treatment indonesian patient t2dm .",F1000Research,01/01/2025
10.1007/s00535-025-02304-1,long-term risk inflammatory bowel disease patient irritable bowel,"Song H, Zhou Y, Liu S, Zhang Q, Zhang S, Zhu S, Wu S","background : irritable bowel syndrome ( ibs ) and inflammatory bowel disease ( ibd ) be distinct gastrointestinal disorder overlap symptom and pathophysiological background . long-term risk ibd be unclear ibs patient . methods : overall , 447 , 631 participant free ibd baseline ( 2006-2010 ) and 76 , 992 individual complete digestive health questionnaire ( 2017-2018 ) uk biobank be enrol longitudinal cohort and cross-sectional analysis , respectively . primary outcome be incident ibd cohort design , and cox proportional hazards model be conduct to estimate associate hazard ratio ( hr ) . prevalent ibd be define primary outcome cross-sectional design , and logistic regression be perform to estimate associate odd ratio ( or ) . result : cohort design , 2 , 916 incident ibd case be identify median 14 . 2 year ' follow-up , 2 , 097 ulcerative colitis ( uc ) and 1 , 015 crohn 's disease ( cd ) , respectively . ibs patient have 68 % , 60 % , and 104 % increase risk ibd ( hr = 1 . 68 , 95 % ci :1 . 47-1 . 92 ) , uc ( hr = 1 . 60 , 1 . 36-1 . 89 ) , and cd ( hr = 2 . 04 , 1 . 66-2 . 51 ) non-ibs participant . moreover , great risk incident ibd persist ibs patient even 10 year ' duration ( hr = 1 . 55 , 1 . 27-1 . 89 ) . cross-sectional analysis , ibs patient exhibit significantly elevate odd ibd ( or = 2 . 40 , 2 . 14-2 . 70 ) , uc ( or = 2 . 18 , 1 . 92-2 . 48 ) , and cd ( or = 3 . 15 , 2 . 68-3 . 70 ) . great odd ibd be observe ibs subtype , show high odd ( or = 3 . 72 , 3 . 24-4 . 28 ) . conclusion : risk incident ibd , either uc or cd , be significantly high ibs patient compare general population , especially ibs-d patient .",Journal of gastroenterology,28/09/2025
10.1002/cam4.71250,comprehensive genomic profiling advanced non-small cell lung cancer : a,"Hormalainen K, Marttila K, Nykter M, Uibu T, Ahvonen J, Fey V, Keinänen M, Bärlund M, Jukkola A","background : non-small cell lung cancer ( nsclc ) be disease low survival rate and poor prognosis . targeted therapy have improve treatment outcome driver mutation have be identify , especially adenocarcinoma . comprehensive genomic profiling ( cgp ) provide insight genetic mutation profile cancer and helps identify actionable mutation . mutational landscape cancer varie base patient 's ethnic background , and be limited information genetic profile nsclc finnish population . material and method : analyse genetic mutational profile 96 advanced nsclcs undergo cgp november 2021 and march 2023 tampere university hospital . additionally , compare genomic alteration cohort international dataset . result : clinically actionable alteration associate targeted therapy be identify 45 % patient , include 63 % never-smoker and 41 % ever-smoker . most common actionable alteration be kras g12c ( 18 % ) , follow egfr alteration ( 14 % ) . however , only 33 % patient actionable alteration receive target therapy . median tumour mutational burden ( tmb ) be 5 , 31 % patient exhibit tmb great 10 . conclusion : cgp affect treatment strategy nsclc . nearly half entire cohort have genetic alteration eligible approve target therapy . finding , cgp provide additional datum to assess treatment decision and outcome , include co-occurre genetic alteration and tmb . real-world clinical practice , practical application information can be restrict vary unavailability optimal treatment .",Cancer medicine,01/10/2025
10.1002/ejhf.70033,"blood pressure , safety and clinical efficacy vericiguat chronic heart","Mentz RJ, Butler J, McMullan CJ, Wojdyla DM, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Zannad F","aim : efficacy and safety vericiguat patient chronic heart failure reduced ejection fraction ( hfref ) contemporary heart failure ( hf ) therapy and recent worsening be investigate victor trial , yet subgroup may be more susceptible symptomatic hypotension . methods and result : victor trial participant receive at least one dose study drug or placebo , describe systolic blood pressure ( sbp ) trajectory time ( mean change baseline ) , symptomatic hypotension event and efficacy vericiguat potentially vulnerable patient subgroup : low baseline blood pressure ( sbp ≤110 mmhg ) , old patient ( > 75 year ) and take angiotensin receptor-neprilysin inhibitor ( arni ) or sodium-glucose co-transporter 2 inhibitor ( sglt2i ) baseline . efficacy outcome cardiovascular death and hf hospitalization and cardiovascular death alone baseline sbp be examine use cox proportional hazard model . overall sbp trajectory show small initial decline baseline vericiguat-treated patient compare placebo ( placebo-corrected difference -1 . 17 [ -1 . 84 , -0 . 50 ] , p = 0 . 0007 ) be relatively stable follow-up . trajectory be similar > 75 year ( vs. young ) as well receive arni or sglt2i ( compare not receive ) or sbp ≤110 mmhg baseline ( compare > 110 mmhg ) . symptomatic hypotension occur 11 . 3 % vericiguat-treated patient compare 9 . 2 % placebo-treated patient adjusted hazard ratio 1 . 24 ( 95 % confidence interval 1 . 06-1 . 46 ) , be similar age , sbp , sglt2i and arni group ( interaction p > 0 . 05 ) . treatment effect vericiguat compare placebo efficacy outcome be similar spectrum baseline sbp ( both interaction p > 0 . 15 ) . conclusion : vericiguat show slight adjust decrease sbp and result more symptomatic hypotension compare placebo but be overall well-tolerate broad population hfref contemporary therapy even predispose hypotension . treatment effect efficacy outcome be consistent regardless baseline sbp .",European journal of heart failure,29/09/2025
10.1007/s00432-025-06336-1,management hepatotoxicity associate cdk4/6 inhibitor and rechallenge,"İlhan N, Baş S, Alkan O, Doğan A, Majidova N, Tunç MA, Erdemoğlu E, Öztosun B, Ökten İN, Gümüş M","background : cyclin-dependent kinase 4/6 ( cdk4/6 ) inhibitor combine endocrine therapy have significantly improve clinical outcome patient hormone receptor-positive , human epidermal growth factor receptor 2-negative ( hr + /her2- ) metastatic breast cancer . hepatotoxicity be know class-related adverse event may interrupt or modify treatment . however , real-world evidence incidence , risk factor , and management strategies-particularly rechallenge approaches-remain limit . study aim to evaluate frequency and clinical characteristic cdk4/6 inhibitor-associated hepatotoxicity , to identify risk factor , and to assess outcome and safety rechallenge follow liver injury . methods : retrospective multicenter study include 544 patient hr+ /her2- metastatic breast cancer be treat ribociclib or palbociclib january 2017 and july 2024 oncology center turkey . abemaciclib be not include reimbursement limitation study period . patient characteristic , comorbiditie , concomitant medication , and herbal or dietary supplement use be record . liver function test and viral hepatitis serology be analyze . hepatotoxicity be grade use common terminology criteria adverse events ( ctcae v5 . 0 ) , and causality be assess roussel uclaf causality assessment method ( rucam ) . management strategies-including dose interruption , dose reduction , switch cdk4/6 inhibitor , and outcome rechallenge be evaluate . result : hepatotoxicity occur 10 . 5 % patient , most commonly hepatocellular pattern . ribociclib be most frequently use agent . young age , herbal supplement use , and hepatitis b carrier status be significantly associate increase risk hepatotoxicity . hepatotoxic event be manage conservatively . none patient develop acute liver failure or require invasive evaluation . dose reduction or switch alternate agent be attempt most patient enzyme normalization and be successful majority , recurrence severe hepatotoxicity . conclusion : cdk4/6 inhibitor-related hepatotoxicity be manageable careful monitoring and individualized strategy . timely dose interruption , switch agent , or cautious rechallenge allow most patient to resume therapy safely . finding support continue use cdk4/6 inhibitor eligible patient , even hepatotoxicity event .",Journal of cancer research and clinical oncology,27/09/2025
10.1038/s41467-025-63864-7,injury-associated lobular microniche be associate classical tumor,"Söderqvist S, Viljamaa A, Geyer N, Keller AL, Ruksha K, Strell C, Hekmati N, Niculae A, Engstrand J, Sparrelid E, Salmén C, Costa TDF, Zhao M, Strömblad S, Zacharouli A, Ghorbani P, Harrizi S, Hamidi Y, Khorosjutina O, Milanova S, Schmierer B, Bozóky B, Fernández Moro C, Gerling M","pancreatic cancer be aggressive disease dense fibrotic stroma and be often accompany chronic inflammation . peritumoral inflammation be typically view reaction nearby tumor growth . here , report inflame pancreatic lobule be frequently invade tumor cell , form distinct , non-fibrotic tumor niche . use semi-supervised machine learn approach annotation clinical sample and multiplex protein profiling , show tumor cell invasion front be closely associate acinar cell undergo damage-induced change , and activate fibroblast express marker injury . invade lobule be link classical tumor phenotype , contrast fibrotic area tumor cell display more basal profile , highlight microenvironment-dependent tumor subtype difference . female mouse , lobular invasion similarly align classical tumor phenotype . together , datum reveal pancreatic tumor colonize injure lobule , create unique niche shape tumor characteristic and contribute to disease biology .",Nature communications,26/09/2025
10.1038/s41467-025-63429-8,age mice alter regionally enrich striatal astrocyte .,"Linker KE, Duran-Laforet V, Ollivier M, Yu X, Schafer DP, Khakh BS","aging affect multiple organ and brain drive distinct molecular change different cell type . striatum encode motor behavior decline age , but understanding cell striatum change remain incomplete . use single-cell rna sequence young and aged mouse identify molecularly distinct astrocyte subtype . show astrocytes change significantly age , exhibit downregulation gene , reduce diversity , and shift more homogenous inflammatory transcriptomic profile . explore striatal astrocyte subtype be locate single-cell resolution , map astrocyte enrich dorsal , medial , and ventral striatum . age increase inflammatory marker transcript dorsal striatal astrocyte , display great age-related change ventral striatal astrocyte . impute molecular interaction astrocyte and neuron and find age particularly reduce interaction relate nrxn2 . datum show age alter regionally enrich striatal astrocyte asymmetrically , dorsal striatal astrocyte exhibit great age-related molecular change .",Nature communications,26/09/2025
10.1002/bcp.70296,prescription use acetaminophen pregnant woman denmark 2000,"Gram EB, Bliddal M, Pflugfelder S, Jensen PB, Damkier P","aim : aim study be to describe prescription use acetaminophen , widely use analgesic and antipyretic generally consider safe pregnancy , pregnant woman 2000 2023 denmark special attention variation follow change ( otc ) availability 2013 . method : population-based drug utilization study , individually link datum nationwide health registry pregnant woman denmark 2000 and 2023 be use to evaluate time trend prescription use acetaminophen and describe distribution maternal characteristic prescription-based drug user and non-user . result : 1 446 841 eligible pregnancy include , 27 1000 pregnant woman redeem least one prescription acetaminophen pregnancy , and , 18 % redeem more one . 2023 , 74 1000 pregnancy be expose prescription use acetaminophen . relative non-user , prescription-based drug user be generally old and have high body mass index . more frequently present pain-related , chronic or psychiatric condition and use other prescription medication study period . however , difference be less pronounce cohort restrict pregnancy end 2015-2023 compare 2000-2012 . conclusion : prescription use acetaminophen pregnant population denmark have increase 2000 , notable sharp increase 2013 onwards , coincide regulatory restriction reduce pack size , concurrent rise general-population prescription use . prescription-base drug user be more likely to have comorbiditie and multiple medication use non-user , difference have become less pronounce recent year .",British journal of clinical pharmacology,27/09/2025
10.1038/s41598-021-82296-z,predict probability gaucher disease subject splenomegaly and,"Motta I, Consonni D, Stroppiano M, Benedetto C, Cassinerio E, Tappino B, Ranalli P, Borin L, Facchini L, Patriarca A, Barcellini W, Lanza F, Filocamo M, Cappellini MD","hematologist be frequently involve diagnostic pathway gaucher disease type 1 ( gd1 ) patient present several hematological sign . however , gd1 be mainly underdiagnose lack awareness . multicenter study , combine use diagnostic algorithm simple test ( β-glucosidase activity dried blood spot ) order to facilitate diagnosis population present hematologist splenomegaly and/or thrombocytopenia associate other hematological sign . high-risk population , prevalence gd1 be 3 . 3 % . propose equation predict probability have gd1 accord three parameter be routinely evaluate : platelet count , ferritin , and transferrin saturation .",Scientific reports,28/01/2021
10.1002/ptr.70100,hesperidin inhibits oxidative stress and apoptosis granulosa cells,"Zhang Q, Yang Z, Ou X, Zhang M, Ji R, Wu G","polycystic ovary syndrome ( pcos ) be most common endocrine-metabolic disorder syndrome woman childbeare age . hesperidin ( hes ) , phytoflavonoid glycoside find citrus fruit such orange and lemon , have variety pharmacological effect . hes have be extensively study to protect variety tissue oxidative damage . however , be not know hes may have therapeutic effect pcos . study , potential therapeutic target hes treatment pcos be identify network pharmacology , altered phosphorylation modification jak2 and pi3 k be verify granular cell pcos patient , and mechanism hes treatment pcos be reveal vivo and vitro experiment . base network-based pharmacological study , pi3k/akt and jak2/stat3 pathway be potential pathway hes treatment pcos , and molecular docking result show jak2 have good binding activity hes . western blotting result show phosphorylation modification jak2 and pi3 k granular cell pcos patient be change . experiment kgn cell line have show hes can reduce dht-induced oxidative stress and apoptotic damage . activate jak2 or inhibit pi3 k can reverse therapeutic effect . vivo experiment have show similar result . hes affect oxidative stress and apoptosis pcos signal crosstalk jak2/stat3 and pi3k/akt pathway .",Phytotherapy research : PTR,27/09/2025
10.1186/s13287-025-04638-2,efficacy and safety single repeat injection mesenchymal stem,"Deng L, Zhao C, Zhou L, Mu X, Sun H, Li L, Zhang Y","background : recent year , mesenchymal stem cell ( mscs ) have be widely apply clinical treatment knee osteoarthritis ( koa ) , demonstrate promise therapeutic efficacy . however , intervention protocol msc have not yet be standardize , and evidence regard impact different injection frequency efficacy and safety msc treatment koa remain limited . objective : study aim to integrate evidence conventional and network meta-analyse to evaluate efficacy and safety different intervention frequency ( single repeat msc injection ) treatment knee osteoarthritis ( koa ) . methods : systematic search be conduct pubmed , embase , cochrane library , and web science database march 1 , 2025 . traditional meta-analysis be perform to assess efficacy and safety msc therapy koa , follow network meta-analysis ( nma ) to evaluate effectiveness single repeat msc injection . outcome measure include womac and vas score 3 , 6 , and 12 month , as well incidence adverse event ( aes ) . traditional meta-analysis and nma be conduct use review manager 5 . 3 and stata se16 . 0 , respectively . result : total 16 rct involve 622 patient be include . traditional meta-analysis show msc therapy significantly improve pain and knee joint function koa patient different time point ( 3 , 6 , and 12 month ) . result network meta-analysis ( nma ) indicate , compare single msc injection , repeat msc injection provide great improvement pain and functional score 6 and 12 month , demonstrate superior efficacy . however , repeat msc injection be also associate high incidence adverse event . conclusion : single and repeat msc injection could improve pain and knee joint function patient koa . compare single injection , repeat msc injection may offer superior therapeutic benefit ; however , be associate high incidence adverse event . clinical practice , potential side effect repeat msc administration must be carefully consider . future research should focus large-scale , multicenter , and long-term randomize control trial to far validate efficacy and safety msc therapy koa .",Stem cell research & therapy,26/09/2025
10.1016/j.tplants.2025.08.020,phytohormone revisit : make compound hormone plant .,Munné-Bosch S,"discovery auxin cell division factor century ago , impressive scientific advance relate phytohormone have revolutionize plant science and human progress . review examine key feature ten hormonal group operate plant , here refer ' classical ten ' : auxin , gibberellin ( gas ) , cytokinin ( cks ) , abscisic acid ( aba ) , ethylene ( eth ) , salicylate ( sas ) , jasmonate ( jas ) , brassinosteroid ( brs ) , peptide hormone ( peps ) , and strigolactone ( sls ) . leverage historical datum and sharpen essential hormonal group , major function be present , discussion make compound phytohormone and can be differentiate hormone-like compound and other signal molecule . hormonal receptor , long-distance transport , and difference hormonal crosstalk , interaction , and complementation be discuss to illustrate basic hormonal action plant .",Trends in plant science,26/09/2025
10.1016/j.ejim.2025.106528,effectiveness tezepelumab severe asthma : multicenter real-world study .,"Poto R, Manganello G, di Salvatore A, Capitelli L, Lagnese G, Messuri C, Muto T, De Michele F, Varricchi G","severe asthma be complex , heterogeneous disease remain major therapeutic challenge . several biologic target type 2 ( t2 ) inflammation , patient remain uncontrolled , highlight need upstream intervention . tezepelumab , monoclonal antibody thymic stromal lymphopoietin ( tslp ) , have show broad efficacy randomized trial regardless eosinophilic status or biomarker level . conduct prospective , multicenter , observational study to assess real-world effectiveness and safety tezepelumab severe asthma . thirty patient be enrol two tertiary center italy september 2023 and december 2024 . inclusion criterion be severe asthma diagnosis ers and gina 2024 guideline and inadequate control maximal inhale therapy . tezepelumab be give 210 mg 4 week . clinical , functional , and biomarker datum be collect baseline , 1 month , and 6 month . six month , patient show significant improvement asthma control test ( act ) score , marked reduction oral glucocorticoid use and exacerbation rate . sinonasal symptom improve time . blood eosinophil and feno decrease significantly , total ige remain unchanged . lung function improve fev(1)/fvc ratio and fef(25-75 ) , suggest benefit airflow limitation and small airway function . serious adverse event occur . improvement be consistent t2-high and t2-low subgroup . real-world study confirm tezepelumab 's clinical effectiveness and safety severe asthma . benefit inflammatory phenotype support tslp blockade broad-spectrum therapeutic approach . large , longer-term study be warrant to confirm result and identify response predictor .",European journal of internal medicine,26/09/2025
10.1016/j.ctrv.2025.103024,impact brain metastasis systemic renal cell carcinoma treatment outcome :,"Charnley N, Fife K, Heng DYC, Larkin J, McGrane J, Négrier S, Vasudev N, Venugopal B, Chisholm A, Ogareva A, Prendergast Á, Albiges L","introduction : brain metastasis ( brm ) be negative prognostic factor renal cell carcinoma ( rcc ) population . patient rcc and brm ( rcc brm + ) may receive systemic therapy and/or brain-targeted ( local ) treatment . perform systematic literature review to identify clinical trial and non-interventional study report datum brm impact systemic treatment outcome patient rcc . method : systematically search medline and embase database january 2024 publication report efficacy/effectiveness and/or safety/tolerability outcome brm status phase 2 and phase 3 clinical trial and non-interventional study systemic rcc therapy . datum be extract publication meeting predefine criterion ( prospero registration , crd42023494896 ) and report accordance prisma guideline . result : sixty-two publication ( 651 screen ) be eligible ( 4 prospective trial ) and include 4 , 637 patient rcc brm + treat systemic therapy . most evaluated systemic therapy be sunitinib , nivolumab , ipilimumab + nivolumab , cabozantinib and sorafenib . tolerability be generally consistent know safety profile rcc trial population . clinical trial , systemic treatment benefit patient rcc brm be equivocal . non-interventional study , survival be generally poor patient rcc brm reference group ( overall/brm- ) . survival and intracranial control benefit patient rcc brm be report multimodal ( systemic plus local ) treatment strategy . be robust comparative datum to guide systemic treatment selection . conclusion : identify need robust datum intracranial and extracranial response systemic therapy patient rcc brm+ , take account prior local therapy exposure .",Cancer treatment reviews,24/09/2025
10.1007/s10528-025-11222-z,"detection vancomycin resistance enterococcus species holding genes vana , vanb ,","Abbas KF, Motaweq ZY","enterococci be hospitalize and resistant numerous antibiotic . present research aim to determine vancomycin sensitivity disc and minimum inhibitory concentrations ( mics ) , also detect relationship vancomycin resistance gene and vancomycin resistance uropathogenic enterococcus specie . totally , 150 urine specimen be obtain patient attend or admit iraq hospital . bacteriological test vietic and ( ddl e . faecalis , ddl e . faecium ) gene be implement identification enterococcus isolate . indicate 27 enterococcus isolate , 18 ( 66 . 7 % ) be e . faecalis , 4 ( 14 . 8 % ) be e . faecium , 5 ( 18 . 5 % ) be other isolate belong rest enterococcus specie . antibiotic resistance disk-diffusion technique penicillin , ampicillin , vancomycin , norfloxacin , erythromycin , ciprofloxacin , rifampin , levofloxacin , chloramphenicol , fosfomycin , doxycycline , minocycline , and nitrofurantoin be 7 ( 25 , 92 % ) , 7 ( 25 , 92 % ) , 6 ( 22 . 22 % ) , 5 ( 18 . 51 % ) , 24 ( 88 . 89 % ) , 5 ( 18 . 51 % ) , 23 ( 85 . 18 % ) , 5 ( 18 . 51 % ) , 4 ( 14 . 81 % ) , 14 ( 51 . 85 % ) , 0 ( 0 % ) , 3 ( 11 . 11 % ) , and 1 ( 3 . 70 % ) , respectively . total isolate be vancomycin resistance enterococci vre use mic technique . positive result vana 23 ( 85 . 18 % ) , vanb 11 ( 40 . 74 % ) , vanc1 3 ( 11 . 11 % ) , vanc2 , and vanc3 3 ( 11 . 11 % ) . result reveal 23 ( 85 . 18 % ) vre isolate possess vancomycin-resistance gene . four isolate do not hold van gene , resistance may be attribute occurrence uncommon gene not identify study ; also efflux pump have role resistance . van gene might be transmit , so important to monitor antibiotic resistance .",Biochemical genetics,27/09/2025
10.1126/sciadv.adx7487,development sars-cov-2 viral vector : novel intranasal bivalent vaccine,"Xu J, Chamblee M, Jiang F, Kc M, Hsu CC, Thongpan I, Chen P, Zhang Y, Chiu CT, Shamseldin MM, Amer HM, Liang X, Amer AO, Boyaka PN, Cormet-Boyaka E, Peeples ME, Li J","negative-sense rna virus have be widely use viral vector vaccine delivery . however , little be know coronaviruse vector deliver vaccine . here , have develop safe sars-cov-2 omicron jn . 1-base live attenuate vaccine candidate combine mutation ( d130a ) viral nsp16 protein , deletion furin cleavage site ( dfcs ) spike protein , deletion accessory protein , and/or modification transcription regulatory sequence ( mtr ) . subsequently , use rjn . 1 , rjn . 1-d130a-dfcs , and rjn . 1-mtrs-d130a-dfcs backbone , generate three recombinant virus express nonfunctional , soluble , and stabilize prefusion f protein human respiratory syncytial virus ( rsvf ) . , rjn . 1-d130a-dfcs-rsvf virus be sufficiently attenuate and highly immunogenic , provide complete protection challenge jn . 1 and rsv hamster . however , rjn . 1-mtrs-d130a-dfcs-rsvf be poorly immunogenic . collectively , demonstrate attenuate sars-cov-2 be effective viral vector deliver rsv vaccine , warrant further development novel intranasal bivalent vaccine sars-cov-2 and rsv .",Science advances,26/09/2025
10.1136/gutjnl-2025-335642,alleviated t cell exhaustion and slc1a3-mediated stroma-remodelling dictate,"Xiang S, Chen Y, Wang C, Wang M, He Y, Liu Z, Zhang JL, Yang LP, Wei YF, Wu QN, Wang ZX, Xi SY, Li Z, Zhao Q, Xu RH, Wang F","background : combine chemotherapy anti-programmed cell death protein-1 ( pd-1 ) improve clinical outcome oesophageal squamous cell carcinoma ( escc ) , yet underlie synergistic mechanism remains obscure . moreover , 30-50 % patient still derive therapeutic benefit combination strategy , highlight need to decipher and overcome resistance . objective : seek to investigate mechanism chemotherapy augment response immune checkpoint blockade and elucidate factor contribute persistent resistance non-responding patient . design : design systematic investigation involve longitudinal sampling escc tissue patient treat chemotherapy plus anti-pd-1 and anti-pd-1 monotherapy . tumour microenvironment ( tme ) be then comprehensively characterise use single-cell transcriptomic , t cell receptor repertoire analysis , multiplex immunohistochemistry and murine model . result : demonstrate combination therapy exert superior antitumour efficacy mitigate immune checkpoint engagement ( tigit-nectin2 and nectin1-cd96 ) epithelial-stress tumour cell and cd8(+ ) t cell , thereby prevent t cell exhaustion and boost vitality . non-responder , identify subset tumour cell high slc1a3 expression , localise tumour boundary and interact col1a1(+ ) myofibroblastic cancer-associated fibroblast , induce extracellular matrix-enriched tme hinder infiltration cd8(+ ) t cell . inhibit slc1a3 significantly enhance efficacy chemotherapy plus anti-pd-1 , underscore potential therapeutic target . conclusion : study elucidate synergistic mechanism and identify key resistance pathway underlie chemo-immunotherapy combination patient escc , provide scientific basis refine future combination therapeutic regimen .",Gut,22/09/2025
10.3390/nu17183002,omega-3 polyunsaturated fatty acids and cognitive decline adults,"Barros MI, Brandão T, Irving SC, Alves P, Gomes F, Correia M","background/objectives : global age accelerate , prevalence mild cognitive impairment ( mci ) continue to rise , challenge healthcare system and diminish old adult ' quality life . be great interest well understand neuroprotective/anti-inflammatory property omega-3 polyunsaturate fatty acid but result many publish study human come different conclusion . review aim to clarify efficacy n-3 fatty acid preventive or therapeutic strategy cognitive health and to inform future clinical recommendation age population . methods : follow prisma guideline and register prospero protocol , review systematic review ( sr ) 2014 2024 assess exclusive n-3 fatty acid supplementation and cognitive outcome mmse . datum be extract intervention detail and cognitive score . meta-analyse use fix and random-effect model , hedges ' estimate overall impact . quality be assess use amstar-2 , and statistical analysis be perform ( spss 28 ) . result : total nine sr incorporate 14 rct be include , represent 26 , 881 participant age 40 year or old . pool random-effect meta-analysis show statistically significant but modest improvement mmse score ( effect size : 0 . 16 ; 95 % ci : 0 . 01-0 . 32 ) . heterogeneity be moderate ( i(2 ) = 42 . 8 % ) , and publication bias be detect . further analysis reveal significant association treatment duration or dosage and cognitive outcome , suggest threshold effect rather dose-response relationship . conclusion : finding support n3-pufa supplementation complementary approach lifestyle-based strategy cognitive health , include diet , physical activity , sleep optimization , and cognitive training . benefit appear modest , consistent effect study warrant further high-quality research and well-designed study to strengthen clinical recommendation .",Nutrients,19/09/2025
10.1212/WNL.0000000000214177,screen congenital myasthenic syndromes adults seronegative,"Krenn M, Wagner M, Schuller H, Pugna I, Rath J, Zulehner G, Keritam O, Weng R, Koneczny I, Schiavo E, Damato V, Kleinveld VEA, Kiss C, Gold V, Quasthoff S, Masi G, O'Connor KC, Canning J, Waters PJ, Lenz D, Blüthner M, Pavlov M, Graf E, Winkelmann J, Löscher WN, Zimprich F, Cetin H","background and objective : myasthenia gravis ( mg ) be disorder neuromuscular junction , typically associate autoantibody ( abs ) impair neuromuscular transmission . however , approximately 10 % case be seronegative . emerge evidence suggest seronegative mg ( snmg ) may be mimic hereditary condition , particularly congenital myasthenic syndrome ( cmss ) , require different treatment . study , aim to determine proportion cms patient diagnose snmg . method : use whole-exome sequence ( wes ) adult patient ( aged ≥18 year ) diagnose snmg be enrol 3 austrian tertiary neuromuscular center august 2022 and january 2024 . genetic testing be conduct individual remain seronegative comprehensive serologic testing to exclude abs ( cluster ) acetylcholine receptor , muscle-specific kinase , lipoprotein receptor-relate protein 4 , and voltage-gated calcium channel . moreover , aim to analyze clinical and demographic factor associate likelihood receive molecular diagnosis . result : total 50 patient snmg ( 35 [ 70 % ] female ) be refer exome-based genetic screening . median age disease onset be 35 year ( interquartile range 24 . 0-46 . 0 year ) . seven patient ( 14 % ) be genetically diagnose cms wes ( 4 chrne and 3 rapsn variant ) . addition , finding uncertain clinical significance be report 4 case , implicate cacna1s , dok7 , dpagt1 , and rapsn . patient cms tend to have young age disease onset univariate analysis ( p = 0 . 04 , r = 0 . 29 ) , clinical or demographic factor remained significantly associate molecular diagnosis correction multiple testing . only 1 patient confirm cms diagnosis report positive family history . six individual cms ( 86 % ) have either receive immunomodulatory treatment ( n = 4 ) or undergone thymectomy ( n = 4 ) . 4 patient cms receiving immunotherapy , 3 be report to have experience least partial response . discussion : finding provide evidence considerable proportion patient diagnose snmg have underlie hereditary etiology . notably , ( subjective ) response immunotherapy do not exclude molecular cms diagnosis . conclusion , offer genetic testing to seronegative patient myasthenic syndrome may have profound therapeutic implication .",Neurology,21/10/2025
10.1016/j.lanmic.2025.101181,"global gonococcal antimicrobial surveillance programme , 2019-22 :","Unemo M, Lahra MM, Cole MJ, Marcano Zamora D, Jacobsson S, Galarza P, Martin I, Kreisel KM, Galas M, Bertagnolio S, Ramon-Pardo P, Maatouk I, Wi T","background : gonorrhoea and gonococcal antimicrobial resistance ( amr ) remain global public health concern , and enhance quality-assured global surveillance gonococcal amr be imperative to inform management guideline and public health policy . aim to describe result surveillance gonococcal amr conduct globally who and discuss action need to retain ability to treat gonorrhoea . method : retrospective observational study , present gonococcal amr datum report who 77 country jan 1 , 2019 , and dec 31 , 2022 . gonococcal isolate be test minimum inhibitory concentration one to four key antimicrobial ( ceftriaxone , cefixime , azithromycin , and ciprofloxacin ) country . use breakpoint resistance and decrease susceptibility antimicrobial european committee antimicrobial susceptibility testing or clinical laboratory and standards institute . finding : 29 ( 39 % ) 75 participate country report least one isolate resistance or decrease susceptibility ceftriaxone , 28 ( 50 % ) 56 report resistance or decrease susceptibility cefixime , 58 ( 88 % ) 66 report resistance azithromycin , and 74 ( 99 % ) 75 report resistance ciprofloxacin . globally , azithromycin resistance be increase , be resistance or decrease susceptibility ceftriaxone and cefixime , especially who western pacific region . resistance ciprofloxacin remain very high globally . 2017-18 , number report country , examine isolate , and resistant isolate have increase . however , surveillance level remain inadequate central america and caribbean , eastern europe , and who african , eastern mediterranean , and south-east asia region . interpretation : global amr surveillance conduct be expand and , select country , improve standardisation and quality assurance , as well implementation extragenital sampling , test cure , and whole-genome sequence . approach provide evidence-based datum management guideline and public health policy . improvement prevention , early diagnosis , treatment patient and contact , surveillance ( infection rate , amr , treatment failure , and antimicrobial use ) , and antimicrobial stewardship be essential . support work several global action plan amr , new global gonorrhoea treatment recommendation , surveillance , and research . funding : none .",The Lancet. Microbe,24/09/2025
10.1016/j.ijbiomac.2025.147928,autophagic damage senescent bone marrow mesenchymal stromal cell : impact,"Huang C, Chen X, Wu D, Chen J, Wang J, Li S, Hu J, Yan Z, Zhu Y, Zhang Y","osteoporosis be major health challenge , particularly postmenopausal woman . bone marrow mesenchymal stromal cell ( bmsc ) be crucial maintain bone homeostasis differentiate osteoblast and adipocyte . however , osteoporotic microenvironment , aging and estrogen deficiency lead oxidative stress , impair bmsc function and promote senescence . piezo1 , mechanosensitive calcium-permeable ion channel highly express bmsc , translate mechanical cue pro-osteogenic signal . study aim to investigate interplay autophagy , piezo1 expression , and bmsc senescence osteoporosis , and explore therapeutic potential modulate autophagy-piezo1 axis . observe piezo1 expression be downregulate bone tissue patient osteoporosis and ovariectomize ( ovx ) mouse , accompany increase senescence-associated marker bmsc . oxidative stress reduce piezo1 expression and promote bmsc senescence , shift differentiation adipogenic rather osteogenic lineage . autophagic flux be impair senescent bmsc , and activate autophagy rapamycin restore piezo1 expression , alleviated senescence , and rebalance osteogenic/adipogenic differentiation . mechanistically , inhibit mtor/s6 k pathway enhance autophagy and piezo1 expression . rapamycin treatment increase bone mass and improved bone microarchitecture ovx mouse promote piezo1 expression and suppress senescence marker . finding highlight critical role autophagy maintain piezo1 expression and bmsc function , suggest target autophagy-piezo1 axis may offer novel therapeutic strategy osteoporosis management .",International journal of biological macromolecules,25/09/2025
10.1186/s13287-025-04617-7,hpdlsc-apoevs attenuate periodontitis and enhance bone regeneration,"Zhang Z, Zeng L, Yu Y, Xu Z, Zhu G, Weng J, Xia J, Peng W, Dong Q, Li Y, Zhang L, Liang L, Pathak JL, Yu L","background : periodontitis be most prevalent oral disease worldwide , lead inflammation , alveolar bone loss , and tooth loss . mesenchymal stem cell ( mscs ) transplantation have potential to alleviate periodontitis and restore alveolar bone , but numerous study have find transplant mscs undergo apoptosis , release apoptotic extracellular vesicle ( apoevs ) . human periodontal ligament stem cell ( hpdlscs ) apoevs have immunomodulatory and tissue regenerative potential . still , role periodontitis treatment and alveolar bone restoration have not be investigate yet . methods : study isolate hpdlscs-apoevs and investigate modulatory effect macrophaghe . explore specific molecular mechanism hpdlsc-apoevs regulate macrophage polarization vitro mrna-seq and inhibitor . co-culture experiment demonstrate hpdlsc-apoevs promote hpdlsc osteogenic differentiation regulate macrophage polarization . finally , verify hpdlsc-apoevs inhibit periodontitis-induced periodontal tissue defect and promote periodontal bone tissue regeneration vivo . result : study find hpdlscs-apoevs regulate m0 anti-inflammatory m2 macrophage polarization , indicate upregulation cd163 , il-10 , and arg1 . hpdlscs-apoevs activate",Stem cell research & therapy,26/09/2025
10.1186/s13287-025-04642-6,traditional herbal decoction regulate skeletal muscle satellite cell,"Jin Z, Da W, Shen Y, Zhao Y, Xu H, Wan H, Wu X, Gao X, Li Y, Shi Q, Tang D","introduction : osteosarcopenic fracture , emerge geriatric syndrome characterize sarcopenia-osteoporotic fracture coexistence , delay fracture healing , and elevated risk re-fracture . limited research have investigate mechanism skeletal muscle satellite cell ( smsc ) promote muscle regeneration and osteoporotic fracture healing . aim study be to investigate impact traditional herbal decoction ( hd ) , invigorate spleen and tonify kidney formula , smsc regulation , muscle regeneration , and fracture healing . method : use conditional knockout mouse , role smsc promote fracture healing and mitigate sarcopenia be evaluate visualize fracture area and surround muscle tissue . signal pathway involve be comprehensively analyze use combination western blotting , real-time pcr analysis , immunohistochemical staining , and immunofluorescent stain . and key element and compound facilitate osteogenesis and myogenesis be identify use hplc and network pharmacology analysis . result : study demonstrate herbal decoction mediate β-catenin signal pathway , mobilize smsc to migrate fracture area , facilitate osteogenic and myogenic differentiation , and enhance osteoporotic fracture healing . knockdown β-catenin smsc pax7-cre(ert2/+) ; β-catenin(fx/fx ) conditional knockout mouse lead sarcopenia and osteoporosis . additionally , herbal decoction significantly increase bone mass , repair bone microstructure , and promote muscle fiber remodel fracture mouse . conclusion : finding provide first evidence hd , β-catenin agonist , not only promote fracture healing modulate osteogenic and myogenic effect smsc but also ameliorate sarcopenia . study offer practical evidence support formula promising therapeutic candidate treat osteosarcopenic fracture .",Stem cell research & therapy,26/09/2025
10.1038/s41418-025-01587-4,aars1-mediate lactylation h3k18 and stat1 promote ferroptosis diabetic,"Hong J, Xu H, Yu L, Yu Z, Chen X, Meng Z, Zhu J, Li J, Zhu M","diabetic nephropathy ( dn ) be primary cause end-stage renal disease worldwide . recent study have reveal lactate-mediated histone lactylation , function novel epigenetic modification , be involve occurrence and development diabetes-related complication . however , little be know role lactyltransferase dn . alanyl-trna synthetase 1 ( aars1 ) be identify novel lactyltransferase modulate histone h3-lysine-18 lactylation ( h3k18la ) . present study , determine aars1-mediate h3k18la participate pathogenesis dn . more importantly , explore potential mechanism involve . mouse dn model consist wild-type and alanyl-trna synthetase ( aars1 ) heterozygote ( aars1(+/- ) ) mouse be utilize study . transcriptomic and lipidomic analysis , combine variety molecular biological methodology , be employ to elucidate potential mechanism aars1 regulate ferroptosis dn . result indicate increase aars1 and h3k18la expression be involve kidney dysfunction and renal cell death modulation ferroptosis dn model . moreover , aars1 induce lipid peroxidation increase fatty acid elongase-5 ( elovl5 ) transcription , ultimately contribute to ferroptosis induction . furthermore , aars1 interact signal transducer and activator transcription 1 ( stat1 ) to jointly regulate elovl5 transcription . additionally , treatment stat1-specific inhibitor fludarabine delay dn progression . addition , observe aars1 modulate lactylation stat1 and h3k18 to regulate elovl5 transcription , thus trigger ferroptosis . inhibition aars1-induced lactylation β-alanine attenuate ferroptosis dn model mouse and hyperglycaemic cell . present study show aars1 induce lactylation h3k18 and stat1 to regulate elovl5 transcription , thus trigger ferroptosis diabetic nephropathy model .",Cell death and differentiation,23/09/2025
10.1016/j.biomaterials.2025.123741,inflammation-targeted nanoplatform : nir-ii imaging-guided encephalitis,"Wang Q, Wang D, Liu P, Tang BZ, Li Y, Yin X","encephalitis , life-threatening neurological disorder high mortality and debilitate long-term sequelae , remain formidable clinical challenge limited therapeutic strategy target underlie pathological mechanism . current intervention , constrain blood-brain barrier ( bbb ) impermeability and focus symptomatic relief , fail to mitigate ferroptosis and reactive oxygen specie ( ros)-mediate neurotoxicity-central driver disease progression . here , present ceo(2)/3tt@np-rvg , multifunctional nanomaterial engineer integrated diagnosis and treatment encephalitis . nanoplatform combine ros-scavenge cerium oxide ( ceo(2 ) ) photothermal",Biomaterials,24/09/2025
10.1001/jamaneurol.2025.3538,menopause impact multiple sclerosis disability progression .,"Bridge F, Sanfilippo PG, Zhu C, Skibina O, Nguyen AL, Kalincik T, Buzzard K, Taylor BV, MacIntyre J, Hall LA, Slee M, Macdonell R, Maltby V, Lechner-Scott J, McCombe P, Butzkueven H, van der Walt A, Jokubaitis VG","importance : most woman multiple sclerosis ( ms ) will experience menopause live ms . , impact menopause ms disease trajectory remain unclear . objective : to assess menopause modify risk disability progression woman relapse-onset ms . design , setting , and participant : retrospective cohort study use prospective clinical datum be collect msbase registry . datum be extract msbase july 1 , 2023 . datum be analyze january 2023 february 2025 . female participant be recruit 8 australian neuroimmunology specialist center ( 1 private practice and 7 tertiary referral center ) 2018 2021 . participant include 1468 woman age 18 year or old complete dedicated retrospective woman 's health survey . , 987 woman relapse-onset ms , 3 or more expanded disability status scale ( edss ) measurement record , and report menopausal status be include primary analysis . secondary analysis include 209 woman 1 or more edss measurement record msbase database predate and postdate menopause onset . exposure : crude and adjust cox proportional hazard model be use to assess impact menopause , model time-varying covariate , progressive disability milestone . analysis be adjust age ms onset , baseline disease duration , baseline edss score , baseline relapse , and exposure high-efficacy disease-modifye therapy model time-varying covariate . main outcome measures : primary analysis , main outcome be time to 6-month confirm disability progression ( cdp ) . secondary outcome be time secondary progressive ms ( spms ) . secondary inflection point analysis examine longitudinal change edss woman be follow menopausal transition . result : primary analysis include 583 premenopausal and 404 postmenopausal woman ms . median age menopause be 48 . 5 year . follow multivariable adjustment , menopause be not associate increase risk cdp or spms ( hazard ratio , 0 . 95 ; 95 % ci , 0 . 70-1 . 29 ; p = .70 and hazard ratio , 1 . 00 ; 95 % ci , 0 . 60-1 . 67 ; p = 1 . 00 ) , respectively . secondary analysis , menopause do not represent inflection point edss worsen follow multivariable adjustment . conclusion and relevance : reproductive aging may be additive effect somatic aging , result do not support menopause lead factor disability progression old woman ms .",JAMA neurology,29/09/2025
10.1016/j.neurot.2025.e00756,metabolomic and lipidomic study serum metabolite signature alzheimer 's,"Mai Y, Huang F, Mi H, Cao Z, Li Y, Zhou K, Liu J, Xie G, Liao W","alzheimer 's disease ( ad ) and mild cognitive impairment ( mci ) be major cause dementia elderly , metabolic alteration not fully understand . study , quantitatively profile serum metabolite participant 2 independent cohort . base datum cohort 1 ( 22 ad patient , 19 mci patient and 19 cognitively normal participant ( cn ) ) , identify 32 differential metabolite ad and 49 mci serum . notably , differential metabolite relate amino acid ( aa ) , organic acid , fatty acid ( fa ) , phosphatidylcholine ( pc ) , sphingomyelin ( sm ) metabolism ad and free fatty acid ( ffa ) , acylcarnitine , pc , sm mci be strongly associate cognitive level , memory , attention and execution function evaluate cognitive scale . pathway analysis base differential metabolite reveal perturbation pathway relate phospholipid metabolism , sphingolipid metabolism , aa metabolism , beta oxidation fas , and carnitine metabolism . use random forest ( rf ) , support vector machine ( svm ) and boruta analysis classification and validate gradient boosting ( gb ) , logistic regression ( lr ) and rf diagnostic model , identify panel 10 metabolite ad and 13 metabolite mci effectively discriminate ad and mci individual cn high accuracy , sensitivity and specificity . diagnostic accuracy model be far validate independent cohort 2 , consist 20 ad , 20 mci and 20 cn individual , consistent result .",Neurotherapeutics : the journal of the American Society for Experimental,25/09/2025
10.1002/alz.70752,evidence-base standardized sample handling protocol accurate blood-base,"Verberk IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, Bongers B, Houtkamp IM, van der Flier WM, Janelidze S, Hansson O, Bastard NL, Vandijck M, Hunter J, Honigberg L, Kirmess KM, Verghese PB, Blennow K, Zetterberg H, Meyers EA, Edelmayer RM, Teunissen C","introduction : blood-base biomarker ( bbms ) have revolutionize alzheimer 's disease diagnosis and monitoring . pre-analytical stability require scrutiny . study assess pre-analytical effect to inform standardized sample handle protocol . methods : assess pre-analytical variation include collection tube type , hemolysis , centrifugation setting , centrifugation/storage delay , tube transfer , and freeze-thawe ( n = 15/experiment ) . phosphorylate tau ( ptau ) isoform be measure simoa , lumipulse , mesoscale discovery , and immunoprecipitation-mass spectrometry . amyloid-beta ( aβ42 , aβ40 ) , glial fibrillary acidic protein ( gfap ) , and neurofilament light ( nfl ) protein be measure simoa . result : assess bbm level vary 10 % collection tube type . aβ peptide be most sensitive , and level decline > more 10 % storage and centrifugation delay , more steeply room temperature ( rt ) compare 2°c 8°c . nfl and gfap level increase more 10 % rt/-20°c storage . ptau isoform demonstrate stability most pre-analytical variation . discussion : establish evidence-based handling protocol to ensure reliable sample handling neurological bbm adoption clinic , trial , and research . highlight : sample handling protocol can mitigate pre-analytical effect bbm result . develop evidence-based , expert-consensus plasma sample handle protocol . primary collection tube and delay centrifuge or freeze impact ad bbm . plasma ptau217 be highly resistant pre-analytical sample handling variation . plasma aβ42 and aβ40 be most sensitive pre-analytical variation .",Alzheimer's & dementia : the journal of the Alzheimer's Association,01/10/2025
10.1038/s41589-025-02031-x,idr-induce car condensation improve cytotoxicity car-ts,"Zhang X, Xiao Q, Zeng L, Hashmi F, Sato K, Hartwich TMP, Mansolf M, Yang-Hartwich Y, Su X","chimeric antigen receptor ( car)-t cell therapy have show remarkable efficacy treat otherwise intractable cancer . however , current clinically approve",Nature chemical biology,29/09/2025
10.1016/j.xcrm.2025.102376,multiplex base editing bcl11a regulatory element to treat sickle cell,"Fontana L, Martinucci P, Amistadi S, Felix T, Mombled M, Tachtsidi A, Corre G, Chalumeau A, Hardouin G, Martin J, Romano O, Amendola M, Antoniou P, Miccio A","sickle cell disease ( scd ) be genetic anemia cause production abnormal adult hemoglobin . elevated level fetal hemoglobin ( hbf ) adulthood reduce disease severity . promising therapy involve treatment hematopoietic stem/progenitor cell ( hspc ) crispr-cas9 to downregulate hbf repressor bcl11a generation double-strand break ( dsb ) +58-kb enhancer . to improve safety and hbf induction , use base editor to target +58-kb and +55-kb enhancer generate dsb . dissect key dna motif recognize transcriptional activator and identify critical nucleotide . multiplex base edit efficiently disrupt site , reactivate hbf level exceed achieve crispr-cas9-induce editing , minimize dsb and genomic rearrangement . base editing be effective long-term repopulate hspc and result robust hbf reactivation vivo . finding demonstrate multiplex base editing bcl11a enhancer be safe , efficient , and durable strategy to treat scd .",Cell reports. Medicine,26/09/2025
10.1016/j.ebiom.2025.105931,artificial intelligence track social behaviour and support autism,"Sun C, McEwan A, Boulton KA, Demetriou EA, Sadozai AK, Lampit A, Guastella AJ","background : artificial intelligence ( ai ) hold promise develop tool can track social behaviour and support clinical assessment and outcome autism spectrum disorders ( asd ) . review evaluate exist ai algorithm extract facial information social interaction assessment and contribute diagnostic accuracy asd assessment and response therapy . methods : systematic review study human participant asd diagnosis , source medline , embase , scopus , web science , ieee xplore , and acm digital library , evaluate diagnostic accuracy ai algorithm asd classification and use track social development facial information clinical application social interaction . bivariate and multi-level model address dependency , heterogeneity , moderator ( modality , algorithm , task ) , and apply robust variance estimation . publication bias be evaluate funnel plot . quadas-2 tool assess risk bias and applicability . study be register prospero ( crd42021249905 ) . finding : 40 , 570 study identify , 38 meet review criterion , and seven provide sufficient datum meta-analysis . pooled diagnostic odd ratio 15 . 917 ( 95 % ci [ 4 . 775-53 . 059 ] ) , and bivariate analysis estimate area receiver operate characteristic curve 0 . 862 . accuracy improve facial feature , unstructured play , support vector machine , and decision tree-based algorithm . ai method can analyse social behaviour , include eye gaze social stimulus , emotional expression , and joint attention asd assessment .",EBioMedicine,26/09/2025
10.3748/wjg.v31.i37.111435,efficacy and safety anti-obesity drug metabolic dysfunction-associate,"Concepción-Zavaleta MJ, Fuentes-Mendoza JM, Gonzáles-Yovera JG, Ruvalcaba-Barbosa GY, Cura-Rodríguez LD, González-Rodríguez JS, Concepción-Urteaga LA, Pérez-Reyes AI, Quiroz-Aldave JE, Paz-Ibarra J","obesity be major driver metabolic dysfunction-associated steatotic liver disease ( masld ) and progressive form , metabolic dysfunction-associated steatohepatitis ( mash ) . global prevalence obesity continue to rise , burden masld/mash be increase , pose significant challenge healthcare system . use anti-obesity medication ( aom ) population be complex alter hepatic metabolism , safety concern , and potential hepatotoxicity . recent advance pharmacologic agent , such glucagon-like peptide-1 ( glp-1 ) receptor agonist ( glp-1 ras ) , dual glp-1/glucose-gastric inhibitory polypeptide ( gip ) agonist , and triple glp-1/gip/glucagon agonist , have show promise metabolic effect general population . ,",World journal of gastroenterology,7/10/2025
10.1038/s41467-025-63619-4,development adeno-associated virus vector gene replacement therapy,"Bai RY, Shi J, Liu J, Sun N, Lu Y, Chen X, Xu M, Lim H, Li Y, Xu H, Weisgerber K, Ren Z, Pratilas CA, Blakeley JO, Fishel ML, Carrió M, Serra E, Staedtke V","neurofibromatosis type 1 ( nf1 ) be tumor predisposition syndrome cause alteration nf1 gene lead tumor growth nervous system , can cause morbidity and mortality , and transform malignancy . nf1 gene replacement therapy , promising , be hinder nf1 gene 's large size and delivery challenge . introduce membrane-targeted , truncate neurofibromin comprise gap-relate domain ( grd ) fuse kras4b c-terminal domain , effectively inhibit ras signal pathway and restore schwann cell differentiation nf1 ipsc-derived model . systemic application , engineer adeno-associated virus ( aav ) vector use vivo capsid evolution sequential dna shuffling and peptide library screening nf1 xenograft mouse model . tailored vector , aav-nf , exhibit greatly reduce liver uptake , enhance tumor target various nf1-relate mpnst , neurofibromas and glioma model , and therapeutic efficacy xenograft mpnst . study not only advance viable aav vector nf1 treatment but also outline replicable strategy vector and payload development other monogenic and tumor-associated disease manifestation .",Nature communications,29/09/2025
10.1038/s41467-025-63505-z,dna2 and msh2 cooperatively repair stabilize g4 and allow efficient telomere,"Fernandez A, Zhou T, Lei Y, Liu N, Esworthy S, Shen C, Liu H, Hess JD, Yuan H, Shi G, Zhou M, Shen L, Zhang S, Kosiyatrakul S, Gaur V, Sommers JA, Srivastava N, Edelmann W, Li GM, Brosh RM Jr, Chai W, Lee MYWT, Zhang D, Schildkraut C, Zheng L, Shen B","g-quadruplexe ( g4s ) be widely exist stable dna secondary structure mammalian cell . long-standing hypothesis be timely resolution g4s be need efficient and faithful dna replication . vitro , g4s may be unwound helicase or alternatively resolve dna2 nuclease mediate g4 cleavage . however , little be know biological significance and regulatory mechanism dna2-mediate g4 removal pathway . here , report dna2 deficiency or chemical inhibition lead significant accumulation g4s and stall replication fork telomere , be demonstrate high-resolution technology : single molecular analysis replicate dna ( smard ) . far identify dna repair complex mutsα ( msh2-msh6 ) bind g4s and stimulate g4 resolution dna2-mediate g4 excision . msh2 deficiency , dna2 deficiency or inhibition , cause g4 accumulation and defective telomere replication . meanwhile , g4-stabilize environmental compound block g4 unwind helicase but not g4 cleavage dna2 . consequently , g4 stabilizer impair telomere replication and cause telomere instability , especially cell deficient dna2 or msh2 .",Nature communications,26/09/2025
10.1016/j.reprotox.2025.109073,explore potential mechanism artificial sweetener polycystic ovary,"He H, Lyu Y, Fu M, Jiang X, Liu J, Xiao M","polycystic ovary syndrome ( pcos ) be complex endocrine and metabolic disorder increasingly prevalent woman reproductive age . artificial sweetener , commonly use sugar substitute , be now scrutiny potential disruption metabolic and hormonal equilibrium . investigation delve molecular mechanism seven artificial sweetener ( aspartame , saccharin , sucralose , acesulfame-k , sodium cyclamate , neotame , and alitame ) may impact development pcos . employ network toxicology and molecular docking methodology , identify 85 common target share gene associate sweetener and link pcos . enrichment analyse use gene ontology ( go ) and kyoto encyclopedia genes and genomes ( kegg ) pathway unveil connection inflammation , insulin resistance , and steroid biosynthesis , particularly implicate pathway such tnf signal , age-rage signaling , and ampk pathway . notably , key target tnf , stat3 , and ifng display high bind affinity artificial sweetener molecular docking simulation . result suggest potential role artificial sweetener exacerbate pcos progression inflammatory and metabolic pathway , underscore need further experimental validation .","Reproductive toxicology (Elmsford, N.Y.)",25/09/2025
10.1186/s13024-025-00889-y,novel alpha-synuclein g14r missense variant be associate atypical,"Brücke C, Al-Azzani M, Ramalingam N, Ramón M, Sousa RL, Buratti F, Zech M, Sicking K, Amaral L, Gelpi E, Chandran A, Agarwal A, Chaves SR, Fernández CO, Dettmer U, Lautenschläger J, Zweckstetter M, Busnadiego RF, Zimprich A, Outeiro TF","background : parkinson 's disease ( pd ) affect million people worldwide , but only 5-10 % patient suffer monogenic form disease mendelian inheritance . snca , gene encode protein alpha-synuclein ( asyn ) , be first to be associate familial form pd and , then , several missense variant and multiplication gene have be establish rare cause autosomal dominant form pd . study , report identification novel snca mutation patient present complex neurogenerative disorder , and unconventional neuropathological finding . also perform depth molecular study effect novel asyn mutation . methods : patient carry novel asyn missense mutation and family member be study . present clinical feature , genetic testing-whole exome sequence ( wes ) , and neuropathological finding . functional consequence asyn variant be extensively investigate use biochemical , biophysical , and cellular assay . result : patient exhibit complex neurodegenerative disease include generalized myocloni , bradykinesia , dystonia left arm and apraxia . wes identify novel heterozygous snca variant ( cdna 40 g > a ; protein g14r ) . neuropathological examination show extensive atypical asyn pathology frontotemporal lobar degeneration ( ftld)-type distribution and nigral degeneration pattern abundant ring-like neuronal inclusion , and few oligodendroglial inclusion . sanger sequence confirm snca variant one healthy , 86-year-old parent patient suggest incomplete penetrance . nmr study suggest g14r mutation induce local structural alteration asyn , and low thioflavin t bind vitro fibrillization assay . interestingly , g14r asyn fiber display different fibrillar morphology lewy body reveal cryo-electron microscopy . cellular study g14r variant reveal increase inclusion formation , enhance membrane association , and impair dynamic reversibility serine-129 phosphorylation . conclusion : atypical neuropathological feature observe , be reminiscent observe g51d asyn variant , suggest causal role snca variant distinct clinical and pathological phenotype , be far support property mutant asyn .",Molecular neurodegeneration,26/09/2025
10.1007/s00204-025-04206-w,"cgas-sting and autophagy : crosstalk , molecular mechanism , and target therapy .","Wang Y, Wu S, Zhang X, Zheng W, Wang Z, Zhang J, Chen J, Wang H","cytosolic dna-sensing cgas-sting pathway and autophagy represent two evolutionarily conserve system critical innate immunity and cellular homeostasis . cgas-sting pathway detect mislocalize dna , trigger inflammation interferon and cytokine production . conversely , autophagy maintain equilibrium degrade damage organelle and pathogen . crucially , system engage reciprocal regulation : autophagy constrain cgas-ste hyperactivity lysosomal degradation immunostimulatory dna and sting , cgas-sting signal induce autophagy tbk1-mediate phosphorylation autophagy adaptor to mitigate self-damage . dysregulation interplay drive pathology . instance , defective autophagy systemic lupus erythematosus permit mitochondrial dna accumulation and cgas-driven interferonopathy , persistent sting activation cancer suppresse autophagic tumor surveillance . review aim to dissect molecular mechanism underpin crosstalk , delineate disruption autoimmune , neurodegenerative , and oncological disease , and critically evaluate emerge therapy design to pharmacologically rebalance axis . include combine cgas-ste inhibitor autophagy enhancer to suppress inflammation interferonopathie , and pair sting agonist autophagy inducer to potentiate antitumor immunity . synthesize preclinical and clinical advance , establish framework develop context-specific therapeutic exploit cgas-sting-autophagy circuit-translate mechanistic insight precision treatment immune dysregulation disorder .",Archives of toxicology,27/09/2025
10.1002/advs.202511856,immunoregulatory roles tumor-originated pericytes identify single-cell,"Chu C, Li F, Zhang Z, Zhu Q, Yan H, Cheng M, Wang H, Cheng L, Zhang Z, Yu X, Man J, Wang W, Li D, Bian XW, Wu HB, Zhang A, Zhou W","pericyte critical vascular support cell not only keep integrity blood-brain barrier but also play profound role brain tumor . yet origin and functional heterogeneity pericyte most common malignant brain tumor glioblastoma ( gbm ) remain unclear . here , single-cell rna-sequencing ( scrna-seq ) be perform cd146(+ ) pericyte human primary gbm . tumor- and normal-originated pericyte ( t-pcs and n-pcs ) have distinctive cell-intrinsic feature and intercellular communication endothelial and immune cell be identify . bioinformatic analysis integrated in-house and public scrna-seq datum have find t-pc metacluster mark cd44 closely associate tumor-associated macrophage ( tams ) . cd44(high ) pericyte be detect human gbm sample and glioma-stem-cell ( gsc)-derived pericyte . coimplantation gsc-derive cd44(high ) pericyte promote m2 polarization tam and growth orthotopic gbm . summary , study unravel existence t-pcs and n-pcs gbm , analyze functional heterogeneity , and unravel immunoregulatory role cd44(high ) pericyte . discovery help to gain insight brain tumor vasculature and inspire therapeutic strategy target vessel and tam gbm treatment .","Advanced science (Weinheim, Baden-Wurttemberg, Germany)",26/09/2025
10.1016/j.xcrm.2025.102371,vorapaxar enhance mitochondria-associated ferroptosis prime cancer,"Zhou Q, Sun Y, Du S, Dian Y, Yao L, Su H, Guo Z, Meng Y, Xiong Y, Deng Z, Kuang X, Liang X, Liu H, Deng G, Chen X, Zeng F","immunotherapy have revolutionize cancer treatment , yet challenge persist , such resistance and lethal thromboembolism , necessitate dual-purpose strategy . target ferroptosis emerge promising strategy to enhance immunotherapy efficacy , prompt investigation antiplatelet agent simultaneously promote ferroptosis and mitigate thromboembolic risk . systematic screening 20 food and drug administration ( fda)-approve antiplatelet agent , identify vorapaxar potent pro-ferroptotic drug . mechanistically , vorapaxar bind forkhead box o1 ( foxo1 ) , inhibit phosphorylation ser256 , and facilitate nuclear translocation upregulate heme oxygenase 1 ( hmox1 ) , promote mitochondrial iron overload and mitochondria-associated ferroptosis . vorapaxar enhance immunotherapy-induced tumor ferroptosis and antitumor immunity diverse melanoma model , include tumor-bearing mouse , braf/pten-driven spontaneous melanoma mouse , and peripheral blood mononuclear cell ( pbmc)-humanize mouse . clinically , high foxo1/hmox1 co-expression correlate improved immunotherapy response and progression-free survival . finding position vorapaxar promising adjunct immunotherapy , offer dual benefit cancer patient require both antithrombotic therapy and immunotherapy .",Cell reports. Medicine,25/09/2025
10.1038/s44161-025-00719-w,association air pollution exposure and genetic susceptibility increase,"Ma Y, Wang J, Tang L, Cui F, Zheng L, Xing M, Tian Y","thoracic aortic aneurysm and dissection ( taad ) represent serious health threat , yet role air pollution exposure development have be underexplored . here investigate relationship air pollutant and taad incidence . cox 's proportional hazard model , hazard ratio ( 95 % confidence interval ) taad interquartile range increase air pollutant be 2 . 15 ( 1 . 96 , 2 . 35 ) particulate matter aerodynamic diameter ≤2 . 5 μm ( pm(2 . 5 ) ; 2 . 15 μg m(-3 ) increase ) , 1 . 76 ( 1 . 61 , 1 . 92 ) pm(10 ) ( 2 . 99 μg m(-3 ) increase ) , 1 . 45 ( 1 . 34 , 1 . 58 ) no(2 ) ( 6 . 97 μg m(-3 ) increase ) and 1 . 40 ( 1 . 29 , 1 . 51 ) no(x ) ( 11 . 58 μg m(-3 ) increase ) . estimate remain consistent use inverse probability weighting and generalize propensity score method . furthermore , study reveal potential joint effect and interaction air pollutant and genetic susceptibility taad risk , especially multiplicative and additive interaction pm(2 . 5 ) and genetic susceptibility . air pollution exposure be associate increase taad risk and genetic susceptibility modify association .",Nature cardiovascular research,26/09/2025
10.1186/s13098-025-01949-5,mediation fast blood glucose relative muscle strength and,"Wang P, Huang L, Zhu Z, Hu X, Wu B, Yang X","background : hypertension and type 2 diabete be major global health burden and often coexist share metabolic risk factor . relative muscle strength ( rms ) , composite measure muscle function , show inverse association hypertension . mechanism underlie link remain unclear . elevated fast blood glucose ( fbg ) reflect impair glucose metabolism and insulin resistance and be associate both reduce muscle strength and high blood pressure . suggest fbg may partly mediate rms-hypertension relationship . yet , large-scale population study have rarely test mediating pathway , leave important knowledge gap . methods : analyze datum two nationally representative cohort : nhanes ( 2011-2014 ; adult aged ≥ 18 year , mean age 48 year ) and charls ( 2011-2012 ; adult age ≥ 45 year , mean age 58 year ) . hypertension prevalence be nearly 30 . 0 % nhanes and 42 . 1 % charls . rms be calculate grip strength divide appendicular skeletal muscle mass ( asm ) . hypertension be define systolic/diastolic blood pressure ≥ 140/90 mmhg or self-reported diagnosis . logistic regression examine rms-hypertension association , and causal mediation analysis quantify fast glucose 's mediating role , and restrict cubic spline model be apply to explore potential non-linear relationship . result : nhanes ( n = 9 , 652 ; hypertension prevalence 30 . 0 % ) , rms be inversely associate hypertension quartile ( q2-q4 q1 : adjust or ( 95 % ci ) 0 . 82 , 0 . 78 , and 0 . 72 , respectively ) . mediation analysis show fast glucose partially mediate association , account 13 . 1 % association . charls ( n = 12 , 946 ; hypertension prevalence 42 . 1 % ) , similar trend be observe ( q2-q4 q1 : adjust or ( 95 % ci ) 0 . 91 , 0 . 76 , and 0 . 66 ) , but fast glucose partially mediate association , explain only 2 . 0 % association . restrict cubic spline model reveal significant nonlinearity charls ( p < 0 . 001 ) but not nhanes ( p = 0 . 921 ) . conclusion : study be first to examine partially mediate role fast blood glucose rms-hypertension relationship diverse population . rms be consistently associate low hypertension risk , vary degree glucose mediation cohort . finding support integrate rms assessment cardiovascular risk screening and highlight muscle strength potential target non-pharmacological prevention . give cross-sectional nature study , longitudinal research be need to clarify causal pathway and inform public health strategy .",Diabetology & metabolic syndrome,26/09/2025
10.1183/13993003.00745-2025,european respiratory society and american thoracic society guideline,"Shoemark A, Goutaki M, Kinghorn B, Ardura-Garcia C, Baz-Redón N, Chilvers M, Davis SD, De Brandt J, Dell S, Dhar R, Dixon L, Ferkol T, Hogg C, Legendre M, Leigh M, Lucas JS, Manion M, Rumman N, Toews I, Labonte V, Wee WB, Kouis P, Horani A","primary ciliary dyskinesia ( pcd ) be cause pathogenetic variant > 55 gene . pcd be associate early-onset chronic wet cough and rhinosinusitis , laterality defect , middle ear disease , and reduce fertility . clinical presentation be heterogeneous , and diagnosis often rely multiple test . american thoracic society ( ats ) and european respiratory society ( ers ) have previously develop separate guideline diagnosis . here , ers and ats member systematically review literature diagnostic tool use practice and develop unified evidence-based guideline pcd diagnosis use grade ( grading recommendations , assessment , development and evaluations ) methodology , and transparent process decision-make use evidence-to-decision ( etd ) framework . task force panel formulate three pico ( patient , intervention , comparison , outcomes ) question and three narrative question . accuracy high-speed video microscopy ( hsvm ) , immunofluorescence ( if ) , and nasal nitric oxide ( nno ) be compare reference test transmission electron microscopy ( tem ) and/or genetic . panel give strong recommendation use hsvm , , and nno adjunct test tem and/or genetic pcd diagnosis . however , adjunct test be suitable standalone test to diagnose pcd and single adjunct or reference test be suitable to exclude pcd . pursue genetic diagnosis be encourage implication management . panel emphasize test should meet minimum standard and propose evaluation patient referral centre experience diagnosis . pret probability base symptom should be consider interpret result .",The European respiratory journal,26/09/2025
10.1016/j.kint.2025.08.030,critical role transcription factor sox4 tubular epithelial cell,"Du H, Jiao B, Xing J, Yang D, Tran M, Wang P, Hu Z, Lefebvre V, Zhou D, Wang Y","introduction : chronic kidney disease ( ckd ) be widely prevalent health issue globally . striking pathological feature ckd be kidney fibrosis characterize excessive production and deposition extracellular matrix ( ecm ) . tubular epithelial cell ( tec ) dedifferentiation and fibroblast activation contribute pathogenesis kidney fibrosis . however , molecular mechanism underlie tec dedifferentiation and fibroblast activation be not fully understand . here , investigate role sry-box transcription factor 4 ( sox4 ) regulate tec dedifferentiation and fibroblast activation development ckd . methods : generate global , tec-specific , and fibroblast-specific sox4 knockout mouse . mouse be subject three preclinical model kidney fibrosis induce unilateral ureteral obstruction , ischemia-reperfusion injury , or high-dose folic acid to examine role sox4 tec dedifferentiation and fibroblast activation development kidney fibrosis . culture tec and fibroblast be employ to determine role and molecular mechanism sox4 regulate tec dedifferentiation and fibroblast activation vitro . result : sox4 be induce injure kidney but deficiency inhibit tec dedifferentiation , fibroblast activation and far impede development kidney fibrosis mouse . vitro , knockdown sox4 preserve epithelial phenotype and inhibit fibroblast activation induce transform growth factor-β1 ( tgf-β1 ) . mechanistically , sox4 facilitate tgf-β1-smad3 signal pathway to promote tec dedifferentiation and fibroblast activation . conclusion : finding identify sox4 critical factor tec dedifferentiation and fibroblast activation suggest sox4 may serve potential therapeutic target treatment ckd .",Kidney international,24/09/2025
10.1002/advs.202505469,gut microbial genetic variation prolongs host healthy longevity and remodels,"Wang L, Yang Z, Pang Y, Wu X, Zhang X, Zhu T, Ding X, Liu W, Zhou Y, Zhang P, Li Y, Zhu Z","microbial genetic variation play crucial role shape host-microbe interaction ; however , impact healthy aging remain largely unexplored . study investigate genetic variation gut-residing saccharomyce cerevisiae affect health and lifespan drosophila melanogaster . study identify 14 yeast mutant significantly extend lifespan d . melanogaster , 13 mutant enhance locomotor function aged fly and two mutant improve reproductive capacity . metabolomic and proteomic analysis reveal mutant yeast rejuvenate metabolic state age gut and alter protein level tissue gut . most protein at least two-fold change be upregulate . datum also highlight mitochondrial energy metabolism key anti-aging mechanism drive yeast . notably , terpenoid metabolite such ergosterol acetate show strong lifespan-extending effect and may influence energy metabolism . conclusion , finding establish strong link gut metabolic status and healthy aging , underscore significance microbial-host mitochondrial axis key mechanism gut microbe promote host health and longevity . furthermore , genetically engineer probiotic model organism offer promising potential strategy extend healthy lifespan , thus merit further investigation translational research model .","Advanced science (Weinheim, Baden-Wurttemberg, Germany)",26/09/2025
10.1038/s41557-025-01966-x,live-cell imaging fluorogenic radical-trappe antioxidant probe reveal,"Xu L, Zhang W, Sánchez Tejeda JF, Holovan D, McCain J, Lovell TC, Cosa G","ferroptosis be form cell death involve formation lipid peroxyl radical , potential therapeutic application . sensitivity to ferroptosis be expect to vary different organelle . to monitor real time onset and progression lipid peroxidation ferroptosis , here report lipophilic fluorogenic radical-trappe antioxidant , embed endoplasmic reticulum , lysosome , mitochondria and plasma membrane . show endoplasmic reticulum- and lysosome-embedde fluorogenic radical-trappe antioxidant be most effective protect cell death . onset lipid peroxidation happen endoplasmic reticulum , lipid hydroperoxide accumulate golgi-associated vesicle . disintegration structure spread lipid hydroperoxide intracellularly , act ' free radical ember ' . outward migration oxidize lipid plasma membrane , ultimate sink oxidized lipid , be record . result underscore golgi-associated structure site to regulate ferroptosis progression . work further position fluorogenic radical-trappe antioxidant valuable tool unravel dynamic subcellular progression ferroptosis .",Nature chemistry,26/09/2025
10.1016/j.neuropharm.2025.110700,ampk activation mitigate α-synuclein pathology and dopaminergic degeneration,"Kim Y, Lee JS, Son S, Park S, Oh H, Choi YK, Kim DE","parkinson 's disease ( pd ) be characterize oxidative stress , mitochondrial dysfunction , and pathological accumulation p-α-synuclein ( p-α-syn ) .",Neuropharmacology,26/09/2025
10.3390/ijms26189044,"gulf war illness , fibromyalgia , myalgic encephalomyelitis/chronic fatigue","Mantle D, Domingo JC, Golomb BA, Castro-Marrero J","gulf war illness ( gwi ) , fibromyalgia ( fm ) , myalgic encephalomyelitis/chronic fatigue syndrome ( me/cfs ) and long covid have distinct origin , article have review evidence disorder comprise group so-calle low-energy associate disorder overlap common symptom underlie pathology . particular , evidence mitochondrial dysfunction , oxidative stress , inflammation , immune dysregulation , neuroendocrine dysfunction , disrupt axis , apoptosis/ferroptosis and telomere shortening common feature pathogenesis disorder have be identify . give role coenzyme q10 ( coq10 ) promote normal mitochondrial function , antioxidant , antiinflammatory and antiapoptotic and antiferroptotic agent , be rationale supplementary coq10 management disorder . report benefit supplementary coq10 administration gwi , fm , me/cfs and long covid have be review ; potential benefit supplementary coq10 reduce telomere shortening and improve efficiency stem cell transfer relevant have also be identify promise therapeutic strategy disorder . review advance previous systematic review and consensus statement overlap similar symptom and underlie biological pathomechanism complex disorder .",International journal of molecular sciences,17/09/2025
11 [pii],splenic tuberculosis--case report .,"Cobelschi C, Maier A, Hogea MD, Gheorghiu AR, Toader I","author advance case patient age 42 , cardiovascular disorder be hospitalize non-specific , but persistent symptomatology : asthenia , fatigability , dyspnoea , night sweat . clinical ( splenomegaly ) , abdominal ultrasonographic ( splenic hypo-echogenic lesion ) and compute tomographic ( splenic hypo-dense lesion ) element lead splenic disorder , but association intra-thoracic and intra-abdominal adenopathies(ct reveal ) raise suspicion chronic lymphoproliferative syndrome . splenectomy open approach be perform and surprise come histopathology : splenic tuberculosis . clinical , diagnostic and therapeutic aspect tuberculosis splenic localization be present .","Chirurgia (Bucharest, Romania : 1990)",01/04/2016
10.7554/eLife.98221,drug repurposing approach reveal targetable epigenetic pathway plasmodium,"Maher SP, Bakowski MA, Vantaux A, Flannery EL, Andolina C, Gupta M, Antonova-Koch Y, Argomaniz M, Cabrera-Mora M, Campo B, Chao AT, Chatterjee AK, Cheng WT, Chuenchob V, Cooper CA, Cottier K, Galinski MR, Harupa-Chung A, Ji H, Joseph SB, Lenz T, Lonardi S, Matheson J, Mikolajczak SA, Moeller T, Orban A, Padín-Irizarry V, Pan K, Péneau J, Prudhomme J, Roesch C, Ruberto A, Sabnis SS, Saney CL, Sattabongkot J, Sereshki S, Suriyakan S, Ubalee R, Wang Y, Wasisakun P, Yin J, Popovici J, McNamara CW, Joyner C, Nosten FH, Witkowski B, Le Roch KG, Kyle DE","radical cure plasmodium vivax malaria must include elimination quiescent ' hypnozoite ' form liver ; however , only fda-approved treatment be contraindicate many vulnerable population . to identify new drug and drug target hypnozoite , screen repurposing , focused rescue , and accelerated medchem ( reframe ) library and collection epigenetic inhibitor p . vivax liver stage . library , identify inhibitor target epigenetic pathway as selectively active p . vivax and p . cynomolgi hypnozoite . include dna methyltransferase inhibitor as well several inhibitor target histone post-translational modification . immunofluorescence stain plasmodium liver form show strong nuclear 5-methylcystosine signal , indicate liver stage parasite dna be methylate . use bisulfite sequence , map genomic dna methylation sporozoite , reveal dna methylation signal most code gene . also demonstrate methylation level proximal promoter region as well first exon gene may affect , least partially , gene expression p . vivax . importance selective inhibitor target epigenetic feature hypnozoite be validate use mmv019721 , acetyl-coa synthetase inhibitor affect histone acetylation and be previously report as active p . falciparum blood stage . summary , datum indicate several epigenetic mechanism be likely modulate hypnozoite formation or persistence and provide avenue discovery and development improved radical cure antimalarial .",eLife,30/09/2025
10.1186/s13073-025-01529-2,adult genomic medicine : lesson multisite study 2700 patient .,"Bakur K, Hamid H, Alhaddad B, Alfadhel M, Alhashem A, Eyaid W, Alanzi T, Al Mutairi F, Alswaid A, Ababneh F, Al Ghamdi M, Mohamed S, Alaskar A, Alqahtani F, Alzaidan H, Al-Owain M, Faqeih EA, Mushiba AM, Alanazi R, Almoallem B, Alsaleh NS, Al Tala S, Alshammari M, Turkistani A, Gosadi G, Hakami F, Alobaid F, Al Rukban H, Alfaidi A, Ba-Abbad R, Almuqbil MA, Al-Boukai A, Alamri AS, Alshehri A, Sulaiman RA, Almontasheri A, Danish E, AlSagheir A, Aljeaid D, Al-Awam BS, Shawli A, Al-Otaibi M, Majdali WS, Azher ZA, Almannai M, Baalawi W, AlAbdi L, Benoukraf T, Alkuraya FS","background : clinical exome and genome sequencing have transform diagnostic workup patient genetic disorder . extensive body evidence support application clinical genomic approach pediatric patient stand stark contrast relative paucity evidence use adult population . here , describe large cohort date adult patient undergo clinical exome and genome sequence suspect genetic diagnosis . method : total 2763 adult patient ( 2529 family ) region saudi arabia be include cohort ( 2202 exome , and 561 genome ) . result : diagnostic rate be 38 . 9 % span 535 mendelian gene and reveal clinical diagnostic error 38 % patient positive report . structured feedback use c-guide demonstrate clinical utility 90 % positive case . consistent highly consanguineous nature local population , majority ( 61 % ) diagnose phenotype be recessive ( 94 . 6 % homozygous ) and founder variant account 85 % ( 414/487 ) variant . same population characteristic have also lead encounter extremely rare , even novel recessive disorder include highly penetrant novel rnf43-related hemochromatosis , nfxl1-related syndrome hyperlaxity , short stature , and kidney disease , as well autosomal recessive form typically dominant disorder . multilocus phenotype be observe 5 % case only 26 . 7 % be cause two recessive variant . 70 % molecular diagnosis encounter cohort be typically describe pediatric patient allow to observe highly unusual clinical presentation adult population . delay diagnosis also represent miss opportunity effective treatment many instance and note availability treatment 26 % diagnose condition . particular interest be patient monogenic disorder could be overlook common multifactorial adult disease ( e.g. , diabetes , dyslipidemia , stroke , chronic kidney disease , and dementia ) . finally , note opportunity deploy adult clinical genomic underrepresented population 45 . 5 % ( 373/819 ) encountered variant be completely absent gnomad . conclusion : result illustrate numerous benefit clinical genomics approach adult medicine and argue broad implementation currently practice .",Genome medicine,29/09/2025
10.1136/gutjnl-2025-335904,hypothesis-generate evaluation multi-armoured oncolytic hsv-1 ( vg161 ),"Shen Y, Jin X, Song W, Fang T, Li Y, Zhao Z, Liang X, Tan Q, Zhao R, Zhang Y, Jia W, Huang H, Wu T, Shi G, Zhang Z, Li E, Wei G, Jiang T, Wang Z, Yang Z, Lin D, Xia L, Guo S, Li J, Wei F, Shi X, Chen S, Tu C, Shou Z, Xie L, Zhang H, Zhou H, Lan P, Ding J, Chen W, Ye Y, Zhang X, Chen Y, Li X, Zhai Z, Hu W, Zhang X, Wang L, Sun X, Zhao Q, Hu X, Wang Y, Zhou Z, Kai J, Li J, Zhang W, Bai X, Liang T","background : intrahepatic cholangiocarcinoma ( icc ) be highly aggressive malignancy limited treatment option and poor prognosis , especially patient fail standard therapy . objective : to explore safety , efficacy and immunological mechanism novel edition oncolytic virus vaccination , vg161 , multiarmed oncolytic herpe simplex virus-1 express interleukin ( il)-12 , il-15 and program death-ligand 1 antagonist , patient advanced icc . design : pool analysis integrate datum two multicentre clinical study : phase dose-escalation study and phase iia exploratory study . 24 patient advanced icc receive ultrasound-guided intratumoral injection vg161 . multiomics analysis be perform longitudinal tumour biopsy to evaluate immune modulation . result : oncolytic virus therapy vg161 be well tolerate and show encourage antitumour activity , include improve overall survival second-line folfox chemotherapy , even most patient receive vg161 third-line or later therapy . notably , patient previously treat immune checkpoint inhibitor ( cpis ) experience enhance benefit . multiomics profiling longitudinal biopsy reveal significant remodelling immunosuppressive tumour microenvironment , proliferated infiltration antigen-presenting cell , cd8(+ ) t cell activation and m2-like macrophage depletion . single-cell and spatial transcriptomic identify epithelial and macrophage subpopulation ( epi-c2 and macro-c1qc ) potential biomarker response and resistance . conclusion : early-phase finding suggest vg161 elicits meaningful immune activation icc and support further investigation . induce direct oncolysis and multilayere immune activation , vg161 show clinical benefit heavily pretreate population and hold promise integration",Gut,29/09/2025
10.1007/s12223-025-01345-6,"β-glucan antiviral defense : mechanism , immune modulation , and therapeutic","Atoom AM, Abdulsahib WK, Jyothi SR, Nayak PP, Chauhan AS, Singla S, Polatova D, Sead FF, Yazdi F","β-glucans , naturally occur β-d-glucose polysaccharide fungus , yeast , bacteria , algae , and cereal , have emerge promise immunomodulatory agent antiviral defense . structural diversity-encompassing , 3 , β-1 , 6 , and , 4 linkages-underpin varied solubility , bioavailability , and biological activity , drive therapeutic potential . conventional antiviral target viral replication , β-glucan enhance host immunity activate innate and adaptive response receptor such dectin-1 , toll-like receptor , and complement receptor 3 , thereby stimulate macrophage , neutrophil , and natural killer cell to produce antiviral cytokine ( e.g. , interferon , interleukin ) and induce train immunity long-term protection . review explore β-glucans 's mechanism combat viral infection , include sars-cov-2 , hpv , hbv , influenza , and hiv , highlight direct antiviral effect ( e.g. , inhibit viral entry sulfated derivative ) , immune modulation ( e.g. , enhance t-cell response and antibody production ) , and inflammation control ( e.g. , mitigate cytokine storm ) . preclinical and clinical evidence underscore ability to reduce viral load , enhance vaccine efficacy , and support tissue repair , see hpv-related lesion . β-glucans also modulate gut microbiota , bolster mucosal immunity . promise outcome , challenge structural heterogeneity and limited large-scale trial persist . article outline therapeutic prospect β-glucan , emphasize potential safe and versatile adjunct to address emerge viral threat and enhance global health resilience .",Folia microbiologica,29/09/2025
10.1016/j.celrep.2025.116351,cd169(+ ) macrophage identify and eliminate tumor cell colorectal cancer,"Hu J, Guo F, Han C, Zhao Q, Yi H, Xu J, Jia H, Wu Y, Dong L, Kao X, Li G, Chen J, Zhang J, Huang Z","tumor-associated macrophage ( tam ) play key role tumor progression and therapy resistance . colorectal cancer ( crc ) , tam heterogeneity challenge macrophage-targeted therapy , certain antitumor macrophage subpopulation not yet fully characterize . study bridge gap identify distinct subset tumoricidal cd169(+ ) macrophage . increase infiltration cd169(+ ) macrophage be observe crc tissue , be significantly associate improved overall survival patient crc . delete cd169(+ ) macrophage genetically engineer mouse model ( mc38 orthotopic/ectopic and cd169(dtr/+)apc(min/+ ) intestinal adenoma ) accelerate tumor growth . integrated multi-omics datum and functional assay , include cell coculture model and animal experiment antibody blockade , reveal antitumor mechanism cd169(+ ) macrophage directly interact crc cell . interaction , mediate cd169/cd43 molecular engagement , lead tumor cell apoptosis high level factor-related apoptosis ligand ( fasl ) . result not only deepen understanding crc tumor microenvironment but also open avenue cancer immunotherapy target .",Cell reports,26/09/2025
10.1007/s00059-023-05179-1,"refined risk stratification , current treatment , and new therapeutic approach",Lange TJ,"2022 european society cardiology/european respiratory society ( esc/ers ) guideline pulmonary hypertension have introduce refine risk stratification to guide initial and subsequent treatment pulmonary arterial hypertension ( pah ) . risk stratification pah diagnosis still comprise three risk category ( low , intermediate , high ) and list new parameter . estimate 1‑year mortality be more 20 % high-risk patient diagnosis , initial triple-combination therapy include parenteral prostacyclin analogue be recommend group . other patient should receive dual-combination therapy endothelin receptor antagonist and phosphodiesterase‑5 inhibitor . however , approach initial combination therapy be only recommend classic pah , monotherapy follow regular follow-up and individualized therapy should be use patient cardiopulmonary comorbiditie . pah patient cardiopulmonary comorbiditie , be recommend to assess risk follow-up new 4‑strata classification , intermediate-risk group be split basis three noninvasive parameter . importantly , change intermediate-high intermediate-low risk have be show to be associate well prognosis . addition , recommendation treatment escalation become more precise addition prostacyclin receptor agonist or switch phosphodiesterase‑5 inhibitor soluble guanylate cyclase stimulator intermediate-low risk and proceed triple-combination therapy parenteral prostacyclin analogue already intermediate-high risk . sotatercept , first non-vasodilator pah treatment will become available near future to far enrich treatment option chronic and still severe disease .",Herz,01/08/2023
10.1073/pnas.2513120122,biliverdin reductase be major determinant protective nrf2 signal .,"Vasavda C, Kothari R, Ammal Kaidery N, Chakraborty S, Jamuna Tripathi S, Dhindsa RS, Ricco C, Shanmukha S, Saberi S, Lefler JE, Kothari P, Chaubey K, Snowman AM, Ostrowski MC, Barone E, Iyer LM, Aravind L, Sharma SM, Pieper AA, Thomas B, Snyder SH, Paul BD","biliverdin reductase ( bvra ) , terminal enzyme heme catabolism , generate neuroprotective and lipophilic antioxidant bilirubin . here , identify nonenzymatic role bvra redox regulation . phylogenetic , genetic , biochemical , and enzymatic assay , find bvra exert critical nonenzymatic antioxidant activity . transcriptomic analysis far reveal bvra physically and genetically interact nuclear factor erythroid-derive factor-like 2 ( nrf2 ) , major transcriptional regulator cellular redox signal . chip-seq and rna-seq analysis reveal bvra and nrf2 coordinate expression antioxidant gene , many be typically dysregulate neurodegenerative condition such alzheimer 's disease . thus , noncanonical",Proceedings of the National Academy of Sciences of the United States of America,7/10/2025
10.1001/jama.2025.16450,early intratracheal budesonide to reduce bronchopulmonary dysplasia extremely,"Ambalavanan N, Carlo WA, Nowak KJ, Wiener LE, Cosby SS, Bhatt AJ, Watterberg KL, Poindexter BB, Keszler M, D'Angio CT, Brion LP, Narendran V, Rau CA, Cotten CM, Laughon MM, Das A, Rysavy MA, Hibbs AM, Fuller J, Puopolo KM, Katheria A, Patel RM, Bermick JR, Laptook AR, Prelipcean I, Wyckoff MH, Moore R, Merhar SL, Ohls RK, Yoder BA, Perez M, Ghavam S, Meyer LR, Chock VY, DeMauro SB, Jackson WM, Handa D, Walsh MC","importance : extremely preterm infant be high risk bronchopulmonary dysplasia ( bpd ) and death . multiple small randomized clinical trial show combination budesonide surfactant compare surfactant alone reduce bpd or death . objective : to determine early intratracheal administration combination budesonide ( 0 . 25 mg/kg ) mix surfactant , compare surfactant alone , reduce physiologic bpd or death 36 week ' postmenstrual age extremely preterm infant . design , setting , and participant : double-masked randomized clinical trial be conduct april 2021 june 2024 17 center united states neonatal research network . infant 22 to 28 week ' gestation or 401 to 1000 g birth weight be enrol clinical decision to give surfactant , first dose surfactant be study drug ( prior surfactant be exclusion criterion ) . intervention : infant be randomly allocate 1 :1 to receive 1 to 2 dose budesonide + surfactant ( poractant alfa ) or surfactant alone endotracheal tube 50 hour birth . main outcomes and measures : primary outcome be physiologic bpd or death 36 week ' postmenstrual age . be 5 prespecifie secondary outcome and multiple prespecifie exploratory and safety outcome . result : trial be stop 641 infant enrol ( 55 . 3 % 1160 plan ; mean birth weight , 810 g [ sd , 256 g ] ; gestational age , 25 . 9 week [ sd , 1 . 9 week ] ) , interim analysis 50 % enrollment reach prespecified futility threshold . incidence bpd or death be 68 . 5 % budesonide + surfactant group and 67 . 9 % surfactant-alone group ( adjust relative risk [ rr ] , 1 . 00 [ 95 % ci , 0 . 90-1 . 11 ] ) . difference be note mortality ( 15 . 3 % 13 . 2 % ; adjusted rr , 1 . 13 [ 95 % ci , 0 . 78-1 . 64 ] ) or bpd survivor 36 week ' postmenstrual age ( 62 . 9 % 63 . 0 % ; adjusted rr , 0 . 99 [ 95 % ci , 0 . 87-1 . 12 ] ) . more infant receive budesonide + surfactant compare surfactant alone have hyperglycemia ( 66 . 7 % 49 . 8 % ; adjusted rr , 1 . 33 [ 95 % ci , 1 . 17-1 . 51 ] ) . conclusions and relevance : large multicenter trial , combination budesonide surfactant do not reduce risk bpd or death 36 week ' postmenstrual age extremely preterm infant . trial registration : clinicaltrials.gov identifi : nct04545866 .",JAMA,30/09/2025
10.1186/s40168-025-02186-8,microbiome heritage : maternal microbiome transmission impact next,"Delaroque C, Chassaing B","birth , infant 's intestine be colonize microorganism , initiate period rapid microbial expansion and major compositional maturation influence maternal and environmental factor . simultaneously , host 's intestinal environment exhibit unique characteristic facilitate critical interaction develop microbiome early-life window . early biological event have lasting effect health , foster immune tolerance environmental exposure or , conversely , increase susceptibility noncommunicable diseases-such allergy , obesity , and inflammatory bowel disease-if microbiome development be disrupt . review , summarize recent advance understand key stage microbiome development birth and explore change maternal environment-especially diet-as well maternal intestinal bacteria and derive molecule shape microbiome 's composition and function early-life , ultimately influence long-term health and disease risk . video abstract .",Microbiome,26/09/2025
10.3390/nu17182955,"vitamin , vascular health and disease .",Ayoub G,"vascular health rely proper function endothelial cell , regulate vascular tone , blood fluidity , and barrier integrity . endothelial dysfunction , often aggravate inadequate vitamin absorption , contribute spectrum clinical disorder , include cardiovascular disease , cerebrovascular disease , peripheral artery disease , age-related macular degeneration , lymphedema , and chronic venous insufficiency . b-group vitamin ( especially folate , or vitamin b9 ) , vitamin b12 , b6 , c , d , and e , be essential maintain endothelial function , support dna synthesis , regulate methylation , enhance cellular repair , mitigate oxidative stress and inflammatory signaling , and curtail vascular damage . folate be note central function one-carbon metabolism and convert homocysteine methionine , thereby reduce vascular toxicity . cover natural dietary source folate , synthetic folic acid , and biologically active form 5-methyl-(6s)-tetrahydrofolate ( l-5-mthf , l-methylfolate ) and 5-formyl-(6s)-tetrahydrofolate ( levoleucovorin ) . therapeutic strategy to address vascular health and prevent hyperhomocysteinemia order to preclude follow-on disorder include target vitamin supplementation , dietary improvement to ensure sufficient intake bioavailable nutrient form , and , certain clinical contexts , use active l-methylfolate or levoleucovorin ( drug product ) bypass metabolic conversion issue . evidence-based intervention aim to restore endothelial homeostasis , slow disease progression , and improve patient outcome variety disorder link poor vascular health .",Nutrients,15/09/2025
10.1126/sciimmunol.adp7092,group 2 innate lymphoid cell regulate nociceptive and gait function,"Deshpande D, Velleman L, Schmitz J, Forster PM, Schinke C, Boulekou S, Düsedau HP, Krug SM, Mertens T, Gao X, Figueiredo C, Jarick KJ, Plum T, Sterczyk N, Leclère PS, Helfrich S, Tappe-Theodor A, Kotsch K, Steffen J, Voehringer D, Duerr CU, Hauser AE, Artis D, Pitzer C, Dunay IR, Klose CSN","peripheral nervous system ( pns ) be involve nociception and gait . contribution pns-resident immune cell function be not fully understand . identify group 2 innate lymphoid cell ( ilc2s ) distinct immune cell population resident pns , unique gene profile facilitate neuron-ilc2 cross-talk . ilc2-deficient mouse display pns dysfunction ( hypersensitivity and gait anomaly ) . functional deficit be attribute structural abnormality sciatic nerve ilc2-deficient mouse . communicate dorsal root ganglion neuron interleukin-13 ( il-13 ) signal pathway to maintain nerve structure and pain threshold . loss share il-4/il-13 receptor ( il-4r/il-13r ) neuron result phenotype similar ilc2-deficient mouse . intrathecally administer il-13 rescue hypersensitivity and gait defect ilc2-deficient mouse , suggest signal pathway may be therapeutically important . work therefore identify function ilc2s regulate nerve structural integrity and nociceptive function pns .",Science immunology,26/09/2025
10.1002/anie.202517917,cleavable antibody-conjugate aβ specific immune exosome combination,"Ma M, Wang J, Zhong W, Li Z, Zhao Y","recent progress antibody-based immunotherapy alzheimer 's disease ( ad ) bring sense cautious optimism year setback . however , approach remain constrain suboptimal pharmacodynamic , modest clinical benefit , and pro-inflammatory adverse effect . here , develop β-secretase-responsive immunotherapeutic agent ( atexo-cl-aa ) synergistically target amyloid-β ( aβ ) and neuroinflammatory response , achieve heighten efficacy reduce side effect associate conventional antibody therapy . intranasal administration , atexo-cl-aa actively migrate ad brain . cleavage overexpressed β-secretase , atexo-cl-aa release aducanumab antibody ( aa ) and exosome derive aβ antigen-specific tregs ( atexo ) , jointly manage aβ and inflammatory microglia , thereby synergistically eradicate aβ and reduce pro-inflammatory response . ad mouse model , atexo-cl-aa demonstrate efficient brain accumulation , robust aβ removal , microglial normalization , neuroinflammation attenuation , and synaptic preservation , ultimately lead improve cognitive function . finding highlight atexo-cl-aa next-generation immunotherapeutic transcend limitation conventional antibody-based treatment ad .",Angewandte Chemie (International ed. in English),26/09/2025
10.1016/j.gie.2025.09.043,novel thin-needle knife high-pressure waterjet colorectal underwater,"de Sire R, Alfarone L, Capogreco A, Massimi D, Vadalà V, Brandaleone L, Spadaccini M, Alkandari A, Bhandari P, Rosch T, Hassan C, Maselli R, Repici A","background and aims : novel thin-needle knife high-pressure waterjet be develop to enhance endoscopic submucosal dissection ( esd ) term ease , speed , and safety . present first clinical result use new device . method : include consecutive colorectal underwater esd case 27 month two therapeutic endoscopy center . new knife ( hybridknife ® flex i-type , 1 . 5 mm ) be use examiner 's discretion and compare various conventional low-pressure waterjet knife . case treat new knife be match 1 :1 control use propensity score analysis base lesion size , location , morphology , vascular pattern , and operator experience . result : forty match pair be analyze . mean long axis vivo speciman be 47 . 2 mm ( sd 18 . 8) . dissection speed be significantly high high-pressure knife ( 36 . 7 mm(2)/min 28 . 2 ; p<0 . 0001 ) , r0 resection rate be comparable ( 97 . 5 % 95 % ; p=0 . 8) . benefit appear more pronounced less experienced operator and technically challenging lesion . three intraprocedural perforation occur control group only , one case post-endoscopic coagulation syndrome be observe group . conclusion : high-pressure thin-needle knife appear to improve dissection speed favorable efficacy and safety profile .",Gastrointestinal endoscopy,25/09/2025
10.1016/j.xcrm.2025.102369,chimeric hemagglutinin-based universal influenza mrna vaccine induce protective,"Styles TM, Akhtar A, Gu C, Neumann G, Muramatsu H, McPartlan JS, Talukder P, Gratz D, Stokdyk K, Turner HL, Ferguson JA, Rodriguez AJ, Loganathan M, Francis B, Abbad A, Chikh G, Tam YK, Qin ZS, Han J, Carreño JM, Ward AB, Chahal JS, Mandl CW, Pardi N, Kawaoka Y, Krammer F, Ahmed R, Amara RR","universal influenza vaccine elicit strong and lasting stalk-specific antibody response be advantageous . utilize nucleoside-modified mrna lipid nanoparticle ( mrna-lnp ) and unmodified self-amplifying mrna modify dendritic nanoparticle ( sam-mdnp ) , express chimeric hemagglutinin ( cha ) antigen to induce stalk-specific humoral immunity non-human primate pre-existing influenza virus immunity . mrna-lnp immunization induce strong stalk-specific bind antibody capable protect mouse lethal heterologous influenza virus challenge and bone marrow plasma cell ( bmpc ) persist to 8 month . sam-mdnp vaccine induce low humoral immunity , show strong innate activation . transcriptomic and cytokine analysis reveal more persistent induction interferon response , interleukin ( il)-1β signal , and il-6 production mrna-lnp group , correlate induction serum antibody response and bmpc . result identify transcriptional signature associate induction bmpc follow mrna vaccination and highlight utility cha-base mrna-lnp vaccine induce persistent stalk-directed protective antibody response .",Cell reports. Medicine,25/09/2025
10.3390/medicina61091569,"proton pump inhibitors ( ppis)-an evidence-base review indications , efficacy ,","Andrawes M, Andrawes W, Das A, Siau K","proton pump inhibitor ( ppi ) be most prescribed drug worldwide owe proven efficacy symptom control and mucosal healing acid-related disorder include gastroesophageal reflux disease ( gord ) , peptic ulcer disease , helicobacter pylori eradication , functional dyspepsia , and gastroprotection high-risk patient . however , long-term use approve indication be increasingly common and have raise safety concern . observational study link chronic ppi use myriad adverse outcome such enteric infection ( e.g. , clostridioides difficile ) , nutrient deficiency ( magnesium , vitamin b12 ) , osteoporotic fracture , chronic kidney disease , dementia , and gastric and colorectal cancer . causality be not always establish , association warrant cautious risk-benefit assessment patient receive prolonged therapy . current guideline advocate periodic review ongoing ppi use and emphasise deprescribe appropriate . strategy include dose reduction , on-demand or intermittent use , and switch h2-receptor antagonist , particularly patient non-erosive reflux disease or functional dyspepsia . tool national institute health and clinical excellence , american college gastroenterology , and canadian deprescribing network assist clinician identify candidate tapering or discontinuation . narrative review focus concept "" ppi stewardship "" provide evidence-based overview ppi indication , risk , and deprescribe strategy to promote appropriate , safe , and patient-centred use acid-suppressive therapy .","Medicina (Kaunas, Lithuania)",31/08/2025
10.3390/nu17183000,effect apple cider vinegar intake body composition humans type 2,"Castagna A, Ferro Y, Noto FR, Bruno R, Aragao Guimaraes A, Pujia C, Mazza E, Maurotti S, Montalcini T, Pujia A","background : apple cider vinegar ( acv ) be naturally ferment beverage potential metabolic health benefit ; however , effect weight loss remain controversial . systematic review and meta-analysis randomize control trial ( rcts ) be conduct to assess effect acv anthropometric measurement adult . method : perform systematic search pubmed , web science , scopus , and central march 2025 randomize control trial ( rcts ) adult ( ≥18 year ) evaluate effect acv ≥4 week body composition parameter . primary outcome include change body weight , bmi , waist circumference , and other anthropometric measure . risk bias be assess use revised cochrane risk-of-bias tool . result : 2961 report screen , 10 rct comprise total 789 participant be eligible inclusion meta-analysis . pooled result use random-effect model show daily acv intake significantly reduce body weight [ smd : -0 . 39 ; 95 % ci : -0 . 63 , -0 . 15 ; p = 0 . 001 ; i(2 ) = 62 % ] , bmi [ smd : -0 . 65 ; 95 % ci : -1 . 05 , -0 . 26 ; p = 0 . 001 ; i(2 ) = 83 % ] , and wc [ smd : -0 . 34 ; 95 % ci : -0 . 67 , -0 . 02 ; p = 0 . 04 ; i(2 ) = 61 % ] . however , significant effect acv be observe other body composition parameter analyze . sensitivity analyse exclude high-risk-of-bias study confirm robustness acv 's beneficial effect body weight and bmi . subgroup analysis suggest acv consumption significantly improve anthropometric parameter administer to 12 week , dose 30 ml/day , and adult be overweight , obese , or have type 2 diabetes . conclusion : overall , meta-analysis suggest acv supplementation may be promising and accessible adjunctive strategy short-term weight management adult excess body weight or metabolic complication .",Nutrients,19/09/2025
10.1186/s13075-025-03647-z,glycolysis-hif-1α axis induce il-1β macrophage rheumatoid arthritis .,"Jia Y, Li R, Huang L, Wu X, Zhao L, Yang H, You X, Fei Y","background : rheumatoid arthritis ( ra ) be aggressive , systemic autoimmune disease overactivate macrophage play critical role pathogenesis . study aim to explore potential role glycolytic reprogramme production proinflammatory cytokine macrophage ra . methods : seahorse assay be conduct ra or healthy control ( hc ) serum-treated human monocyte-derived macrophage ( hmdms ) to evaluate glycolysis level . rna sequence be perform to identify activate signal pathway and key molecule hmdm stimulate ra serum . proinflammatory cytokine and hypoxia-inducible factor 1α ( hif-1α ) be verify western blotting and quantitative polymerase chain reaction ( qpcr ) . result : find hmdm stimulate ra serum show high aerobic glycolysis level treat hc serum , high expression glycolysis-related gene , include hexokinase2 ( hk2 ) , pyruvate kinase l/r ( pklr ) , and phosphoglycerate kinase 1 ( pgk1 ) . furthermore , ra serum-treated macrophage exhibit high level interleukin-1 beta ( il-1β ) , and expression il-1β positively correlate hk2 . inhibition glycolysis 3-bromopyruvate ( 3brpa ) or hk2 knockdown significantly suppress il-1β production macrophage .",Arthritis research & therapy,26/09/2025
10.1186/s13024-025-00891-4,hippo signal pathway therapeutic target alzheimer 's disease .,"Chen D, Wigglesworth-Littlewood S, Gunn-Moore FJ","hippo signal pathway be well-known regulation organ size , cell proliferation , apoptosis , and cell migration and differentiation . recent study have demonstrate hippo signal also play important role nervous system , be involve neuroinflammation , neuronal differentiation , and neuronal death and degeneration . such , dysregulation hippo signal , particularly core kinase mst1/2 and lats1/2 , have begin to attract attention alzheimer 's disease ( ad ) field . here , discuss therapeutic potential target hippo pathway ad provide overview hippo signal regard function nervous system , evidence dysregulation ad patient and model , and recent study involve genetic or pharmacological modulation pathway ad .",Molecular neurodegeneration,26/09/2025
10.1016/j.chom.2025.09.006,microbiota extend reproductive lifespan mouse safeguard,"Munyoki SK, Goff JP, Reshke A, Wilderoter E, Mafarachisi N, Kolobaric A, Sheng Y, Mullett SJ, King GE, DeSchepper JD, Bookser RJ, Castro CA, Gelhaus SL, Grizotte-Lake M, Morrison KE, Zeleznik AJ, Hand TW, Brieño-Enriquez MA, Jašarević E","infertility affect one six people , but underlie mechanism remain unclear . show microbiota govern female reproductive longevity mouse . germ-free mouse have few primordial follicle , increase atresia , and ovarian fibrosis , lead small litter , few offspring , and short reproductive lifespan . germ-free mouse be bear similar ovarian reserve but display excessive activation , impaired progression , and increase atresia post-natal development . microbiome colonization critical post-natal window rescue premature ovarian reserve loss normalize follicle kinetic and gene expression pattern . change parallel increase short-chain fatty acid ( scfas ) , and scfa administration mitigate ovarian dysfunction germ-free mouse . similar oocyte dysfunction occur conventionally raise mouse feed high-fat diet , but additional dietary fiber help preserve oocyte quality and embryo competence . thus , host-microbe interaction shape female fertility , and microbiota-targeted intervention may offer strategy to address reproductive disorder .",Cell host & microbe,25/09/2025
10.1016/j.xcrm.2025.102374,foundational architecture ai agent healthcare .,"Liu F, Niu Y, Zhang Q, Wang K, Dong Z, Wong IN, Cheng L, Li T, Duan L, Li K, Li G, Hou TW, Fok M, Luo H, Chen X, Zhang K, Yin Y","medical ai agent represent transformative paradigm healthcare , distinguish traditional ai autonomy , adaptability , and ability to manage complex task . review introduce conceptual framework agent build four core component : planning , action , reflection , and memory . examine framework 's application key clinical domain , enhance diagnostic accuracy and personalize treatment guide robotic surgery and enable real-time patient monitoring . review critically analyze implementation challenge , include technical integration , clinician adoption , regulatory adaptation , and ethical consideration datum privacy and algorithmic bias . future direction be explore , include shift proactive , multi-agent collaborative system and visionary ai agent hospital concept . agent hold immense potential to revolutionize healthcare delivery improve efficiency and patient outcome , successful and equitable integration hinge navigate profound technical , ethical , and regulatory hurdle .",Cell reports. Medicine,26/09/2025
10.1038/s42255-025-01355-1,non-apoptotic caspase-8-meteorin pathway hepatocyte promote mash fibrosis .,"Wang X, Moore MP, Shi H, Xiao Y, Zhang J, Faccioli LAP, Hu Z, Khalid S, Saleheen D, Stupack DG, Kisseleva T, Soto Gutierrez A, Lazar MA, Tabas I","metabolic-dysfunction-associate steatohepatitis ( mash ) be lead cause chronic liver disease , but incomplete understanding mash-induced liver fibrosis have limit therapeutic option . here show hepatocyte caspase-8 drive mash fibrosis apoptosis-independent mechanism . hepatic caspase-8 expression correlate liver fibrosis both human and experimental mash , and hepatocyte-specific caspase-8 deletion male mouse mash suppress liver fibrosis and hepatic stellate cell ( hsc ) activation affect hepatocyte apoptosis . mechanistic study show caspase-8-yy1 pathway hepatocyte induce secretory meteorin ( metrn ) , activate hsc c-kit-stat3 pathway . meteorin expression be increase human and male mouse mash liver and decrease deletion hepatocyte caspase-8 mash mouse and human and mouse primary hepatocyte . genetic restoration hepatocyte meteorin hepatocyte-caspase-8-delete mash mouse restore hsc activation and liver fibrosis silence hepatocyte meteorin lower liver fibrosis . finding reveal therapeutically targetable pathway promote mash fibrosis involve non-apoptotic function caspase-8 and newly discover hsc activator , meteorin .",Nature metabolism,26/09/2025
10.1038/s41564-025-02120-6,nasal staphylococcus aureus carriage promote depressive behaviour mouse,"Xiang G, Wang Y, Ni K, Luo H, Liu Q, Song Y, Miao P, He L, Jian Y, Yang Z, Chen T, Xu K, Sun X, Shen Z, Ji C, Zhao N, He M, Pan Y, Luo Y, Hu J, Otto M, Li M","human microbiome have pronounce impact human physiology and behaviour . unique anatomical connection brain , role nasal microbiome neurological disease be understudied . here , use human datum and experiment mouse , show nasal staphylococcus aureus be link depression . nasal microbiome analysis reveal positive correlation depression score and s . aureus abundance patient depression and healthy control . metabolomic nasal cavity show decrease sex hormone , estradiol and testosterone patient depression control . nasal microbiota transplant patient reproduce depression-like behaviour mouse differential abundance s . aureus . further homology and mutational analysis uncover s . aureus sex hormone-degrade enzyme , 17b-hydroxysteroid dehydrogenase ( hsd12 ) , degrade testosterone and estradiol mouse , lead low level dopamine and serotonin murine brain . finding reveal nasal commensal influence depressive behaviour and provide insight nose-brain axis .",Nature microbiology,22/09/2025
10.3348/kjr.2025.0416,state-of-the-art imaging antibody-drug conjugate treatment advanced,"Eid S, Al-Yousef AS, Kim KW, Yoon S, Nawfal R, Bellmunt J, Choueiri TK, Krajewski KM","antibody-drug conjugate ( adcs ) have revolutionize treatment landscape advanced bladder cancer , particularly vedotin and trastuzumab deruxtecan , target nectin-4 and human epidermal growth factor receptor 2 ( 2 ) , respectively . adc have show substantial efficacy , improve survival patient have progress chemotherapy and immunotherapy . imaging play pivotal role adc-based therapy , extend diagnosis and staging assess treatment response , detect recurrence , and evaluate toxicity . computed tomography ( ct ) , multiparametric magnetic resonance imaging ( mri ) , and fluorodeoxyglucose positron emission tomography ( fdg-pet ) be widely use purpose . efficacy adcs , resistance mechanism such antigen loss and payload resistance continue to pose challenge , necessitate development next-generation adcs . response assessment largely rely response evaluation criteria solid tumors ( recist ) 1 . 1 , grow interest multiparametric mri evaluate complete response bladder lesion . additionally , imaging help identify adc-related toxicity , include pneumonitis and gastrointestinal complication . radiologist must be aware evolve therapeutic and imaging paradigm to optimize patient management . integration imaging adc-base treatment require multidisciplinary approach to improve outcome . review highlight critical role image adc therapy and underscore need radiologist to adapt advancement bladder cancer treatment .",Korean journal of radiology,01/10/2025
10.1038/s41370-017-0006-9,exposure to acute air pollution and risk bronchiolitis and otitis medium,"Girguis MS, Strickland MJ, Hu X, Liu Y, Chang HH, Kloog I, Belanoff C, Bartell SM, Vieira VM","aim be to estimate association acute increase particulate matter diameter 2 . 5 µm or less ( pm(2 . 5 ) ) concentration and risk infant bronchiolitis and otitis medium massachusetts birth bear 2001 2008 . case-crossover study include 20 , 017 infant bronchiolitis and 42 , 336 otitis medium clinical encounter visit . pm(2 . 5 ) be model use satellite , remote sensing , meteorological and land use datum . apply conditional logistic regression to estimate odd ratio ( or ) and confidence interval ( ci ) 10-µg/m(3 ) increase pm(2 . 5 . ) assess effect modification to determine most susceptible subgroup . infant bronchiolitis risk be elevate pm(2 . 5 ) exposure 1 day ( or = 1 . 07 , 95 % ci = 1 . 03-1 . 11 ) and 4 day ( or = 1 . 04 , 95 % ci = 0 . 99-1 . 08 ) prior clinical encounter , but not 7 day . non-significant association otitis medium vary depend lag . preterm infant be substantially increase risk bronchiolitis 1 day prior clinical encounter ( or = 1 . 17 , 95 % ci = 1 . 08-1 . 28 ) and otitis medium 4 and 7 day prior clinical encounter ( or = 1 . 09 , 95 % ci = 1 . 02-1 . 16 and or = 1 . 08 , 95 % ci = 1 . 02-1 . 15 , respectively ) . conclusion , preterm infant be most susceptible infant bronchiolitis and otitis medium associate acute pm(2 . 5 ) exposure .",Journal of exposure science & environmental epidemiology,01/06/2018
10.1177/21501319251379740,healthcare utilization unchanged control arm randomized clinical,"Gongloor P, Nadeem S, Yu X, Raji M, Mena KD, Vaughan EM","background : low-income setting , clinical trial participation may influence participant behavior , include control group . increase access care and heighten health awareness trial enrollment could lead altered behavior , phenomenon know hawthorne effect , may obscure true intervention impact ; however , effect remains poorly study low-income environment . aim : to conduct secondary exploratory analysis healthcare utilization control participant randomized clinical trial ( rct ) . methods : retrospectively analyze electronic medical record control arm ( n = 26 ) rct involve low-income hispanic adult type 2 diabete receive care community clinic . randomization 12-month diabetes education intervention or usual care ( control ) , participant undergo on-site measurement hba1c , blood pressure , and weight . healthcare utilization control participant be compare year before and study , include type exposure : provider visit and other service ( eg , order ) . result : total healthcare utilization be similar pre-period ( 11 . 9 exposures/year ) and study-period ( 11 . 4 exposures/year ; p = .93 ) , significant change visit type . be significant difference fit mean monthly visit pre- and study-period ( p = .93 ) , nor time ( p = .89 ) . conclusion : exploratory study find evidence hawthorne effect healthcare utilization control participant . may suggest consistent healthcare behavior , may also highlight important public health concern : individual low-income setting may lack resource to translate increase awareness health-related action . large study be need to far elucidate behavioral pattern low-income population .",Journal of primary care & community health,01/12/2025
10.1186/s40001-025-03108-y,identification hub gene and immune infiltration lyme disease reveal,"Dong Y, Liu M, Luo Y, Chen Y, Chen X, Liu X, Cai X, Yang F, Song C, Zhou G","introduction : lyme disease ( ld ) , cause spirochete borrelia burgdorferi ( bb ) , be multisystem disorder early symptom such erythema migrans and late manifestation include arthritis and neuroborreliosis . molecular mechanism drive tissue damage and inflammatory dysregulation ld remain incompletely characterize . give central role peripheral blood mononuclear cell ( pbmc ) orchestrate immune response , aim to identify optimal feature gene ( ofgs ) pbmc associate ld pathogenesis and delineate immune infiltration pattern use integrated bioinformatic . methods : transcriptomic dataset ( gse42606 , gse68765 , gse103481 ) be retrieve geo . differential expression analysis identify ld-relate gene . weighted gene co-expression network analysis ( wgcna ) screen disease-associated module . feature selection be perform svm-recursive feature elimination ( svm-rfe ) , least absolute shrinkage and selection operator ( lasso ) regression , and random forest ( rf ) to pinpoint ofg . immune cell infiltration be quantify use cibersort , follow correlation analysis ofg and immune subset . single-gene gene set enrichment analysis ( gsea ) be perform to explore functional association ofg . biological pathway link ofg be infer single-sample gsea ( ssgsea ) . diagnostic utility be assess roc curve and nomogram modeling . finally , use rt-qpcr to confirm bioinformatics result . result : study identify 174 deg ld patient , 156 gene locate "" turquoise "" module wgcna , exhibit most robust correlation clinical characteristic . , kiaa1199 turn to be unique ofg , select three distinct machine learn methodology , possess exceptional diagnostic potential . single-gene gene set enrichment analysis show kiaa1199 be strongly correlate multiple immune-related pathway . furthermore , rt-qpcr validate candidate gene expression thp-1 cellular model . conclusion : conclusion , study integrate wgcna and machine learn methodology to identify one core gene associate ld pbmc gene expression datum : kiaa1199 . predictive model construct use gene demonstrate robust diagnostic accuracy , provide basis further research host immune response and development new diagnostic method .",European journal of medical research,26/09/2025
10.1021/acs.biochem.5c00468,molecular mechanisms underlie construction ciliary doublet microtubules .,"Chen Z, Ou G","motile cilia and flagella be complex microtubule-based organelle essential cell motility , fluid flow , and sensory function . core organelle lie doublet microtubule ( dmt ) , specialized structure consist a-tubule and b-tubule serve scaffold axonemal complex . recent advance have uncover intricate architecture dmt , highlight inner and outer junction protein , luminal scaffold , and interdoublet linker critical structural stability and function . study model organism such chlamydomonas , tetrahymena , and caenorhabditis elegan have identify conserved regulator orchestrate dmt assembly . parallel insight human genetic reveal mutation dmt-associated protein underlie subset case primary ciliary dyskinesia and other ciliopathie . review synthesize current understanding dmt biogenesis molecular , structural , and disease perspective , illuminate coordinate assembly ensure ciliary function and disruption lead human disease .",Biochemistry,29/09/2025
10.1186/s12951-025-03676-5,neutrophil membrane-encapsulated nanosonosensitizer ultrasound-reinforced,"Du C, Wang S, Cheng Y, Li J, Zhang Y, Li Z, Zhu B, Wu Z, Zhang X, Zhou L","pneumonia cause pseudomonas aeruginosa ( p . aeruginosa ) infection remain formidable clinical challenge persistent biofilm formation and intrinsic antibiotic resistance , exacerbate bacterial iron homeostasis stabilize biofilm architecture and neutralize oxidative stress . herein , present fe/tnt@nm , biomimetic nanosonosensitizer activate ultrasound ( us ) to dismantle biofilm dual extracellular-intracellular mechanism . nanosonosensitizer feature iron-doped titanate nanotube ( fe/tnt ) core encapsulate neutrophil membrane ( nm ) . us irradiation , fe/tnt@nm generate sonodynamic reactive oxygen specie ( ros ) extracellularly and enhance fe(3 + ) release . ion catalyze fenton reaction extracellularly to amplify chemodynamic effect and disrupt intracellular iron homeostasis , trigger bacterial ferroptosis . nm coating enable immune evasion and biofilm-targeted delivery . ultrasound-reinforced ferroptosis strategy synchronize extracellular ros storm intracellular iron dyshomeostasis , achieve dual-action biofilm dismantling and eradication drug-resistant p . aeruginosa . murine pneumonia model , fe/tnt@nm suppresse biofilm and mitigate pulmonary injury . converge biomimetic targeting , sonodynamic-chemodynamic cascade , and ultrasound-augmented ferroptosis , nanosonosensitizer present paradigm-shifting approach to combat refractory biofilm infection and antibiotic resistance .",Journal of nanobiotechnology,26/09/2025
10.1016/j.ejmech.2025.118197,bufalin target inhibit occurrence and metastasis oral cancer,"Zhang H, Sun F, Ding X, Dong X, Yang F, Chen R, Zhang X, Wen Z, Su M, Yu C, Wang Y, Yang L, Li B","oral cancer ( oc ) be malignant tumor arise mucosal tissue oral cavity and be commonly treat surgical resection . bufalin be one most potent anticancer monomer extract bufonis venenum and have be show to have anticancer effect wide range cancer , include lung cancer , gastric cancer and hepatocellular carcinoma . however , be few study role bufalin oc and lack clear target . moreover , bufalin be more difficult to apply clinically cardiac glycoside effect . notably , oral cancer be facial tumor , and bufalin act first oral tissue and do not need to go blood circulation to reach heart , greatly mitigate risk and overcome major limitation . effect bufalin proliferation and migration oral cancer cell be detect cck-8 assay , wound heal assay , transwell assay and western blot . potential direct interact protein bufalin be screen human proteomic microarray , and bind site be predict use molecular docking technology . vitro and vivo biological experiment be perform to verify role bufalin direct interact protein and mechanism bufalin target protein to inhibit oc metastasis . result show bufalin inhibit proliferation and migration oc cell line cal-27 , hn30 and",European journal of medicinal chemistry,23/09/2025
10.3390/molecules30183823,vitamin d associate exercise can be use promising tool,"Farina G, Crescioli C","neurodegenerative disease , include parkinson 's disease , alzheimer 's disease , multiple sclerosis , and huntington 's disease , represent unmet medical and social need . still , definitive cure exist illness , hence therapeutic approach molecule able to prevent/downtone/modify disease seem highly attractive . remarkably , high risk neurodegenerative disease be associate low vitamin d level . vitamin d be multifaceted molecule able to target critical neuroinflammatory process underlie neurodegeneration , act genomic or rapid signaling . narrative review aim to focus vitamin d 's potential to be optimal neuroprotective molecule , base ability to target and counteract aberrant biomolecular process involve neuroinflammation/neurodegeneration . noticeably , exercise can potentiate vitamin d 's protective effect anti-inflammatory action exert share biomolecular target . thus , vitamin d be not strictly drug , could be potentially allocate therapeutic approach neurodegenerative disease combination adapt exercise , well early intervention . topic complexity concern dose supplementation and datum discrepancy trial be address . urgent demand be to test and clarify vitamin d efficacy and safety , combine or not exercise , clinical setting .","Molecules (Basel, Switzerland)",21/09/2025
10.3390/molecules30183814,efficacy melatonergic receptor agonists use clinical practice,"Żełabowski K, Pichowicz W, Skowron I, Szwach J, Biedka K, Wesołowski M, Błaszczyk K, Ziobro O, Petrov W, Kukula-Koch W, Chłopaś-Konowałek A","insomnia be common and complex disorder , root dysregulation circadian rhythm , impaired neurotransmitter function , and disturbance sleep-wake homeostasis . conventional hypnotic such benzodiazepine and z-drug be effective short term , use be limit high potential dependence , cognitive side effect , and withdrawal symptom . contrast , melatonergic receptor agonists-melatonin , ramelteon , tasimelteon , and agomelatine-represent pharmacologically target alternative modulate mt1 and mt2 receptor , be pivotal regulation circadian timing and sleep initiation . clinical evidence support efficacy agent reduce sleep onset latency , extend total sleep duration , and re-aligne disrupt circadian rhythm , particularly old individual and patient non-24 h sleep-wake disorder . notably , agomelatine offer additional antidepressant property selective antagonism 5-ht(2c ) receptor micromolar concentration . contrast , agonistic activity melatonergic receptor be observe low sub-nanomolar range , illustrate complexity drug 's interaction human body . compound review demonstrate generally favorable safety and tolerability profile . accumulate evidence highlight select medicinal plant , such chamomilla , lemon balm , black cumin , valeriana , passionflow and lavender , may exert relevant hypnotic or anxiolytic effect , thus complement melatonergic strategy management insomnia . structured narrative review present comprehensive analysis molecular pharmacology , receptor affinity , signal pathway , and clinical outcome associate melatonergic agent . also examine functional interplay serotonergic , gabaergic , dopaminergic , and orexinergic system involve arousal and sleep regulation . comparative synthesis pharmacokinetic and neurochemical mechanism , work aim to inform development evidence-based strategy treatment insomnia and circadian rhythm sleep-wake disorder .","Molecules (Basel, Switzerland)",19/09/2025
10.1038/s41467-025-63592-y,vivo crispr screen head and neck cancer reveal uchl5,"Fu C, Saddawi-Konefka R, Chinai JM, Kim SY, Kammula AV, Perera JJ, Jiang A, Tiwari P, Kistler EN, Tang S, Luna SM, Colvin KJ, Dubrot J, Anderson S, Fetterman RA, Chuong CL, Lane-Reticker SK, Cheruiyot CK, Muscato AJ, Alipour Z, Adkins DR, Griffin GK, Bernstein BE, Egloff AM, Yates KB, Chernock RD, Gutkind JS, Uppaluri R, Manguso RT","recurrent/metastatic head and neck squamous cell carcinoma ( hnscc ) be aggressive malignancy significant unmet need enhance immunotherapy response give current modest efficacy . here , perform vivo crispr screen hnscc mouse model to identify immune evasion gene . identify several regulator immune checkpoint blockade ( icb ) response , include ubiquitin c-terminal hydrolase 5 ( uchl5 ) . loss uchl5 tumor increase cd8(+ ) t cell infiltration and improve icb response . uchl5 deficiency attenuate extracellular matrix ( ecm ) production and epithelial-mesenchymal-transition ( emt ) transcriptional program , contribute stromal desmoplasia , histologic finding describe associate reduce anti-pd1 response human hnscc . col17a1 , collagen highly and specifically express hnscc , mediate part uchl5-mediated immune evasion . finding suggest unappreciated role uchl5 promote emt hnscc and highlight ecm modulation strategy to improve immunotherapy response .",Nature communications,29/09/2025
10.2147/JIR.S514838,microbiome-gut-brain axis : implication link inflammatory bowel,"Tian CM, Yang MF, Kong C, Luo D, Yue NN, Zhao HL, Zhang Y, Lu JP, Liang YJ, Song Y, Wei DR, Yao J, Wang LS, Li DF","brain and gastrointestinal tract be closely interconnect important sensory organ process signal both environmental and internal cue . recent study have show dysregulation gut microbiota inflammatory bowel disease activate gut immune system . cross-talk mechanism gut-brain axis be implicate development neuropsychiatric disorder such autism , depression , anxiety , alzheimer 's disease , and parkinson 's disease . here , discuss molecular mechanism involve signal gut-brain axis , include immune and neuroendocrine system , intestinal permeability , microbial composition , and bacterial extracellular vesicle . focus link specific inflammatory bowel disease , microbial genera and psychiatric and neurological disorder , and propose result preclinical and clinical study open possibility target gut microbiota to treat neuropsychiatric disorder be alter gut interaction .",Journal of inflammation research,01/01/2025
10.1038/s41580-025-00899-0,unified framework function endoplasmic reticulum exit site .,"Farhan H, Raote I, Campelo F, Ge L, Hirschberg K, Forrester A, Zanetti G, Lippincott-Schwartz J, Pastor-Pareja JC, Perez F, Saito K, Malhotra V","endoplasmic reticulum exit site ( eres ) be specialize , ribosome-free er subdomain serve dynamic portal copii-mediate export protein er . role secretory pathway , eres be implicate diverse process , include autophagy and maturation lipid droplet , highlight functional plasticity . eres integrate cargo load , membrane tension and spatial cue to remodel architecture and function real time . roadmap synthesize current knowledge biogenesis , structural diversity and regulatory logic eres . highlight key unanswered question field , particularly concern eres integrate signal to coordinate protein trafficking vary cellular state . finally , propose multidisciplinary framework - leverage advance high-resolution imaging , synthetic reconstitution and computational modelling - to delineate principle govern function and plasticity eres . understand mechanism hold significant potential develop targeted therapeutic strategy disease link traffic dysfunction .",Nature reviews. Molecular cell biology,29/09/2025
10.1016/j.devcel.2025.09.004,lmo3-expresse peri-isthmus progenitor cell sustain renewal and repair,"Jiang D, Zhu G, Zhang Y, Wang J, Qian N, Jin Z, Sun Q, Yu H, Tang K, Cai T, Wang F, Xi R","intestinal telocyte reside immediately intestinal epithelium exert niche-supporting role intestinal stem cell and progeny . be heterogeneous cell compartmentalize crypt-villus axis , but mechanism govern maintenance telocyte population remain unclear . here , identify distinct population subepithelial mesenchymal cell develop mouse embryo , mark lim domain only 3 ( lmo3 ) , cellular origin post-natal intestinal telocyte . lmo3(+ ) cell emerge prior villus formation embryonic day 13 . 5 , and birth , progressively acquire spatial confinement intestinal isthmus region , persist long-lived , slow-cycling cell , supply peri-villus and peri-crypt telocyte . far , show lmo3(+ ) cell respond rapidly to tissue damage , becoming activate to promote repair telocyte niche . therefore , quiescent and damage-responsive progenitor cell population mark lmo3 maintain intestinal telocyte niche .",Developmental cell,26/09/2025
10.1038/s41392-025-02391-9,ninjurin-1 mediate cell lysis and detrimental inflammation panoptosis,"Xu Y, Zheng Y, Liu Y, Wei C, Ren J, Zuo W, Gu R, Liu H, Deng X, Liu Y, Shang X, Ge W, Li Z, Huang Y, He D, Shen X, Wang Z, Lyu C, Wang Z, Mu Y, Zhang Z, Wu H, Li H, Cao B","influenza virus ( iav ) induce zbp1-mediate panoptosis , form lytic inflammatory cell death characterize concurrent activation pyroptosis , necroptosis and apoptosis pathway . ninjurin-1 ( ninj1 ) be recently identify mediator plasma membrane rupture but function diversely different type cell death . however , little be know role ninj1 iav-induce panoptosis and viral pneumonia . here , report iav infection trigger increase expression ninj1 , then oligomerize and mediate cell lysis infect macrophage . deficiency ninj1 prevent plasma membrane rupture and release damp and il-1β affect progression cell death . activation single panoptosis pathway be sufficient to trigger oligomerization ninj1 and robust cell lysis . accordingly , only panoptosis pathway be concurrently block could oligomerization ninj1 , cell death , and cell rupture be prevent . ablation ninj1 vivo also alleviate iav-induced lung injury and mortality . furthermore , reveal association ninj1 upregulation and poor outcome patient covid-19 . collectively , finding indicate pivotal role ninj1 immunopathology iav infection and potential bioindicator disease severity and prognosis viral pneumonia and viral sepsis .",Signal transduction and targeted therapy,23/09/2025
10.1016/j.cell.2025.09.004,functional rna splitting drive evolutionary emergence type v crispr-cas,"Jin S, Zhu Z, Li Y, Zhang S, Liu Y, Li D, Li Y, Luo Y, Cheng Z, Zhao KT, Gao Q, Yang G, Li H, Liang R, Zhang R, Qiu JL, Zhang YE, Liu JG, Gao C","transposon-encode tnpb nuclease give rise to type v crispr-cas12 effector multiple independent domestication event . system use different rna molecule guide dna targeting : transposon-derived right-end rnas ( rernas or omega rnas ) tnpb and crispr rnas type v crispr-cas system . however , molecular mechanism bridge transposon activity and crispr immunity remain unclear . identify trancs ( transposon-crispr intermediate ) derive distinct is605- or is607-tnpb lineage . trancs utilize crispr rnas and rernas direct dna cleavage . cryoelectron microscopy ( cryo-em ) structure latranc lawsonibacter sp . closely resemble isdra2 tnpb complex ; however , single-molecule rerna , latranc guide rna be functionally split tracrrna and crrna . engineered rna split isdra2 tnpb enable activity crispr array . finding indicate functional rna splitting be primary molecular event drive emergence diverse type v crispr-cas system transposon .",Cell,29/09/2025
10.1038/s43587-025-00961-8,elastin-derived extracellular matrix fragment drive aging innate immune,"Yi J, Wang Y, Sui H, Chen Z, Ye T, Zhong Y, Qian J, Wu B, Huang J, Tian T, Bao F, Chen X, Xiao X, Wang J, Hu J, Xie Y, Zhang H, Jin P, Xia X, Yao X, Chen Y, Yin Z, Shen W, Zhou J, Zou X, Liu H, Ouyang H","role cell systemic aging have be systematically investigate , role extracellular matrix ( ecm ) and degradation have be largely overlook . herein , show serum content elastin- , hyaluronic acid- and fibronectin-derived fragment be positively correlate age . elastin-derived fragment exhibit most potent lifespan-shortening effect mouse and positive correlation various age indicator human cohort ( n = 1 , 068 ) . mechanistically , vgvapg oligopeptide ( e-motif ) elastin-derived fragment activate monocyte and macrophage neu1 , component elastin receptor complex , consequently cause inflammatory response . therapeutically , neu1 inhibitor extend lifespan to 17 % wild-type naturally aged mouse and alleviated aging-related phenotype wild-type mouse , immune-humanized mouse and pig . study uncover degrade ecm act circulate driver aging , provide anti-aging intervention strategy focus particular elastin fragment signal .",Nature aging,29/09/2025
10.3389/fnut.2025.1657587,trajectory health condition predict cardiovascular disease risk,"Li W, Liu T, Hu Y, Zhou H, Liu Y, Zeng H, Zhang Y, Zhang C, Li K, Hu Z, Chen P, Wang H, Xie B, Zhong X","background : most previous study have focus association health condition measure single time point and risk cardiovascular disease ( cvd ) , evidence regard impact long-term trajectory health condition be limited . study aim to construct model health condition trajectory and to evaluate association cvd risk and predictive value . method : study include 2 , 512 participant age 45 year and old china health and retirement longitudinal study ( charls ) , be follow 2011 2018 . trajectory multimorbidity status , activity daily living ( adls ) limitation , body roundness index ( bri ) , pain , sleep duration , depressive symptom , and cognitive function be identify use latent class growth model ( lcgms ) . cox regression model be use to assess association trajectory and incident cvd . ten machine learning ( ml ) algorithm be apply to evaluate predictive capacity different variable group cvd . additionally , shapley additive explanation ( shap ) value be use to interpret predictor importance and direction machine learning model . result : distinct high-risk trajectory physical and psychological health be independently associate increase cvd risk . high risk cvd be observe moderate-ascending ( hr = 1 . 42 , 95 % ci : 1 . 08-1 . 89 ) and high-ascending ( 3 . 01 , 2 . 16-4 . 20 ) trajectory multimorbidity status ; high-ascending trajectory adls limitation ( 2 . 58 , 1 . 87-3 . 56 ) ; high-stable trajectory bri ( 1 . 67 , 1 . 03-2 . 70 ) ; moderate-ascending ( 1 . 51 , 1 . 07-2 . 12 ) and high-ascending ( 2 . 28 , 1 . 56-3 . 35 ) trajectory pain ; moderate-descending ( 1 . 51 , 1 . 09-2 . 10 ) , low-ascende ( 1 . 70 , 1 . 22-2 . 38 ) , and high-posterior-ascending ( 2 . 54 , 1 . 69-3 . 82 ) trajectory depressive symptom ; and low-ascending trajectory sleep duration ( 1 . 33 , 1 . 02-1 . 74 ) . notably , model base trajectory health condition achieve high predictive performance variable group ( catboost auc = 0 . 740 ) , shap analysis confirm trajectory multimorbidity status , bri , and adls limitation be most influential predictor . conclusion : long-term deterioration both physical and psychological health be strongly associate increase cvd risk , highlight importance early intervention and continuous health monitoring .",Frontiers in nutrition,01/01/2025
10.1016/j.phymed.2025.157307,dihydroartemisinin inhibit histone lactylation yap1 to act ' hot ',"Gao Y, Gong Y, Song X, Xiong Y, Lu J, Yang Y, Gong Y, Du Z, Wang S, Jia R, Gong P, Shi X","background : hepatocellular carcinoma ( hcc ) be characterize ' cold ' tumor microenvironment ( tme ) , limit efficacy immune checkpoint inhibitor ( ici ) . previous study , demonstrate dihydroartemisinin ( dha ) could disrupt immunosuppressive tme and delay hcc progression . purpose : study aim to explore precise mechanism underlie shift tme immunosuppressive immunostimulatory state . methods : construct hcc subcutaneous allograft mice model to investigate in vivo antitumor effect dha . far perform single-cell rna sequence ( scrna-seq ) and multiplex immunohistochemistry ( mihc ) to analyze immune dynamic dha-induced tme transition hcc . use ncg mouse ( lack t , b , and nk cell ) , balb/c nude mouse ( lack t cell ) , and cd8(+ ) t cell-deplete mouse , assess antitumor effect dha hcc depend immune function and determine key role t cell antitumor immunity . additional downstream mechanism be explore use yap1 knockdown hcc cell and liver-specific yap1 knockout mice technique such western blot , immunofluorescence ( if ) , metabolic flux analysis , co-immunoprecipitation ( co-ip ) , chemokine chip , and flow cytometry ( fcm ) . result : observe dha transform tme hcc immune-cold immune-hot state increase abundance and proportion t cell , nk cell , tam , and dcs . notably , dha be find to enhance proportion ifn-γ(+ ) cd8(+ ) t cell tme hcc-beare mouse , and therapeutic effect be dependent cd8(+ ) t cell . result suggest dha could suppress histone lactylation ( kla ) and acetylation ( kac ) hcc cell inhibit yap1 . mechanistically , dha reduce lactate transport , thereby decrease lactate accumulation tme , lower p300/cbp catalytic activity , and enhance deacetylation effect hdac1-3 . finding reveal new mechanism dha , metabolic change and epigenetic regulation , remodel tme hcc . additionally , combination strategy involve dha and anti-pd-1 therapy demonstrate potential to reshape cold hcc tme inhibition yap1-lactylation positive feedback loop . conclusion : study confirm dha inhibit histone kla hcc cell yap1 inhibition , shift tme immune-cold immune-hot state . moreover , dha enhance anti-hcc immune response dependent cd8(+ ) t cell , thereby sensitize anti-pd-1 therapy . novel finding position dha promising strategy optimize anti-pd-1 therapy hcc , warrant further clinical application study .",Phytomedicine : international journal of phytotherapy and phytopharmacology,23/09/2025
10.1002/alz.70726,alzheimer 's disease diagnostic progression be associate cerebrovascular,"Edwards NC, Lao PJ, Alshikho MJ, Ericsson OM, Rizvi B, Petersen ME, O'Bryant S, Flores-Aguilar L, Simoes S, Mapstone M, Tudorascu DL, Janelidze S, Hansson O, Handen BL, Christian BT, Lee JH, Lai F, Rosas HD, Zaman S, Lott IT, Yassa MA, Gutierrez J, Wilcock DM, Head E, Brickman AM","introduction : have few vascular risk factor , people down syndrome ( ds ) have mri evidence cerebrovascular disease ( cvd ) and neuroinflammation worsen alzheimer 's disease ( ad ) severity . investigate marker cvd and inflammation be associate ad-relate diagnostic progression people ds . methods : include 149 participant ( mean age [ sd ] = 44 . 6 [ 9 ] ) alzheimer 's biomarkers consortium-down syndrome have two ( n = 24 ) or three follow-up visit ( n = 125 ) . derive white matter hyperintensity ( wmh ) volume and plasma biomarker ( glial fibrillary acidic protein [ gfap ] , amyloid beta [ aβ]42/aβ40 , hyperphosphorylated tau-217 [ p-tau217 ] , and neurofilament light [ nfl ] ) concentration baseline and examine association progression clinical diagnosis . result : high baseline wmh volume and high gfap be associate great likelihood diagnostic progression . combine wmh and gfap p-tau217 improve clinical conversion classification accuracy ad biomarker alone . individual evidence amyloidosis , both wmh and gfap be associate clinical progression . discussion : ds , marker cvd and inflammation be independently and synergistically associate clinical ad progression . highlight : high baseline white matter hyperintensity ( wmh ) volume and plasma glial fibrillary acidic protein ( gfap ) concentration be associate high likelihood progress cognitively stable either mild cognitive impairment or clinical alzheimer 's disease down syndrome . wmh volume and gfap concentration discriminate progress and do not . model include independent and interactive effect wmh and gfap more accurately discriminate participant progress diagnostically do not . individual evidence amyloid pathology be more likely to progress also have elevate wmh or gfap .",Alzheimer's & dementia : the journal of the Alzheimer's Association,01/10/2025
10.1089/rej.2012.1389,protective effect ginger root extract alzheimer disease-induced behavioral,"Zeng GF, Zhang ZY, Lu L, Xiao DQ, Zong SH, He JM","aim study be to assess ability traditional chinese medicinal ginger root extract ( gre ) to prevent behavioral dysfunction alzheimer disease ( ad ) rat model . rat ad model be establish operation ( op ) rat be treat one-time intra-cerebroventricuiar injection amyloid β-protein ( aβ ) and continuous gavage aluminum chloride day 4 week . gre be administer intra-gastrically rat . 35 day , learning and memory be assess rat . brain section be process immunohistochemistry and hematoxylin & eosin ( h&e ) and nissl stain . latency to show significant memory deficit be short group receive op high dose gre ( hg)(op+hg ) group receive op low or moderate dose gre ( lg , mg)(op+lg , op+mg ) ( p<0 . 05 ) . expression superoxide dismutase ( sod ) and catalase ( cat ) op+mg and op+lg group be up-regulate compare op+hg group ( p<0 . 05 ) . rat op+hg group have low level nuclear factor-κb ( nf-κb ) , interleukin-1β ( il-1β ) , and malondialdehyde ( mda ) expression rat op+mg and op+lg group ( p<0 . 05 ) . experiment demonstrate administration gre reverse behavioral dysfunction and prevent symptom rat model .",Rejuvenation research,01/04/2013
10.1038/s41586-025-09541-7,ribonucleotide incorporation mitochondrial dna drive inflammation .,"Bahat A, Milenkovic D, Cors E, Barnett M, Niftullayev S, Katsalifis A, Schwill M, Kirschner P, MacVicar T, Giavalisco P, Jenninger L, Clausen AR, Paupe V, Prudent J, Larsson NG, Rogg M, Schell C, Muylaert I, Lekholm E, Nolte H, Falkenberg M, Langer T","metabolic dysregulation can lead inflammatory responses(1 , 2 ) . imbalanced nucleotide synthesis trigger release mitochondrial dna ( mtdna ) cytosol and innate immune response cgas-sting signalling(3 ) . however , nucleotide deficiency drive mtdna-dependent inflammation have not be elucidate . here show nucleotide imbalance lead increase misincorporation ribonucleotide mtdna age-dependent renal inflammation mouse model lack mitochondrial exonuclease mgme1(4 ) , various tissue aged mouse and cell lack mitochondrial i-aaa protease yme1l . similarly , reduce deoxyribonucleotide synthesis increase ribonucleotide content mtdna cell-cycle-arrested senescent cell . lead mtdna release cytosol , cgas-sting activation and mtdna-dependent senescence-associate secretory phenotype ( sasp ) , can be suppress exogenously add deoxyribonucleoside . result highlight sensitivity mtdna to aberrant ribonucleotide incorporation and show imbalance nucleotide metabolism lead age- and mtdna-dependent inflammatory response and sasp senescence .",Nature,24/09/2025
10.1016/j.clinph.2020.11.036,influence unfused cranial bone magnetoencephalography signal human,"Lew S, Hämäläinen MS, Ahlfors SP, Okada Y","objective : to clarify effect unfused cranial bone magnetoencephalography ( meg ) signal early development . method : simulation study , compare meg signal spherical head model circular hole mimic anterior fontanel same head model fontanel different head and fontanel size vary skull thickness and conductivity . result : fontanel have small effect accord three index . sum difference signal sensor array fontanel , example , be < 6 % sum fontanel . however , fontanel effect be extensive dipole source deep brain or fontanel large fontanel . effect be comparable magnitude tangential and radial source . skull thickness significantly increase effect , skull conductivity have minor effect . conclusion : meg signal be weakly affect fontanel . however , effect can be extensive and significant radial source , thick skull and large fontanel . fontanel effect can be intuitively explain concept secondary source fontanel wall . significance : minor influence unfused cranial bone simplifie meg analysis , but should be consider quantitative analysis .",Clinical neurophysiology : official journal of the International Federation of,01/03/2021
10.1161/HYPERTENSIONAHA.112.190991,influence high glycemic index and glycemic load diet blood pressure,"Gopinath B, Flood VM, Rochtchina E, Baur LA, Smith W, Mitchell P","aim to prospectively examine association glycemic index and glycemic load food consume and dietary intake carbohydrate , sugar , fiber , and principal carbohydrate-containing food group ( eg , bread , cereal , and sugary drink ) change blood pressure adolescence . total 858 student age 12 year baseline ( 422 girl and 436 boy ) be examine 2004-2005 2009-2011 . dietary datum be assess validate semiquantitative food frequency questionnaire . blood pressure be measure use standard protocol . girl , adjust age , ethnicity , parental education , parental history hypertension , baseline height , baseline blood pressure , change body mass index , and time spend physical and sedentary activity , 1-sd ( 1-sd = 7 . 10 g/d ) increase baseline dietary intake total fiber be associate 0 . 96- , 0 . 62- , and 0 . 75-mmhg decrease mean systolic ( p = 0 . 02 ) , diastolic ( p = 0 . 01 ) , and arterial blood pressure ( p = 0 . 002 ) , respectively , 5 year later . girl , 1-sd increase dietary glycemic index , glycemic load , carbohydrate , and fructose be concurrently relate increase 1 . 81 ( p = 0 . 001 ) , 4 . 02 ( p = 0 . 01 ) , 4 . 74 ( p = 0 . 01 ) , and 1 . 80 mm hg ( p = 0 . 03 ) systolic blood pressure , respectively , > 5 year . significant association carbohydrate nutrition variable and blood pressure be not observe boy . excessive dietary intake carbohydrate , specifically high glycemic index/glycemic load food , could adversely influence blood pressure , particularly girl , fiber-rich diet may be protective elevated blood pressure adolescence .","Hypertension (Dallas, Tex. : 1979)",01/06/2012
10.1016/j.jhep.2025.09.016,"phase ii integris-psc trial bexotegrast , αvβ6/αvβ1 integrin inhibitor ,","Hirschfield GM, Kowdley KV, Trivedi PJ, Eksteen B, Hameed B, Vincent C, Chen T, Goel A, Reddy KG, Orman E, Joshi D, Lefebvre ÉA, Schaub JR, An MC, Clark A, Barnes CN, Pencek R, Thorburn D, Montano-Loza AJ, Schramm C, Bowlus CL, Trauner M, Levy C","background & aims : transform growth factor-β signal activate α(v)β(6 ) and α(v)β(1 ) integrin drive liver fibrosis primary sclerosing cholangitis ( psc ) . study investigate safety and exploratory pharmacodynamic bexotegrast ( pln-74809 ) , oral , once-daily inhibitor α(v)β(6 ) and α(v)β(1 ) integrin , participant psc and liver fibrosis . method : phase 2 , double-blind , dose-ranging study , 117 participant psc be randomize 3 :1 to receive once-daily oral bexotegrast or placebo 3 cohort ( 40 mg or placebo 12 week [ part 1 ] ; 80 mg , 160 mg , or placebo 12 week [ part 2 ] ; and 320 mg or placebo ≤40 week [ part 3 ] ) . primary endpoint be incidence treatment-emergent adverse event ( teae ) . exploratory pharmacodynamic endpoint include change alkaline phosphatase value , enhance liver fibrosis ( elf ) score , neoepitope-specific n-terminal pro-peptide type iii collagen level , liver stiffness measurement , magnetic resonance imaging ( mri ) measure use gadoxetate , and itch numeric rating scale . result : total 117 participant receive bexotegrast ( 40 mg [ n=22 ] , 80 mg [ n=21 ] , 160 mg [ n=21 ] , 320 mg [ n=27 ] ) or placebo ( n=30 ) . bexotegrast be well tolerate , similar rate teae pool bexotegrast and placebo group ( 72 . 7 % and 70 . 0 % ) . teae be mild to moderate , and serious teae relate to study drug be observe . numerically less pharmacodynamic progression be observe bexotegrast elf score , pro-c3 , and mri assessment week 12 compare placebo . pharmacodynamic result week 24 show limited change week 12 mri parameter continue to improve . conclusion : bexotegrast be well tolerate participant psc and liver fibrosis to 40 week numerically less progression observe exploratory pharmacodynamic marker . trial registration number : nct04480840 primary source funding : pliant therapeutics , inc. impact and implication : primary sclerose cholangitis ( psc ) be rare cholestatic disease unknown etiology . currently , be unmet medical need safe and effective therapy capable halt or reverse progression psc . phase 2 study participant psc and suspect liver fibrosis , bexotegrast , oral , once-daily , dual selective inhibitor α(v)β(6 ) and α(v)β(1 ) integrin , have favorable safety and tolerability profile . study support target integrin-mediated transform growth factor-β activation potential therapeutic approach psc .",Journal of hepatology,26/09/2025
10.1001/jamanetworkopen.2025.34485,sglt2 inhibitors and external genital infection male patients type 2,"Cheng TH, Lin KC, Chuang AT, Cheng MC, Shao SC, Lin SJ, Lin TY, Tsai YS, Lai EC, Hu CY, Wu KY","importance : new medication type 2 diabetes ( t2d ) control , such sodium-glucose inhibitor ( sglt2is ) and glucagon-like peptide-1 receptor agonist ( glp-1ras ) , have emerge . however , us food and drug administration have warn potential risk fournier gangrene , severe genital infection associate sglt2i use . objective : to determine comparative risk male external genital infection ( megi ) adult male patient t2d treat sglt2is . design , setting , and participant : population-based cohort study analyze taiwan 's national health insurance research database be conduct to evaluate megi risk adult male patient t2d newly treat sglt2is january 1 , 2009 , and december 31 , 2020 . patient newly treat glp-1ras be choose same period active-comparator group , and propensity score inverse probability treatment weighting be apply to balance baseline characteristic 2 treatment group . datum analysis be conduct february 2023 and april 2025 . exposures : treatment sglt2is or glp-1ras . main outcomes and measures : primary outcome be incidence megi , identify use international classification diseases , tenth revision , clinical modification diagnosis code . to examine result consistency , subgroup analysis base age ( old or young 60 year ) , diabete severity ( insulin use or not ) , and kidney function be conduct . result : study include 239 757 patient ; 224 360 initiate sglt2is ( mean [ sd ] age , 58 . 4 [ 12 . 3 ] year ) and 15 397 initiate",JAMA network open,2/09/2025
10.1002/mco2.70411,cholesterol 25-hydroxylase enhances myeloid-derived suppressor cell ( mdsc ),"Zhou D, Chen Y, Liu X, He J, Shen L, He Y, Zhang J, Zhou Y, Zhang N, Xu Y, Lei J, Ren R, Zhao H, Zeng X, Li Y","myeloid-derived suppressor cell ( mdsc ) represent significant immunosuppressive population tumor microenvironment colorectal cancer ( crc ) . activity have be strongly associate reprogramming cholesterol metabolism , underlie mechanism remain unclear . to investigate , generate myeloid-specific cholesterol 25-hydroxylase ( ch25h ) knockdown mouse and differentiate bone marrow cell wild-type ( wt ) or ch25h ( f/f ) lyz2(cre ) mouse mdsc , subsequently treat 25-hydroxycholesterol ( 25hc ) . immune function be evaluate use flow cytometry , western blotting , and real-time polymerase chain reaction ( pcr ) . finding indicate ch25h and metabolite 25hc be significantly upregulate",MedComm,01/10/2025
10.1007/s12282-025-01783-7,global mapping artificial intelligence application breast cancer,"Nguyen THT, Jeon S, Yoon J, Park B","background : artificial intelligence ( ai ) have become increasingly integral various aspect breast cancer care , include screening , diagnosis , and treatment . study aim to critically examine application ai breast cancer care continuum to elucidate key research development , emerge trend , and prevalent pattern . method : english article and review publish 1988 and 2024 be retrieve web science database , focus study apply ai breast cancer research . collaboration country be analyze use co-authorship network and co-occurrence mapping . additionally , cluster analysis use latent dirichlet allocation ( lda ) be conduct topic modeling , linear regression be employ to assess trend research output time . result : total 8 , 711 publication be include analysis . united states have lead research apply ai breast cancer care continuum , follow china and india . recent publication have increasingly focus utilization deep learning and machine learning ( ml ) algorithm automated breast cancer detection mammography and histopathology . moreover , integration multi-omic datum and molecular profiling ai have emerge significant trend . however , research application robotic and ml technology surgical oncology and postoperative care remain limited . overall , volume research address ai early detection , diagnosis , and classification breast cancer have markedly increase past five year . conclusion : rapid expansion ai-related research breast cancer underscore potential impact . however , significant challenge remain . ongoing rigorous investigation be essential to ensure ai technology yield evidence-based benefit diverse patient population , thereby avoid inadvertent exacerbation exist healthcare disparity .","Breast cancer (Tokyo, Japan)",29/09/2025
10.3390/healthcare13182259,real-world safety concerns tirzepatide : retrospective analysis faer datum,"Almansour HA, Thaibah HA, Alfarhan M, Al-Qahtani SA, Khardali AA, Alshammari TM","background : tirzepatide ( mounjaro or zepbound ) , dual glp-1/gip receptor agonist , be approve type 2 diabete and weight management . efficacy , real-world safety datum remain limited . study analyze post-marketing adverse event ( aes ) associate tirzepatide use fda adverse event reporting system ( faer ) to identify emerge safety concern . method : faer report 2022 q1 2025 be analyze . disproportionality analysis ( proportional reporting ratio [ prr ] , report odd ratio [ ror ] , empirical bayes geometric mean [ ebgm ] , and information component [ ic ] ) be perform to detect safety signal . report be stratify year , demographic , and ae type , focus case tirzepatide be primary suspect . result : 65 , 974 report , majority originate u . s . ( 96 % ) , middle-aged female ( 40-59 year ; 67 % ) most frequently affect . incorrect dose administration be top ae , increase 8-fold 1248 ( 2022 ) 9800 ( 2024 ) , strong risk signal ( ror 22 . 15 , 95 % ci ( 20 . 75-23 . 65 ) , and ror 23 . 43 , 95 % ci ( 22 . 82-24 . 05 ) , respectively , and prr 16 . 80 , 95 % ci ( 15 . 74-17 . 93 ) , and prr 17 . 62 , 95 % ci ( 17 . 16-18 . 09 ) , respectively ) . other common ae include injection-site reaction ( e.g. , pain [ 5273 case 2024 ] ) , gastrointestinal issue ( nausea [ 3602 2024 ] ) , and off-label use . class-relate aes ( e.g. , decrease appetite and blood glucose fluctuation ) be also report . conclusion : tirzepatide be associate significant dosing error , injection-site reaction , and gastrointestinal ae real-world use . rise trend report underscore need enhanced provider and patient education , clear dose guideline , and proactive monitoring . further research be warrant to explore causative factor and optimize risk mitigation strategy .","Healthcare (Basel, Switzerland)",9/09/2025
10.1371/journal.pone.0332876,statin effect arrhythmogenic cardiomyopathy disease progression ( search ):,"Sommariva E, Lippi M, Bruttini F, Cannata F, Baggiano A, Schiavone M, Salina G, Sabatino M, Vettor G, Sicuso R, Pizzamiglio F, Ribatti V, Maragna R, Carbucicchio C, DeLuca F, Catto V, Iezzi A, Salè EO, Valeri Y, Barbarossa A, Caiazza M, Monda E, Frisso G, Borrelli F, Gasperetti A, Turco A, De Luca L, Corino VDA, Galotta A, Bonomi A, Pompilio G, Pontone G, Muratori M, Limongelli G, Lombardi R, Casella M, Tondo C","arrhythmogenic cardiomyopathy ( acm ) be inherit cardiac disorder predispose affected individual , especially young patient , to malignant arrhythmia , sudden cardiac death , and heart failure . disease be characterize myocardial atrophy and fibro-fatty replacement , predominantly affect right ventricle . current pharmacological treatment primarily aim to alleviate symptom address arrhythmias and heart failure . approach be often complement invasive intervention such implantable cardioverter defibrillator ( icds ) and radiofrequency ablation . however , none strategy effectively halt disease progression , highlight urgent need novel disease-modifying therapy . recently demonstrate elevated plasma level oxidize low-density lipoprotein ( oxldl ) correlate more advanced stage acm patient . moreover , treatment atorvastatin , reduce oxldl level , prevent disease manifestation mouse model acm . base finding , hypothesize statin may attenuate disease progression acm patient not only lipid-lowering effect , but also pleiotropic action such antioxidant , anti-inflammatory , and autonomic modulation . to test hypothesis , design search ( statin effect arrhythmogenic cardiomyopathy ) , investigator-initiated , multicenter , prospective , randomize , double-blind , placebo-controlled clinical trial , aim evaluate efficacy atorvastatin prevent acm progression ( nct06922994 ) . total 102 patient meet acm diagnostic criterion will be enrol and randomize 1 :1 ratio to receive either atorvastatin 80 mg/die or placebo 18 month . primary outcome will be change right ventricular global longitudinal strain , sensitive echocardiographic measure ventricular function , baseline 18 month . secondary outcome will include change arrhythmic burden , electrocardiography parameter , additional structural and functional cardiac index , and circulate biomarker . tertiary and exploratory outcome include validation risk score acm progression and identification variable predict good responder to atorvastatin . participant will undergo comprehensive evaluation baseline , 9 month , and 18 month , include cardiology visit , echocardiography , electrocardiography , blood testing , icd or loop recorder interrogation , and cardiac magnetic resonance imaging ( enrollment and 18 month only ) . additional safety assessment and telephone follow-up will be conduct study to monitor treatment adherence and potential adverse event . search trial be expect to generate first clinical evidence efficacy atorvastatin slow acm progression , thereby address major unmet therapeutic need . finding will shape design future large-scale study and may pave way novel , disease-modifye treatment strategy to improve outcome and quality life patient acm .",PloS one,01/01/2025
10.1016/j.diabres.2025.112924,glp-1 receptor agonist and sarcopenia : weight loss cost ? brief narrative,"Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N","glucagon-like peptide-1 receptor agonist ( glp-1 ras ) and dual agonist target glp-1 and glucose-dependent insulinotropic polypeptide receptor ( glp-1/gip ras ) be establish therapy type 2 diabetes mellitus ( t2dm ) and obesity . however , be evidence treatment agent may lead significant loss muscle mass , potentially result sarcopenia or sarcopenic obesity . brief narrative review explore complex relationship glp-1 base therapy and muscle health . study have link glp-1 ra and dual glp-1/gip ras significant reduction lean mass , and sarcopenia . however , preclinical evidence suggest agent can attenuate skeletal muscle atrophy , improve muscle function , and enhance mitochondrial health . moreover , limited clinical datum indicate potential role preserve muscle mass certain condition . management include optimise diet , targeted exercise , and novel pharmacological intervention , such blockade growth differentiation factor-8 ( gdf8 ) and activin a ( acta ) . measure hold potential to preserve muscle mass and to improve patient outcome . further research be warrant to clarify mechanism and to evaluate combination therapy aim prevent sarcopenia patient receive glp-1 ra .",Diabetes research and clinical practice,27/09/2025
10.1177/17562848251375844,efficacy and safety risankizumab moderate-to-severe crohn 's disease : first,"Chung CS, Chang CH, Kuo CJ, Chou JW, Huang TY, Hsu WH, Chang CW, Le PH","background : crohn 's disease ( cd ) remain challenging condition , especially patient moderate-to-severe disease . risankizumab ( rzb ) , anti-il-23p19 monoclonal antibody , have show efficacy clinical trial . however , real-world datum ( rwd ) asian population be limited . objectives : to assess effectiveness and safety risankizumab asian patient cd . design : multicenter cohort study . method : study enrol adult patient moderate-to-severe cd receive risankizumab september 2024 and may 2025 taiwan . efficacy be assess week 4 , 8 , and 12 use cd activity index ( cdai ) , patient-reported outcomes-2 ( pro2 ) , and inflammatory bowel disease ( ibd)-disk score . safety outcome and treatment response prior biologic exposure , include ustekinumab ( ust ) , be evaluate . result : forty-nine patient ( mean age 41 . 5 year , 69 . 4 % male ) be include . clinical response rate be 53 . 1 % , 75 . 5 % , and 91 . 8 % week 4 , 8 , and 12 , respectively ; clinical remission be achieve 12 . 2 % , 22 . 4 % , and 42 . 9 % . pro2 remission reach 53 . 5 % week 12 . cdai and ibd-disk score improve week 4 , 8 , and 12 statistical significance ( p < 0 . 0001 ) . transmural healing be observe 16 . 3 % patient week 12 . clinical remission week 12 be consistent regardless prior ustekinumab exposure ( expose 36 . 36 % naïve 44 . 74 % , p = 0 . 630 ) or biologic-naïve status ( expose 36 . 84 % naïve 63 . 63 % , p = 0 . 119 ) . severe adverse event be report , but mild event include headache and transient liver enzyme elevation ( 2 . 04 % ) . conclusion : risankizumab may demonstrate significant short-term efficacy and favorable safety real-world treatment moderate-to-severe cd asian cohort . long-term datum be need to confirm sustained outcome and guide optimal use diverse cd population .",Therapeutic advances in gastroenterology,01/01/2025
10.1016/j.lanwpc.2025.101684,pan-asian consortium treatment and research als ( pactals ) guideline,"Vucic S, Shahrizaila N, Kano O, Menon P, Agustini S, Kulkantrakorn K, Atchayaram N, Lee YC, Prado MB Jr, Ng KWP, Chai J, Son B, Talman P, Nghia HTT, Tuan LTQ, Shibuya K, Izumi Y, Atsuta N, Henderson RD, Cui L, Liu M, Ohnmar O, Rabani R, Hong YH, Sung JJ, Fan D, Raykar V, Kuwabara S, Kim SH, Sobue G, Kiernan MC","pan-asian consortium treatment and research als ( pactals ) guideline be develop management amyotrophic lateral sclerosis ( als ) patient live asia-pacific country , take consideration ethnic , racial and economic diversity region . majority patient reside low-income ( limited-resource setting ) and middle-income country . grading recommendations assessment , development , and evaluation ( grade ) methodology be utilise development pactals management guideline . nine broad research question , divide section , be address . evidence be derive exist cochrane review , systematic review , meta-analysis , and randomize control trial ( rct ) consensus evidence be limited . recommendation be provide diagnostic pathway , use disease modifying therapy , appropriateness multidisciplinary care model , management respiratory dysfunction , communication and nutrition , address symptom affect quality life , manage cognitive , behavioural and emotional symptom as well appropriate implementation palliative care service and address end-of-life issue . pactal guideline provide much-needed framework management als patient live asia-pacific region . management guideline will be update treatment landscape evolve and evidence novel management approach become available .",The Lancet regional health. Western Pacific,01/09/2025
10.1126/sciadv.ady5876,polymerase-associated factor 1 complex modulate growth-defense tradeoff,"Guo Y, Li C, Liu Y, Mao H, Zhang Y, Genschik P, Wang L, Yan S","plant have evolve sophisticated mechanism to balance growth and defense . evolutionarily conserve polymerase-associated factor 1 complex ( paf1c ) play multiple role transcription . here , show paf1c regulate growth-defense tradeoff repress defense gene expression arabidopsis . loss paf1c lead increase expression defense gene , enhance disease resistance , but compromise growth . mechanistically , paf1c bind defense gene , interact histone deacetylase , such hda6 , to promote histone deacetylation , thereby repress defense gene expression . plant immune hormone salicylic acid ( sa ) promote interaction paf1 and sa receptor npr1 , function e3 ubiquitin ligase to mediate polyubiquitination and degradation paf1 . genetically , loss paf1 suppress immune defect npr1 mutant , support notion paf1 function downstream npr1 . collectively , study identify npr1-paf1c-hda6 module regulate growth-defense tradeoff .",Science advances,26/09/2025
